
<html lang="en"     class="pb-page"  data-request-id="68845e4e-ab00-45a5-81f8-818010c9be44"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00723"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthetic Modification within the “RPRL” Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma Degradation" /></meta><meta name="dc.Creator" content="Shaun M. K.  McKinnie" /></meta><meta name="dc.Creator" content="Wang  Wang" /></meta><meta name="dc.Creator" content="Conrad  Fischer" /></meta><meta name="dc.Creator" content="Tyler  McDonald" /></meta><meta name="dc.Creator" content="Kevin R.  Kalin" /></meta><meta name="dc.Creator" content="Xavier  Iturrioz" /></meta><meta name="dc.Creator" content="Catherine  Llorens-Cortes" /></meta><meta name="dc.Creator" content="Gavin Y.  Oudit" /></meta><meta name="dc.Creator" content="John C.  Vederas" /></meta><meta name="dc.Description" content="Apelin is an important mammalian peptide hormone with a range of physiological roles, especially in the cardiovascular system. The apelinergic system is a promising target for treatment of disease,..." /></meta><meta name="Description" content="Apelin is an important mammalian peptide hormone with a range of physiological roles, especially in the cardiovascular system. The apelinergic system is a promising target for treatment of disease,..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 7, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00723" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00723" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00723" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00723" /></link>
        
    
    

<title>Synthetic Modification within the “RPRL” Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma Degradation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00723" /></meta><meta property="og:title" content="Synthetic Modification within the “RPRL” Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma Degradation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0012.jpeg" /></meta><meta property="og:description" content="Apelin is an important mammalian peptide hormone with a range of physiological roles, especially in the cardiovascular system. The apelinergic system is a promising target for treatment of disease, but this remains to be realized due to rapid proteolysis of apelin-derived peptides by proteases, including neprilysin (NEP). The synthetic analogues modified within the NEP degradation site (“RPRL” motif) showed improved in vitro proteolytic stability while maintaining receptor-binding affinities, with three candidate peptides retaining full cardiovascular activities for potential therapeutic application. Many such analogues proved physiologically inactive even with relatively conservative modifications, highlighting the importance of this region for full agonist activity of this peptide hormone." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00723"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00723">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00723&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00723&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00723&amp;href=/doi/10.1021/acs.jmedchem.7b00723" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6408-6427</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00699" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00766" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthetic Modification within the “RPRL” Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma Degradation</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaun+M.+K.++McKinnie">Shaun M. K. McKinnie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wang++Wang">Wang Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Conrad++Fischer">Conrad Fischer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tyler++McDonald">Tyler McDonald</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+R.++Kalin">Kevin R. Kalin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Iturrioz">Xavier Iturrioz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Llorens-Cortes">Catherine Llorens-Cortes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gavin+Y.++Oudit">Gavin Y. Oudit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+C.++Vederas">John C. Vederas</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2996-0326" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, University of Alberta, 11227 Saskatchewan Drive NW, Edmonton, Alberta T6G 2G2, Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Medicine, University of Alberta, 8440-112 Street NW, Edmonton, Alberta T6G 2B7, Canada</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Mazankowski Alberta Heart Institute, University of Alberta, 8440-112 Street NW, Edmonton, Alberta T6G 2B7, Canada</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Laboratory of Central Neuropeptides in the Regulation of Body Fluid Homeostasis and Cardiovascular Functions, INSERM, U1050, Paris, F-75005, France</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Center for Interdisciplinary Research in Biology (CIRB), College de France, Paris, F-75005, France</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">CNRS, UMR 7241, Paris, F-75005, France</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#771d181f1959011213120516043702161b1512050316591416"><span class="__cf_email__" data-cfemail="23494c4b4d0d554647465142506356424f41465157420d4042">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00723&amp;href=/doi/10.1021%2Facs.jmedchem.7b00723" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6408–6427</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 7, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 May 2017</li><li><span class="item_label"><b>Published</b> online</span>7 July 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00723" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00723</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6408%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShaun%2BM.%2BK.%2BMcKinnie%252C%2BWang%2BWang%252C%2BConrad%2BFischer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D14%26contentID%3Dacs.jmedchem.7b00723%26title%3DSynthetic%2BModification%2Bwithin%2Bthe%2B%25E2%2580%259CRPRL%25E2%2580%259D%2BRegion%2Bof%2BApelin%2BPeptides%253A%2BImpact%2Bon%2BCardiovascular%2BActivity%2Band%2BStability%2Bto%2BNeprilysin%2Band%2BPlasma%2BDegradation%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6427%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00723"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1383</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">23</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00723" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthetic Modification within the “RPRL” Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma Degradation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shaun&quot;,&quot;last_name&quot;:&quot;M. K. McKinnie&quot;},{&quot;first_name&quot;:&quot;Wang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Conrad&quot;,&quot;last_name&quot;:&quot;Fischer&quot;},{&quot;first_name&quot;:&quot;Tyler&quot;,&quot;last_name&quot;:&quot;McDonald&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;R. Kalin&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Iturrioz&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Llorens-Cortes&quot;},{&quot;first_name&quot;:&quot;Gavin&quot;,&quot;last_name&quot;:&quot;Y. Oudit&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;C. Vederas&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;6408-6427&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00723&quot;},&quot;abstract&quot;:&quot;Apelin is an important mammalian peptide hormone with a range of physiological roles, especially in the cardiovascular system. The apelinergic system is a promising target for treatment of disease, but this remains to be realized due to rapid proteolysis of apelin-derived peptides by proteases, including neprilysin (NEP). The synthetic analogues modified within the NEP degradation site (“RPRL” motif) showed improved in vitro proteolytic stability while maintaining receptor-binding affinities, with three candidate peptides retaining full cardiovascular activities for potential therapeutic application. Many such analogues proved physiologically inactive even with relatively conservative modifications, highlighting the importance of this region for full agonist activity of this peptide hormone.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00723&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00723" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00723&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00723" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00723&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00723" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00723&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00723&amp;href=/doi/10.1021/acs.jmedchem.7b00723" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00723" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00723" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00723%26sid%3Dliteratum%253Aachs%26pmid%3D28685579%26genre%3Darticle%26aulast%3DMcKinnie%26date%3D2017%26atitle%3DSynthetic%2BModification%2Bwithin%2Bthe%2B%25E2%2580%259CRPRL%25E2%2580%259D%2BRegion%2Bof%2BApelin%2BPeptides%253A%2BImpact%2Bon%2BCardiovascular%2BActivity%2Band%2BStability%2Bto%2BNeprilysin%2Band%2BPlasma%2BDegradation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D14%26spage%3D6408%26epage%3D6427%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292161" title="Modification">Modification</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/jmcmar.2017.60.issue-14/20170727/jmcmar.2017.60.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Apelin is an important mammalian peptide hormone with a range of physiological roles, especially in the cardiovascular system. The apelinergic system is a promising target for treatment of disease, but this remains to be realized due to rapid proteolysis of apelin-derived peptides by proteases, including neprilysin (NEP). The synthetic analogues modified within the NEP degradation site (“RPRL” motif) showed improved in vitro proteolytic stability while maintaining receptor-binding affinities, with three candidate peptides retaining full cardiovascular activities for potential therapeutic application. Many such analogues proved physiologically inactive even with relatively conservative modifications, highlighting the importance of this region for full agonist activity of this peptide hormone.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Apelin is an endogenous mammalian peptide hormone discovered in 1998.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Genetically encoded as a 77 amino acid prepropeptide, apelin is degraded into three major isoforms: pyr-1-apelin-13 (<b>1</b>), apelin-17 (<b>2</b>), and apelin-36 (<b>3</b>), which all possess conserved C-terminal 12 amino acids (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). These isoforms have differential distributions in the organ systems, with <b>1</b> being the most dominant in the cardiovascular system.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Bioactive apelin isoforms <b>1</b>–<b>3</b>, with identified sites of NEP and ACE2 proteolytic degradation highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The apelinergic system has generated scientific and therapeutic interest due to its diverse tissue distribution and numerous roles in human physiology and pathology.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6">(3-6)</a> When bound to its cognate apelin receptor (APJ), a GPCR with close homology to the angiotensin receptor,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> this peptide hormone has a role in body fluid regulation,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> energy metabolism and the adipoinsular axis,<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10-14)</a> and inhibiting HIV infection.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Apelin has also a strong beneficial role in the cardiovascular system, such as initiating vasodilation through a NO-mediated mechanism,<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17-21)</a> positive inotropy,<a onclick="showRef(event, 'ref2 ref22'); return false;" href="javascript:void(0);" class="ref ref2 ref22">(2, 22)</a> angiogenesis,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and the prevention of myocardial ischemic reperfusion injury.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Despite the potent and beneficial physiological effects of the apelinergic system, the life span of apelin peptides is heavily regulated via proteolysis. Angiotensin converting enzyme 2 (ACE2) is a well-known monocarboxypeptidase that efficiently catalyzes the removal of the conserved C-terminal phenylalanine from apelin isoforms in vitro<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and in vivo.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Des-phenylalanine apelin isoforms behave as biased agonists by retaining native binding and forskolin-induced cAMP inhibition but abolishing apelin receptor internalization and β-arrestin recruitment.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> Truncated analogues show a diminished capacity to lower blood pressure and have no ability to protect against myocardial ischemic reperfusion injury,<a onclick="showRef(event, 'ref26 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref28">(26, 28)</a> making the C-terminal Phe residue essential for full agonist activity. To negate the impact of ACE2 degradation on apelin isoforms, we and others developed resistant analogues (apelin “A2” analogues) with C-terminal Nle11, Aib12, and para-BrPhe13 amino acid substitutions.<a onclick="showRef(event, 'ref24 ref29'); return false;" href="javascript:void(0);" class="ref ref24 ref29">(24, 29)</a> Both pyr-1-apelin-13 A2 and apelin-17 A2 analogues (<b>4</b>, <b>5</b>) showed complete in vitro ACE2 stability, retained full beneficial cardiovascular activity, and improved pharmacokinetics through in vitro plasma stability.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, analogues such as <b>4</b> and <b>5</b> were still degraded through additional proteolytic events at unique positions that mirrored previously reported in vitro apelin degradation trends.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a></div><div class="NLM_p last">Through the use of a FRET-based assay and activity-guided fractionation of human blood plasma, we recently discovered that metalloprotease neutral endopeptidase 24.11 (neprilysin, NEP) has a role in the in vitro proteolysis of apelin.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> NEP is a significant protease implicated in the degradation and inactivation of vasoactive peptides bradykinin,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> angiotensins,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> atrial naturatic factor (ANP),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and endothelins<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> in addition to many other peptide hormones in other organ systems.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Previous structure–activity relationship studies on apelin have highlighted the essential nature of the amino acid residues surrounding the site of NEP proteolysis (the “RPRL” motif). Alanine substitution,<a onclick="showRef(event, 'ref16 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref18">(16, 18)</a> epimerization,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or truncation<a onclick="showRef(event, 'ref18 ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref18 ref27 ref29">(18, 27, 29)</a> of amino acids within this region is deleterious to receptor binding and subsequent GPCR activation and internalization. Although apelin isoforms show no dominant secondary structure in aqueous solutions by circular dichroism, NMR structural characterization of <b>2</b> has shown that this “RPRL” motif has an enhanced rigidity and is suggested to induce a β-turn conformation upon binding.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The two Arg residues have been proposed to form key electrostatic interactions with acidic amino acids on the exterior of the apelin receptor to facilitate ligand binding. This has been supported through site-directed mutagenesis experiments<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and NMR structural elucidation of the N-terminal tail and first transmembrane helix of the receptor.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> This indicates that the site of NEP proteolysis is also structurally and functionally an essential feature for apelin binding and subsequent physiological activity. The preparation of analogues with enhanced stability to NEP could not only generate potent therapeutic peptides but also facilitate investigation into the physiological role of this enzyme in apelin degradation and give further insight into the importance of this “RPRL” region of the peptide for its activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">To negate the impact of ACE2 cleavage, the ACE2 resistant “A2” C-terminus was incorporated into all Arg/Leu modified analogues. To efficiently synthesize a variety of novel analogues, Fmoc-<i>p</i>-BrPhe-OH was loaded onto 2-chlorotrityl chloride resin in 1.0 mmol batches (<b>6</b>) and extended by solid phase peptide synthesis until heptapeptide <b>7</b> was obtained. For each novel analogue series, 0.2 mmol of <b>7</b> was extended to the dodecapeptide stage, incorporating the targeted Arg/Leu modification at the appropriate position as protected amino acids, dipeptides, or tripeptides. The resin was subsequently halved for the divergent syntheses of pyr-1-apelin-13 A2 or apelin-17 A2 analogues (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General SPPS Approach for the Divergent Syntheses of Arg/Leu Modified Apelin A2 Analogues, with Areas of Synthetic Modification Shown in Red</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To enhance A2 peptides to NEP stability, we proposed to use a variety of substitutions known to enhance proteolytic stability at amino acid residues surrounding the cleavage site. We selected to incorporate the following synthetic modifications into both the pyr-1-apelin-13 and apelin-17 A2 scaffolds: <span class="smallcaps smallerCapital">d</span>-amino acids, N-methylations, α-methylations, and aza-peptide isosteres to generate a total of 12 novel analogues (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Targeted synthetic modifications to improve apelin proteolytic stability against NEP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">D-Substituted apelin A2 analogues were easily accessible due to the commercial availability of Fmoc-protected D-amino acids. Previous D-scan experiments highlighted Leu5 as the only residue within the NEP proteolytic region of pyr-1-apelin-13 that retained modest APJ receptor binding compared to native <b>1</b>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Following the Fmoc-SPPS strategy previously outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, <span class="smallcaps smallerCapital">d</span>-Leu analogues of pyr-1-apelin-13 A2 (<b>8</b>) and apelin-17 A2 (<b>9</b>) were synthesized.</div><div class="NLM_p">N-methylated Leu dipeptide <b>20</b> was synthesized through the HATU coupling of commercially available <i>N</i>-methylleucine benzyl ester <i>p</i>-TsOH salt with Fmoc-Orn(Boc)-OH (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The ornithine δ-amine was deprotected under acidic conditions and then guanidinylated with 1,3-di-Boc-2-(trifluoromethylsulfonyl)guanidine to produce di-Boc protected arginine dipeptide <b>21</b>. Benzyl ester removal under Pd-catalyzed hydrogenolysis generated free acid <b>22</b>, which was incorporated into <i>N</i>-MeLeu apelin 13 and 17 A2 analogues <b>10</b> and <b>11</b>, respectively.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Dipeptide <b>22</b> for the Preparation of <i>N</i>-Methylleucine Apelin A2 Analogues <b>10</b> and <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Steric occlusion of the susceptible amide bond through α-methylation had previously been successful in conferring resistance to ACE2 by the incorporation of Aib N-terminal to the monocarboxypeptidase cleavage site.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Ala-Ni(II)-(<i>S</i>)-BPB Schiff base complex <b>23</b> was used to enantioselectively prepare target α-methylated amino acids due to ease of synthesis, recyclability of the chiral ligand, and ability to separate individual diastereomers by flash chromatography.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Complex <b>23</b> was synthesized according to literature protocol<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and was used to divergently synthesize both α-methylarginine and α-methylleucine amino acids.</div><div class="NLM_p">For the synthesis of α-methylarginine, <b>23</b> was deprotonated with KO<sup><i>t</i></sup>Bu and alkylated with 1-azido-3-iodopropane (<b>24</b>)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> to generate α,α-disubstituted Ni-complex <b>25</b>. The desired (<i>S</i>,<i>S</i>)-diastereomer was purified by silica flash chromatography in 69% yield, and the absolute stereochemistry was confirmed by X-ray crystallography (CCDC 1528624, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf" class="ext-link">Supporting Information Figure S1</a>). Complex <b>25</b> was hydrolyzed under acidic conditions, and the resulting amino acid was Fmoc-protected (<b>26</b>). A HATU-mediated peptide coupling with H-Leu-OMe HCl salt afforded dipeptide <b>27</b>, which was subsequently converted to αMe-Arg containing dipeptide <b>28</b> through azide hydrogenolysis and guanidinylation. Methyl ester deprotection<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> gave the SPPS-compatible dipeptide <b>29</b> for the eventual preparation of αMeArg analogues <b>12</b> and <b>13</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Dipeptide <b>29</b> for the Preparation of α-Methylarginine Apelin A2 Analogues <b>12</b> and <b>13</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To prepare α-methylleucine, <b>23</b> was alkylated with 2-methyl-1-iodopropane to generate the desired (<i>S</i>,<i>S</i>)-diastereomer <b>30</b>, with the absolute stereochemistry confirmed by X-ray crystallography (CCDC 1528625, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>). Acid hydrolysis followed by Fmoc-protection produced amino acid <b>31</b>, which was subsequently coupled to H-Ser(<sup><i>t</i></sup>Bu)-OMe to give dipeptide <b>32</b>. Methyl ester deprotection<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> gave the SPPS-compatible dipeptide <b>33</b>, which was used for αMeLeu apelin analogues <b>14</b> and <b>15</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Dipeptide <b>33</b> for the Preparation of α-Methylleucine Apelin A2 Analogues <b>14</b> and <b>15</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Azadipeptide <b>34</b> was prepared by the sequential addition of disuccinimidyl carbonate, then a solution of H-Leu-O<sup><i>t</i></sup>Bu in DIPEA to benzophenone hydrazone analogous to previously established literature protocol.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> Regioselective semicarbazone alkylation was achieved with tetraethylammonium hydroxide and 3-chloro-1-bromopropane to yield chloroalkylated product <b>35</b>. Displacement of the primary alkyl chloride with sodium azide afforded <b>36</b>, which was deprotected to semicarbazide <b>37</b> with hydroxylamine hydrochloride. Fmoc-protection of <b>37</b> was unsuccessful in our hands, but fortunately the semicarbazide could be aminoacylated with the next N-terminal amino acid (Fmoc-Pro-OH) to generate azatripeptide <b>38</b>. The SPPS compatible tripeptide <b>39</b> was synthesized following <i>tert</i>-butyl ester deprotection, hydrogenolysis of the azide, and guanidinylation of the primary amine. Tripeptide <b>39</b> was incorporated into azaArg apelin analogues <b>16</b> and <b>17</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Azatripeptide <b>39</b> for the Preparation of Aza-arginine Apelin A2 Analogues <b>16</b> and <b>17</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To prepare a synthetic azaLeu tripeptide, <b>40</b> was prepared by the sequential addition of disuccinimidyl carbonate, then a solution of H-Ser(<sup><i>t</i></sup>Bu)-O<sup><i>t</i></sup>Bu in DIPEA to benzophenone hydrazone. Semicarbazone alkylation was accomplished using tetraethylammonium hydroxide and 3-bromo-2-methylpropene to yield <b>41</b>. Concomitant Pd-catalyzed hydrogenation and hydrogenolysis afforded semicarbazide <b>42</b>, which was coupled to Fmoc-Orn(2-Cl-Cbz)-OH to generate azatripeptide <b>43</b>. Chemoselective <i>tert</i>-butyl ester deprotection to free acid <b>44</b> was accomplished by addition of silica in refluxing toluene to protected azatripeptide <b>43</b>. Subsequent 2-chloro-Cbz deprotection and guanidinylation of the resultant primary amine yielded azatripeptide <b>45</b>, which was further employed to generate azaLeu-containing analogues <b>18</b> and <b>19</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Azatripeptide <b>45</b> for the Preparation of Aza-leucine Apelin A2 Analogues <b>18</b> and <b>19</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro NEP Stability</h3><div class="NLM_p">We initially compared the in vitro NEP stability of these Arg/Leu analogues to native apelin isoforms and their A2 substituted counterparts. Analogues were incubated with recombinant human NEP (rhNEP, Sino Biological) at 37 °C for up to 72 h, and the extent of degradation was analyzed via LC–MS because of the overlapping elution patterns of peptide fragments (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Native apelin isoforms (<b>1</b>, <b>2</b>) and their respective A2 substituted analogues (<b>4</b>, <b>5</b>) were degraded by NEP at rates comparable to those previously reported.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Analogue <b>5</b> interestingly showed increased susceptibility to NEP despite all synthetic modifications being at minimum 6 amino acids (P6′) away from the site of endoprotease cleavage. Distal amino acid substitutions have been shown to modulate NEP proteolysis in the breakdown of Aβ<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and synthetic substrates,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and previous in vitro plasma degradation experiments observed that C-terminal modifications to apelin analogues markedly affected the presence of key peptide fragments.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro NEP degradation trends for (a) pyr-1-apelin-13 analogues and (b) apelin-17 analogues, comparing native apelin isoforms (<b>1</b>, <b>2</b>), ACE2-resistant analogues (<b>4</b>, <b>5</b>), and novel Arg/Leu substituted analogues <b>8</b>–<b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When examining the impact of Arg/Leu-substitution, all analogues <b>8</b>–<b>19</b> showed dramatically improved proteolytic stability to NEP compared to either native peptide (<b>1</b>, <b>2</b>) or the corresponding A2 substituted analogues (<b>4</b>, <b>5</b>). Overall, Arg/Leu-substituted apelin-17 A2 analogues showed an enhanced stability compared to the pyr-1-apelin-13 A2 analogues. However, the proteolysis of these analogues was not due to degradation at either location associated with NEP endoprotease activity. Instead, analogues were slowly degraded between Nle-Aib within the A2-modified C-terminus (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf" class="ext-link">Supporting Information Figure S3</a>). NEP does have significant carboxydipeptidase activity as exemplified in the degradation of neurological enkephalin pentapeptides,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and key amino acids have been implicated in binding and orienting the C-terminus of the peptide substrate to facilitate proteolysis.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> C-terminal dipeptide excision was not observed with native isoforms <b>1</b>–<b>3</b>, likely due to the unfavorable geometry of proline in the P1′ position. Although Pro to Aib substitution in the A2 analogue series enabled an additional NEP in vitro proteolytic site, we are proposing that this dipeptide excision is negligible in comparison to in vivo peptide hormone degradation and metabolism.</div><div class="NLM_p last">We additionally investigated the ability of synthetic analogues <b>8</b>–<b>19</b> to inhibit the inherent proteolytic activity of NEP. Although NEP inhibition via sacubitril (Entresto)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> is currently a clinically approved method for the treatment of heart disease, our focus was to minimize analogue interference with this important regulatory protease. Following preincubation of NEP with equimolar concentrations of <b>8</b>–<b>19</b>, degradation of <b>1</b> was nearly identical in either the presence or absence of analogues (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf" class="ext-link">Supporting Information Figure S4</a>), suggesting that in vitro proteolytic activity is not significantly impacted.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro Analogue Stability: Plasma</h3><div class="NLM_p">We next explored the in vitro plasma stability of synthetic apelin analogues <b>8</b>–<b>19</b>. Triplicate assessments were performed in human blood plasma and analyzed by RP-HPLC (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Arg/Leu substitution had a varying impact on the different apelin isoforms. With the exception of <b>11</b>, apelin-17 A2 analogues showed enhanced stability compared to native <b>2</b> or A2-substitued analogue <b>5</b>. Most notably, azaArg8 analogue <b>17</b> showed very little degradation during the time course examined. In contrast, there was a much greater range of in vitro stabilities when examining the Arg/Leu substituted pyr-1-apelin-13 A2 analogues. Analogues substituted at the Arg4 position (<b>12</b>, <b>16</b>) or directly on the susceptible amide bond (<b>10</b>) showed comparable stability to that of <b>4</b>, while Leu5-modified analogues (<b>8</b>, <b>14</b>, <b>18</b>) showed enhanced proteolysis compared to native <b>1</b> or A2-modified analogue <b>4</b>. On the basis of our previous kinetic studies<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and combined in vitro NEP and plasma pharmacokinetics, NEP proteolysis appears to be more significant in the degradation of apelin-17 isoforms. However, the enhanced in vitro stabilities of Arg/Leu-modified analogues to both NEP and nonspecific plasma proteolysis were encouraging prior to interrogating their individual physiological activities.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Remaining Percentage of Apelin Analogues after in Vitro Human Plasma Incubation</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">pyr-1-apelin-13 analogue</th><th class="rowsep1 colsep0" colspan="3" align="center">apelin-17 analogue</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Arg-Leu modification</th><th class="colsep0 rowsep0" align="center">analogue</th><th class="colsep0 rowsep0" align="center">% apelin, 30 min</th><th class="colsep0 rowsep0" align="center"><i>% apelin,</i> 60 min</th><th class="colsep0 rowsep0" align="center">analogue</th><th class="colsep0 rowsep0" align="center">% apelin, 30 min</th><th class="colsep0 rowsep0" align="center">% apelin, 60 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">none (native)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">45 ± 8</td><td class="colsep0 rowsep0" align="left">12 ± 2</td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">51 ± 17</td><td class="colsep0 rowsep0" align="left">39 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">none (A2)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">77 ± 19</td><td class="colsep0 rowsep0" align="left">65 ± 14</td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">43 ± 1</td><td class="colsep0 rowsep0" align="left">35 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">d</span>-Leu</td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">32 ± 2</td><td class="colsep0 rowsep0" align="left">22 ± 1</td><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">80 ± 3</td><td class="colsep0 rowsep0" align="left">80 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>N</i>-MeLeu</td><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">77 ± 3</td><td class="colsep0 rowsep0" align="left">59 ± 6</td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">49 ± 10</td><td class="colsep0 rowsep0" align="left">47 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α-MeArg</td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">88 ± 4</td><td class="colsep0 rowsep0" align="left">62 ± 6</td><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">61 ± 10</td><td class="colsep0 rowsep0" align="left">55 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α-MeLeu</td><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">45 ± 6</td><td class="colsep0 rowsep0" align="left">38 ± 3</td><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">77 ± 4</td><td class="colsep0 rowsep0" align="left">48 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">azaArg</td><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">83 ± 3</td><td class="colsep0 rowsep0" align="left">57 ± 1</td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">96 ± 6</td><td class="colsep0 rowsep0" align="left">94 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">azaLeu</td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">19 ± 5</td><td class="colsep0 rowsep0" align="left">2 ± 1</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">82 ± 1</td><td class="colsep0 rowsep0" align="left">68 ± 4</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Binding Affinity of Apelin Analogues</h3><div class="NLM_p">To examine the impact of synthetic modification within the critical RPRL motif of the apelin peptide analogues, we evaluated the ability of novel analogues to bind to the wild-type rat apelin receptor. Membrane preparations from CHO cells stably expressing the wild-type apelin receptor tagged at its C-terminus with EGFP were generated as previously described,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and the affinities of native isoforms <b>1</b> and <b>2</b>, parent analogues <b>4</b> and <b>5</b>, and Arg/Leu-analogues <b>8</b>–<b>19</b> were determined by their abilities to displace [<sup>125</sup>I]-pyr-1-apelin-13 (0.2 nM). Native isoforms <b>1</b> and <b>2</b> inhibited specific binding to the wild-type rat apelin receptor with inhibitory constant (<i>K</i><sub>i</sub>) values of 0.3 and 0.05 nM, respectively (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Pyr-1-apelin-13 analogues <b>8</b>, <b>10</b>, <b>14</b>, and <b>18</b> showed a modest improvement in receptor binding, while parent analogue <b>4</b> and azaArg4- and αMeArg4-substituted analogues (<b>16</b> and <b>12</b>, respectively) exhibited a slightly weaker affinity compared to <b>1</b> (by a factor of 6, 3, and 2, respectively). In contrast, Arg/Leu substitution slightly reduced the binding affinity of all apelin-17 analogues compared to native <b>2</b>, exhibiting <i>K</i><sub>i</sub> values in the subnanomolar range, about 3 times less potent. However, these data showed no drastic effect on in vitro apelin receptor binding, thus supporting our hypothesis that our selected synthetic modifications within the RPRL motif of apelin were not deleterious for receptor binding.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Affinities of Pyr-1-apelin-13 and Apelin-17 Analogues toward Rat APJ Determined by Radioligand Binding of Pyr-1-apelin-13 and Apelin-17 Analogues<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">pyr-1-apelin-13 analogues</th><th class="rowsep1 colsep0" colspan="2" align="center">apelin-17 analogues</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Arg-Leu modification</th><th class="colsep0 rowsep0" align="center">analogue</th><th class="colsep0 rowsep0" align="center">affinity, <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">analogue</th><th class="colsep0 rowsep0" align="center">affinity, <i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">none (native)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.3 ± 0.07 (4)</td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.053 ± 0.009 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">none (A2)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">2 ± 0.3 (3)</td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">0.19 ± 0.025 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">d</span>-Leu</td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">0.12 ± 0.035 (3)</td><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">0.14 ± 0.056 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>N</i>-MeLeu</td><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">0.10 ± 0.048 (3)</td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0.45 ± 0.110 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α-MeArg</td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0.56 ± 0.033 (3)</td><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.13 ± 0.032 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α-MeLeu</td><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">0.17 ± 0.050 (3)</td><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">0.18 ± 0.079 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">azaArg</td><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">1 ± 0.10 (3)</td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">0.14 ± 0.009 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">azaLeu</td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.13 ± 0.063 (3)</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">0.15 ± 0.015 (3)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Affinity values are the mean ± SE (<i>n</i>), with <i>n</i> representing the number of independent experiments performed in duplicate.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Physiological Experiments</h3><div class="NLM_p">Synthetic analogues <b>8</b>–<b>19</b> were tested for blood pressure lowering abilities in anesthetized mice. Apelin peptide analogues were delivered systemically via the right internal jugular vein while blood pressure (BP) and heart rate (HR) were continuously monitored in the aorta cannulated via the right carotid artery. Surprisingly, the potent physiological effects of <b>4</b> were not observed with any of the Arg/Leu-substituted pyr-1-apelin-13 A2 analogues (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Conservative substitutions such as epimerization (<b>8</b>) or N-methylation (<b>10</b>) at the Leu5 position showed no ability to decrease blood pressure in this assay. However, select analogues (<b>10</b>, <b>14</b>, <b>16</b>) did have a significant and pronounced effect of increasing the murine HR following injection. Tachycardia is directly correlated with native apelin isoforms binding to the receptor<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and suggests that these analogues, while not fully functional, still have some inherent physiological activities.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo systolic (SBP, A/E), diastolic (DBP, B/F), mean arterial blood pressure (MABP, C/G), and heart rate analyses (HR, D/H) following injection of pyr-1-apelin-13 A2 (left) and apelin-17 A2 (right) analogues in anesthetized mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This differential physiological activity was further observed when investigating the impact of the same substitutions on the apelin-17 A2 isoform. All Arg/Leu modifications, even those inactive in the 13 A2 isoform, showed an ability to induce tachycardia. Most significantly, three analogues (<b>11</b>, <b>17</b>, <b>19</b>) showed potent hypotensive activity that rivaled or bested that of native <b>2</b> or A2 variant <b>5</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Analogues that retained activity involved <i>N</i>-methyl Leu9 analogue <b>11</b> and both conformationally flexible aza-analogues <b>17</b> and <b>19</b>, suggesting that these synthetic modifications in the apelin-17 framework were flexible or conservative enough to induce full biological activity upon binding to the apelin receptor.</div><div class="NLM_p">Analogues that showed hypotensive activity were further examined for their abilities to prevent myocardial ischemic reperfusion injury using the Langendorff protocol. Stable isolated rat hearts were exposed to a 30 min period of ischemia, then reperfused with saline (vehicle); native <b>2</b>; vasoactive analogues <b>11</b>, <b>17</b>, <b>19</b>; or inactive <b>18</b>; in a postconditioning protocol. The ex vivo heart was assessed for a variety of parameters (heart rate (HR), left ventricle developed pressure (LVDP), maximum derivative of change in systolic pressure over time (max d<i>P</i>/d<i>t</i>), minimum derivative of change in diastolic pressure over time (min d<i>P</i>/d<i>t</i>), and rate-pressure product (RPP)) indicative of general heart function and performance (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Langendorff experiments following reperfusion of saline (negative control, sham), native <b>2</b> (positive control) and analogues <b>11</b>, <b>17</b>–<b>19</b> after a 30 min period of ischemia, assessing heart rate (HR, A), maximum derivative of change in systolic pressure over time (max d<i>P</i>/d<i>t</i>, B), left ventricle developed pressure (LVDP, C), minimum derivative of change in diastolic pressure over time (min d<i>P</i>/d<i>t</i>, D), and rate–pressure product (RPP, E).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Following Langendorff experiments, the potent hypotensive apelin-17 A2 analogues <b>11</b>, <b>17</b>, and <b>19</b> showed an equivalent ability to rescue the heart from ischemia–reperfusion injury compared to native isoform <b>2</b>. In all assessed parameters, these analogues showed full potency, with <b>17</b> behaving very analogously to <b>2</b>, while <b>11</b> and <b>19</b> showed a slight improvement over the native isoform in max/min d<i>P</i>/d<i>t</i>, LVDP and RPP. Unsurprisingly, the inactive pyr-1-apelin-13 A2 analogue <b>18</b> behaved comparably to that of the negative saline control, having no beneficial cardiovascular effects following periods of ischemia.</div><div class="NLM_p">Synthetic substitution of the site of NEP proteolysis gave rise to three potent analogues (<b>11</b>, <b>17</b>, and <b>19</b>) with full beneficial cardiovascular activities, subnanomolar receptor affinities, and improved in vitro NEP and plasma stabilities. As well, these analogues showed no ability to inhibit the inherent activity of NEP. Further optimization of the two apelin-17 A2 azapeptide derivatives (<b>17</b>, <b>19</b>) due to their improved pharmacokinetics is encouraging in the pursuit of an apelin analogue with practical therapeutic applicability. This study additionally provides insight into the limited tolerance to modification within the “RPRL” motif and further supports its significant role in the apelinergic system. Most notably, any Arg/Leu modification abolished full agonistic activity within the pyr-1-apelin-13 A2 scaffold. Even conservative substitutions employed such as epimerization, N- or α-methylations, or α-carbon replacement with nitrogen failed to retain full physiological activity despite having comparable in vitro apelin receptor binding. We propose the inactivity of the Arg/Leu modifications within the 13A2 scaffold is due to a shorter N-terminal region that has a lesser ability to be induced into the proposed active β-turn-like conformation<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> in the presence of the apelin receptor. However, the fact that some of these same modifications show potency in the apelin-17 A2 series suggests that the longer N-terminal extension is capable of facilitating the appropriate receptor interactions and internalization necessary to induce full physiological activity.</div><div class="NLM_p">The inactivity of both <span class="smallcaps smallerCapital">d</span>-Leu substituted analogues <b>8</b> and <b>9</b> was particularly surprising because of literature precedent that <span class="smallcaps smallerCapital">d</span>-Leu pyr-1-apelin-13 retained acceptable abilities to bind (∼10-fold decrease in affinity) and inhibit forskolin-induced cAMP accumulation.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Epimerization within or adjacent to an inducible structural element such as a β-turn would likely be detrimental to activity. However, a recent apelin-17 analogue (P92) with full agonistic activity has been reported with multiple epimerizations, including two flanking both the N- (<span class="smallcaps smallerCapital">d</span>-Gln) and C- (<span class="smallcaps smallerCapital">d</span>-Leu) termini of the “RPRL” region.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> This analogue has additional substitutions that make direct comparison with our analogues difficult, but it is encouraging to know that physiological activity and stability can be enhanced through epimerizations.</div><div class="NLM_p last">Select pyr-1-apelin-13 A2 (<b>10</b>, <b>14</b>, <b>16</b>) and apelin-17 A2 (<b>9</b>, <b>13</b>, <b>15</b>) analogues had an impact on the heart rate of mice following perfusion without inducing any vasoactive effects. This may be rationalized through the biased agonism of these analogues for G-protein pathways instead of being internalized. It is known that β-arrestin recruitment and internalization initiates vasodilation and additional cardioprotective effects of apelin, and the C-terminal phenylalanine of apelin plays a critical role in this process.<a onclick="showRef(event, 'ref27 ref28 ref54'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref54">(27, 28, 54)</a> However, much less is understood about how tachycardia is initiated. The vasoactive and inotropic activities of apelin have previously been decoupled through the pharmacological inhibition of neuronal ganglion in rats,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and additional studies have suggested that the Gα<sub>q</sub> pathway is responsible for the cardiac contractility associated with apelin.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> A comparable effect has been seen with a synthetic apelin analogue tested in humans, where the critical “RPRL” motif is constrained within an intramolecular disulfide bridge. This compound shows a potent increase in cardiac output and slight increase in heart rate without inducing vasoactive effects.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Although we have not observed an equivalent physiological activity to what has been reported, these results suggest that these analogues are not wholly inactive. These physiological results clearly highlight the significant role of the “RPRL” motif within apelin peptide and show that it has limited ability to be manipulated synthetically to produce fully active analogues.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The continued investigation of the diverse roles of apelin peptides in mammalian physiology has strengthened their therapeutic potential for the treatment of cardiovascular disease and other pathologies. However, the susceptibility of native apelin isoforms to proteases such as ACE2,<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> NEP,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and prolyl carboxypeptidase<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> dramatically limits their direct use. The preparation of analogues with improved proteolytic stabilities that conserve beneficial interactions with the cognate APJ receptor enables potential therapeutic application. In this manuscript, the preparation of 12 novel analogues, modified surrounding the NEP proteolytic site, afforded three potent compounds with full cardiovascular activities and improved in vitro pharmacokinetic stabilities. The differentiation of activities of these Arg/Leu-substituted analogues adds insight into the significant physiological role of this region of the peptide hormone. These active and robust apelin analogues will assist in harnessing the potent cardiovascular benefits of the apelinergic system for future therapeutic applications.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Information. Reagents, Solvents, and Purification</h3><div class="NLM_p last">Commercially available chemical and biological reagents were purchased from Sigma-Aldrich Canada, Chem-Impex International Inc., Fisher Scientific Ltd., Alfa Aesar Ltd., R&D Systems, Tocris Bioscience, Harvard Apparatus, Caledon, or VWR International and used without further purification unless otherwise stated. All solvents were of American Chemical Society (ACS) grade and were used without further purification. All anhydrous reactions were conducted under positive pressure of argon using flame-dried glassware. Solvents for anhydrous reactions were distilled prior to use: dichloromethane and dichloroethane were distilled over calcium hydride, tetrahydrofuran and diethyl ether were distilled over sodium with benzophenone as an indicator, and methanol was distilled over magnesium. HPLC grade acetonitrile, dimethylformamide, 2-propanol, hexanes, and methanol were used without further purification. Commercially available ACS grade solvents (>99.0% purity) were used for column chromatography without further purification. Deionized water was obtained from a Milli-Q reagent water filtration system (Millipore Co., Milford, MA). All reactions and fractions from column chromatography were monitored by thin layer chromatography (TLC) using glass plates with a UV fluorescent indicator (normal SiO<sub>2</sub>, Merck 60 F<sub>254</sub>). Visualization was performed following UV absorption by fluorescence quenching, staining with phosphomolybdic acid in ethanol (10 g/100 mL), ninhydrin (ninhydrin/acetic acid/<i>n</i>-butanol, 0.6 g/6 mL/200 mL) or potassium permanganate (KMnO<sub>4</sub>/K<sub>2</sub>CO<sub>3</sub>/NaOH/H<sub>2</sub>O, 1.5 g/10 g/0.12 g/200 mL). Flash chromatography was performed using Merck type 60, 230–400 mesh silica gel. Semipreparative and analytical scale high performance liquid chromatography (HPLC) was performed on a Gilson chromatograph equipped with model 322 pump heads, a model 171 diode array detector, a FC 203B fraction collector, and a Rheodyne 7725i injector fitted with a 1000 μL sample loop. HPLC solvents were filtered through a Millipore filtration system under vacuum prior to use. Peptides were purified to >95% purity as assessed by analytical reinjection.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Characterization</h3><div class="NLM_p">Optical rotations were measured on a PerkinElmer 241 polarimeter with a microcell (10 cm, 1 mL) at ambient temperature and are reported in units of 10<sup>–1</sup> deg cm<sup>2</sup> g<sup>–1</sup>. All reported optical rotations were referenced against air and measured at the sodium D line (λ = 589.3 nm).</div><div class="NLM_p">Infrared spectra (IR) were recorded on a Nicolet Magna 750 or a 20SX FT-IR spectrometer. Cast refers to the evaporation of a solution on a NaCl plate.</div><div class="NLM_p">Nuclear magnetic resonance (NMR) spectra were recorded on an Agilent/Varian Inova 600, Inova 400, Inova 300, DD2 MR 400, VNMRS 700, or Unity 500 spectrometer at 27 °C. For <sup>1</sup>H (300, 400, 500, 600, or 700 MHz) spectra, δ values were referenced to CDCl<sub>3</sub> (7.26 ppm), D<sub>2</sub>O (4.79 ppm), or CD<sub>3</sub>OD (3.30 ppm), and for <sup>13</sup>C (100, 125, 150, or 175 MHz) spectra, δ values were referenced to CDCl<sub>3</sub> (77.0 ppm) or CD<sub>3</sub>OD (49.0 ppm) as the solvents. Reported splitting patterns are abbreviated as s = singlet, d = doublet, t = triplet, q = quartet, sept = septet, m = multiplet.</div><div class="NLM_p last">Mass spectra (MS) were recorded on a Kratos AEIMS-50, Bruker 9.4 T Apex-Qe FTICR (high resolution, HRMS) or on a Perspective Biosystems Voyager Elite MALDI-TOF MS using 4-hydroxy-α-cyanocinnamic acid (HCCA) as a matrix. MS/MS was performed on a Bruker Ultraflextreme MALDI/TOF/TOF. LC–MS was performed on an Agilent Technologies 6130 LCMS instrument.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">1 General Apelin Analogue SPPS Elongation Method</h3><div class="NLM_p last">A suspension of resin in DMF (10 mL) was bubbled under Ar gas for 15 min to swell. The N-terminal Fmoc group was removed by bubbling a solution of 20% piperidine in DMF (3 × 10 mL) for 3 min, washing considerably with DMF (3 × 10 mL) after each deprotection. Fmoc-deprotection was monitored by TLC, with the dibenzofulvene–piperidine adduct appearing as a bright purple spot under UV. DIPEA (6.0 equiv) was added to a solution of Fmoc-protected amino acid (3.0 equiv compared to resin loading), HATU (3.0 equiv), and HOAt (3.0 equiv) in DMF (10 mL) and stirred for 5 min. The activated amino acid solution was added to the resin and bubbled under Ar gas for 1–3 h. The resin was washed with DMF (3 × 10 mL), and the extent of coupling was assessed by either (i) cleaving a small sample of resin with a solution of 95:2.5:2.5 TFA/TIPS/H<sub>2</sub>O for 1 h and MALDI-TOF analysis or (ii) performing a Kaiser test to detect the presence of free amines. A solution of 20% acetic anhydride in DMF (10 mL) was added to the resin and bubbled under Ar gas for 10 min to end-cap any unreacted amines. The resin was rinsed thoroughly with DMF (3 × 10 mL) and subjected to Fmoc-deprotection to further elongate the peptide or rinsed with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL) and MeOH (3 × 10 mL), dried thoroughly, and stored under Ar gas at −20 °C.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">2 General Method for Apelin Analogue Resin Cleavage</h3><div class="NLM_p last">Resin-bound apelin analogue (0.05 mmol) was suspended in 95:2.5:2.5 TFA/TIPS/H<sub>2</sub>O with shaking under an Ar atmosphere for 2–3 h. The resin was removed via filtration through glass wool, rinsed with TFA, and the solution was concentrated in vacuo. Cold diethyl ether (2 × 5 mL) was added to triturate the crude peptide. The diethyl ether was decanted into a 15 mL Falcon tube and briefly centrifuged to pellet any residual peptide. The diethyl ether pellet and triturated crude residue were pooled together and dissolved in 10% aqueous acetonitrile, 0.1% TFA.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">3 Apelin Peptide Purification Methods</h3><div class="NLM_p">Peptides were purified using C<sub>18</sub> RP-HPLC using aqueous 0.1% TFA (solvent A) and 0.1% TFA in acetonitrile (solvent B) as eluents. The following purification methods were used:</div><div class="NLM_p">Method A (semiprep purification, 3 mL/min, Phenomenex Luna 5u, C18(2) 100 Å, 5 μm, 10.00 mm × 250 mm): 10% B (3 min), 10–25% B (1.5 min), 25–42% B (17 min), 42–95% B (2.5 min), 95% B (3 min), 95–10% B (0.5 min), 10% B (2.5 min).</div><div class="NLM_p last">Method B (analytical reinjection, 1 mL/min, Alltech Prosphere 300 Å, 5 μm, 4.6 mm × 250 mm): 27% B (3 min), 27–35% B (10 min), 35% B (2 min), 35–27% B (1 min), 27% B (2 min).</div></div><div id="sec4_2_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4 Apelin Analogue Syntheses. Reference Compounds</h3><div class="NLM_p">The syntheses and characterization of ACE2-resistant analogues <b>4</b> and <b>5</b> have been previously described.<a onclick="showRef(event, 'ref24 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref26">(24, 26)</a> Synthetic compounds <b>23</b><a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and <b>24</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> were prepared according to literature protocols.</div><div id="sec4_2_4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Fmoc-<i>p</i>BrPhe-2-Cl-Trt (<b>6</b>)</h4><div class="NLM_p last">2-Chlorotrityl chloride resin (1.05 mmol) was transferred to a SPPS vessel, washed with CH<sub>2</sub>Cl<sub>2</sub> (2 × 10 mL), DMF (2 × 10 mL), and finally suspended in DMF and bubbled under Ar gas for 10 min. Fmoc-<i>p</i>-bromo-<span class="smallcaps smallerCapital">l</span>-phenylalanine (1.0 mmol) was suspended in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) with DIPEA (5.0 equiv) and added to the swollen resin. This solution was bubbled under Ar gas for 2.5 h. The functionalized resin was washed considerably with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL) and DMF (3 × 10 mL), and then unreacted sites were capped by bubbling with dry MeOH (5 mL) under Ar gas for 45 min. The resin was dried thoroughly under Ar, weighed, divided into 0.2 mmol portions, and stored under an Ar atmosphere at −20 °C.</div></div><div id="sec4_2_4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Fmoc-His(Trt)-Lys(Boc)-Gly-Pro-Nle-Aib-<i>p</i>BrPhe-2-Cl-Trt (<b>7</b>)</h4><div class="NLM_p last">Functionalized resin <b>6</b> was elongated by manual SPPS, introducing amino acids in the following order: Fmoc-Aib-OH, Fmoc-Nle-OH, Fmoc-Pro-OH, Fmoc-Gly-OH, Fmoc-Lys(Boc)-OH, and Fmoc-His(Trt)-OH. A small sample of the resin was cleaved and analyzed by MALDI-TOF: calculated for C<sub>53</sub>H<sub>68</sub>BrN<sub>10</sub>O<sub>10</sub> 1083.4, found 1083.0 (M + H)<sup>+</sup>.</div></div></div><div id="sec4_2_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <span class="smallcaps smallerCapital">d</span>-Leu Substituted A2 Analogues</h3><div id="sec4_2_4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <span class="smallcaps smallerCapital">d</span>-Leu5-pyr-1-apelin-13 A2 (<b>8</b>)</h4><div class="NLM_p last">Advanced intermediate <b>7</b> (0.1 mmol) was subjected to manual SPPS, introducing amino acids in the following order: Fmoc-Ser(<sup><i>t</i></sup>Bu)-OH, Fmoc-<span class="smallcaps smallerCapital">d</span>-Leu-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Pro-OH, Fmoc-Arg(Pmc)-OH, and pyr-Glu-OH. A portion (0.05 mmol) of resin-bound peptide was cleaved and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 20.6 min. The desired peptide was isolated as a white solid after lyophilization (11.3 mg, 14%). Monoisotopic MW calculated for C<sub>69</sub>H<sub>111</sub>BrN<sub>22</sub>O<sub>16</sub> 791.3860, found high resolution (FTICR-ESI-MS) 791.3846 (M + 2H)<sup>2+</sup>.</div></div><div id="sec4_2_4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <span class="smallcaps smallerCapital">d</span>-Leu9-apelin-17 A2 (<b>9</b>)</h4><div class="NLM_p last">Advanced intermediate <b>7</b> (0.1 mmol) was subjected to manual SPPS, introducing amino acids in the following order: Fmoc-Ser(<sup><i>t</i></sup>Bu)-OH, Fmoc-<span class="smallcaps smallerCapital">d</span>-Leu-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Pro-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Gln(Trt)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Phe-OH, and Fmoc-Lys(Boc)-OH. A portion (0.05 mmol) of resin-bound peptide was cleaved and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 11.2 min. The desired peptide was isolated as a white solid after lyophilization (9.9 mg, 9.1%). Monoisotopic MW calculated for C<sub>96</sub>H<sub>161</sub>BrN<sub>34</sub>O<sub>20</sub> 547.2947, found high resolution (FTICR-ESI-MS) 547.2942 (M + 4H)<sup>4+</sup>.</div></div></div><div id="sec4_2_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-Methylleucine A2 Analogues</h3><div id="sec4_2_4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Benzyl <i>N</i>-((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((<i>tert</i>-butoxycarbonyl)amino)pentanoyl)-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-leucinate (<b>20</b>)</h4><div class="NLM_p last">Fmoc-Orn(Boc)-OH (1.23 g, 2.70 mmol), HATU (1.03 g, 2.70 mmol), HOAt (4.5 mL [0.6 M solution in DMF], 2.70 mmol), and DIPEA (1.28 mL, 7.36 mmol) were dissolved in dry DMF (10 mL) and stirred for 5 min to preactivate the amino acid. A solution of <i>N</i>-Me-Leu-OBn <i>p</i>-TsOH salt (1.00 g, 2.45 mmol) and DIPEA (0.43 mL, 2.45 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added, and the reaction was stirred for 17 h at room temperature. The reaction was washed with 10% aqueous NaHCO<sub>3</sub> (20 mL), 10% aqueous citric acid (20 mL), and brine (20 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The dipeptide was purified using flash chromatography (silica gel, 25% EtOAc in hexanes), obtaining <b>20</b> as a crunchy white solid (1.25 g, 76%) (<i>R</i><sub><i>f</i></sub> = 0.9 on SiO<sub>2</sub>, 1:3 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> −17.4 (<i>c</i> 1.0, CH<sub>2</sub>Cl<sub>2</sub>); IR (CH<sub>2</sub>Cl<sub>2</sub> cast) 3315, 3066, 3037, 2957, 2870, 1714, 1645, 1513, 1451, 1251, 1172 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.76 (d, <i>J</i> = 7.5 Hz, 2H, Ar-H), 7.59 (d, <i>J</i> = 7.5 Hz, 2H, Ar-H), 7.43–7.27 (m, 9H, Ar-H), 5.65 (d, <i>J</i> = 8.5 Hz, 1H, Fmoc-NH), 5.35 (dd, <i>J</i> = 10.8, 5.0 Hz, 1H, Leu-CHα), 5.19–5.06 (m, 2H, Bn-OCH<sub>2</sub>), 4.68 (ddd, <i>J</i> = 7.7, 7.7, 4.8 Hz, 1H, Orn-CHα), 4.51 (s, 1H, Boc-NH), 4.37 (ddd, <i>J</i> = 10.6, 7.1, 7.1 Hz, 2H, Fmoc-CH<sub>2</sub>), 4.21 (t, <i>J</i> = 7.1 Hz, 1H, Fmoc-CH), 3.09–3.04 (m, 2H, Orn-CH<sub>2</sub>δ), 2.93 (s, 3H, N-CH<sub>3</sub>), 1.81–1.65 (m, 3H, 2 × Leu-CH<sub>2</sub>β, Orn-CH<sub>2</sub>β), 1.56–1.46 (m, 4H, Orn-CH<sub>2</sub>β, 2 × Orn-CH<sub>2</sub>γ, Leu-CH(CH<sub>3</sub>)<sub>2</sub>), 1.44 (s, 9H, -C(CH<sub>3</sub>)<sub>3</sub>), 1.01–0.84 (m, 6H, -CH(CH<sub>3</sub>)<sub>2</sub>). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 172.6, 171.3, 156.0, 155.9, 143.9, 143.8, 141.3, 141.3, 135.4, 128.7, 128.5, 128.4, 127.7, 127.1, 127.1, 125.2, 120.0, 79.1, 67.1, 67.0, 54.9, 50.7, 47.2, 40.1, 36.8, 31.1, 30.0, 28.5, 25.4, 24.9, 23.2, 21.4. HRMS (ES) calculated for C<sub>39</sub>H<sub>50</sub>N<sub>3</sub>O<sub>7</sub> 672.3643, found 672.3642 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Benzyl (11<i>S</i>,14<i>S,E</i>)-11-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((<i>tert</i>-butoxycarbonyl)amino)-14-isobutyl-2,2,13-trimethyl-4,12-dioxo-3-oxa-5,7,13-triazapentadec-5-en-15-oate (<b>21</b>)</h4><div class="NLM_p last">The guanidinylation reaction was adapted from a literature procedure.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> TFA (5 mL) was added to a solution of dipeptide <b>20</b> (0.701 g, 1.04 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and stirred for 1 h. The reaction was concentrated in vacuo, using diethyl ether coevaporations to remove residual TFA. The yellow oil was resuspended in dry CH<sub>2</sub>Cl<sub>2</sub> (20 mL), and 1,3-di-Boc-2-(trifluoromethylsulfonyl)guanidine (0.449 g, 1.15 mmol) and triethylamine (0.32 mL, 2.30 mmol) were added and stirred for 80 min. The reaction was washed with 2 N aqueous sodium bisulfate (10 mL) and 10% NaHCO<sub>3</sub> (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The dipeptide was purified using flash chromatography (silica gel, 20% EtOAc in hexanes), obtaining <b>21</b> as a crunchy white solid (0.820 g, 97%) (<i>R</i><sub><i>f</i></sub> = 0.5 on SiO<sub>2</sub>, 3:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> −12.5 (<i>c</i> 1.21 CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3331, 2959, 2871, 1721, 1640, 1451, 1415, 1330, 1156, 1134 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 8.29 (t, <i>J</i> = 5.4 Hz, 1H, Arg-N<u class="uu">H</u>ε), 7.76 (d, <i>J</i> = 7.6 Hz, 2H, Ar-<u class="uu">H</u>), 7.60 (d, <i>J</i> = 7.6 Hz, 2H, Ar-<u class="uu">H</u>), 7.43–7.27 (m, 9H, Ar-<u class="uu">H</u>), 5.68 (d, <i>J</i> = 8.5 Hz, 1H, Fmoc-N<u class="uu">H</u>), 5.37–5.28 (m, 1H, Leu-C<u class="uu">H</u>α), 5.23–5.05 (m, 2H, -OC<u class="uu">H</u><sub>2</sub>Ph), 4.67 (td, <i>J</i> = 8.1, 4.3 Hz, 1H, Arg-C<u class="uu">H</u>α), 4.44–4.31 (m, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.21 (t, <i>J</i> = 6.9 Hz, 1H, Fmoc-C<u class="uu">H</u>), 3.36 (ddd, <i>J</i> = 7.4, 5.0, 3.2 Hz, 2H, Arg-C<u class="uu">H</u><sub>2</sub>δ), 2.93 (s, 3H, N-C<u class="uu">H</u><sub>3</sub>), 1.82–1.75 (m, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.75–1.66 (m, 2H, Leu-C<u class="uu">H</u><sub>2</sub>β, Arg-C<u class="uu">H</u><sub>2</sub>β), 1.63–1.55 (m, 3H, Arg-C<u class="uu">H</u><sub>2</sub>β, 2 × Arg-C<u class="uu">H</u><sub>2</sub>γ) 1.49 (m, 10H, Leu-C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.48 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.93 (d, <i>J</i> = 6.6 Hz, 3H, Leu-CH(C<u class="uu">H</u><sub>3</sub>)<sub>2</sub>), 0.90 (d, <i>J</i> = 6.5 Hz, 3H, Leu-CH(C<u class="uu">H</u><sub>3</sub>)<sub>2</sub>). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 172.5, 171.2, 163.6, 156.2, 156.0, 153.3, 143.9, 143.8, 141.3, 141.3, 135.4, 128.7, 128.6, 128.4, 127.7, 127.1, 127.1, 125.2, 125.2, 120.0, 83.1, 79.2, 67.1, 67.0, 54.9, 50.8, 47.2, 40.3, 36.8, 31.2, 29.9, 28.3, 28.1, 27.9, 27.9, 24.9, 23.2, 21.4. HRMS (ES) calculated for C<sub>45</sub>H<sub>60</sub>N<sub>5</sub>O<sub>9</sub> 814.4386, found 814.4378 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (11<i>S</i>,14<i>S,E</i>)-11-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((<i>tert</i>-butoxycarbonyl)amino)-14-isobutyl-2,2,13-trimethyl-4,12-dioxo-3-oxa-5,7,13-triazapentadec-5-en-15-oic Acid (<b>22</b>)</h4><div class="NLM_p last">A solution of <b>21</b> (0.501 g, 0.62 mmol) was dissolved in methanol (50 mL) and had 10% Pd/C (20 mg) added. The suspension was stirred under hydrogen gas for 22 h, filtered through a pad of Celite, and concentrated in vacuo. The crude residue was purified using flash chromatography (silica gel, 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, 0.1% AcOH), yielding <b>22</b> as a white solid (0.378 g, 85%) (<i>R</i><sub><i>f</i></sub> = 0.2 on SiO<sub>2</sub>, 1% AcOH in EtOAc); [α]<sub>D</sub><sup>26</sup> −2.8 (<i>c</i> 1.0, CH<sub>2</sub>Cl<sub>2</sub>); IR (CH<sub>2</sub>Cl<sub>2</sub> cast) 3326, 3140, 3066, 2959, 2872, 1721, 1641, 1618, 1451, 1415, 1331, 1253, 1136 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 8.48 (s, 1H, Arg-N<u class="uu">H</u>ε), 7.76 (d, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 7.61 (d, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 7.40 (t, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 7.32 (tdd, <i>J</i> = 7.5, 3.4, 1.2 Hz, 2H, Ar-<u class="uu">H</u>), 6.05 (d, <i>J</i> = 7.6 Hz, 1H, Fmoc-N-<u class="uu">H</u>), 5.37 (dd, <i>J</i> = 10.7, 5.1 Hz, 1H, Leu-C<u class="uu">H</u>α), 4.80 (dd, <i>J</i> = 5.4, 5.3 Hz, 1H, Arg-C<u class="uu">H</u>α), 4.38 (dd, <i>J</i> = 10.6, 7.2 Hz, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.21 (t, <i>J</i> = 7.1 Hz, 1H, Fmoc-C<u class="uu">H</u>), 3.55–3.45 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>δ), 3.14–3.05 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>δ), 2.98 (s, 3H, N-C<u class="uu">H</u><sub>3</sub>), 1.92–1.56 (m, 6H, 2 × Leu-C<u class="uu">H</u><sub>2</sub>β, 2 × Arg-C<u class="uu">H</u><sub>2</sub>β, 2 × Arg-C<u class="uu">H</u><sub>2</sub>γ), 1.52 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.49 (m, 10H, Leu-C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.96 (d, <i>J</i> = 6.6 Hz, 3H, Leu-CH(C<u class="uu">H</u><sub>3</sub>)<sub>2</sub>), 0.93 (d, <i>J</i> = 6.5 Hz, 3H, Leu-CH(C<u class="uu">H</u><sub>3</sub>)<sub>2</sub>). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 172.3, 172.1, 162.8, 156.3, 155.7, 153.2, 144.9, 143.8, 141.4, 141.3, 127.7, 127.7, 127.1, 127.1, 125.2, 125.2, 120.0, 119.9, 83.1, 80.6, 66.9, 54.7, 51.1, 47.3, 40.6, 36.1, 30.7, 28.4, 28.1, 28.1, 24.8, 23.2, 21.4. HRMS (ES) calculated for C<sub>38</sub>H<sub>54</sub>N<sub>5</sub>O<sub>9</sub> 724.3916, found 724.3924 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-MeLeu5-pyr-1-apelin-13 A2 (<b>10</b>)</h4><div class="NLM_p last">Advanced intermediate <b>7</b> (0.1 mmol) was subjected to manual SPPS, introducing amino acids in the following order: Fmoc-Ser(<sup><i>t</i></sup>Bu)-OH,<b>22</b>, Fmoc-Pro-OH, Fmoc-Arg(Pmc)-OH. The resin was split into half, and Fmoc-SPPS was continued on 0.1 mmol scale, coupling pyr-Glu-OH. No end-capping was performed following addition of <b>22</b>. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 11.2 min. The desired peptide was isolated as a white solid after lyophilization (6.0 mg, 7%). Monoisotopic MW calculated for C<sub>70</sub>H<sub>114</sub>BrN<sub>22</sub>O<sub>16</sub> 532.5983, found high resolution (FTICR-ESI-MS) 532.5972 (M + 3H)<sup>3+</sup>.</div></div><div id="sec4_2_4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-MeLeu9-apelin-17 A2 (<b>11</b>)</h4><div class="NLM_p last">The remaining 0.1 mmol carried over from the synthesis of <b>10</b> was coupled with Fmoc-Gln(Trt)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Phe-OH, and Fmoc-Lys(Boc)-OH. No end-capping was performed following addition of <b>22</b>. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 11.3 min. The desired peptide was isolated as a white solid after lyophilization (23.8 mg, 22%). Monoisotopic MW calculated for C<sub>97</sub>H<sub>163</sub>BrN<sub>34</sub>O<sub>20</sub> 550.7986, found high resolution (FTICR-ESI-MS) 550.7983 (M + 4H)<sup>4+</sup>.</div></div></div><div id="sec4_2_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> α-Methylarginine A2 Analogues</h3><div id="sec4_2_4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-Azido-3-iodopropane (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was prepared according to literature procedures.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> A solution of 1-chloro-3-iodopropane (2.63 mL, 24.5 mmol) and sodium azide (1.91 g, 29.4 mmol) in dry DMF (60 mL) was stirred at room temperature for 24 h. The reaction was diluted by the addition of water (100 mL), and diethyl ether washes (2 × 100 mL) were used to extract organic components. The diethyl ether fractions were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo until a small volume (∼10 mL) of ether remained. The reaction was diluted in acetone (60 mL), and following the addition of sodium iodide (5.50 g, 36.7 mmol), the reaction was heated at 60 °C for 24 h. The solution was concentrated in vacuo until a small volume (∼10 mL) remained, then diluted with diethyl ether (100 mL) and washed with H<sub>2</sub>O (2 × 100 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, vacuum filtered through a small plug of alumina, and concentrated in vacuo, obtaining the desired product as a light yellow oil (3.91 g, 76%). IR (CH<sub>2</sub>Cl<sub>2</sub> cast) 2927, 2869, 2098, 1449, 1428, 1347, 1290, 1224, 1173 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 3.44 (t, <i>J</i> = 6.4 Hz, 2H, -CH<sub>2</sub>N<sub>3</sub>), 3.25 (t, <i>J</i> = 6.6 Hz, 2H, -CH<sub>2</sub>I), 2.04 (app pentet, <i>J</i> = 6.5 Hz, 2H, -CH<sub>2</sub>-). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 51.5, 32.4, 2.3.</div></div><div id="sec4_2_4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (2<i>S</i>)-2-(3′-Azidopropyl)-2-methylglycine-Ni(II)-(<i>S</i>)-BPB (<b>25</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0013.gif" alt="" id="fx1" /></img><div class="NLM_p last">Complex <b>25</b> was prepared according to literature procedure.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Nickel complex <b>23</b> (6.49 g, 12.7 mmol) and potassium <i>tert</i>-butoxide (2.13 g, 19.0 mmol) were added to an RBF and dissolved in dry DMF (50 mL) at 0 °C under an Ar atmosphere. This solution was stirred for 3 min, followed by the addition of a solution of <b>24</b> (5.01 g, 19.0 mmol) in dry DMF (10 mL). The reaction was stirred at 0 °C for 45 min, then warmed to room temperature for 75 min. 5% aqueous acetic acid (200 mL) was added to quench the reaction, followed by extraction with CH<sub>2</sub>Cl<sub>2</sub> (3 × 75 mL). Pooled organic layers were washed with brine (2 × 75 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The desired diastereomer was purified by flash chromatography (silica gel; 2.5% MeOH in EtOAc), yielding <b>25</b> as a red solid (5.18 g, 69%). Crystals of <b>25</b> were obtained after dissolution in minimal CH<sub>2</sub>Cl<sub>2</sub>, dilution with hexanes, and slow evaporation (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf" class="ext-link">Supporting Information Figure S1</a>) (<i>R</i><sub><i>f</i></sub> = 0.6 on SiO<sub>2</sub>, 9:1 EtOAc/MeOH); [α]<sub>D</sub><sup>26</sup> 1853.4 (<i>c</i> 1.0, CH<sub>2</sub>Cl<sub>2</sub>); IR (CH<sub>2</sub>Cl<sub>2</sub> cast) 3060, 2937, 2869, 2097, 1673, 1639, 1574, 1439, 1359, 1253, 1165 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 8.12–8.07 (m, 2H, Ar-<u class="uu">H</u><sub>1</sub>), 8.05 (dd, <i>J</i> = 8.7, 0.9 Hz, 1H, Ar-<u class="uu">H</u><sub>4</sub>), 7.55–7.48 (m, 2H, Ar-<u class="uu">H</u><sub>8</sub>, Ar-<u class="uu">H</u><sub>9</sub>), 7.47–7.41 (m, 3H, Ar-<u class="uu">H</u><sub>2</sub>, Ar-<u class="uu">H</u><sub>11</sub>), 7.35–7.28 (m, 2H, Ar-<u class="uu">H</u><sub>3</sub>, Ar-<u class="uu">H</u><sub>10</sub>), 7.16 (ddd, <i>J</i> = 8.5, 5.8, 2.7 Hz, 1H, Ar-<u class="uu">H</u><sub>5</sub>), 7.08 (dt, <i>J</i> = 7.6, 1.3 Hz, 1H Ar-<u class="uu">H</u><sub>12</sub>), 6.69–6.62 (m, 2H, Ar-<u class="uu">H</u><sub>6</sub>, Ar-<u class="uu">H</u><sub>7</sub>), 4.50 (d, <i>J</i> = 12.7 Hz, 1H, Ph-C<u class="uu">H</u><sub>2</sub>-N), 3.70 (dd, <i>J</i> = 18.7, 11.8 Hz, 2H, Ph-C<u class="uu">H</u><sub>2</sub>-N, Pro-C<u class="uu">H</u><sub>2</sub>δ), 3.51–3.42 (m, 2H, Pro-C<u class="uu">H</u>α, -C<u class="uu">H</u><sub>2</sub>N<sub>3</sub>), 3.32–3.20 (m, 2H, -C<u class="uu">H</u><sub>2</sub>N<sub>3</sub>, Pro-C<u class="uu">H</u><sub>2</sub>γ), 2.71 (dddd, <i>J</i> = 12.8, 7.1, 5.8, 2.6 Hz, 1H, Pro-C<u class="uu">H</u><sub>2</sub>β), 2.58–2.43 (m, 2H, Pro-C<u class="uu">H</u><sub>2</sub>β, -C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>N<sub>3</sub>), 2.26–2.04 (m, 3H, -C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>N<sub>3</sub>, Pro-C<u class="uu">H</u><sub>2</sub>γ, Pro-C<u class="uu">H</u><sub>2</sub>δ), 1.86 (ddd, <i>J</i> = 13.8, 12.4, 4.2 Hz, 1H, -C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N<sub>3</sub>), 1.76 (ddd, <i>J</i> = 13.7, 12.4, 4.6 Hz, 1H, -C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N<sub>3</sub>), 1.28 (s, 3H, -C<u class="uu">H</u><sub>3</sub>); <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 182.0, 180.6, 172.8, 141.6, 136.4, 133.4, 133.4, 131.8, 131.7, 130.2, 129.6, 129.1, 129.0, 128.5, 128.1, 127.3, 127.1, 124.0, 120.8, 77.4, 70.0, 63.5, 57.2, 51.3, 37.5, 30.7, 29.4, 25.5, 23.4. HRMS (ES) calculated for C<sub>31</sub>H<sub>32</sub>N<sub>6</sub>NaNiO<sub>3</sub> 617.1782, found 617.1785 (M + Na)<sup>+</sup>.</div></div><div id="sec4_2_4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-5-azido-2-methylpentanoic Acid (<b>26</b>)</h4><div class="NLM_p last">A solution of 3 N HCl/MeOH (1:1, 40 mL) was heated to 70 °C and had <b>25</b> (2.60 g, 4.37 mmol) dissolved in MeOH (10 mL) added dropwise over 5 min. The reaction mixture was stirred for 50 min at 70 °C, turning from dark red to green as the reaction proceeded. The reaction was cooled to room temperature, concentrated in vacuo, and resuspended in 10% aqueous sodium carbonate (20 mL). EDTA disodium salt (3.25 g, 8.73 mmol) was added and stirred for 0.5 h at room temperature. The reaction was cooled to 0 °C and had a solution of Fmoc-OSu (1.62 g, 4.80 mmol) dissolved in acetone (20 mL) added to it. This reaction was slowly warmed to room temperature and stirred for 16 h. The following day, the reaction was diluted with EtOAc (50 mL) and washed with 1 N HCl (3 × 20 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The product was purified by flash chromatography (silica gel, 1–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub> gradient), yielding <b>26</b> as a white solid (1.64 g, 95%) (<i>R</i><sub><i>f</i></sub> = 0.4 on SiO<sub>2</sub>, 9:1 EtOAc/MeOH). <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.77 (d, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 7.58 (d, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 7.40 (td, <i>J</i> = 7.4, 3.1 Hz, 2H, Ar-<u class="uu">H</u>), 7.32 (tdd, <i>J</i> = 7.4, 2.6, 1.1 Hz, 2H, Ar-<u class="uu">H</u>), 5.57 (br s, 1H, Fmoc-N<u class="uu">H</u>), 4.48–4.36 (m, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.21 (t, <i>J</i> = 6.2 Hz, 1H, Fmoc-C<u class="uu">H</u>), 3.32–3.19 (m, 2H, -C<u class="uu">H</u><sub>2</sub>N<sub>3</sub>), 2.28–2.17 (m, 1H, Orn-C<u class="uu">H</u><sub>2</sub>γ), 2.02–1.90 (m, 1H, Orn-C<u class="uu">H</u><sub>2</sub>γ), 1.60 (br s, 3H, -C<u class="uu">H</u><sub>3</sub>), 1.50–1.39 (m, 2H, Orn-C<u class="uu">H</u><sub>2</sub>β). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 170.1, 153.9, 143.8, 141.4, 127.7, 127.1, 125.0, 120.0, 66.6, 51.1, 47.2, 34.0, 33.4, 23.7, 23.5. HRMS (ES) calculated for C<sub>21</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub> 393.1568, found 393.1566 (M – H)<sup>−</sup>.</div></div><div id="sec4_2_4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl ((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-5-azido-2-methylpentanoyl)-<span class="smallcaps smallerCapital">l</span>-leucinate (<b>27</b>)</h4><div class="NLM_p last">Compound <b>26</b> (1.61 g, 4.09 mmol), HATU (1.55 g, 4.09 mmol), HOAt (0.68 mL [0.6 M solution in DMF], 0.41 mmol), and DIPEA (2.85 mL, 16.4 mmol) were dissolved in dry DMF (25 mL) and stirred for 5 min to preactivate the amino acid. A solution of H-Leu-OMe·HCl (0.780 g, 4.29 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the reaction was stirred for 16 h at room temperature. The reaction was concentrated in vacuo, resuspended in EtOAc (50 mL), and washed with 10% citric acid, water, and brine (50 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Crude <b>27</b> was purified using flash chromatography (silica gel, 33% EtOAc in hexanes), obtaining the desired dipeptide as a yellow oil (1.22 g, 57%) (<i>R</i><sub><i>f</i></sub> = 0.5 on SiO<sub>2</sub>, 2:1 hexane/EtOAc); [α]<sub>D</sub><sup>26</sup> −1.2 (<i>c</i> 1.0, CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3342, 2956, 2872, 2097, 1731, 1664, 1495, 1450, 1249, 1089 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.76 (dd, <i>J</i> = 7.4, 1.0 Hz, 2H, Ar-<u class="uu">H</u>), 7.59 (ddd, <i>J</i> = 7.5, 4.0, 1.0 Hz, 2H, Ar-<u class="uu">H</u>), 7.44–7.35 (m, 2H, Ar-<u class="uu">H</u>), 7.32 (dddd, <i>J</i> = 7.5, 7.5, 2.2, 1.2 Hz, 2H, Ar-<u class="uu">H</u>), 6.38 (br s, 1H, Leu-N<u class="uu">H</u>), 5.83 (br s, 1H, Fmoc-N<u class="uu">H</u>), 4.60 (ddd, <i>J</i> = 8.6, 8.0, 4.7 Hz, 1H, Leu-C<u class="uu">H</u>α), 4.49–4.35 (m, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.20 (t, <i>J</i> = 6.6 Hz, 1H, Fmoc-C<u class="uu">H</u>), 3.72 (s, 3H, -OC<u class="uu">H</u><sub>3</sub>), 3.34–3.18 (m, 2H, Arg-C<u class="uu">H</u><sub>2</sub>δ), 2.47–2.23 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>β), 1.84–1.76 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>β), 1.70–1.40 (m, 8H, Arg-C<u class="uu">H</u><sub>3</sub>, 2 × Arg-C<u class="uu">H</u><sub>2</sub>γ, 2 × Leu-C<u class="uu">H</u><sub>2</sub>β, -C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 0.93 (m, 6H, -CH(C<u class="uu">H</u><sub>3</sub>)<sub>2</sub>). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 173.4, 173.1, 154.6, 143.9, 143.9, 141.4, 127.7, 127.1, 127.1, 125.0, 120.0, 66.5, 59.4, 52.4, 51.2, 51.1, 47.3, 41.3, 33.9, 25.0, 24.0, 23.5, 22.8, 21.9. HRMS (ES) calculated for C<sub>28</sub>H<sub>35</sub>N<sub>5</sub>NaO<sub>5</sub> 544.2530, found 544.2527 (M + Na)<sup>+</sup>.</div></div><div id="sec4_2_4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl ((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((<i>Z</i>)-2,3-bis(<i>tert</i>-butoxycarbonyl)guanidino)-2-methylpentanoyl)-<span class="smallcaps smallerCapital">l</span>-leucinate (<b>28</b>)</h4><div class="NLM_p last">The guanidinylation reaction was adapted from a literature procedure.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Dipeptide <b>27</b> (1.16 g, 2.23 mmol) was dissolved in MeOH (50 mL) and had 10% Pd/C (20 mg) added. The suspension was stirred under hydrogen gas for 2 h, filtered through a pad of Celite, and concentrated in vacuo. The crude residue was suspended in CH<sub>2</sub>Cl<sub>2</sub> (30 mL), and 1,3-di-Boc-2-(trifluoromethylsulfonyl)guanidine (0.961 g, 2.45 mmol) and triethylamine (0.69 mL, 4.91 mmol) were added. This reaction was stirred at room temperature under Ar for 18 h, concentrated in vacuo, and purified using flash chromatography (silica gel, 35% EtOAc in hexanes), yielding <b>28</b> as a white solid (1.08 g, 66%) (<i>R</i><sub><i>f</i></sub> = 0.4 on SiO<sub>2</sub>, 3:1 hexane/EtOAc); [α]<sub>D</sub><sup>26</sup> 3.2 (<i>c</i> 1.0, CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3332, 2959, 1723, 1644, 1619, 1495, 1451, 1369, 1332, 1234, 1155, 1135, 1057 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 8.28 (s, 1H, Arg-N<u class="uu">H</u>ε), 7.76 (dt, <i>J</i> = 7.5, 0.9 Hz, 2H, Ar-<u class="uu">H</u>), 7.60 (ddq, <i>J</i> = 7.7, 5.0, 1.0 Hz, 2H, Ar-<u class="uu">H</u>), 7.46–7.36 (m, 2H, Ar-<u class="uu">H</u>), 7.32 (dddd, <i>J</i> = 7.4, 7.4, 3.8, 1.2 Hz, 2H, Ar-<u class="uu">H</u>), 6.39 (br s, 1H, Leu-N<u class="uu">H</u>), 5.82 (br s, 1H, Fmoc-N<u class="uu">H</u>), 4.62–4.53 (m, 1H, Leu-C<u class="uu">H</u>α), 4.46–4.36 (m, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.21 (t, <i>J</i> = 6.7 Hz, 1H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 3.71 (s, 3H, -OC<u class="uu">H</u><sub>3</sub>), 3.44–3.32 (m, 2H, Arg-C<u class="uu">H</u><sub>2</sub>δ), 2.35–2.19 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>β), 1.82–1.71 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>β), 1.70–1.51 (m, 8H, Arg-C<u class="uu">H</u><sub>3</sub>, 2 × Arg-C<u class="uu">H</u><sub>2</sub>γ, 2 × Leu-C<u class="uu">H</u><sub>2</sub>β, -C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 1.49 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.48 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.93 (d, <i>J</i> = 6.2 Hz, 6H, -CH(C<u class="uu">H</u><sub>3</sub>)<sub>2</sub>). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 173.5, 173.2, 163.5, 156.2, 153.2, 143.9, 143.9, 141.3, 127.7, 127.1, 127.1, 125.0, 120.0, 83.1, 79.3, 66.5, 59.5, 52.4, 51.1, 47.3, 41.2, 40.6, 28.3, 28.1, 25.0, 24.0, 23.7, 22.8, 21.8. HRMS (ES) calculated for C<sub>39</sub>H<sub>56</sub>N<sub>5</sub>O<sub>9</sub> 738.4073, found 738.4069 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> ((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((<i>Z</i>)-2,3-bis(<i>tert</i>-butoxycarbonyl)guanidino)-2-methylpentanoyl)-<span class="smallcaps smallerCapital">l</span>-leucine (<b>29</b>)</h4><div class="NLM_p last">Methyl ester deprotection conditions were adapted from a literature protocol.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Dipeptide <b>28</b> (1.06 g, 1.44 mmol) was dissolved in aqueous 2-propanol (70% 2-propanol in water, 50 mL) and had CaCl<sub>2</sub>·2H<sub>2</sub>O (5.88 g) added to generate a 0.8 M Ca<sup>2+</sup> solution. Sodium hydroxide (0.115 g, 2.87 mmol) was added, and the reaction was stirred for 3.5 h. Acetic acid (0.164 mL, 2.87 mmol) was added to neutralize residual base, and the reaction was concentrated in vacuo. The crude residue was dissolved in minimal MeOH and the dipeptide was precipitated by the addition of H<sub>2</sub>O and collected by vacuum filtration, yielding <b>29</b> as a white solid (0.982 g, 94%) (<i>R</i><sub><i>f</i></sub> = 0.05 on SiO<sub>2</sub>, 1:1 hexane/EtOAc); [α]<sub>D</sub><sup>26</sup> −6.0 (<i>c</i> 1.0 MeOH); IR (MeOH cast) 3347, 2957, 1722, 1641, 1450, 1416, 1368, 1331, 1135 cm<sup>–1</sup>. <sup>1</sup>H (CD<sub>3</sub>OD, 500 MHz): δ 7.89 (s, 1H, Arg-N<u class="uu">H</u>ε), 7.78 (dt, <i>J</i> = 7.6, 0.9 Hz, 2H, Ar-<u class="uu">H</u>), 7.70–7.64 (m, 2H, Ar-<u class="uu">H</u>), 7.41–7.34 (m, 2H, Ar-<u class="uu">H</u>), 7.30 (td, <i>J</i> = 7.4, 1.1 Hz, 3H, Ar-<u class="uu">H</u>), 4.38 (d, <i>J</i> = 6.6 Hz, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.25–4.19 (m, 2H, Fmoc-C<u class="uu">H</u>, Leu-C<u class="uu">H</u>α), 3.33–3.27 (m, 2H, Arg-C<u class="uu">H</u><sub>2</sub>δ), 2.03–1.94 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>β), 1.84–1.75 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>β), 1.68–1.52 (m, 4H, -C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>, 2 × Leu-C<u class="uu">H</u><sub>2</sub>β, Arg-C<u class="uu">H</u><sub>2</sub>γ), 1.50 (d, <i>J</i> = 3.7 Hz, 10H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>, Arg-C<u class="uu">H</u><sub>2</sub>γ), 1.44 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.40 (s, 3H, Arg-C<u class="uu">H</u><sub>3</sub>), 0.88 (d, <i>J</i> = 6.4 Hz, 3H, -CH(C<u class="uu">H</u><sub>3</sub>)<sub>2</sub>), 0.87 (d, <i>J</i> = 6.4 Hz, 3H, -CH(C<u class="uu">H</u><sub>3</sub>)<sub>2</sub>). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 176.3, 172.4, 164.6, 157.5, 154.1, 145.3, 142.7, 128.9, 128.2, 126.2, 121.0, 84.5, 80.4, 79.5, 67.8, 60.6, 49.6, 49.3, 41.8, 28.6, 28.3, 26.1, 24.7, 23.7, 22.1. HRMS (ES) calculated for C<sub>38</sub>H<sub>54</sub>N<sub>5</sub>O<sub>9</sub> 724.3916, found 724.3913 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> α-MeArg4-pyr-1-apelin-13 A2 (<b>12</b>)</h4><div class="NLM_p last">Advanced intermediate <b>7</b> (0.2 mmol) was subjected to manual SPPS, introducing amino acids in the following order: Fmoc-Ser(<sup><i>t</i></sup>Bu)-OH,<b>29</b>, Fmoc-Pro-OH, Fmoc-Arg(Pmc)-OH. The resin was split into half, and Fmoc-SPPS was continued on 0.1 mmol scale, coupling pyr-Glu-OH. No end-capping was performed following addition of <b>29</b>. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 13.4 min. The desired peptide was isolated as a white solid after lyophilization (8.5 mg, 11%). Monoisotopic MW calculated for C<sub>70</sub>H<sub>114</sub>BrN<sub>22</sub>O<sub>16</sub> 532.5983, found high resolution (FTICR-ESI-MS) 532.5973 (M + 3H)<sup>3+</sup>.</div></div><div id="sec4_2_4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> α-MeArg8-apelin-17 A2 (<b>13</b>)</h4><div class="NLM_p last">The remaining 0.1 mmol carried over from the synthesis of <b>12</b> was coupled with Fmoc-Gln(Trt)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Phe-OH, and Fmoc-Lys(Boc)-OH. No end-capping was performed following addition of <b>29</b>. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 13.0 min. The desired peptide was isolated as a white solid after lyophilization (12.5 mg, 11%). Monoisotopic MW calculated for C<sub>97</sub>H<sub>163</sub>BrN<sub>34</sub>O<sub>20</sub> 550.7986, found high resolution (FTICR-ESI-MS) 550.7974 (M + 4H)<sup>4+</sup>.</div></div></div><div id="sec4_2_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> α-Methylleucine A2 Analogues</h3><div id="sec4_2_4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (2<i>S</i>)-2-(2′-Methylpropyl)-2-methylglycine-Ni(II)-(<i>S</i>)-BPB (<b>30</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0014.gif" alt="" id="fx2" /></img><div class="NLM_p last">Alkylation conditions were adapted from literature protocol.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Nickel complex <b>23</b> (3.20 g, 6.25 mmol) and potassium <i>tert</i>-butoxide (1.05 g, 9.37 mmol) were added to an RBF and dissolved in dry DMF (25 mL) at 0 °C under an Ar atmosphere. This solution was stirred for 3 min, followed by the addition of 1-iodo-2-methylpropane (2.16 mL, 18.7 mmol). The reaction was stirred at 0 °C for 30 min, then warmed to room temperature for an additional 75 min. 5% aqueous acetic acid (100 mL) was added to quench the reaction, followed by extraction with CH<sub>2</sub>Cl<sub>2</sub> (3 × 75 mL). The pooled organic layers were washed with brine (2 × 75 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The desired diastereomer was purified by flash chromatography (silica gel; 2.5% MeOH in EtOAc), yielding <b>30</b> as a red solid (2.43 g, 69%). Crystals of <b>30</b> were obtained after dissolution in minimal CH<sub>2</sub>Cl<sub>2</sub>, dilution with hexanes, and slow evaporation (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>) (<i>R</i><sub><i>f</i></sub> = 0.6 on SiO<sub>2</sub>, 9:1 EtOAc/MeOH); [α]<sub>D</sub><sup>26</sup> 1683.7 (<i>c</i> 1.0, CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 2959, 2870, 1668, 1639, 1535, 1439, 1360, 1253, 1170 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 8.12–8.06 (m, 3H Ar-H<sub>1</sub>, Ar-H<sub>4</sub>), 7.51–7.43 (m, 2H, Ar-H<sub>8</sub>, Ar-H<sub>9</sub>), 7.42–7.36 (m, 3H, Ar-H<sub>2</sub>, Ar-H<sub>11</sub>), 7.34–7.22 (m, 2H, Ar-H<sub>3</sub>, Ar-H<sub>10</sub>), 7.12 (ddd, <i>J</i> = 8.6, 6.7, 1.9 Hz, 1H, Ar-H<sub>5</sub>), 7.06–7.00 (m, 1H, Ar-H<sub>12</sub>), 6.64–6.53 (m, 2H, Ar-H<sub>6</sub>, Ar-H<sub>7</sub>), 4.48 (d, <i>J</i> = 12.7 Hz, 1H, Ph-CH<sub>2</sub>-N), 3.74–3.64 (m, 2H, Ph-CH<sub>2</sub>-N, Pro-CH<sub>2</sub>δ), 3.45 (dd, <i>J</i> = 10.6, 6.1 Hz, 1H, Pro-CHα), 3.26–3.10 (m, 1H, Pro-CH<sub>2</sub>γ), 2.74–2.65 (m, 1H, Pro-CH<sub>2</sub>β), 2.56–2.37 (m, 2H, Pro-CH<sub>2</sub>β, Leu-CHγ), 2.13–2.00 (m, 2H, Pro-CH<sub>2</sub>γ, Pro-CH<sub>2</sub>δ), 1.73–1.60 (m, 2H, Leu-CH<sub>2</sub>β), 1.27 (d, <i>J</i> = 6.6 Hz, 3H, Leu-CH<sub>3</sub>δ), 1.22 (s, 3H, Leu-CH<sub>3</sub>β), 1.14 (d, <i>J</i> = 6.7 Hz, 3H, Leu-CH<sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 182.9, 180.6, 172.3, 141.7, 136.8, 133.6, 133.5, 131.7, 131.6, 130.5, 129.4, 129.0, 128.9, 128.4, 127.8, 126.9, 123.8, 120.6, 77.5, 70.2, 63.6, 57.1, 48.5, 30.7, 30.7, 25.6, 24.5, 23.3, 23.3. HRMS (ES) calculated for C<sub>32</sub>H<sub>36</sub>N<sub>3</sub>NiO<sub>3</sub> 568.2105, found 568.2100 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-2,4-dimethylpentanoic Acid (<b>31</b>)</h4><div class="NLM_p last">A solution of 3 N HCl/MeOH (1:1, 10 mL) was heated to 70 °C and had <b>30</b> (2.36 g, 4.16 mmol) dissolved in MeOH (5 mL) added dropwise over 5 min. The reaction mixture was stirred for 40 min, turning from dark red to green as the reaction proceeded. The reaction was cooled to room temperature, concentrated in vacuo, and resuspended in 10% aqueous sodium carbonate (25 mL). EDTA disodium salt (3.09 g, 8.31 mmol) was added and stirred for 0.5 h at room temperature. The reaction was cooled to 0 °C and had a solution of Fmoc-OSu (1.54 g, 4.57 mmol) dissolved in acetone (25 mL) added to it. This reaction was slowly warmed to room temperature and stirred for 22 h. The following day, the reaction was diluted with EtOAc (50 mL) and washed with 1 N HCl (3 × 50 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The product was purified by flash chromatography (silica gel, 1–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub> gradient), yielding <b>31</b> as a white solid (1.45 g, 95%) (<i>R</i><sub><i>f</i></sub> = 0.35 on SiO<sub>2</sub>, 7.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>). <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.80–7.74 (m, 2H, Ar-<u class="uu">H</u>), 7.64–7.57 (m, 2H, Ar-<u class="uu">H</u>), 7.43–7.38 (m, 2H, Ar-<u class="uu">H</u>), 7.37–7.29 (m, 2H, Ar-<u class="uu">H</u>), 5.92 (br s, 1H, N-<u class="uu">H</u>), 4.46–4.33 (m, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.32 (t, 1H, <i>J</i> = 6.0 Hz Fmoc-C<u class="uu">H</u>), 2.26–2.19 (m, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.83–1.73 (m, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.70–1.55 (m, 4H, Leu-C<u class="uu">H</u>γ, Leu-C<u class="uu">H</u><sub>3</sub>β), 0.96–0.82 (m, 6H, 2 × Leu-CH<sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 179.4, 155.2, 143.9, 141.6, 127.8, 127.1, 124.8, 120.0, 65.1, 47.3, 24.9, 24.7, 23.8, 23.0. HRMS (ES) calculated for C<sub>22</sub>H<sub>24</sub>NO<sub>4</sub> 366.1711, found 366.1706 (M – H)<sup>−</sup>.</div></div><div id="sec4_2_4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl <i>N</i>-((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-2,4-dimethylpentanoyl)-<i>O</i>-(<i>tert</i>-butyl)-<span class="smallcaps smallerCapital">l</span>-serinate (<b>32</b>)</h4><div class="NLM_p last">Amino acid <b>31</b> (1.53 g, 4.16 mmol), HATU (1.58 g, 4.16 mmol), HOAt (0.69 mL [0.6 M solution in DMF], 0.42 mmol), and DIPEA (2.90 mL, 16.6 mmol) were dissolved in dry DMF (25 mL) and stirred for 5 min to preactivate the amino acid. A solution of H-Ser(<sup><i>t</i></sup>Bu)-OMe·HCl (0.925 g, 4.37 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the reaction was stirred for 20 h at room temperature. The reaction was concentrated in vacuo, resuspended in EtOAc (50 mL), and washed with 10% citric acid, water, and brine (50 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Crude <b>32</b> was purified using flash chromatography (silica gel, 25% EtOAc in hexanes), obtaining the desired product as a white solid (0.872 g, 40%) (<i>R</i><sub><i>f</i></sub> = 0.2 on SiO<sub>2</sub>, 3:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> 20.4 (<i>c</i> 1.0, CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3440, 3384, 2973, 2956, 2872, 1730, 1669, 1493, 1364, 1241, 1099 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.76 (dd, <i>J</i> = 7.6, 0.9 Hz, 2H, Ar-<u class="uu">H</u>), 7.64–7.58 (m, 2H, Ar-<u class="uu">H</u>), 7.39 (ddd, <i>J</i> = 6.8, 6.8, 0.8 Hz, 2H, Ar-<u class="uu">H</u>), 7.31 (ddd, <i>J</i> = 7.4, 6.8, 1.1 Hz, 2H, Ar-<u class="uu">H</u>), 6.64 (br s, 1H, Ser-N<u class="uu">H</u>), 6.09 (s, 1H, Fmoc-N<u class="uu">H</u>), 4.74–4.68 (m, 1H, Ser-C<u class="uu">H</u>α), 4.43–4.30 (m, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.22 (t, <i>J</i> = 6.8 Hz, 1H, Fmoc-C<u class="uu">H</u>), 3.81 (d, <i>J</i> = 8.8 Hz, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 3.75 (s, 3H, -OC<u class="uu">H</u><sub>3</sub>), 3.57 (d, <i>J</i> = 8.8 Hz, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 2.44–2.31 (m, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.73–1.52 (m, 5H, Leu-C<u class="uu">H</u><sub>2</sub>β, Leu-C<u class="uu">H</u>γ, Leu-C<u class="uu">H</u><sub>3</sub>β), 1.13 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.94–0.82 (m, 6H, 2 × Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 173.9, 170.7, 154.4, 144.1, 144.0, 141.3, 127.6, 127.1, 125.1, 120.0, 73.4, 66.4, 61.9, 59.6, 53.1, 52.4, 47.3, 45.1, 27.3, 25.2, 24.7, 23.7, 23.6. HRMS (ES) calculated for C<sub>30</sub>H<sub>41</sub>N<sub>2</sub>O<sub>6</sub> 525.2959, found 525.2956 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-2,4-dimethylpentanoyl)-<i>O</i>-(<i>tert</i>-butyl)-<span class="smallcaps smallerCapital">l</span>-serine (<b>33</b>)</h4><div class="NLM_p last">Methyl ester deprotection conditions were adapted from literature procedure.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Dipeptide <b>32</b> (0.853 g, 1.63 mmol) was dissolved in aqueous 2-propanol (70% 2-propanol in water, 50 mL) and had CaCl<sub>2</sub>·2H<sub>2</sub>O (5.88 g) added to generate a 0.8 M Ca<sup>2+</sup> solution. Sodium hydroxide (0.130 g, 3.25 mmol) was added, and the reaction was stirred for 4 h. Acetic acid (0.186 mL, 3.25 mmol) was added to neutralize residual base, and the reaction was concentrated in vacuo. The crude residue was purified by flash chromatography (silica gel, 50% EtOAc in hexanes 0.1% AcOH), yielding dipeptide <b>33</b> as a white sticky solid (0.368 g, 44%) (<i>R</i><sub><i>f</i></sub> = 0.3 on SiO<sub>2</sub>, 0.1% AcOH in EtOAc); [α]<sub>D</sub><sup>26</sup> 27.0 (<i>c</i> 1.0, CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3386, 3320, 3068, 3018, 2974, 2876, 1727, 1665, 1497, 1450, 1240, 1194, 1105 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.76 (dd, <i>J</i> = 7.7, 0.9 Hz, 2H, Ar-<u class="uu">H</u>), 7.59 (ddd, <i>J</i> = 7.5, 2.0, 1.0 Hz, 2H, Ar-<u class="uu">H</u>), 7.40 (ddd, <i>J</i> = 7.5, 7.5, 0.9 Hz, 2H, Ar-<u class="uu">H</u>), 7.31 (ddd, <i>J</i> = 7.7, 7.5, 1.2, Hz, 2H, Ar-<u class="uu">H</u>), 6.78 (br s, 1H, Ser-N<u class="uu">H</u>), 5.73 (s, 1H, Fmoc-N<u class="uu">H</u>), 4.67–4.56 (m, 1H, Ser-C<u class="uu">H</u>α), 4.48–4.34 (m, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.20 (t, <i>J</i> = 6.6 Hz, 1H, Fmoc-C<u class="uu">H</u>), 3.95–3.88 (m, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 3.54–3.48 (m, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 2.19–2.07 (m, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.72–1.59 (m, 2H, Leu-C<u class="uu">H</u><sub>2</sub>β, Leu-C<u class="uu">H</u>γ), 1.54 (s, 3H, Leu-C<u class="uu">H</u><sub>3</sub>β), 1.19 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.94–0.82 (m, 6H, 2 × Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 174.3, 172.0, 154.9, 143.8, 141.4, 129.1, 128.2, 127.7, 127.1, 125.0, 120.0, 74.7, 66.6, 61.0, 59.9, 52.7, 47.2, 45.8, 27.7, 24.4, 24.0, 23.6. HRMS (ES) calculated for C<sub>29</sub>H<sub>37</sub>N<sub>2</sub>O<sub>6</sub> 509.2657, found 509.2657 (M – H)<sup>−</sup>.</div></div><div id="sec4_2_4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> α-MeLeu5-pyr-1-apelin-13 A2 (<b>14</b>)</h4><div class="NLM_p last">Advanced intermediate <b>7</b> (0.2 mmol) was subjected to manual SPPS, introducing amino acids in the following order: <b>33</b>, Fmoc-Pro-OH, and Fmoc-Arg(Pmc)-OH. The resin was split into half, and Fmoc-SPPS was continued on 0.1 mmol scale, coupling pyr-Glu-OH. No end-capping was performed following addition of <b>33</b>. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 13.7 min. The desired peptide was isolated as a white solid after lyophilization (8.5 mg, 11%). Monoisotopic MW calculated for C<sub>70</sub>H<sub>114</sub>BrN<sub>22</sub>O<sub>16</sub> 532.5983, found high resolution (FTICR-ESI-MS) 532.5972 (M + 3H)<sup>3+</sup>.</div></div><div id="sec4_2_4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> α-MeLeu9-apelin-17 A2 (<b>15</b>)</h4><div class="NLM_p last">The remaining 0.1 mmol carried over from the synthesis of <b>14</b> was coupled with Fmoc-Gln(Trt)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Phe-OH, and Fmoc-Lys(Boc)-OH. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 11.5 min. The desired peptide was isolated as a white solid after lyophilization (14.3 mg, 13%). Monoisotopic MW calculated for C<sub>97</sub>H<sub>163</sub>BrN<sub>34</sub>O<sub>20</sub> 550.7986, found high resolution (FTICR-ESI-MS) 550.7974 (M + 4H)<sup>4+</sup>.</div></div></div><div id="sec4_2_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Aza-arginine A2 Analogues</h3><div id="sec4_2_4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>tert</i>-Butyl (2-(Diphenylmethylene)hydrazine-1-carbonyl)-<span class="smallcaps smallerCapital">l</span>-leucinate (<b>34</b>)</h4><div class="NLM_p last">Semicarbazone <b>34</b> was prepared by modifying a literature procedure.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> A solution of benzophenone hydrazone (4.39 g, 22.4 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was cooled to 0 °C and cannulated into a 0 °C solution of disuccinimidyl carbonate (7.41 g [85% purity], 24.6 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and dry DMF (10 mL). The reaction was warmed to room temperature for 45 min, then cooled down to 0 °C. A 0 °C solution of H-Leu-O<sup><i>t</i></sup>Bu·HCl (5.00 g, 22.4 mmol) and DIPEA (7.79 mL, 44.7 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was then cannulated into the reaction vessel and allowed to slowly come up to room temperature over 16 h. The reaction was concentrated in vacuo and purified by flash chromatography (silica gel, 20% EtOAc in hexanes), yielding a light yellow sticky solid (8.29 g, 91%) (<i>R</i><sub><i>f</i></sub> = 0.8 on SiO<sub>2</sub>, 1:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> 36.7 (<i>c</i> 1.27 CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3414, 3355, 3188, 3062, 2957, 2871, 1732, 1682, 1519, 1446, 1368, 1153, 1113 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 400 MHz): δ 7.59 (s, 1H, = N-N<u class="uu">H</u>), 7.57–7.46 (m, 5H, Ar-<u class="uu">H</u>), 7.40–7.29 (m, 3H, Ar-<u class="uu">H</u>), 7.29–7.22 (m, 2H, Ar-<u class="uu">H</u>), 6.68 (d, <i>J</i> = 9.0 Hz, 1H, Leu-N<u class="uu">H</u>), 4.52 (ddd, <i>J</i> = 8.8, 8.8, 5.6 Hz, 1H, Leu-C<u class="uu">H</u>α), 1.85–1.74 (m, 1H, Leu-C<u class="uu">H</u>γ), 1.74–1.60 (m, 2H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.50 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.00 (d, <i>J</i> = 6.5 Hz, 6H, 2 × Leu-C<u class="uu">H</u><sub>3</sub>δ); <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 172.6, 154.9, 148.2, 137.0, 131.9, 129.8, 129.7, 129.4, 129.3, 128.8, 128.5, 128.3, 128.1, 127.2, 126.5, 81.7, 51.9, 42.4, 28.1, 25.0, 23.0, 22.1. HRMS (ES) calculated for C<sub>24</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub> 410.2438, found 410.2438 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>tert</i>-Butyl (1-(3-Chloropropyl)-2-(diphenylmethylene)hydrazine-1-carbonyl)-<span class="smallcaps smallerCapital">l</span>-leucinate (<b>35</b>)</h4><div class="NLM_p last">Alkylation conditions were initially adapted from a literature procedure.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Semicarbazone <b>34</b> (2.47 g, 6.03 mmol) was dissolved in THF (50 mL) and cooled to 0 °C. Aqueous tetraethylammonium hydroxide (22.2 mL [20% solution], 30.1 mmol) was added and stirred for 30 min, followed by the addition of 1-bromo-3-chloropropane (4.47 mL, 45.2 mmol) at 0 °C. The reaction was slowly warmed to room temperature and was quenched after 72 h by the addition of 10% citric acid (20 mL) followed by brine (20 mL). Organic components were extracted with EtOAc (3 × 100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Alkylated semicarbazone 204 was purified by flash chromatography (silica gel, 15% EtOAc in hexanes) and was isolated as a yellow oil (2.16 g, 74%) (<i>R</i><sub><i>f</i></sub> = 0.85 on SiO<sub>2</sub>, 2:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> 67.5 (<i>c</i> 1.42 CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3414, 3061, 2959, 2870, 1734, 1682, 1499, 1446, 1368, 1154 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.55–7.41 (m, 6H, Ar-<u class="uu">H</u>), 7.41–7.30 (m, 4H, Ar-<u class="uu">H</u>), 6.69 (d, <i>J</i> = 8.7 Hz, 1H, Leu-N<u class="uu">H</u>), 4.47 (ddd, <i>J</i> = 8.8, 8.7, 5.6 Hz, 1H, Leu-C<u class="uu">H</u>α), 3.46 (dt, <i>J</i> = 14.7, 6.8 Hz, 1H, N-C<u class="uu">H</u><sub>2</sub>), 3.38–3.27 (m, 3H, N-C<u class="uu">H</u><sub>2</sub>, 2 × N-CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>), 1.80–1.72 (m, 3H, 2 × -C<u class="uu">H</u><sub>2</sub>Cl, Leu-C<u class="uu">H</u>γ), 1.66 (ddd, <i>J</i> = 13.6, 8.0, 5.6 Hz, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.61–1.51 (m, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.48 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.98 (d, <i>J</i> = 6.6 Hz, 6H, 2 × Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 172.8, 159.4, 158.3, 138.6, 135.7, 130.2, 129.8, 128.9, 128.8, 128.6, 128.2, 81.3, 52.7, 44.1, 42.4, 42.1, 30.0, 28.1, 25.1, 22.9, 22.2. HRMS (ES) calculated for C<sub>27</sub>H<sub>37</sub>ClN<sub>3</sub>O<sub>3</sub> 486.2518, found 486.2518 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>tert</i>-Butyl (1-(3-Azidopropyl)-2-(diphenylmethylene)hydrazine-1-carbonyl)-<span class="smallcaps smallerCapital">l</span>-leucinate (<b>36</b>)</h4><div class="NLM_p last">This reaction was adapted from a literature procedure.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Chloroalkylated semicarbazone <b>35</b> (2.08 g, 4.27 mmol) and sodium azide (0.833 g, 12.8 mmol) were dissolved in DMF (50 mL) and heated at 60 °C for 20 h. The reaction was cooled and had H<sub>2</sub>O (150 mL) added to it, followed by EtOAc (3 × 150 mL) washes to extract organic components. Pooled EtOAc layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The product was purified using flash chromatography (silica gel, 10% EtOAc in hexanes), generating azide <b>36</b> as a yellow oil (1.90 g, 90%) (<i>R</i><sub><i>f</i></sub> = 0.2 on SiO<sub>2</sub>, 9:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> 53.8 (<i>c</i> 1.00 CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3411, 3061, 2958, 2871, 2097, 1734, 1683, 1499, 1446, 1368, 1257, 1154 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.54–7.40 (m, 6H, Ar-<u class="uu">H</u>), 7.40–7.26 (m, 4H, Ar-<u class="uu">H</u>), 6.74 (d, <i>J</i> = 8.7 Hz, 1H, Leu-N<u class="uu">H</u>), 4.47 (ddd, <i>J</i> = 8.8, 8.7, 5.6 Hz, 1H, Leu-C<u class="uu">H</u>α), 3.42 (dt, <i>J</i> = 14.7, 7.0 Hz, 1H, N-C<u class="uu">H</u><sub>2</sub>), 3.27 (dt, <i>J</i> = 14.7, 6.8 Hz, 1H, N-C<u class="uu">H</u><sub>2</sub>), 3.05 (t, <i>J</i> = 7.1 Hz, 2H, -C<u class="uu">H</u><sub>2</sub>N<sub>3</sub>), 1.76 (ddsept, <i>J</i> = 12.9, 7.8, 6.5 Hz, 1H, Leu-C<u class="uu">H</u>γ), 1.70–1.62 (m, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.61–1.55 (m, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.56–1.49 (m, 2H, -C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>N<sub>3</sub>), 1.48 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.99 (d, <i>J</i> = 6.6 Hz, 3H, Leu-C<u class="uu">H</u><sub>3</sub>δ), 0.98 (d, <i>J</i> = 6.6 Hz, 3H, Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 172.8, 158.5, 158.4, 138.6, 135.8, 130.2, 129.8, 128.9, 128.8, 128.5, 128.3, 81.3, 52.7, 48.9, 43.4, 42.1, 28.1, 26.2, 25.1, 22.9, 22.2. HRMS (ES) calculated for C<sub>27</sub>H<sub>37</sub>N<sub>6</sub>O<sub>3</sub> 493.2922, found 493.2922 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>tert</i>-Butyl (1-(3-Azidopropyl)hydrazine-1-carbonyl)-<span class="smallcaps smallerCapital">l</span>-leucinate (<b>37</b>)</h4><div class="NLM_p last">This procedure was adapted from literature protocols.<a onclick="showRef(event, 'ref46 ref59'); return false;" href="javascript:void(0);" class="ref ref46 ref59">(46, 59)</a> Azide <b>36</b> (1.89 g, 3.84 mmol) was dissolved in a solution of hydroxylamine hydrochloride (1.07 g, 15.4 mmol) in pyridine (75 mL) and heated to 60 °C for 22 h. The reaction was cooled to room temperature, then concentrated in vacuo, using CH<sub>2</sub>Cl<sub>2</sub> and EtOAc coevaporations to remove residual pyridine. The product was purified using flash chromatography (silica gel, 60% EtOAc in hexanes, 0.1% DIPEA) yielding semicarbazide <b>37</b> as a yellow oil (1.19 g, 94%) (<i>R</i><sub><i>f</i></sub> = 0.5 on SiO<sub>2</sub>, 1:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> 5.0 (<i>c</i> 0.92 CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3406, 3335, 3216, 2958, 2934, 2871, 2098, 1732, 1654, 1510, 1368, 1257, 1155 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 6.67 (d, <i>J</i> = 8.8 Hz, 1H, Leu-N<u class="uu">H</u>), 4.33 (ddd, <i>J</i> = 8.9, 8.8, 5.5 Hz, 1H, Leu-C<u class="uu">H</u>α), 3.64 (s, 2H, <u class="uu">H</u><sub>2</sub>N-N), 3.62–3.51 (m, 2H, N-C<u class="uu">H</u><sub>2</sub>), 3.36 (t, <i>J</i> = 6.7 Hz, 2H, -C<u class="uu">H</u><sub>2</sub>N<sub>3</sub>), 1.84 (app p, <i>J</i> = 6.8 Hz, 2H, -C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>N<sub>3</sub>), 1.71 (ddsept, <i>J</i> = 8.2, 8.0, 6.5 Hz, 1H, Leu-C<u class="uu">H</u>γ), 1.59 (ddd, <i>J</i> = 13.6, 8.1, 5.5 Hz, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.53–1.47 (m, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.45 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.95 (d, <i>J</i> = 6.6 Hz, 6H, 2 × Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 173.5, 158.7, 81.3, 52.3, 49.2, 48.0, 42.4, 28.1, 26.3, 25.0, 22.9, 22.1. HRMS (ES) calculated for C<sub>14</sub>H<sub>29</sub>N<sub>6</sub>O<sub>3</sub> 329.2296, found 329.2290 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (9<i>H</i>-Fluoren-9-yl)methyl (<i>S</i>)-2-(2-(3-Azidopropyl)-2-(((<i>S</i>)-1-(<i>tert</i>-butoxy)-4-methyl-1-oxopentan-2-yl)carbamoyl)hydrazine-1-carbonyl)pyrrolidine-1-carboxylate (<b>38</b>)</h4><div class="NLM_p last">A solution of Fmoc-Pro-OH (1.65 g, 4.88 mmol), HATU (1.86 g, 4.88 mmol), HOAt (0.81 mL [0.6 M solution], 0.49 mmol), and DIPEA (2.13 mL, 12.2 mmol) were dissolved in dry DMF (20 mL) and preactivated for 5 min before the addition of a solution of semicarbazide <b>37</b> (1.34 g, 4.07 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (20 mL). The reaction mixture was stirred under Ar gas for 18 h and then concentrated in vacuo. The crude reaction mixture was resuspended in EtOAc (75 mL) and washed with 10% citric acid (50 mL), water (50 mL), and brine (50 mL). Pooled aqueous layers were washed with EtOAc (2 × 75 mL), and pooled organic fractions were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The product was purified by flash chromatography (silica gel, 50% EtOAc in hexanes) yielding azatripeptide <b>38</b> as a white solid (1.74 g, 66%) (<i>R</i><sub><i>f</i></sub> = 0.4 on SiO<sub>2</sub>, 1:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> −7.2 (<i>c</i> 0.83 CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3357, 3229, 2957, 2872, 2097, 1690, 1529, 1452, 1424, 1367, 1257, 1155 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 8.20 (s, 1H, C(O)N<u class="uu">H</u>-N), 7.80–7.74 (m, 2H, Ar-<u class="uu">H</u>), 7.61–7.54 (m, 2H, Ar-<u class="uu">H</u>), 7.47–7.37 (m, 2H, Ar-<u class="uu">H</u>), 7.31 (t, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 6.04 (d, <i>J</i> = 8.2 Hz, 1H, Leu-N<u class="uu">H</u>), 4.47 (dd, <i>J</i> = 10.5, 7.1 Hz, 1H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.42–4.29 (m, 2H, Fmoc-C<u class="uu">H</u><sub>2</sub>, Leu-C<u class="uu">H</u>α), 4.25 (t, <i>J</i> = 6.8 Hz, 1H, Fmoc-C<u class="uu">H</u>), 4.19 (dd, <i>J</i> = 7.4, 4.5 Hz, 1H, Pro-C<u class="uu">H</u>α), 3.67–3.54 (m, 3H, 2 × N-C<u class="uu">H</u><sub>2</sub>, Pro-C<u class="uu">H</u><sub>2</sub>δ), 3.55–3.46 (m, 1H, Pro-C<u class="uu">H</u><sub>2</sub>δ), 3.44–3.33 (m, 2H, -C<u class="uu">H</u><sub>2</sub>N<sub>3</sub>), 2.27 (ddd, <i>J</i> = 11.5, 5.3, 4.9 Hz, 1H, Pro-C<u class="uu">H</u><sub>2</sub>β), 2.17–2.06 (m, 2H, Pro-C<u class="uu">H</u><sub>2</sub>β, Pro-C<u class="uu">H</u><sub>2</sub>γ), 2.01–1.93 (m, 1H, Pro-C<u class="uu">H</u><sub>2</sub>γ), 1.82–1.72 (m, 2H, -C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>N<sub>3</sub>), 1.63 (ddd, <i>J</i> = 13.4, 6.7, 6.5 Hz, 1H, Leu-C<u class="uu">H</u>γ), 1.54 (ddd, <i>J</i> = 7.1, 6.7, 6.7 Hz, 1H, Leu-C<u class="uu">H</u><sub>2</sub>β), 1.48–1.38 (m, 10H, Leu-C<u class="uu">H</u><sub>2</sub>β, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.84 (d, <i>J</i> = 6.5, 3H, Leu-C<u class="uu">H</u><sub>3</sub>δ), 0.83 (d, <i>J</i> = 6.5, 3H, Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 173.5, 170.9, 156.8, 156.0, 143.7, 141.4, 127.9, 127.1, 125.0, 120.1, 81.3, 68.0, 59.2, 52.6, 49.2, 47.2, 47.1, 46.2, 41.9, 28.8, 28.0, 27.2, 25.0, 24.7, 22.8, 22.1. HRMS (ES) calculated for C<sub>34</sub>H<sub>46</sub>N<sub>7</sub>O<sub>6</sub> 648.3504, found 648.3503 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (2-((<i>S</i>)-1-(((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)pyrrolidine-2-carboxamido)-7-((<i>tert</i>-butoxycarbonyl)amino)-11,11-dimethyl-9-oxo-10-oxa-2,6,8-triazadodec-7-enoyl)-<span class="smallcaps smallerCapital">l</span>-leucine (<b>39</b>)</h4><div class="NLM_p last">A solution of azatripeptide <b>38</b> (0.803 g, 1.24 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was cooled to 0 °C and had TFA (10 mL) added, and the mixture was stirred for 15 min. The reaction was warmed to room temperature for 90 min and concentrated in vacuo, using toluene coevaporations to remove residual TFA. The product was resuspended in MeOH (20 mL), 10% Pd/C (25 mg) was added, and the reaction was stirred under an atmosphere of hydrogen gas for 75 min. The reaction mixture was filtered through a pad of Celite, concentrated in vacuo to dryness, and resuspended in dry CH<sub>2</sub>Cl<sub>2</sub> (20 mL) with triethylamine (0.76 mL, 5.45 mmol) and 1,3-di-Boc-2-(trifluoromethylsulfonyl)guanidine (0.801 g, 2.05 mmol) for 40 h. Solvents were removed in vacuo, and <b>39</b> was purified using flash chromatography (silica gel, 90% EtOAc in hexanes, 0.1% AcOH), yielding a white solid (0.413 g, 41%) (<i>R</i><sub><i>f</i></sub> = 0.05 on SiO<sub>2</sub>, 0.1% AcOH in EtOAc); [α]<sub>D</sub><sup>26</sup> −42.4 (<i>c</i> 1.00 CH<sub>3</sub>OH); IR (CH<sub>3</sub>OH cast) 3328, 2959, 1721, 1688, 1642, 1530, 1419, 1335, 1156, 1136 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 9.47 (br s, 1H, Arg-N<u class="uu">H</u>ε), 8.53 (s, 1H, C(O)N<u class="uu">H</u>-N), 7.75 (d, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 7.56 (d, <i>J</i> = 7.5 Hz, 1H, Ar-<u class="uu">H</u>), 7.54 (d, <i>J</i> = 7.5 Hz, 1H, Ar-<u class="uu">H</u>), 7.39 (app t, <i>J</i> = 7.4 Hz, 2H, Ar-<u class="uu">H</u>), 7.30 (app t, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 6.47 (br s, 1H, Leu-N<u class="uu">H</u>), 4.39 (dd, <i>J</i> = 10.4, 7.1 Hz, 1H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.30–4.23 (m, 2H, Fmoc-C<u class="uu">H</u><sub>2,</sub> Leu-C<u class="uu">H</u>α), 4.23–4.17 (m, 2H, Fmoc-C<u class="uu">H</u>, Pro-C<u class="uu">H</u>α), 3.84–3.69 (m, 1H, Arg-N-C<u class="uu">H</u><sub>2</sub>β), 3.64–3.57 (m, 1H, Pro-C<u class="uu">H</u><sub>2</sub>δ), 3.56–3.48 (m, 2H, Pro-C<u class="uu">H</u><sub>2</sub>δ, Arg-C<u class="uu">H</u><sub>2</sub>δN), 3.46–3.38 (m, 1H, Pro-C<u class="uu">H</u><sub>2</sub>δ), 3.35–3.26 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>δN), 2.21–2.09 (m, 2H, Pro-C<u class="uu">H</u><sub>2</sub>β, Arg-C<u class="uu">H</u><sub>2</sub>γ), 2.09–2.01 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>γ), 1.93–1.86 (m, 1H, Pro-C<u class="uu">H</u><sub>2</sub>β), 1.84–1.72 (m, 2H, Pro-C<u class="uu">H</u><sub>2</sub>γ), 1.70–1.54 (m, 3H, Leu-C<u class="uu">H</u>γ, 2 × Leu-C<u class="uu">H</u><sub>2</sub>β), 1.49 (m, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.46 (s, 9H, -C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.95–0.77 (m, 6H, 2 × Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 171.8, 163.1, 158.7, 156.5, 155.3, 153.1, 143.7, 141.3, 129.0, 128.2, 127.8, 127.1, 127.1, 125.3, 125.0, 120.0, 83.4, 79.8, 67.8, 58.7, 53.1, 47.1, 44.9, 39.9, 37.9, 29.7, 28.3, 28.1, 27.2, 24.9, 24.5, 22.8, 21.8. HRMS (ES) calculated for C<sub>41</sub>H<sub>56</sub>N<sub>7</sub>O<sub>10</sub> 806.4094, found 806.4088 (M-H)<sup>−</sup>.</div></div><div id="sec4_2_4_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> azaArg4-pyr-1-apelin-13 A2 (<b>16</b>)</h4><div class="NLM_p last">Advanced intermediate <b>7</b> (0.2 mmol) was subjected to manual SPPS, introducing amino acids in the following order: Fmoc-Ser(<sup><i>t</i></sup>Bu)-OH, <b>39</b>, and Fmoc-Arg(Pmc)-OH. The resin was split into half, and Fmoc-SPPS was continued on 0.1 mmol scale, coupling pyr-Glu-OH. No end-capping was performed following addition of <b>39</b>. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 13.5 min. The desired peptide was isolated as a white solid after lyophilization (5.5 mg, 7%). Monoisotopic MW calculated for C<sub>68</sub>H<sub>111</sub>BrN<sub>23</sub>O<sub>16</sub> 528.2582, found high resolution (FTICR-ESI-MS) 528.2571 (M + 3H)<sup>3+</sup>.</div></div><div id="sec4_2_4_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> azaArg8-apelin-17 A2 (<b>17</b>)</h4><div class="NLM_p last">The remaining 0.1 mmol carried over from the synthesis of <b>16</b> was coupled with Fmoc-Gln(Trt)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Phe-OH, and Fmoc-Lys(Boc)-OH. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 11.1 min. The desired peptide was isolated as a white solid after lyophilization (15.6 mg, 14%). Monoisotopic MW calculated for C<sub>95</sub>H<sub>160</sub>BrN<sub>35</sub>O<sub>20</sub> 547.5435, found high resolution (FTICR-ESI-MS) 547.5430 (M + 4H)<sup>4+</sup>.</div></div></div><div id="sec4_2_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Aza-leucine A2 Analogues</h3><div id="sec4_2_4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>tert</i>-Butyl <i>O</i>-(<i>tert</i>-Butyl)-<i>N</i>-(2-(diphenylmethylene)hydrazine-1-carbonyl)-<span class="smallcaps smallerCapital">l</span>-serinate (<b>40</b>)</h4><div class="NLM_p last">This molecule was prepared by adapting a literature procedure.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> A solution of benzophenone hydrazone (1.55 g, 7.88 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was cooled to 0 °C and cannulated into a 0 °C solution of disuccinimidyl carbonate (2.61 g [85% purity], 8.67 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and dry DMF (5 mL). The reaction was warmed to room temperature for 45 min, then cooled down to 0 °C. A 0 °C solution of H-Ser(<sup><i>t</i></sup>Bu)-O<sup><i>t</i></sup>Bu·HCl (2.00 g, 7.88 mmol) and DIPEA (2.75 mL, 15.8 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was then cannulated into the reaction vessel and allowed to slowly come up to room temperature over 24 h. The reaction was concentrated in vacuo and purified by flash chromatography (silica gel, 25% EtOAc in hexanes), yielding a light yellow sticky solid (2.94 g, 83%) (<i>R</i><sub><i>f</i></sub> = 0.4 on SiO<sub>2</sub>, 1:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> 28.0 (<i>c</i> 1.0, CH<sub>2</sub>Cl<sub>2</sub>); IR (CH<sub>2</sub>Cl<sub>2</sub> cast) 3425, 3173, 3059, 2975, 2932, 1751, 1743, 1693, 1518, 1367, 1161 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.61 (s, 1H, = N-NH), 7.58–7.45 (m, 5H, Ar-H), 7.38–7.29 (m, 3H, Ar-H), 7.29–7.23 (m, 2H, Ar-H), 7.17 (d, <i>J</i> = 8.9 Hz, 1H, Ser-NH), 4.55 (ddd, <i>J</i> = 8.9, 3.3, 2.9 Hz, 1H, Ser-CHα), 3.88 (dd, <i>J</i> = 8.6, 2.9 Hz, 1H, Ser-CH<sub>2</sub>β), 3.64 (dd, <i>J</i> = 8.6, 3.3 Hz, 1H, Ser-CH<sub>2</sub>β), 1.50 (s, 9H, C(O)OC(CH<sub>3</sub>)<sub>3</sub>), 1.22 (s, 9H, -CH<sub>2</sub>OC(CH<sub>3</sub>)<sub>3</sub>); <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 169.9, 155.2, 147.9, 137.1, 131.9, 129.7, 129.2, 128.5, 128.2, 127.1, 81.6, 73.1, 62.7, 53.8, 28.1, 27.5. HRMS (ES) calculated for C<sub>25</sub>H<sub>34</sub>N<sub>3</sub>O<sub>4</sub> 440.2544, found 440.2549 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>tert</i>-Butyl <i>O</i>-(<i>tert</i>-Butyl)-<i>N</i>-(2-(diphenylmethylene)-1-(2-methylallyl)hydrazine-1-carbonyl)-<span class="smallcaps smallerCapital">l</span>-serinate (<b>41</b>)</h4><div class="NLM_p last">Alkylation conditions were adapted from a literature procedure.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Semicarbazone <b>40</b> (0.945 g, 2.15 mmol) was dissolved in THF (10 mL) and cooled to 0 °C. Aqueous tetraethylammonium hydroxide (7.91 mL [20% solution], 10.8 mmol) was added and stirred for 30 min, followed by the addition of 3-bromo-2-methylpropene (1.63 mL, 16.1 mmol) at 0 °C. The reaction was slowly warmed to room temperature and was quenched after 60 h by the addition of 10% citric acid (15 mL) followed by brine (15 mL). Organic components were extracted with EtOAc (3 × 75 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Alkylated semicarbazone <b>41</b> was purified by flash chromatography (silica gel, 20% EtOAc in hexanes) and was isolated as a yellow oil (1.06 g, 99%) (<i>R</i><sub><i>f</i></sub> = 0.6 on SiO<sub>2</sub>, 3:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> 6.1 (<i>c</i> 0.75 CH<sub>2</sub>Cl<sub>2</sub>); IR (CH<sub>2</sub>Cl<sub>2</sub> cast) 3421, 3062, 2974, 2935, 2877, 1745, 1687, 1496, 1366, 1154, 1098 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.50–7.39 (m, 6H, Ar-<u class="uu">H</u>, Ser-N<u class="uu">H</u>), 7.39–7.34 (m, 1H, Ar-<u class="uu">H</u>), 7.32–7.27 (m, 4H, Ar-<u class="uu">H</u>), 4.71 (dq, <i>J</i> = 1.4, 1.1 Hz, 1H, ═C<u class="uu">H</u>H), 4.58 (ddd, <i>J</i> = 8.9, 3.2, 3.2 Hz, 1H, Ser-C<u class="uu">H</u>α), 4.48–4.43 (m, 1H, ═CH<u class="uu">H</u>), 3.98 (d, <i>J</i> = 17.0 Hz, 1H, Leu-NC<u class="uu">H</u><sub>2</sub>β), 3.88–3.79 (m, 2H, Ser-C<u class="uu">H</u><sub>2</sub>β, Leu-NC<u class="uu">H</u><sub>2</sub>β), 3.62 (dd, <i>J</i> = 8.6, 3.3 Hz, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 1.48 (s, 9H, C(O)OC(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.41–1.32 (m, 3H, -C<u class="uu">H</u><sub>3</sub>), 1.17 (s, 9H, -CH<sub>2</sub>OC(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 170.2, 158.5, 154.1, 139.8, 139.2, 135.9, 129.5, 129.4, 128.3, 128.2, 128.0, 111.8, 81.3, 72.9, 62.8, 54.7, 50.6, 28.1, 27.4 19.5. HRMS (ES) calculated for C<sub>29</sub>H<sub>40</sub>N<sub>3</sub>O<sub>4</sub> 494.3013, found 494.3010 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>tert</i>-Butyl <i>O</i>-(<i>tert</i>-Butyl)-<i>N</i>-(1-isobutylhydrazine-1-carbonyl)-<span class="smallcaps smallerCapital">l</span>-serinate (<b>42</b>)</h4><div class="NLM_p last">Alkylated semicarbazone <b>41</b> (2.19 g, 4.43 mmol) was dissolved in MeOH (50 mL) and had 10% Pd/C (20 mg) added. The suspension was stirred under hydrogen gas for 20 h, filtered through a pad of Celite, and concentrated in vacuo. The crude residue purified using flash chromatography (silica gel, 50% EtOAc in hexanes), yielding semicarbazide <b>42</b> as a yellow oil (1.37 g, 93%) (<i>R</i><sub><i>f</i></sub> = 0.6 on SiO<sub>2</sub>, 3:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> 20.8 (<i>c</i> 0.45 CH<sub>2</sub>Cl<sub>2</sub>); IR (CH<sub>2</sub>Cl<sub>2</sub> cast) 3420, 3331, 3217, 2974, 2934, 2873, 1741, 1656, 1509, 1366, 1232, 1157, 1100 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 7.04 (d, <i>J</i> = 9.0 Hz, 1H, Ser-N<u class="uu">H</u>), 4.45 (ddd, <i>J</i> = 9.0, 3.1, 3.0 Hz, 1H, Ser-C<u class="uu">H</u>α), 3.78 (dd, <i>J</i> = 8.6, 3.1 Hz, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 3.56 (s, 2H, <u class="uu">H</u><sub><u class="uu">2</u></sub>N-N), 3.52 (dd, <i>J</i> = 8.6, 3.2 Hz, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 3.36 (dd, <i>J</i> = 13.9, 7.7 Hz, 1H, Leu-NC<u class="uu">H</u><sub>2</sub>β), 3.26 (dd, <i>J</i> = 13.9, 7.4 Hz, 1H, Leu-NC<u class="uu">H</u><sub>2</sub>β), 2.01–1.89 (m, 1H, Leu-C<u class="uu">H</u>γ), 1.46 (s, 9H, C(O)OC(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.14 (s, 9H, -CH<sub>2</sub>OC(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.92 (d, <i>J</i> = 6.7 Hz, 3H, Leu-C<u class="uu">H</u><sub>3</sub>δ), 0.91 (d, <i>J</i> = 6.7 Hz, 3H, Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 170.8, 159.1, 81.1, 72.8, 63.1, 57.4, 54.4, 28.1, 27.4, 26.1, 19.9. HRMS (ES) calculated for C<sub>16</sub>H<sub>34</sub>N<sub>3</sub>O<sub>4</sub> 332.2544, found 332.2539 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>tert</i>-Butyl <i>N</i>-(2-((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((((2-chlorobenzyl)oxy)carbonyl)amino)pentanoyl)-1-isobutylhydrazine-1-carbonyl)-<i>O</i>-(<i>tert</i>-butyl)-<span class="smallcaps smallerCapital">l</span>-serinate (<b>43</b>)</h4><div class="NLM_p last">A solution of Fmoc-Orn(2-Cl-Cbz)-OH (2.59 g, 4.91 mmol), HATU (1.87 g, 4.91 mmol), HOAt (0.82 mL [0.6 M solution], 0.49 mmol), and DIPEA (2.14 mL, 12.3 mmol) was dissolved in dry DMF (20 mL) and preactivated for 5 min before the addition of a solution of semicarbazide <b>42</b> (1.36 g, 4.09 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (20 mL). This reaction was stirred under Ar for 30 h and then concentrated in vacuo. The crude reaction was resuspended in EtOAc (100 mL) and washed with 10% citric acid (2 × 100 mL) and brine (100 mL). Pooled aqueous layers were washed with EtOAc (2 × 100 mL), and pooled organic fractions were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The reaction was purified by flash chromatography (silica gel, 40% EtOAc in hexanes) yielding azatripeptide <b>43</b> as a white solid (2.64 g, 77%), with a 17% recovery of <b>42</b> (<i>R</i><sub><i>f</i></sub> = 0.2 on SiO<sub>2</sub>, 1:1 hexanes/EtOAc); [α]<sub>D</sub><sup>26</sup> 11.8 (<i>c</i> 1.00 CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3321, 3007, 2974, 2934, 2873, 1700, 1657, 1523, 1450, 1367, 1247, 1157 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 8.31 (s, 1H, C(O)N<u class="uu">H</u>-N), 7.79–7.74 (m, 2H, Fmoc-Ar-<u class="uu">H</u>), 7.59 (d, <i>J</i> = 7.5 Hz, 2H, Fmoc-Ar-<u class="uu">H</u>), 7.39 (m, 4H, 2 × Fmoc-Ar-<u class="uu">H</u>, 2 × 2-Cl-Ar-<u class="uu">H</u>), 7.34–7.28 (m, 2H, Fmoc-Ar-<u class="uu">H</u>), 7.27–7.23 (m, 2H, 2 × 2-Cl-Ar-<u class="uu">H</u>), 5.82 (d, <i>J</i> = 8.2 Hz, 1H, Ser-N<u class="uu">H</u>), 5.53 (d, <i>J</i> = 7.8 Hz, 1H, Orn-N<u class="uu">H</u>α), 5.27–5.20 (m, 2H, -OC<u class="uu">H</u><sub>2</sub>(2-Cl)Ph, Orn-N<u class="uu">H</u>ε), 5.16 (d, <i>J</i> = 13.0 Hz, 1H, -OC<u class="uu">H</u><sub>2</sub>(2-Cl)Ph), 4.48–4.38 (m, 3H, Ser-C<u class="uu">H</u>α, Orn-C<u class="uu">H</u>α, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.38–4.32 (m, 1H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.21 (t, <i>J</i> = 7.0 Hz, 1H, Fmoc-C<u class="uu">H</u>), 3.71 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 3.54–3.45 (m, 2H, Ser-C<u class="uu">H</u><sub>2</sub>β, Orn-C<u class="uu">H</u><sub>2</sub>δ), 3.44–3.36 (m, 1H, Leu-NC<u class="uu">H</u><sub>2</sub>β), 3.33–3.24 (m, 1H, Leu-NC<u class="uu">H</u><sub>2</sub>β), 3.24–3.15 (m, 1H, Orn-C<u class="uu">H</u><sub>2</sub>δ), 2.00–1.90 (m, 1H, Orn-C<u class="uu">H</u><sub>2</sub>β), 1.86–1.77 (m, 1H, Leu-C<u class="uu">H</u>γ), 1.75–1.56 (m, 3H, Orn-C<u class="uu">H</u><sub>2</sub>β, 2 × Orn-C<u class="uu">H</u><sub>2</sub>γ), 1.41 (s, 9H, C(O)OC(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.08 (s, 9H, -CH<sub>2</sub>OC(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.89 (d, <i>J</i> = 6.6 Hz, 6H, 2 × Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 173.7, 170.2, 157.1, 156.7, 156.4, 143.6, 141.3, 134.1, 133.5, 129.7, 129.5, 129.4, 127.8, 127.1, 126.8, 125.1, 120.0, 81.6, 72.9, 67.3, 64.1, 62.6, 55.4, 54.5, 52.1, 47.1, 39.7, 29.8, 28.0, 27.3, 26.9, 26.2, 20.0, 20.0. HRMS (ES) calculated for C<sub>44</sub>H<sub>59</sub>ClN<sub>5</sub>O<sub>9</sub> 836.3996, found 836.4008 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-(2-((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((((2-chlorobenzyl)oxy)carbonyl)amino)pentanoyl)-1-isobutylhydrazine-1-carbonyl)-<i>O</i>-(<i>tert</i>-butyl)-<span class="smallcaps smallerCapital">l</span>-serine (<b>44</b>)</h4><div class="NLM_p last">Azatripeptide <b>43</b> (1.21 g, 1.44 mmol) was dissolved in toluene (100 mL) and had flash-grade silica (25.0 g) added. This suspension was refluxed at 115 °C for 95 min, checking TLC and LC–MS every 30 min. The reaction was cooled to room temperature and a 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub> solution (100 mL) was added, then filtered through a pad of Celite. The reaction was concentrated in vacuo and purified by flash chromatography (silica gel, 0–2% MeOH in EtOAc, 0.1% AcOH). The desired product was obtained as a sticky white solid (0.770 g, 69%) (<i>R</i><sub><i>f</i></sub> = 0.3 on SiO<sub>2</sub>, 1:4 hexanes/EtOAc, 0.1% AcOH); [α]<sub>D</sub><sup>26</sup> 14.5 (<i>c</i> 1.00 CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3313, 3018, 2971, 2874, 1697, 1528, 1450, 1249, 1193, 1104 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 8.10 (s, 1H, C(O)N<u class="uu">H</u>-N), 7.71 (d, <i>J</i> = 7.6 Hz, 2H, Fmoc-Ar-<u class="uu">H</u>), 7.54 (d, <i>J</i> = 7.5 Hz, 2H, Fmoc-Ar-<u class="uu">H</u>), 7.40–7.29 (m, 4H, 2 × Fmoc-Ar-<u class="uu">H</u>, 2 × 2-Cl-Ar-<u class="uu">H</u>), 7.29–7.16 (m, 4H, 2 × Fmoc-Ar-<u class="uu">H</u>, 2 × 2-Cl-Ar-<u class="uu">H</u>), 6.05 (br s, 1H, Ser-N<u class="uu">H</u>), 5.53 (br s, 1H, Orn-N<u class="uu">H</u>α), 5.22–5.11 (m, 2H, -OC<u class="uu">H</u><sub>2</sub>(2-Cl)Ph), 4.42–4.37 (m, 2H, Ser-C<u class="uu">H</u>α, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.35–4.27 (m, 1H, Orn-C<u class="uu">H</u>α), 4.21 (dd, <i>J</i> = 10.1, 8.7 Hz, 1H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.14 (t, <i>J</i> = 8.3 Hz, 1H, Fmoc-C<u class="uu">H</u>), 3.76–3.68 (m, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 3.52–3.46 (m, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 3.33–3.13 (m, 4H, 2 × Orn-C<u class="uu">H</u><sub>2</sub>δ, 2 × Leu-NC<u class="uu">H</u><sub>2</sub>β), 1.89–1.80 (m, 1H, Orn-C<u class="uu">H</u><sub>2</sub>β), 1.79–1.65 (m, 2H, Orn-C<u class="uu">H</u><sub>2</sub>β, Leu-C<u class="uu">H</u>γ), 1.62–1.54 (m, 2H, Orn-C<u class="uu">H</u><sub>2</sub>γ), 1.02 (s, 9H, -CH<sub>2</sub>OC(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.83 (d, <i>J</i> = 6.5 Hz, 3H, Leu-C<u class="uu">H</u><sub>3</sub>δ), 0.81 (d, <i>J</i> = 6.5 Hz, 3H, Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 171.8, 170.4, 159.7, 158.3, 156.6, 143.6, 141.2, 134.2, 133.4, 129.6, 129.5, 129.3, 127.8, 127.1, 126.9, 125.1, 120.0, 73.6, 67.3, 63.9, 62.1, 55.7, 55.2, 52.5, 47.0, 39.9, 29.7, 27.3, 27.0, 25.9, 20.0. HRMS (ES) calculated for C<sub>40</sub>H<sub>49</sub>ClN<sub>5</sub>O<sub>9</sub> 778.3224, found 778.3208 (M – H)<sup>−</sup>.</div></div><div id="sec4_2_4_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-((<i>S</i>)-5-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-10-((<i>tert</i>-butoxycarbonyl)amino)-2-isobutyl-14,14-dimethyl-4,12-dioxo-13-oxa-2,3,9,11-tetraazapentadec-10-enoyl)-<i>O</i>-(<i>tert</i>-butyl)-<span class="smallcaps smallerCapital">l</span>-serine (<b>45</b>)</h4><div class="NLM_p last">A solution of <b>44</b> (0.730 g, 0.94 mmol) in MeOH (50 mL) had 10% Pd/C (25 mg) added, and the suspension was stirred under an atmosphere of hydrogen gas for 135 min. The reaction mixture was filtered through a pad of Celite, concentrated in vacuo to dryness, and resuspended in dry CH<sub>2</sub>Cl<sub>2</sub> (30 mL) with triethylamine (0.59 mL, 4.21 mmol) and 1,3-di-Boc-2-(trifluoromethylsulfonyl)guanidine (0.549 g, 1.40 mmol) for 30 h. Solvents were removed in vacuo and the azatripeptide product was purified using flash chromatography (silica gel, 90% EtOAc in hexanes, 0.1% AcOH), yielding white solid <b>45</b> (0.161 g, 20%) (<i>R</i><sub><i>f</i></sub> = 0.1 on SiO<sub>2</sub>, 1:4 hexanes/EtOAc, 0.1% AcOH); [α]<sub>D</sub><sup>26</sup> 2.3 (<i>c</i> 0.85 CHCl<sub>3</sub>); IR (CHCl<sub>3</sub> cast) 3326, 2978, 2934, 1722, 1644, 1531, 1368, 1331, 1136, 1054 cm<sup>–1</sup>. <sup>1</sup>H (CDCl<sub>3</sub>, 500 MHz): δ 8.94 (br s, 1H, C(O)N<u class="uu">H</u>-N), 8.46 (br s, 1H, Arg-N<u class="uu">H</u>ε), 7.75 (d, <i>J</i> = 7.6 Hz, 2H, Ar-<u class="uu">H</u>), 7.58 (d, <i>J</i> = 7.6 Hz, 2H, Ar-<u class="uu">H</u>), 7.39 (t, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 7.30 (t, <i>J</i> = 7.5 Hz, 2H, Ar-<u class="uu">H</u>), 6.16 (br s, 1H, Arg-N<u class="uu">H</u>α), 6.08 (s, 1H, Ser-N<u class="uu">H</u>), 4.49–4.40 (m, 3H, Arg-C<u class="uu">H</u>α, Ser-C<u class="uu">H</u>α, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.34–4.28 (m, 1H, Fmoc-C<u class="uu">H</u><sub>2</sub>), 4.18 (t, <i>J</i> = 7.0 Hz, 1H, Fmoc-C<u class="uu">H</u>), 3.81–3.75 (m, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 3.61–3.49 (m, 1H, Ser-C<u class="uu">H</u><sub>2</sub>β), 3.49–3.24 (m, 4H, 2 × Arg-C<u class="uu">H</u><sub>2</sub>δ, 2 × Leu-NC<u class="uu">H</u><sub>2</sub>β), 1.92–1.83 (m, 1H, Arg-C<u class="uu">H</u><sub>2</sub>β), 1.81–1.60 (m, 4H, Arg-C<u class="uu">H</u><sub>2</sub>β, 2 × Arg-C<u class="uu">H</u><sub>2</sub>γ, Leu-C<u class="uu">H</u>γ), 1.50 (s, 9H, Arg-C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.47 (s, 9H, Arg-C(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 1.12 (s, 9H, -CH<sub>2</sub>OC(C<u class="uu">H</u><sub>3</sub>)<sub>3</sub>), 0.91–0.85 (m, 6H, 2 × Leu-C<u class="uu">H</u><sub>3</sub>δ). <sup>13</sup>C (CDCl<sub>3</sub>, 125 MHz): δ 171.1, 170.2, 163.3, 162.4, 157.7, 156.5, 153.2, 143.7, 141.3, 127.8, 127.1, 125.0, 120.0, 83.6, 79.9, 74.7, 67.3, 61.5, 55.8, 54.0, 53.1, 47.1, 40.4, 29.4, 28.3, 28.0, 27.3, 27.0, 25.5, 20.2, 20.1. HRMS (ES) calculated for C<sub>43</sub>H<sub>64</sub>N<sub>7</sub>O<sub>11</sub> 854.4658, found 854.4654 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> azaLeu5-pyr-1-apelin-13 A2 (<b>18</b>)</h4><div class="NLM_p last">Advanced intermediate <b>7</b> (0.2 mmol) was subjected to manual SPPS, introducing amino acids in the following order: <b>45</b>, Fmoc-Pro-OH, and Fmoc-Arg(Pmc)-OH. The resin was split into half, and Fmoc-SPPS was continued on 0.1 mmol scale, coupling pyr-Glu-OH. No end-capping was performed following addition of <b>45</b>. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 13.3 min. The desired peptide was isolated as a white solid after lyophilization (4.8 mg, 6%). Monoisotopic MW calculated for C<sub>68</sub>H<sub>111</sub>BrN<sub>23</sub>O<sub>16</sub> 528.2582, found high resolution (FTICR-ESI-MS) 528.2576 (M + 3H)<sup>3+</sup>.</div></div><div id="sec4_2_4_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> azaLeu9-pyr-1-apelin-13 A2 (<b>19</b>)</h4><div class="NLM_p last">The remaining 0.1 mmol carried over from the synthesis of <b>18</b> was coupled with Fmoc-Gln(Trt)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Phe-OH, and Fmoc-Lys(Boc)-OH. A portion (0.05 mmol) of resin-bound peptide was cleaved as previously described and purified using a C<sub>18</sub> RP-HPLC analytical column (method A), eluting at 11.3 min. The desired peptide was isolated as a white solid after lyophilization (4.4 mg, 4%). Monoisotopic MW calculated for C<sub>95</sub>H<sub>160</sub>BrN<sub>35</sub>O<sub>20</sub> 547.5435, found high resolution (FTICR-ESI-MS) 547.5420 (M + 4H)<sup>4+</sup>.</div></div></div><div id="sec4_2_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69">5 In Vitro Protease Experiments. Neprilysin Degradation Assays</h3><div class="NLM_p last">Apelin peptides were dissolved in Milli-Q water (1 mM). Recombinant human neprilysin (rhNEP, Sino Biological) was reconstituted in Tris buffer (100 mM Tris, 100 mM NaCl, 10 μM ZnCl<sub>2</sub>, pH 7.5). To initiate the assay, rhNEP was diluted in Tris buffer (3.1 nM final concentration) and preincubated at 37 °C for 10 min prior to the addition of 5 μL of apelin peptide (1 mM) and 1.5 μL of internal standard dansyl-Tyr-Val-Gly-OH (1 mM). Aliquots (10 μL) were removed at 0, 1, 4, 24, and 72 h, quenched with 0.1 M EDTA (10 μL), diluted to 100 μL with Milli-Q water, and analyzed by LC–MS. Assays were performed in triplicate (<i>n</i> = 3) for each time point. Integrated peak areas of the parent apelin peptide and internal standard derived from LC–MS analyses were extracted using Mass Hunter software (version B.04.00) and compared in positive extracted ion count modus (+EIC). The extent of proteolysis was determined by comparing the initial (0 h) ratio of the integrated extracted ions of the parent apelin peptide to the internal dansyl-YVG standard (apelin/dansyl-YVG) to the same ratio at the different assay time points. The decrease in apelin/dansyl-YVG ratio was converted to a percentage of cleaved peptide over time.</div></div><div id="sec4_2_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Neprilysin Inhibition Assays</h3><div class="NLM_p last">A solution of rhNEP (3.1 nM in 100 mM Tris, 100 mM NaCl, 10 μM ZnCl<sub>2</sub>, pH 7.5) was preincubated with 5 μL of apelin analogue (1 mM) and 1.5 μL of internal standard dansyl-Tyr-Val-Gly-OH (1 mM, dansyl-YVG-OH, Sigma-Aldrich) at 37 °C for 10 min prior to the addition of 5 μL of pyr-1-apelin-13 (1 mM). Aliquots (10 μL) were removed at 0, 1, 4, 24, and 72 h and quenched and analyzed as previously described. Assays were performed in duplicate (<i>n</i> = 2) for each time point.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71">6 Isolation and Quantification of Apelin Peptides from Plasma</h3><div class="NLM_p last">20 μL of plasma was portioned into microfuge tubes and prewarmed to 37 °C. 5 μL of apelin peptide (400 μM) was added and incubated at 37 °C for varying lengths of time. Experiments were quenched by the addition of 20 μL of 10% aqueous TFA. 5 μL of internal standard (1 mM dansyl-Tyr-Val-Gly-OH) was added, and experiments were diluted up to 100 μL with 0.1% aqueous TFA. These assays were loaded onto a pre-equilibrated C<sub>18</sub> spin column (Harvard Apparatus), which had previously been wet with 2 × 300 μL of 50% acetonitrile in 0.1% aqueous TFA and 2 × 300 μL of 0.1% aqueous TFA respectively, centrifuging at 300<i>g</i> for 2 min between each 300 μL aliquot. Quenched plasma assays were centrifuged at 300<i>g</i> until the sample was loaded. The resultant filtrate was reloaded onto the column along with 100 μL of 0.1% aqueous TFA and centrifuged at 300<i>g</i> two additional times. The desired plasma peptides were washed by the addition of 2 × 300 μL of 0.1% aqueous TFA and centrifuged at 300<i>g</i> for 2 min, discarding the filtrate after each wash. Desired peptides were eluted by the addition of 300 μL of 40% acetonitrile (human plasma) in 0.1% aqueous TFA and centrifugation at 300<i>g</i> for 2 min. Eluted samples were diluted with 0.1% aqueous trifluoroacetic acid prior to analysis by C<sub>18</sub> RP-HPLC. To analyze the remaining percentage of apelin peptides in plasma, incubations of pyr-1-apelin-13 or apelin-17 in plasma were immediately quenched, worked up, and analyzed by C<sub>18</sub> RP-HPLC as previously described, and the ratio of apelin peptide to internal standard was calculated based on the area under the peaks. This 0 min incubation ratio was used to compare the apelin peptide/internal standard ratios for the time experiments.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72">7 APJ Radioligand Binding Experiments</h3><div class="NLM_p last">Membrane preparations from CHO cells stably expressing the wild-type rat apelin receptor-EGFP were prepared as previously described.<a onclick="showRef(event, 'ref39 ref54'); return false;" href="javascript:void(0);" class="ref ref39 ref54">(39, 54)</a> Crude membrane preparations (1 μg total mass of membranes/assay) were incubated for 3 h at 20 °C with 0.2 nM [<sup>125</sup>I]-pyr-1-apelin-13 (monoiodinated on Lys<sup>8</sup> with Bolton–Hunter reagent, PerkinElmer, Wellesley, MA, USA) in binding buffer (50 mM HEPES, 5 mM MgCl<sub>2</sub>, pH 7.5, BSA 1%) alone or in the presence of the different compounds at various concentrations. The reaction was stopped by adding 4 mL of cold binding buffer, filtered on Whatman GF/C filters, and washed with 5 mL of cold binding buffer. Radioactivity was then counted using a Wizard 1470 Wallac γ counter (PerkinElmer, Turku, Finland). Binding experiment data were analyzed with GraphPad Prism.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73">8 Blood Pressure Assays</h3><div class="NLM_p last">Mice were anesthetized with 1.5% isoflurane/oxygen, and body temperature was monitored and maintained at 36 °C by a heating pad. The aorta was cannulated via the right carotid artery using a PV loop catheter (model 1.2F from Scisense, Transonic) in order to continuously record arterial blood pressure and heart rate (LabScribe 2.0, Scisense). Peptides <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, <b>8</b>–<b>19</b> (1.4 μM/kg body weight) or the same volume of saline was injected via the right jugular vein. Results are reported as systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MABP), and heart rate (HR).</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74">9 Langendorff Isolated Heart Technique Experiments</h3><div class="NLM_p last">Langendorff heart perfusion and ischemia–reperfusion injury were prepared, and cardiac function was measured. Mice were heparinized and anesthetized with 1.5–2% isoflurane inhalation. The heart was excised, mounted on a Langendorff system, and perfused at a consistent pressure of 80 mmHg with modified Krebs–Henseleit solution (116 mM NaCl, 3.2 mM KCl, 2.0 mM CaCl<sub>2</sub>, 1.2 mM MgSO<sub>4</sub>, 25 mM NaHCO<sub>3</sub>, 1.2 mM KH<sub>2</sub>PO<sub>4</sub>, 11 mM glucose, 0.5 mM EDTA, and 2 mM pyruvate), which was kept at 37 °C and continuously oxygenated with 95% O<sub>2</sub> and 5% CO<sub>2</sub> which maintained the perfusion buffer at pH 7.4. After stabilization and 10 min of baseline recording, global ischemia was induced for 30 min followed by 40 min of reperfusion. Apelin 17 (<b>2</b>) or apelin analogues (<b>11</b>, <b>17</b>, <b>18</b>, or <b>19)</b> were given at the start of reperfusion for 10 min at a concentration of 1 μM. Left ventricular functions were obtained continuously by PowerLab system (ADInstruments, Australia). Data were reported as mean value of every 5 min. Left ventricular functions were reported as left ventricular developed pressure (LVDP), heart rate (HR), maximum derivative of change in systolic pressure over time (max d<i>P</i>/d<i>t</i>), minimum derivative of change in diastolic pressure over time (min d<i>P</i>/d<i>t</i>), and rate pressure product (RPP).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00723">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00723" class="ext-link">10.1021/acs.jmedchem.7b00723</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Crystal structures of <b>25</b> and <b>30</b>, LCMS chromatograms, MS profiles, and results of degradation studies (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Crystallographic information for C<sub>31</sub>H<sub>32</sub>N<sub>6</sub>NiO<sub>3</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_002.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Crystallographic information for C<sub>32</sub>H<sub>35</sub>N<sub>3</sub>NiO<sub>3</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_003.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_004.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf">jm7b00723_si_001.pdf (2.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_002.cif">jm7b00723_si_002.cif (871.45 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_003.cif">jm7b00723_si_003.cif (665.45 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_004.csv">jm7b00723_si_004.csv (8.07 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00723" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John C. Vederas</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University of Alberta, 11227 Saskatchewan Drive NW, Edmonton, Alberta T6G
2G2, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2996-0326" title="Orcid link">http://orcid.org/0000-0002-2996-0326</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5b31343335752d3e3f3e293a281b2e3a37393e292f3a75383a"><span class="__cf_email__" data-cfemail="3a50555254144c5f5e5f485b497a4f5b56585f484e5b14595b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaun M. K. McKinnie</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University of Alberta, 11227 Saskatchewan Drive NW, Edmonton, Alberta T6G
2G2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wang Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, University of Alberta, 8440-112 Street NW, Edmonton, Alberta T6G 2B7, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Mazankowski Alberta Heart Institute, University of Alberta, 8440-112 Street NW, Edmonton, Alberta T6G 2B7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Conrad Fischer</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University of Alberta, 11227 Saskatchewan Drive NW, Edmonton, Alberta T6G
2G2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tyler McDonald</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University of Alberta, 11227 Saskatchewan Drive NW, Edmonton, Alberta T6G
2G2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin R. Kalin</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University of Alberta, 11227 Saskatchewan Drive NW, Edmonton, Alberta T6G
2G2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Iturrioz</span> - <span class="hlFld-Affiliation affiliation">Laboratory of Central Neuropeptides in the Regulation
of Body Fluid Homeostasis and Cardiovascular Functions, INSERM, U1050, Paris, F-75005, France</span>; 
    <span class="hlFld-Affiliation affiliation">Center for Interdisciplinary Research in Biology (CIRB), College de France, Paris, F-75005, France</span>; 
    <span class="hlFld-Affiliation affiliation">CNRS, UMR 7241, Paris, F-75005, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Llorens-Cortes</span> - <span class="hlFld-Affiliation affiliation">Laboratory of Central Neuropeptides in the Regulation
of Body Fluid Homeostasis and Cardiovascular Functions, INSERM, U1050, Paris, F-75005, France</span>; 
    <span class="hlFld-Affiliation affiliation">Center for Interdisciplinary Research in Biology (CIRB), College de France, Paris, F-75005, France</span>; 
    <span class="hlFld-Affiliation affiliation">CNRS, UMR 7241, Paris, F-75005, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gavin Y. Oudit</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, University of Alberta, 8440-112 Street NW, Edmonton, Alberta T6G 2B7, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Mazankowski Alberta Heart Institute, University of Alberta, 8440-112 Street NW, Edmonton, Alberta T6G 2B7, Canada</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d234e7654-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Jing Zheng, Bela Reiz, Dr. Angie Morales-Izquierdo, and Dr. Randy Whittal (University of Alberta Mass Spectrometry Facility) for assistance with mass spectrometry characterization and analyses of peptides and peptide fragments, Wayne Moffat and Jennifer Jones (University of Alberta Analytical Laboratory) for assistance with IR and optical rotation experiments, Dr. Bob McDonald (University of Alberta X-ray Crystallography Laboratory) for assistance with small molecule crystallography, and Isaac Jones for preliminary synthetic work. This work was supported by the Canadian Institutes of Health Research (CIHR Grant 136921), the Natural Sciences and Engineering Council of Canada (NSERC), Alberta Innovates Health Solutions (AIHS), the Institut National de la Santé et de la Recherche Médicale (INSERM), and the College de France.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i78" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i78"> Abbreviations Used</h2><tr><td class="NLM_term">ACE2</td><td class="NLM_def"><p class="first last">angiotensin-converting enzyme 2</p></td></tr><tr><td class="NLM_term">Aib</td><td class="NLM_def"><p class="first last">aminoisobutyric acid</p></td></tr><tr><td class="NLM_term">APJ</td><td class="NLM_def"><p class="first last">apelin receptor</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">EIC</td><td class="NLM_def"><p class="first last">extracted-ion chromatogram</p></td></tr><tr><td class="NLM_term">HOAt</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazole</p></td></tr><tr><td class="NLM_term">LVDP</td><td class="NLM_def"><p class="first last">left ventricle developed pressure</p></td></tr><tr><td class="NLM_term">MABP</td><td class="NLM_def"><p class="first last">mean arterial blood pressure</p></td></tr><tr><td class="NLM_term">max d<i>P</i>/d<i>t</i></td><td class="NLM_def"><p class="first last">maximum derivative of change in systolic pressure over time</p></td></tr><tr><td class="NLM_term">min d<i>P</i>/d<i>t</i></td><td class="NLM_def"><p class="first last">minimum derivative of change in diastolic pressure over time</p></td></tr><tr><td class="NLM_term">NEP</td><td class="NLM_def"><p class="first last">neprilysin</p></td></tr><tr><td class="NLM_term">Nle</td><td class="NLM_def"><p class="first last">norleucine</p></td></tr><tr><td class="NLM_term">Orn</td><td class="NLM_def"><p class="first last">ornithine</p></td></tr><tr><td class="NLM_term"><i>p</i>-TsOH</td><td class="NLM_def"><p class="first last"><i>para</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">Pmc</td><td class="NLM_def"><p class="first last">2,2,5,7,8-pentamethylchroman-6-sulfonyl</p></td></tr><tr><td class="NLM_term">rh</td><td class="NLM_def"><p class="first last">recombinant human</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reversed phase</p></td></tr><tr><td class="NLM_term">RPP</td><td class="NLM_def"><p class="first last">rate-pressure product</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid phase peptide synthesis</p></td></tr><tr><td class="NLM_term">Trt</td><td class="NLM_def"><p class="first last">trityl</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00154" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00154" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Tatemoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukusumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, M.</span><span> </span><span class="NLM_article-title">Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span><span class="refDoi"> DOI: 10.1006/bbrc.1998.9489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1006%2Fbbrc.1998.9489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=9792798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADyaK1cXmvF2msbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1998&pages=471-476&author=K.+Tatemotoauthor=M.+Hosoyaauthor=Y.+Habataauthor=R.+Fujiiauthor=T.+Kakegawaauthor=M.-X.+Zouauthor=Y.+Kawamataauthor=S.+Fukusumiauthor=S.+Hinumaauthor=C.+Kitadaauthor=T.+Kurokawaauthor=H.+Ondaauthor=M.+Fujino&title=Isolation+and+characterization+of+a+novel+endogenous+peptide+ligand+for+the+human+APJ+receptor&doi=10.1006%2Fbbrc.1998.9489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor</span></div><div class="casAuthors">Tatemoto, Kazuhiko; Hosoya, Masaki; Habata, Yugo; Fujii, Ryo; Kakegawa, Tadao; Zou, Min-Xu; Kawamata, Yuji; Fukusumi, Shoji; Hinuma, Shuji; Kitada, Chieko; Kurokawa, Tsutomu; Onda, Haruo; Fujino, Masahiko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">In the search for an endogenous ligand of the orphan G protein-coupled receptor APJ, the presence of the ligand in various tissue exts. was examd. by measuring the increase in extracellular acidification rate of the cells expressing the APJ receptor as a specific signal induced by the interaction of the receptor and ligand.  By monitoring this activity, the authors isolated an APJ receptor ligand, designated apelin, from bovine stomach exts.  The structures of bovine and human apelin preproproteins were deduced from the sequences of the corresponding cDNAs.  The preproproteins consisted of 77 amino acid residues, and the apelin sequence was encoded in the C-terminal regions.  Synthetic peptides derived from the C-terminal amino acid sequence of bovine preproapelin were capable of specifically promoting the acidification rate in the cells expressing the APJ receptor in a range from 10-7 to 10-10 M, indicating that apelin is an endogenous ligand for the APJ receptor.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfZFYcVKcQs7Vg90H21EOLACvtfcHk0ljV1vyUiIF3fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvF2msbY%253D&md5=54a069e5884731979abfdc1738ba6d44</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.9489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.9489%26sid%3Dliteratum%253Aachs%26aulast%3DTatemoto%26aufirst%3DK.%26aulast%3DHosoya%26aufirst%3DM.%26aulast%3DHabata%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DR.%26aulast%3DKakegawa%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DM.-X.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DFukusumi%26aufirst%3DS.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DKitada%26aufirst%3DC.%26aulast%3DKurokawa%26aufirst%3DT.%26aulast%3DOnda%26aufirst%3DH.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520a%2520novel%2520endogenous%2520peptide%2520ligand%2520for%2520the%2520human%2520APJ%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1998%26volume%3D251%26spage%3D471%26epage%3D476%26doi%3D10.1006%2Fbbrc.1998.9489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Maguire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitkin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, A. P.</span><span> </span><span class="NLM_article-title">[Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span><span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.109.134619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FHYPERTENSIONAHA.109.134619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=19597036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsleksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=598-604&author=J.+J.+Maguireauthor=M.+J.+Kleinzauthor=S.+L.+Pitkinauthor=A.+P.+Davenport&title=%5BPyr1%5Dapelin-13+identified+as+the+predominant+apelin+isoform+in+the+human+heart%3A+vasoactive+mechanisms+and+inotropic+action+in+disease&doi=10.1161%2FHYPERTENSIONAHA.109.134619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">[Pyr1]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart</span></div><div class="casAuthors">Maguire, Janet J.; Kleinz, Matthias J.; Pitkin, Sarah L.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">598-604</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Apelin receptors, present on vascular smooth muscle cells, endothelium, and cardiomyocytes, are activated by the family of apelin peptides to elicit cardiovascular effects in exptl. animals, but functional activity in humans has not been studied in detail.  The authors detected low levels of apelin immunoreactivity in plasma of volunteers consistent with an autocrine/paracrine action and detected apelin immunoreactivity in the supernatant from human cultured endothelial cells.  The authors found that [Pyr1]apelin-13 was the predominant isoform in cardiac tissue from patients with coronary artery disease.  The authors tested the hypothesis that apelins have vascular and cardiac actions in human tissues in vitro and compared responses to [Pyr1]apelin-13, apelin-13, and apelin-36.  In endothelium-intact mammary artery, all 3 of the apelins induced concn.-dependent vasodilatation with comparable potency (EC50: 0.6 to 1.6 nM; max. response: 40% to 50%).  Vasodilatation was abolished after endothelial removal or preincubation with indomethacin but was unaffected by preincubation with NG-nitro-l-arginine Me ester, indicating involvement of prostanoids but not NO in dilatation by apelins in this patient group.  Apelins were potent constrictors of endothelium-denuded saphenous vein (EC50: 0.6 to 1.6 nM; max. response: 17% to 26%) and mammary artery ([Pyr1]apelin-13; EC50: 0.2 nM; max. response: 29%).  In paced atrial strips, all 3 of the peptides increased the force of contraction with subnanomolar potencies (EC50: 40 to 125 pM).  For the first time, the authors demonstrate that the 3 principal forms of apelin have comparable potency and efficacy in human cardiovascular tissues.  Apelins are potent endothelium-dependent vasodilators acting via a prostanoid-dependent mechanism; however, removal of the endothelium revealed direct vasoconstrictor actions in both the artery and vein.  Furthermore, in human cardiac tissue, the apelin peptides are among the most potent endogenous pos. inotropic agents yet reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0rlY7c6SsibVg90H21EOLACvtfcHk0ljV1vyUiIF3fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsleksL4%253D&md5=bf568a68931b0815502522cc785df8ca</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.109.134619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.109.134619%26sid%3Dliteratum%253Aachs%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DKleinz%26aufirst%3DM.%2BJ.%26aulast%3DPitkin%26aufirst%3DS.%2BL.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3D%255BPyr1%255Dapelin-13%2520identified%2520as%2520the%2520predominant%2520apelin%2520isoform%2520in%2520the%2520human%2520heart%253A%2520vasoactive%2520mechanisms%2520and%2520inotropic%2520action%2520in%2520disease%26jtitle%3DHypertension%26date%3D2009%26volume%3D54%26spage%3D598%26epage%3D604%26doi%3D10.1161%2FHYPERTENSIONAHA.109.134619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Pitkin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, A. P.</span><span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span><span class="refDoi"> DOI: 10.1124/pr.110.002949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1124%2Fpr.110.002949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=20605969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=331-342&author=S.+L.+Pitkinauthor=J.+J.+Maguireauthor=T.+I.+Bonnerauthor=A.+P.+Davenport&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXIV.+Apelin+receptor+nomenclature%2C+distribution%2C+pharmacology%2C+and+function&doi=10.1124%2Fpr.110.002949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function</span></div><div class="casAuthors">Pitkin, Sarah L.; Maguire, Janet J.; Bonner, Tom I.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-342</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  A gene encoding a novel class a G-protein-coupled receptor was discovered in 1993 by homol. cloning and was called APJ.  It was designated an "orphan" receptor until 1998, when its endogenous ligand was identified and named apelin (for APJ endogenous ligand).  Since this pairing, both apelin and its receptor have been found to have a widespread distribution in both the central nervous system and the periphery.  A no. of physiol. and pathophysiol. roles for the receptor have emerged, including regulation of cardiovascular function, fluid homeostasis, and the adipoinsular axis.  This review outlines the official International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification nomenclature, designating the receptor protein as the apelin receptor, together with current knowledge of its pharmacol., distribution, and functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFGewTc6bK7Vg90H21EOLACvtfcHk0li6Zpz8qRUlrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbO&md5=d2a5fb55e8436a098491c1eb002fd971</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002949%26sid%3Dliteratum%253Aachs%26aulast%3DPitkin%26aufirst%3DS.%2BL.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXIV.%2520Apelin%2520receptor%2520nomenclature%252C%2520distribution%252C%2520pharmacology%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D331%26epage%3D342%26doi%3D10.1124%2Fpr.110.002949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S. P.</span><span> </span><span class="NLM_article-title">Regulation of the apelinergic system and its potential in cardiovascular disease: Peptides and small molecules as tools for discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7913</span><span class="NLM_x">–</span> <span class="NLM_lpage">7927</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00527</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00527" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7913-7927&author=S.+Narayananauthor=D.+L.+Harrisauthor=R.+Maitraauthor=S.+P.+Runyon&title=Regulation+of+the+apelinergic+system+and+its+potential+in+cardiovascular+disease%3A+Peptides+and+small+molecules+as+tools+for+discovery&doi=10.1021%2Facs.jmedchem.5b00527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery</span></div><div class="casAuthors">Narayanan, Sanju; Harris, Danni L.; Maitra, Rangan; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7913-7927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apelin peptides and the apelin receptor represent a relatively new therapeutic axis for the potential treatment of cardiovascular disease.  Several reports suggest apelin receptor activation with apelin peptides results in cardioprotection as noted through pos. ionotropy, angiogenesis, redn. of mean arterial blood pressure, and apoptosis.  Considering the potential therapeutic benefit attainable through modulation of the apelinergic system, research is expanding to develop novel therapies that limit the inherent rapid degrdn. of endogenous apelin peptides and produce metabolically stable small mol. agonists and antagonists to more rigorously interrogate the apelin receptor system.  This review details the structure-activity relationships for chem. modified apelin peptides and recent disclosures of small mol. agonists and antagonists and summarizes the peer reviewed and patented literature.  Development of metabolically stable ligands of apelin receptor and their effects in various models over the coming years will hopefully lead to establishment of this receptor as a validated target for cardiovascular indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTIngNdWxX87Vg90H21EOLACvtfcHk0li6Zpz8qRUlrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7rN&md5=6c116a42d7b523905e811c33c46e256f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00527%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DD.%2BL.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DRegulation%2520of%2520the%2520apelinergic%2520system%2520and%2520its%2520potential%2520in%2520cardiovascular%2520disease%253A%2520Peptides%2520and%2520small%2520molecules%2520as%2520tools%2520for%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7913%26epage%3D7927%26doi%3D10.1021%2Facs.jmedchem.5b00527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Zhong, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnie, S. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vederas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudit, G. Y.</span><span> </span><span class="NLM_article-title">Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">1863</span><span class="NLM_x">, </span> <span class="NLM_fpage">1942</span><span class="NLM_x">–</span> <span class="NLM_lpage">1950</span><span class="refDoi"> DOI: 10.1016/j.bbadis.2016.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.bbadis.2016.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=27825851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVahtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2017&pages=1942-1950&author=J.-C.+Zhongauthor=Z.-Z.+Zhangauthor=W.+Wangauthor=S.+M.+K.+McKinnieauthor=J.+C.+Vederasauthor=G.+Y.+Oudit&title=Targeting+the+apelin+pathway+as+a+novel+therapeutic+approach+for+cardiovascular+diseases&doi=10.1016%2Fj.bbadis.2016.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases</span></div><div class="casAuthors">Zhong, Jiu-Chang; Zhang, Zhen-Zhou; Wang, Wang; McKinnie, Shaun M. K.; Vederas, John C.; Oudit, Gavin Y.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1942-1950</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The apelin/apelin receptor system is widely distributed and has a dominant role in cardiovascular homeostasis and disease.  The apelin gene is X-linked and is synthesized as a 77 amino acid pre-pro-peptide that is subsequently cleaved to generate a family of apelin peptides that possess similar functions but display different tissue distribution, potency and receptor binding affinity.  Loss-of-function expts. using the apelin and the apelin receptor knockout mice and gain-of-function expts. using apelin peptides have delineated a well-defined role of the apelin axis in cardiovascular physiol. and diseases.  Activation of the apelin receptor by its cognate peptide ligand, apelin, induces a wide range of physiol. effects, including vasodilation, increased myocardial contractility, angiogenesis, and balanced energy metab. and fluid homeostasis.  The apelin/apelin receptor pathway is also implicated in atherosclerosis, hypertension, coronary artery disease, heart failure, diabetes and obesity, making it a promising therapeutic target.  Hence, research is expanding to develop novel therapies that inhibit degrdn. of endogenous apelin peptides or their analogs.  Chem. synthesis of stable apelin receptor agonists aims to more efficiently enhance the activation of the apelin system.  Targeting the apelin/apelin receptor axis has emerged as a novel therapeutic approach against cardiovascular diseases and an increased understanding of cardiovascular actions of the apelin system will help to develop effective interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqosnvaOVUBwrVg90H21EOLACvtfcHk0li6Zpz8qRUlrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVahtLvK&md5=915d2b52697db35097bc1794506ff779</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2016.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2016.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DJ.-C.%26aulast%3DZhang%26aufirst%3DZ.-Z.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMcKinnie%26aufirst%3DS.%2BM.%2BK.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26aulast%3DOudit%26aufirst%3DG.%2BY.%26atitle%3DTargeting%2520the%2520apelin%2520pathway%2520as%2520a%2520novel%2520therapeutic%2520approach%2520for%2520cardiovascular%2520diseases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2017%26volume%3D1863%26spage%3D1942%26epage%3D1950%26doi%3D10.1016%2Fj.bbadis.2016.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, A. P.</span><span> </span><span class="NLM_article-title">Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1016/j.tips.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.tips.2015.06.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=560-567&author=P.+Yangauthor=J.+J.+Maguireauthor=A.+P.+Davenport&title=Apelin%2C+Elabela%2FToddler%2C+and+biased+agonists+as+novel+therapeutic+agents+in+the+cardiovascular+system&doi=10.1016%2Fj.tips.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DApelin%252C%2520Elabela%252FToddler%252C%2520and%2520biased%2520agonists%2520as%2520novel%2520therapeutic%2520agents%2520in%2520the%2520cardiovascular%2520system%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D560%26epage%3D567%26doi%3D10.1016%2Fj.tips.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">O’Dowd, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, H. H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petronis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span> </span><span class="NLM_article-title">A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/0378-1119(93)90495-O</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2F0378-1119%2893%2990495-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=8294032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFGnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1993&pages=355-360&author=B.+F.+O%E2%80%99Dowdauthor=M.+Heiberauthor=A.+Chanauthor=H.+H.+Q.+Hengauthor=L.-C.+Tsuiauthor=J.+L.+Kennedyauthor=X.+Shiauthor=A.+Petronisauthor=S.+R.+Georgeauthor=T.+Nguyen&title=A+human+gene+that+shows+identity+with+the+gene+encoding+the+angiotensin+receptor+is+located+on+chromosome+11&doi=10.1016%2F0378-1119%2893%2990495-O"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11</span></div><div class="casAuthors">O'Dowd, Brian F.; Heiber, Michael; Chan, Audrey; Heng, Henry H. Q.; Tsui, Lap Chee; Kennedy, James L.; Shi, Xiaomei; Petronis, Arturas; George, Susan R.; Nguyen Tuan</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">355-60</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    </div><div class="casAbstract">The authors report the cloning of a gene, intron-less in its coding region, which the authors have named APJ.  This gene was cloned using the polymerase chain reaction (PCR), with a set of primers designed on the basis of the conservation that members of G protein-coupled receptors (GPCR) have in their transmembrane (TM) regions.  The putative receptor protein, APJ, shares closest identity to the angiotensin receptor (AT1) ranging from 40 to 50% in the hydrophobic TM regions of these receptors.  The transcripts for this gene were detected in many regions of the brain.  PCR anal. of somatic cell lines found APJ-related sequences to be only present on chromosome 11, and high-resoln. mapping by fluorescence in situ hybridization (FISH) sub-localized APJ on band q12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqp2kdIKETdbVg90H21EOLACvtfcHk0liCjL9WgOek4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFGnsL0%253D&md5=4beb37696cbf0f919df6c1d22088e719</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2F0378-1119%2893%2990495-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-1119%252893%252990495-O%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DB.%2BF.%26aulast%3DHeiber%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DHeng%26aufirst%3DH.%2BH.%2BQ.%26aulast%3DTsui%26aufirst%3DL.-C.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DPetronis%26aufirst%3DA.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DNguyen%26aufirst%3DT.%26atitle%3DA%2520human%2520gene%2520that%2520shows%2520identity%2520with%2520the%2520gene%2520encoding%2520the%2520angiotensin%2520receptor%2520is%2520located%2520on%2520chromosome%252011%26jtitle%3DGene%26date%3D1993%26volume%3D136%26spage%3D355%26epage%3D360%26doi%3D10.1016%2F0378-1119%2893%2990495-O" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Reaux-Le Goazigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skultetyova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenkei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Messari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallatz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvol, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkovits, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2001.00320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1046%2Fj.1471-4159.2001.00320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=11359874" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2001&pages=1085-1096&author=A.+Reaux-Le+Goazigoauthor=N.+De+Motaauthor=I.+Skultetyovaauthor=Z.+Lenkeiauthor=S.+El+Messariauthor=K.+Gallatzauthor=P.+Corvolauthor=M.+Palkovitsauthor=C.+Llorens-Cortes&title=Physiological+role+of+a+novel+neuropeptide%2C+apelin%2C+and+its+receptor+in+the+rat+brain&doi=10.1046%2Fj.1471-4159.2001.00320.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00320.x%26sid%3Dliteratum%253Aachs%26aulast%3DReaux-Le%2BGoazigo%26aufirst%3DA.%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DSkultetyova%26aufirst%3DI.%26aulast%3DLenkei%26aufirst%3DZ.%26aulast%3DEl%2BMessari%26aufirst%3DS.%26aulast%3DGallatz%26aufirst%3DK.%26aulast%3DCorvol%26aufirst%3DP.%26aulast%3DPalkovits%26aufirst%3DM.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DPhysiological%2520role%2520of%2520a%2520novel%2520neuropeptide%252C%2520apelin%252C%2520and%2520its%2520receptor%2520in%2520the%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D77%26spage%3D1085%26epage%3D1096%26doi%3D10.1046%2Fj.1471-4159.2001.00320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">De Mota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaux-Le Goazigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Messari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chartrel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dujardin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaudry, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">10464</span><span class="NLM_x">–</span> <span class="NLM_lpage">10469</span><span class="refDoi"> DOI: 10.1073/pnas.0403518101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1073%2Fpnas.0403518101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15231996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVyrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=10464-10469&author=N.+De+Motaauthor=A.+Reaux-Le+Goazigoauthor=S.+El+Messariauthor=N.+Chartrelauthor=D.+Roeschauthor=C.+Dujardinauthor=C.+Kordonauthor=H.+Vaudryauthor=F.+Moosauthor=C.+Llorens-Cortes&title=Apelin%2C+a+potent+diuretic+neuropeptide+counteracting+vasopressin+actions+through+inhibition+of+vasopressin+neuron+activity+and+vasopressin+release&doi=10.1073%2Fpnas.0403518101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release</span></div><div class="casAuthors">De Mota, Nadia; Reaux-Le Goazigo, Annabelle; El Messari, Said; Chartrel, Nicolas; Roesch, Darren; Dujardin, Cynthia; Kordon, Claude; Vaudry, Hubert; Moos, Francoise; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10464-10469</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apelin, a recently isolated neuropeptide that is expressed in the supraoptic and the paraventricular nuclei, acts on specific receptors located on vasopressinergic neurons.  The increased phasic pattern of these neurons facilitates sustained antidiuresis during dehydration or lactation.  Here, we investigated whether apelin interacts with arginine vasopressin (AVP) to maintain body fluid homeostasis.  We first characterized the predominant mol. forms of endogenous hypothalamic and plasma apelin as corresponding to apelin 13 and, to a lesser extent, to apelin 17.  We then demonstrated that, in lactating rats, apelin was colocalized with AVP in supraoptic nucleus magnocellular neurons and given intracerebroventricularly inhibited the phasic elec. activity of AVP neurons.  In lactating mice, intracerebroventricular administration of apelin 17 reduced plasma AVP levels and increased diuresis.  Moreover, water deprivation, which increases systemic AVP release and causes depletion of hypothalamic AVP stores, decreased plasma apelin concns. and induced hypothalamic accumulation of the peptide, indicating that AVP and apelin are conversely regulated to facilitate systemic AVP release and suppress diuresis.  Opposite effects of AVP and apelin are likely to occur at the hypothalamic level through autocrine modulation of the phasic elec. activity of AVP neurons.  Altogether, these data demonstrate that apelin acts as a potent diuretic neuropeptide counteracting AVP actions through inhibition of AVP neuron activity and AVP release.  The coexistence of apelin and AVP in magnocellular neurons, their opposite biol. effects, and regulation are likely to play a key role for maintaining body fluid homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXfnm1Ia_ee7Vg90H21EOLACvtfcHk0liCjL9WgOek4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVyrsLg%253D&md5=3890a3d0ab4318b3e57d1c528b17599c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0403518101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0403518101%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DReaux-Le%2BGoazigo%26aufirst%3DA.%26aulast%3DEl%2BMessari%26aufirst%3DS.%26aulast%3DChartrel%26aufirst%3DN.%26aulast%3DRoesch%26aufirst%3DD.%26aulast%3DDujardin%26aufirst%3DC.%26aulast%3DKordon%26aufirst%3DC.%26aulast%3DVaudry%26aufirst%3DH.%26aulast%3DMoos%26aufirst%3DF.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DApelin%252C%2520a%2520potent%2520diuretic%2520neuropeptide%2520counteracting%2520vasopressin%2520actions%2520through%2520inhibition%2520of%2520vasopressin%2520neuron%2520activity%2520and%2520vasopressin%2520release%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D10464%26epage%3D10469%26doi%3D10.1073%2Fpnas.0403518101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Boucher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daviaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guigne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzucotelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castan-Laurell, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tack, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knibiehler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpene, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audigier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valet, P.</span><span> </span><span class="NLM_article-title">Apelin, a newly identified adipokine up-regulated by insulin and obesity</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">1764</span><span class="NLM_x">–</span> <span class="NLM_lpage">1771</span><span class="refDoi"> DOI: 10.1210/en.2004-1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1210%2Fen.2004-1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15677759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1yqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=1764-1771&author=J.+Boucherauthor=B.+Masriauthor=D.+Daviaudauthor=S.+Gestaauthor=C.+Guigneauthor=A.+Mazzucotelliauthor=I.+Castan-Laurellauthor=I.+Tackauthor=B.+Knibiehlerauthor=C.+Carpeneauthor=Y.+Audigierauthor=J.+S.+Saulnier-Blacheauthor=P.+Valet&title=Apelin%2C+a+newly+identified+adipokine+up-regulated+by+insulin+and+obesity&doi=10.1210%2Fen.2004-1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, a newly identified adipokine up-regulated by insulin and obesity</span></div><div class="casAuthors">Boucher, Jeremie; Masri, Bernard; Daviaud, Daniele; Gesta, Stephane; Guigne, Charlotte; Mazzucotelli, Anne; Castan-Laurell, Isabelle; Tack, Ivan; Knibiehler, Bernard; Carpene, Christian; Audigier, Yves; Saulnier-Blache, Jean-Sebastien; Valet, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1764-1771</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The results presented herein demonstrate that apelin is expressed and secreted by both human and mouse adipocytes.  Apelin mRNA levels in isolated adipocytes are close to other cell types present in white adipose tissue or other organs known to express apelin such as kidney, heart, and to a lesser extent brown adipose tissue.  Apelin expression is increased during adipocyte differentiation stage.  A comparison of four different models of obesity in mice showed a large increase in both apelin expression in fat cells and apelin plasma levels in all the hyperinsulinemia-assocd. obesities and clearly demonstrated that obesity or high-fat feeding are not the main determinants of the rise of apelin expression.  The lack of insulin in streptozotocin-treated mice is assocd. with a decreased expression of apelin in adipocytes.  Furthermore, apelin expression in fat cells is strongly inhibited by fasting and recovered after refeeding, in a similar way to insulin.  A direct regulation of apelin expression by insulin is obsd. in both human and mouse adipocytes and clearly assocd. with the stimulation of phosphatidylinositol 3-kinase, protein kinase C, and MAPK.  These data provide evidence that insulin exerts a direct control on apelin gene expression in adipocytes.  In obese patients, both plasma apelin and insulin levels were significantly higher, suggesting that the regulation of apelin by insulin could influence blood concns. of apelin.  The present work identifies apelin as a novel adipocyte endocrine secretion and focuses on its potential link with obesity-assocd. variations of insulin sensitivity status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJGvlrRJpOQrVg90H21EOLACvtfcHk0lj3S-irdd065Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1yqtLo%253D&md5=5cc5ffb5bae182603c1d567f44b287fd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1210%2Fen.2004-1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2004-1427%26sid%3Dliteratum%253Aachs%26aulast%3DBoucher%26aufirst%3DJ.%26aulast%3DMasri%26aufirst%3DB.%26aulast%3DDaviaud%26aufirst%3DD.%26aulast%3DGesta%26aufirst%3DS.%26aulast%3DGuigne%26aufirst%3DC.%26aulast%3DMazzucotelli%26aufirst%3DA.%26aulast%3DCastan-Laurell%26aufirst%3DI.%26aulast%3DTack%26aufirst%3DI.%26aulast%3DKnibiehler%26aufirst%3DB.%26aulast%3DCarpene%26aufirst%3DC.%26aulast%3DAudigier%26aufirst%3DY.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DValet%26aufirst%3DP.%26atitle%3DApelin%252C%2520a%2520newly%2520identified%2520adipokine%2520up-regulated%2520by%2520insulin%2520and%2520obesity%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26spage%3D1764%26epage%3D1771%26doi%3D10.1210%2Fen.2004-1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Heinonen, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purhonen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miettinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhava, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, K. H.</span><span> </span><span class="NLM_article-title">Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding</span> <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1016/j.regpep.2005.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.regpep.2005.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15970339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1Srs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2005&pages=7-13&author=M.+V.+Heinonenauthor=A.+K.+Purhonenauthor=P.+Miettinenauthor=M.+Paakkonenauthor=E.+Pirinenauthor=E.+Alhavaauthor=K.+Akermanauthor=K.+H.+Herzig&title=Apelin%2C+orexin-A+and+leptin+plasma+levels+in+morbid+obesity+and+effect+of+gastric+banding&doi=10.1016%2Fj.regpep.2005.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding</span></div><div class="casAuthors">Heinonen, M. V.; Purhonen, A. K.; Miettinen, P.; Paeaekkoenen, M.; Pirinen, E.; Alhava, E.; Aakerman, K.; Herzig, K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">7-13</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maintenance of human energy homeostasis is regulated by a complex network.  Peptides secreted from the gastrointestinal tract (GI) are signaling to the brain and other organs initiating or terminating food intake and energy expenditure.  In the present study we investigated basal plasma levels of apelin, orexin-A, and leptin in morbid obese patients.  In addn., we measured in a subgroup of these patients in the same individual orexin-A and leptin plasma levels one year after gastric banding surgery.  Methods: Basal plasma values were detd. in obese patients (BMI = 48±1 kg/m2 n = 32) after an overnight fast and compared to healthy, normal weighted (BMI = 22±2 kg/m2 n = 12) controls.  In addn., blood samples were collected in a subgroup of patients (BMI = 48±1 kg/m2 n = 8) the day before surgery and 1 yr after the operation.  Apelin, orexin-A, and leptin levels were analyzed using ELISAs.  Results: One year after the operation obese patients significantly lost wt. (from 48±2 kg/m2 to 39±2 kg/m2; p < 0,001).  Apelin, orexin-A and leptin levels in obese patients were significantly higher compared to control individuals (736±50 pg/mL vs. 174±14 pg/mL, p < 0.0001; 75.3±24.1 pg/mL vs. 0.8±0.4 pg/mL, p < 0.0001; 79.0±2.4 ng/mL vs. 5.8±0.8 ng/mL, p < 0.0001, resp.).  Apelin and leptin plasma concns. also correlated significantly with BMI (r = 0.769, p < 0.0001; r = 0.778; p < 0.0001, resp.), while orexin-A correlation was rather weak (r = 0.335, p < 0.03).  No difference between pre- and post-operative orexin-A levels was obsd., while leptin plasma levels significantly decreased from 45.1±5.4 ng/mL to 27.3±6.0 ng/mL (p = 0.015).  Conclusions: Apelin, orexin-A, and leptin plasma levels correlated pos. with the BMI.  One year after gastric banding with significant loss in BMI basal plasma levels of leptin decreased, while orexin-A remained unchanged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzXQz_ivPw27Vg90H21EOLACvtfcHk0lj3S-irdd065Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1Srs7k%253D&md5=666856f02b2187fc35d30cd9c13de12c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.regpep.2005.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.regpep.2005.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DHeinonen%26aufirst%3DM.%2BV.%26aulast%3DPurhonen%26aufirst%3DA.%2BK.%26aulast%3DMiettinen%26aufirst%3DP.%26aulast%3DPaakkonen%26aufirst%3DM.%26aulast%3DPirinen%26aufirst%3DE.%26aulast%3DAlhava%26aufirst%3DE.%26aulast%3DAkerman%26aufirst%3DK.%26aulast%3DHerzig%26aufirst%3DK.%2BH.%26atitle%3DApelin%252C%2520orexin-A%2520and%2520leptin%2520plasma%2520levels%2520in%2520morbid%2520obesity%2520and%2520effect%2520of%2520gastric%2520banding%26jtitle%3DRegul.%2520Pept.%26date%3D2005%26volume%3D130%26spage%3D7%26epage%3D13%26doi%3D10.1016%2Fj.regpep.2005.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aillaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaven, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quertermous, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, P. S.</span><span> </span><span class="NLM_article-title">Apelin is necessary for the maintenance of insulin sensitivity</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">E59</span><span class="NLM_x">–</span> <span class="NLM_lpage">E67</span><span class="refDoi"> DOI: 10.1152/ajpendo.00385.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1152%2Fajpendo.00385.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=19861585" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2010&pages=E59-E67&author=P.+Yueauthor=H.+Jinauthor=M.+Aillaudauthor=A.+C.+Dengauthor=J.+Azumaauthor=T.+Asagamiauthor=R.+K.+Kunduauthor=G.+M.+Reavenauthor=T.+Quertermousauthor=P.+S.+Tsao&title=Apelin+is+necessary+for+the+maintenance+of+insulin+sensitivity&doi=10.1152%2Fajpendo.00385.2009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00385.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00385.2009%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DAillaud%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DA.%2BC.%26aulast%3DAzuma%26aufirst%3DJ.%26aulast%3DAsagami%26aufirst%3DT.%26aulast%3DKundu%26aufirst%3DR.%2BK.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26aulast%3DQuertermous%26aufirst%3DT.%26aulast%3DTsao%26aufirst%3DP.%2BS.%26atitle%3DApelin%2520is%2520necessary%2520for%2520the%2520maintenance%2520of%2520insulin%2520sensitivity%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D298%26spage%3DE59%26epage%3DE67%26doi%3D10.1152%2Fajpendo.00385.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span> </span><span class="NLM_article-title">Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1634</span><span class="NLM_x">–</span> <span class="NLM_lpage">1639</span><span class="refDoi"> DOI: 10.1016/j.peptides.2011.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.peptides.2011.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1634-1639&author=H.+Chenauthor=C.+Zhengauthor=X.+Zhangauthor=J.+Liauthor=J.+Liauthor=L.+Zhengauthor=K.+Huang&title=Apelin+alleviates+diabetes-associated+endoplasmic+reticulum+stress+in+the+pancreas+of+Akita+mice&doi=10.1016%2Fj.peptides.2011.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2011.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2011.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DK.%26atitle%3DApelin%2520alleviates%2520diabetes-associated%2520endoplasmic%2520reticulum%2520stress%2520in%2520the%2520pancreas%2520of%2520Akita%2520mice%26jtitle%3DPeptides%26date%3D2011%26volume%3D32%26spage%3D1634%26epage%3D1639%26doi%3D10.1016%2Fj.peptides.2011.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Attané, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foussal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gonidec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daviaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanecq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzmán-Ruiz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezaire, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancoule, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Gayo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burcelin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pénicaud, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castan-Laurell, I.</span><span> </span><span class="NLM_article-title">Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span><span class="refDoi"> DOI: 10.2337/db11-0100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.2337%2Fdb11-0100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=310-320&author=C.+Attan%C3%A9author=C.+Foussalauthor=S.+Le+Gonidecauthor=A.+Benaniauthor=D.+Daviaudauthor=E.+Wanecqauthor=R.+Guzm%C3%A1n-Ruizauthor=C.+Drayauthor=V.+Bezaireauthor=C.+Rancouleauthor=K.+Kubaauthor=M.+Ruiz-Gayoauthor=T.+Levadeauthor=J.+M.+Penningerauthor=R.+Burcelinauthor=L.+P%C3%A9nicaudauthor=P.+Valetauthor=I.+Castan-Laurell&title=Apelin+treatment+increases+complete+fatty+acid+oxidation%2C+mitochondrial+oxidative+capacity%2C+and+biogenesis+in+muscle+of+insulin-resistant+mice&doi=10.2337%2Fdb11-0100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2337%2Fdb11-0100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb11-0100%26sid%3Dliteratum%253Aachs%26aulast%3DAttan%25C3%25A9%26aufirst%3DC.%26aulast%3DFoussal%26aufirst%3DC.%26aulast%3DLe%2BGonidec%26aufirst%3DS.%26aulast%3DBenani%26aufirst%3DA.%26aulast%3DDaviaud%26aufirst%3DD.%26aulast%3DWanecq%26aufirst%3DE.%26aulast%3DGuzm%25C3%25A1n-Ruiz%26aufirst%3DR.%26aulast%3DDray%26aufirst%3DC.%26aulast%3DBezaire%26aufirst%3DV.%26aulast%3DRancoule%26aufirst%3DC.%26aulast%3DKuba%26aufirst%3DK.%26aulast%3DRuiz-Gayo%26aufirst%3DM.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DBurcelin%26aufirst%3DR.%26aulast%3DP%25C3%25A9nicaud%26aufirst%3DL.%26aulast%3DValet%26aufirst%3DP.%26aulast%3DCastan-Laurell%26aufirst%3DI.%26atitle%3DApelin%2520treatment%2520increases%2520complete%2520fatty%2520acid%2520oxidation%252C%2520mitochondrial%2520oxidative%2520capacity%252C%2520and%2520biogenesis%2520in%2520muscle%2520of%2520insulin-resistant%2520mice%26jtitle%3DDiabetes%26date%3D2012%26volume%3D61%26spage%3D310%26epage%3D320%26doi%3D10.2337%2Fdb11-0100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Choe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cayabyab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorf, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J.</span><span> </span><span class="NLM_article-title">The orphan seven-transmembrane receptor Apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">6113</span><span class="NLM_x">–</span> <span class="NLM_lpage">6118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=9621075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFGltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1998&pages=6113-6118&author=H.+Choeauthor=M.+Farzanauthor=M.+Konkelauthor=K.+Martinauthor=Y.+Sunauthor=L.+Marconauthor=M.+Cayabyabauthor=M.+Bermanauthor=M.+E.+Dorfauthor=N.+Gerardauthor=C.+Gerardauthor=J.+Sodroski&title=The+orphan+seven-transmembrane+receptor+Apj+supports+the+entry+of+primary+T-cell-line-tropic+and+dualtropic+human+immunodeficiency+virus+type+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan seven-transmembrane receptor Apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1</span></div><div class="casAuthors">Choe, Hyeryun; Farzan, Michael; Konkel, Miriam; Martin, Kathleen; Sun, Ying; Marcon, Luisa; Cayabyab, Mark; Berman, Michael; Dorf, Martin E.; Gerard, Norma; Gerard, Craig; Sodroski, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">6113-6118</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 (HIV-1) enters target cells by sequential binding to CD4 and specific seven-transmembrane-segment (7TMS) coreceptors.  Viruses use the chemokine receptor CCR5 as a coreceptor in the early, asymptomatic stages of HIV-1 infection but can adapt to the use of other receptors such as CXCR4 and CCR3 as the infection proceeds.  Here the authors identify one such coreceptor, Apj, which supported the efficient entry of several primary T-cell-line tropic (T-tropic) and dual-tropic HIV-1 isolates and the simian immunodeficiency virus SIVmac316.  Another 7TMS protein, CCR9, supported the less efficient entry of one primary T-tropic isolate.  MRNAs for both receptors were present in phytohemagglutinin- and interleukin-2-activated peripheral blood mononuclear cells.  Apj and CCR9 share with other coreceptors for HIV-1 and SIV an N-terminal region rich in arom. and acidic residues.  These results highlight properties common to 7TMS proteins that can function as HIV-1 coreceptors, and they may contribute to an understanding of viral evolution in infected individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbgaNfbFnzebVg90H21EOLACvtfcHk0liBAfnbXvZe0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFGltb4%253D&md5=8f1bfc80c58dfc8e5382d09aaf72e3fd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DKonkel%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMarcon%26aufirst%3DL.%26aulast%3DCayabyab%26aufirst%3DM.%26aulast%3DBerman%26aufirst%3DM.%26aulast%3DDorf%26aufirst%3DM.%2BE.%26aulast%3DGerard%26aufirst%3DN.%26aulast%3DGerard%26aufirst%3DC.%26aulast%3DSodroski%26aufirst%3DJ.%26atitle%3DThe%2520orphan%2520seven-transmembrane%2520receptor%2520Apj%2520supports%2520the%2520entry%2520of%2520primary%2520T-cell-line-tropic%2520and%2520dualtropic%2520human%2520immunodeficiency%2520virus%2520type%25201%26jtitle%3DJ.%2520Virol.%26date%3D1998%26volume%3D72%26spage%3D6113%26epage%3D6118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Fan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhtar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, R. J.</span><span> </span><span class="NLM_article-title">Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">10163</span><span class="NLM_x">–</span> <span class="NLM_lpage">10168</span><span class="refDoi"> DOI: 10.1021/bi030049s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi030049s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=10163-10168&author=X.+Fanauthor=N.+Zhouauthor=X.+Zhangauthor=M.+Mukhtarauthor=Z.+Luauthor=J.+Fangauthor=G.+C.+DuBoisauthor=R.+J.+Pomerantz&title=Structural+and+functional+study+of+the+apelin-13+peptide%2C+an+endogenous+ligand+of+the+HIV-1+coreceptor%2C+APJ&doi=10.1021%2Fbi030049s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi030049s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030049s%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMukhtar%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DDuBois%26aufirst%3DG.%2BC.%26aulast%3DPomerantz%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520and%2520functional%2520study%2520of%2520the%2520apelin-13%2520peptide%252C%2520an%2520endogenous%2520ligand%2520of%2520the%2520HIV-1%2520coreceptor%252C%2520APJ%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D10163%26epage%3D10168%26doi%3D10.1021%2Fbi030049s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lee, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariyawasam, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osmond, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dowd, B. F.</span><span> </span><span class="NLM_article-title">Characterization of apelin, the ligand for the APJ receptor</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0740034.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1046%2Fj.1471-4159.2000.0740034.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10617103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Oi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=34-41&author=D.+K.+Leeauthor=R.+Chengauthor=T.+Nguyenauthor=T.+Fanauthor=A.+P.+Kariyawasamauthor=Y.+Liuauthor=D.+H.+Osmondauthor=S.+R.+Georgeauthor=B.+F.+O%E2%80%99Dowd&title=Characterization+of+apelin%2C+the+ligand+for+the+APJ+receptor&doi=10.1046%2Fj.1471-4159.2000.0740034.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of apelin, the ligand for the APJ receptor</span></div><div class="casAuthors">Lee, Dennis K.; Cheng, Regina; Nguyen, Tuan; Fan, Theresa; Kariyawasam, Anula P.; Liu, Yang; Osmond, Daniel H.; George, Susan R.; O'Dowd, Brian F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The apelin peptide was recently discovered and demonstrated to be the endogenous ligand for the G protein-coupled receptor, APJ.  A search of the GenBank databases retrieved a rat expressed sequence tag partially encoding the preproapelin sequence.  The GenBank search also revealed a human sequence on chromosome Xq25-26.1, contg. the gene encoding preproapelin.  We have used the rat sequence to screen a rat brain cDNA library to obtain a cDNA encoding the full-length open reading frame of rat preproapelin.  This cDNA encoded a protein of 77 amino acids, sharing an identity of 82% with human preproapelin.  Northern and in situ hybridization analyses revealed both human and rat apelin and APJ to be expressed in the brain and periphery.  Both sequence and mRNA expression distribution analyses revealed similarities between apelin and angiotensin II, suggesting they that share related physiol. roles.  A synthetic apelin peptide was injected i.v. into male Wistar rats, resulting in immediate lowering of both systolic and diastolic blood pressure, which persisted for several minutes.  The i.p. apelin injections induced an increase in drinking behavior within the first 30 min after injection, with a return to baseline within 1 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpATFrP5oOMprVg90H21EOLACvtfcHk0lg8SqIBzZAgDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Oi&md5=1481d406743b55c8efb532ffb80fe782</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0740034.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0740034.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BK.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DT.%26aulast%3DKariyawasam%26aufirst%3DA.%2BP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DOsmond%26aufirst%3DD.%2BH.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DB.%2BF.%26atitle%3DCharacterization%2520of%2520apelin%252C%2520the%2520ligand%2520for%2520the%2520APJ%2520receptor%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D34%26epage%3D41%26doi%3D10.1046%2Fj.1471-4159.2000.0740034.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winborn, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrie, K. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hervieu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolaky, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrity, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdock, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darker, J. G.</span><span> </span><span class="NLM_article-title">Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.01587.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1046%2Fj.1471-4159.2003.01587.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=12603839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1ejtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=1162-1172&author=A.+D.+Medhurstauthor=C.+A.+Jenningsauthor=M.+J.+Robbinsauthor=R.+P.+Davisauthor=C.+Ellisauthor=K.+Y.+Winbornauthor=K.+W.+M.+Lawrieauthor=G.+Hervieuauthor=G.+Rileyauthor=J.+E.+Bolakyauthor=N.+C.+Herrityauthor=P.+Murdockauthor=J.+G.+Darker&title=Pharmacological+and+immunohistochemical+characterization+of+the+APJ+receptor+and+its+endogenous+ligand+apelin&doi=10.1046%2Fj.1471-4159.2003.01587.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin</span></div><div class="casAuthors">Medhurst, Andrew D.; Jennings, Carol A.; Robbins, Melanie J.; Davis, Robert P.; Ellis, Catherine; Winborn, Kim Y.; Lawrie, Kenneth W. M.; Hervieu, Guillaume; Riley, Graham; Bolaky, Jane E.; Herrity, Nicole C.; Murdock, Paul; Darker, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1162-1172</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Apelin peptides have recently been identified to be the endogenous ligands for the G protein-coupled receptor APJ.  However, little is known about the physiol. roles of this ligand-receptor pairing.  In the present study the authors investigated the pharmacol. of several apelin analogs at the human recombinant APJ receptor using radioligand binding and functional assays.  This has led to the identification of key residues in the apelin peptide required for functional potency and binding affinity through structure-activity studies.  In particular, the authors have identified that replacement of leucine in position 5, or arginine in position 2 and 4 of the C-terminal apelin peptide, apelin-13, resulted in significant changes in pharmacol.  The authors also investigated the detailed localization of pre-proapelin and APJ receptor mRNA in a wide range of human, rat and mouse tissues using quant. RT-PCR, and carried out a detailed immunohistochem. study of the distribution of the APJ receptor in rat brain and spinal cord.  Interestingly, the APJ receptor was not only co-localized in white matter with GFAP in the spinal cord, but was also clearly localized on neurons in the brain, suggesting that this receptor and its peptide may be involved in a wide range of biol. process yet to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99tyPHrKfxLVg90H21EOLACvtfcHk0lg8SqIBzZAgDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1ejtb8%253D&md5=4a83eb10e5612872943c2a327659ab6d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.01587.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.01587.x%26sid%3Dliteratum%253Aachs%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DJennings%26aufirst%3DC.%2BA.%26aulast%3DRobbins%26aufirst%3DM.%2BJ.%26aulast%3DDavis%26aufirst%3DR.%2BP.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DWinborn%26aufirst%3DK.%2BY.%26aulast%3DLawrie%26aufirst%3DK.%2BW.%2BM.%26aulast%3DHervieu%26aufirst%3DG.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DBolaky%26aufirst%3DJ.%2BE.%26aulast%3DHerrity%26aufirst%3DN.%2BC.%26aulast%3DMurdock%26aufirst%3DP.%26aulast%3DDarker%26aufirst%3DJ.%2BG.%26atitle%3DPharmacological%2520and%2520immunohistochemical%2520characterization%2520of%2520the%2520APJ%2520receptor%2520and%2520its%2520endogenous%2520ligand%2520apelin%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D84%26spage%3D1162%26epage%3D1172%26doi%3D10.1046%2Fj.1471-4159.2003.01587.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Japp, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruden, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudie, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megson, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flapan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newby, D. E.</span><span> </span><span class="NLM_article-title">Vascular effects of apelin in vivo in man</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1016/j.jacc.2008.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.jacc.2008.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=18772060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyjsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=908-913&author=A.+G.+Jappauthor=N.+L.+Crudenauthor=D.+A.+Amerauthor=V.+K.+Liauthor=E.+B.+Goudieauthor=N.+R.+Johnstonauthor=S.+Sharmaauthor=I.+Neilsonauthor=D.+J.+Webbauthor=I.+L.+Megsonauthor=A.+D.+Flapanauthor=D.+E.+Newby&title=Vascular+effects+of+apelin+in+vivo+in+man&doi=10.1016%2Fj.jacc.2008.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Effects of Apelin In Vivo in Man</span></div><div class="casAuthors">Japp, Alan G.; Cruden, Nicholas L.; Amer, David A. B.; Li, Vivienne K. Y.; Goudie, Ewan B.; Johnston, Neil R.; Sharma, Sushma; Neilson, Ilene; Webb, David J.; Megson, Ian L.; Flapan, Andrew D.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">908-913</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This study was designed to establish the direct vascular effects of apelin in vivo in man.  Apelin is the endogenous ligand for the previously orphaned G-protein-coupled receptor, APJ.  This novel pathway is widely expressed in the cardiovascular system and is emerging as an important mediator of cardiovascular homeostasis.  In pre-clin. models, apelin causes venous and arterial vasodilation.  Vascular effects of apelin were assessed in 24 healthy volunteers.  Dorsal hand vein diam. was measured by the Aellig technique during local i.v. infusions (0.1 to 3 nmol/min) of apelin-36, (Pyr1)apelin-13, and sodium nitroprusside (0.6 nmol/min).  Forearm blood flow was measured by venous occlusion plethysmog. during intrabrachial infusions of apelin-36 and (Pyr1)apelin-13 (0.1 to 30 nmol/min) and subsequently in the presence or absence of a "nitric oxide clamp" (nitric oxide synthase inhibitor, L-N G-monomethylarginine [8 μmol/min], coinfused with nitric oxide donor, sodium nitroprusside [90 to 900 ng/min]), or a single oral dose of aspirin (600 mg) or matched placebo.  Although sodium nitroprusside caused venodilation (p < 0.0001), apelin-36 and (Pyr1)apelin-13 had no effect on dorsal hand vein diam. (p = 0.2).  Both apelin isoforms caused reproducible vasodilation in forearm resistance vessels (p < 0.0001).  (Pyr1)apelin-13-mediated vasodilation was attenuated by the nitric oxide clamp (p = 0.004) but unaffected by aspirin (p = 0.7).  Although having no apparent effect on venous tone, apelin causes nitric oxide-dependent arterial vasodilation in vivo in man.  The apelin-APJ system merits further clin. investigation to det. its role in cardiovascular homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFV91OuN1h07Vg90H21EOLACvtfcHk0ljfAtZrgrhZ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyjsbnE&md5=77645b8ab8034837a4f6c3f02868f4ab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2008.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2008.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DAmer%26aufirst%3DD.%2BA.%26aulast%3DLi%26aufirst%3DV.%2BK.%26aulast%3DGoudie%26aufirst%3DE.%2BB.%26aulast%3DJohnston%26aufirst%3DN.%2BR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DNeilson%26aufirst%3DI.%26aulast%3DWebb%26aufirst%3DD.%2BJ.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26aulast%3DFlapan%26aufirst%3DA.%2BD.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DVascular%2520effects%2520of%2520apelin%2520in%2520vivo%2520in%2520man%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2008%26volume%3D52%26spage%3D908%26epage%3D913%26doi%3D10.1016%2Fj.jacc.2008.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Barnes, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veitch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruden, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Japp, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newby, D. E.</span><span> </span><span class="NLM_article-title">Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure</span> <span class="citation_source-journal">Circ.: Heart Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span><span class="refDoi"> DOI: 10.1161/CIRCHEARTFAILURE.111.000077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FCIRCHEARTFAILURE.111.000077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=23519586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSntbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=482-491&author=G.+D.+Barnesauthor=S.+Alamauthor=G.+Carterauthor=C.+M.+Pedersenauthor=K.+M.+Leeauthor=T.+J.+Hubbardauthor=S.+Veitchauthor=H.+Jeongauthor=A.+Whiteauthor=N.+L.+Crudenauthor=L.+Husonauthor=A.+G.+Jappauthor=D.+E.+Newby&title=Sustained+cardiovascular+actions+of+APJ+agonism+during+renin-angiotensin+system+activation+and+in+patients+with+heart+failure&doi=10.1161%2FCIRCHEARTFAILURE.111.000077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained Cardiovascular Actions of APJ Agonism During Renin-Angiotensin System Activation and in Patients With Heart Failure</span></div><div class="casAuthors">Barnes, Gareth D.; Alam, Shirjel; Carter, Gordon; Pedersen, Christian M.; Lee, Kristina M.; Hubbard, Thomas J.; Veitch, Scott; Jeong, Herim; White, Audrey; Cruden, Nicholas L.; Huson, Les; Japp, Alan G.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation: Heart Failure</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">CHFICM</span>;
        ISSN:<span class="NLM_cas:issn">1941-3289</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: To assess cardiovascular actions of APJ agonism during prolonged (Pyr)apelin-13 infusion and renin-angiotensin system activation.  METHODS AND RESULTS-: Forty-eight volunteers and 12 patients with chronic stable heart failure attended a series of randomized placebo-controlled studies.  Forearm blood flow, cardiac index, left ventricular dimensions, and mean arterial pressure were measured using bilateral venous occlusion plethysmog., bioimpedance cardiog., transthoracic echocardiog., and sphygmomanometry, resp., during brief local (0.3-3.0 nmol/min) and systemic (30-300 nmol/min) or prolonged systemic (30 nmol/min) (Pyr)apelin-13 infusions in the presence or absence of renin-angiotensin system activation with sodium depletion or angiotensin II coinfusion.  During sodium depletion and angiotensin II coinfusion, (Pyr)apelin-13-induced vasodilatation was preserved (P<0.02 for both).  Systemic i.v. (Pyr)apelin-13 infusion increased cardiac index, whereas reducing mean arterial pressure and peripheral vascular resistance index (P<0.001 for all) irresp. of sodium depletion or angiotensin II (0.5 ng/kg per min) coinfusion (P>0.05 for all).  Prolonged 6-h (Pyr)apelin-13 infusion caused a sustained increase in cardiac index with increased left ventricular ejection fraction in patients with chronic heart failure (ANOVA; P<0.001 for all).  CONCLUSIONS-: APJ agonism has sustained cardiovascular effects that are preserved in the presence of renin-angiotensin system activation or heart failure.  APJ agonism may hold major promise to complement current optimal medical therapy in patients with chronic heart failure.  Clin. TRIAL REGISTRATION-: URL: http://www.clinicaltrials.gov.  Unique identifiers: NCT00901719, NCT00901888, NCT01049646, NCT01179061.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWOAUpCsQtubVg90H21EOLACvtfcHk0ljfAtZrgrhZ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSntbvM&md5=7aa0219a8f5a363c3092b1b6a0631ed2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1161%2FCIRCHEARTFAILURE.111.000077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCHEARTFAILURE.111.000077%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DG.%2BD.%26aulast%3DAlam%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DG.%26aulast%3DPedersen%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DK.%2BM.%26aulast%3DHubbard%26aufirst%3DT.%2BJ.%26aulast%3DVeitch%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DHuson%26aufirst%3DL.%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DSustained%2520cardiovascular%2520actions%2520of%2520APJ%2520agonism%2520during%2520renin-angiotensin%2520system%2520activation%2520and%2520in%2520patients%2520with%2520heart%2520failure%26jtitle%3DCirc.%253A%2520Heart%2520Failure%26date%3D2013%26volume%3D6%26spage%3D482%26epage%3D491%26doi%3D10.1161%2FCIRCHEARTFAILURE.111.000077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Japp, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruden, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gemeren, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denvir, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megson, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flapan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newby, D. E.</span><span> </span><span class="NLM_article-title">Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">1818</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.109.911339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FCIRCULATIONAHA.109.911339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=20385929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2010&pages=1818-1827&author=A.+G.+Jappauthor=N.+L.+Crudenauthor=G.+Barnesauthor=N.+van+Gemerenauthor=J.+Mathewsauthor=J.+Adamsonauthor=N.+R.+Johnstonauthor=M.+A.+Denvirauthor=I.+L.+Megsonauthor=A.+D.+Flapanauthor=D.+E.+Newby&title=Acute+cardiovascular+effects+of+apelin+in+humans%3A+potential+role+in+patients+with+chronic+heart+failure&doi=10.1161%2FCIRCULATIONAHA.109.911339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Acute Cardiovascular Effects of Apelin in Humans: Potential Role in Patients With Chronic Heart Failure</span></div><div class="casAuthors">Japp, A. G.; Cruden, N. L.; Barnes, G.; van Gemeren, N.; Mathews, J.; Adamson, J.; Johnston, N. R.; Denvir, M. A.; Megson, I. L.; Flapan, A. D.; Newby, D. E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1818-1827</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND: Apelin, the endogenous ligand for the novel G protein-coupled receptor APJ, has major cardiovascular effects in preclin. models.  The study objectives were to establish the effects of acute apelin administration on peripheral, cardiac, and systemic hemodynamic variables in healthy volunteers and patients with heart failure.  METHODS AND RESULTS: Eighteen patients with New York Heart Assocn. class II to III chronic heart failure, 6 patients undergoing diagnostic coronary angiog., and 26 healthy volunteers participated in a series of randomized, double-blind, placebo-controlled studies.  Measurements of forearm blood flow, coronary blood flow, left ventricular pressure, and cardiac output were made by venous occlusion plethysmog., Doppler flow wire and quant. coronary angiog., pressure wire, and thoracic bioimpedance, resp.  Intrabrachial infusions of (Pyr)apelin-13, acetylcholine, and sodium nitroprusside caused forearm vasodilatation in patients and control subjects (all P < 0.0001).  Vasodilatation to acetylcholine (P = 0.01) but not apelin (P = 0.3) or sodium nitroprusside (P = 0.9) was attenuated in patients with heart failure.  Intracoronary bolus of apelin-36 increased coronary blood flow and the max. rate of rise in left ventricular pressure and reduced peak and end-diastolic left ventricular pressures (all P < 0.05).  Systemic infusions of (Pyr)apelin-13 (30 to 300 nmol/min) increased cardiac index and lowered mean arterial pressure and peripheral vascular resistance in patients and healthy control subjects (all P<0.01) but increased heart rate only in control subjects (P < 0.01).  CONCLUSIONS: Acute apelin administration in humans causes peripheral and coronary vasodilatation and increases cardiac output.  APJ agonism represents a novel potential therapeutic target for patients with heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiqCbkcSGzQ7Vg90H21EOLACvtfcHk0ljfAtZrgrhZ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVOls7k%253D&md5=35dd169c74c36b03d9c82c1215401467</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.109.911339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.109.911339%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DBarnes%26aufirst%3DG.%26aulast%3Dvan%2BGemeren%26aufirst%3DN.%26aulast%3DMathews%26aufirst%3DJ.%26aulast%3DAdamson%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DN.%2BR.%26aulast%3DDenvir%26aufirst%3DM.%2BA.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26aulast%3DFlapan%26aufirst%3DA.%2BD.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DAcute%2520cardiovascular%2520effects%2520of%2520apelin%2520in%2520humans%253A%2520potential%2520role%2520in%2520patients%2520with%2520chronic%2520heart%2520failure%26jtitle%3DCirculation%26date%3D2010%26volume%3D121%26spage%3D1818%26epage%3D1827%26doi%3D10.1161%2FCIRCULATIONAHA.109.911339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Szokodi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Földes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voutilainen-Myllylä, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilves, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokola, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikkarainen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piuhola, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rysä, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tóth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruskoaho, H.</span><span> </span><span class="NLM_article-title">Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1161/01.RES.0000033522.37861.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2F01.RES.0000033522.37861.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=12215493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2002&pages=434-440&author=I.+Szokodiauthor=P.+Taviauthor=G.+F%C3%B6ldesauthor=S.+Voutilainen-Myllyl%C3%A4author=M.+Ilvesauthor=H.+Tokolaauthor=S.+Pikkarainenauthor=J.+Piuholaauthor=H.+Rys%C3%A4author=M.+T%C3%B3thauthor=H.+Ruskoaho&title=Apelin%2C+the+novel+endogenous+ligand+of+the+orphan+receptor+APJ%2C+regulates+cardiac+contractility&doi=10.1161%2F01.RES.0000033522.37861.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility</span></div><div class="casAuthors">Szokodi, Istvan; Tavi, Pasi; Foeldes, Gabor; Voutilainen-Myllylae, Sari; Ilves, Mika; Tokola, Heikki; Pikkarainen, Sampsa; Piuhola, Jarkko; Rysae, Jaana; Toth, Miklos; Ruskoaho, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The orphan receptor APJ and its recently identified endogenous ligand, apelin, exhibit high levels of mRNA expression in the heart.  However, the functional importance of apelin in the cardiovascular system is not known.  In isolated perfused rat hearts, infusion of apelin (0.01 to 10 nmol/L) induced a dose-dependent pos. inotropic effect (EC50: 33.1±1.5 pmol/L).  Moreover, preload-induced increase in dP/dtmax was significantly augmented (P<0.05) in the presence of apelin.  Inhibition of phospholipase C (PLC) with U-73122 and suppression of protein kinase C (PKC) with staurosporine and GF-109203X markedly attenuated the apelin-induced inotropic effect (P<0.001).  In addn., zoniporide, a selective inhibitor of Na+-H+ exchange (NHE) isoform-1, and KB-R7943, a potent inhibitor of the reverse mode Na+-Ca2+ exchange (NCX), significantly suppressed the response to apelin (P<0.001).  Perforated patch-clamp recordings showed that apelin did not modulate L-type Ca2+ current or voltage-activated K+ currents in isolated adult rat ventricular myocytes.  Apelin mRNA was markedly downregulated in cultured neonatal rat ventricular myocytes subjected to mech. stretch and in vivo in two models of chronic ventricular pressure overload.  The present study provides the first evidence for the physiol. significance of apelin in the heart.  Our results show that apelin is one of the most potent endogenous pos. inotropic substances yet identified and that the inotropic response to apelin may involve activation of PLC, PKC, and sarcolemmal NHE and NCX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAJihT3bR9_bVg90H21EOLACvtfcHk0ljWiTUAUJ1yqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVKktL0%253D&md5=78b3fb521970692595debb7c819f0e3b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000033522.37861.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000033522.37861.69%26sid%3Dliteratum%253Aachs%26aulast%3DSzokodi%26aufirst%3DI.%26aulast%3DTavi%26aufirst%3DP.%26aulast%3DF%25C3%25B6ldes%26aufirst%3DG.%26aulast%3DVoutilainen-Myllyl%25C3%25A4%26aufirst%3DS.%26aulast%3DIlves%26aufirst%3DM.%26aulast%3DTokola%26aufirst%3DH.%26aulast%3DPikkarainen%26aufirst%3DS.%26aulast%3DPiuhola%26aufirst%3DJ.%26aulast%3DRys%25C3%25A4%26aufirst%3DH.%26aulast%3DT%25C3%25B3th%26aufirst%3DM.%26aulast%3DRuskoaho%26aufirst%3DH.%26atitle%3DApelin%252C%2520the%2520novel%2520endogenous%2520ligand%2520of%2520the%2520orphan%2520receptor%2520APJ%252C%2520regulates%2520cardiac%2520contractility%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D91%26spage%3D434%26epage%3D440%26doi%3D10.1161%2F01.RES.0000033522.37861.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kidoya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7601982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1038%2Fsj.emboj.7601982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=18200044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1KgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=522-534&author=H.+Kidoyaauthor=M.+Uenoauthor=Y.+Yamadaauthor=N.+Mochizukiauthor=M.+Nakataauthor=T.+Yanoauthor=R.+Fujiiauthor=N.+Takakura&title=Spatial+and+temporal+role+of+the+apelin%2FAPJ+system+in+the+caliber+size+regulation+of+blood+vessels+during+angiogenesis&doi=10.1038%2Fsj.emboj.7601982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis</span></div><div class="casAuthors">Kidoya, Hiroyasu; Ueno, Masaya; Yamada, Yoshihiro; Mochizuki, Naoki; Nakata, Mitsugu; Yano, Takashi; Fujii, Ryo; Takakura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">522-534</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Blood vessels change their caliber to adapt to the demands of tissues or organs for oxygen and nutrients.  This event is mainly organized at the capillary level and requires a size-sensing mechanism.  However, the mol. regulatory mechanism involved in caliber size modification in blood vessels is not clear.  Here we show that apelin, a protein secreted from endothelial cells under the activation of Tie2 receptor tyrosine kinase on endothelial cells, plays a role in the regulation of caliber size of blood vessel through its cognate receptor APJ, which is expressed on endothelial cells.  During early embryogenesis, APJ is expressed on endothelial cells of the new blood vessels sprouted from the dorsal aorta, but not on pre-existing endothelial cells of the dorsal aorta.  Apelin-deficient mice showed narrow blood vessels in intersomitic vessels during embryogenesis.  Apelin enhanced endothelial cell proliferation in the presence of vascular endothelial growth factor and promoted cell-to-cell aggregation.  These results indicated that the apelin/APJ system is involved in the regulation of blood vessel diam. during angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhOQ-cRW5awbVg90H21EOLACvtfcHk0ljWiTUAUJ1yqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1KgtL0%253D&md5=ecd5cf685abcf0ed85c225c29fc815ad</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601982%26sid%3Dliteratum%253Aachs%26aulast%3DKidoya%26aufirst%3DH.%26aulast%3DUeno%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DNakata%26aufirst%3DM.%26aulast%3DYano%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DR.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSpatial%2520and%2520temporal%2520role%2520of%2520the%2520apelin%252FAPJ%2520system%2520in%2520the%2520caliber%2520size%2520regulation%2520of%2520blood%2520vessels%2520during%2520angiogenesis%26jtitle%3DEMBO%2520J.%26date%3D2008%26volume%3D27%26spage%3D522%26epage%3D534%26doi%3D10.1038%2Fsj.emboj.7601982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnie, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddad, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhabyeyev, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandalam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiri, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vederas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudit, G. Y.</span><span> </span><span class="NLM_article-title">Loss of apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic apelin analogues</span> <span class="citation_source-journal">J. Am. Heart Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e000249</span><span class="refDoi"> DOI: 10.1161/JAHA.113.000249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FJAHA.113.000249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=23817469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yrs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e000249&author=W.+Wangauthor=S.+M.+McKinnieauthor=V.+B.+Patelauthor=G.+Haddadauthor=Z.+Wangauthor=P.+Zhabyeyevauthor=S.+K.+Dasauthor=R.+Basuauthor=B.+McLeanauthor=V.+Kandalamauthor=J.+M.+Penningerauthor=Z.+Kassiriauthor=J.+C.+Vederasauthor=A.+G.+Murrayauthor=G.+Y.+Oudit&title=Loss+of+apelin+exacerbates+myocardial+infarction+adverse+remodeling+and+ischemia-reperfusion+injury%3A+therapeutic+potential+of+synthetic+apelin+analogues&doi=10.1161%2FJAHA.113.000249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic apelin analogues</span></div><div class="casAuthors">Wang, Wang; McKinnie, Shaun M. K.; Patel, Vaibhav B.; Haddad, George; Wang, Zuocheng; Zhabyeyev, Pavel; Das, Subhash K.; Basu, Ratnadeep; McLean, Brent; Kandalam, Vijay; Penninger, Josef M.; Kassiri, Zamaneh; Vederas, John C.; Murray, Allan G.; Oudit, Gavin Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Heart Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">E000249/1-E000249/17, SE000249/1-SE000249/16</span>CODEN:
                <span class="NLM_cas:coden">JAHABZ</span>;
        ISSN:<span class="NLM_cas:issn">2047-9980</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background-Coronary artery disease leading to myocardial ischemia is the most common cause of heart failure.  Apelin (APLN), the endogenous peptide ligand of the APJ receptor, has emerged as a novel regulator of the cardiovascular system.  Methods and Results-Here we show a crit. role of APLN in myocardial infarction (MI) and ischemia-reperfusion (IR) injury in patients and animal models.  Myocardial APLN levels were reduced in patients with ischemic heart failure.  Loss of APLN increased MI-related mortality, infarct size, and inflammation with drastic redns. in prosurvival pathways resulting in greater systolic dysfunction and heart failure.  APLN deficiency decreased vascular sprouting, impaired sprouting of human endothelial progenitor cells, and compromised in vivo myocardial angiogenesis.  Lack of APLN enhanced susceptibility to ischemic injury and compromised functional recovery following ex vivo and in vivo IR injury.  We designed and synthesized two novel APLN analogs resistant to angiotensin converting enzyme 2 cleavage and identified one analog, which mimicked the function of APLN, to be markedly protective against ex vivo and in vivo myocardial IR injury linked to greater activation of survival pathways and promotion of angiogenesis.  Conclusions-APLN is a crit. regulator of the myocardial response to infarction and ischemia and pharmacol. targeting this pathway is feasible and represents a new class of potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxx4Vdp5pa0rVg90H21EOLACvtfcHk0ljWiTUAUJ1yqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yrs7jN&md5=9d8c022491281ef1688196cb1886e6cb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1161%2FJAHA.113.000249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FJAHA.113.000249%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMcKinnie%26aufirst%3DS.%2BM.%26aulast%3DPatel%26aufirst%3DV.%2BB.%26aulast%3DHaddad%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhabyeyev%26aufirst%3DP.%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DBasu%26aufirst%3DR.%26aulast%3DMcLean%26aufirst%3DB.%26aulast%3DKandalam%26aufirst%3DV.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DKassiri%26aufirst%3DZ.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26aulast%3DMurray%26aufirst%3DA.%2BG.%26aulast%3DOudit%26aufirst%3DG.%2BY.%26atitle%3DLoss%2520of%2520apelin%2520exacerbates%2520myocardial%2520infarction%2520adverse%2520remodeling%2520and%2520ischemia-reperfusion%2520injury%253A%2520therapeutic%2520potential%2520of%2520synthetic%2520apelin%2520analogues%26jtitle%3DJ.%2520Am.%2520Heart%2520Assoc.%26date%3D2013%26volume%3D2%26spage%3De000249%26doi%3D10.1161%2FJAHA.113.000249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Vickers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaushik, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baronas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P.</span><span> </span><span class="NLM_article-title">Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">14838</span><span class="NLM_x">–</span> <span class="NLM_lpage">14843</span><span class="refDoi"> DOI: 10.1074/jbc.M200581200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1074%2Fjbc.M200581200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=11815627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD38XjslSgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=14838-14843&author=C.+Vickersauthor=P.+Halesauthor=V.+Kaushikauthor=L.+Dickauthor=J.+Gavinauthor=J.+Tangauthor=K.+Godboutauthor=T.+Parsonsauthor=E.+Baronasauthor=F.+Hsiehauthor=S.+Actonauthor=M.+Pataneauthor=A.+Nicholsauthor=P.+Tummino&title=Hydrolysis+of+biological+peptides+by+human+angiotensin-converting+enzyme-related+carboxypeptidase&doi=10.1074%2Fjbc.M200581200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase</span></div><div class="casAuthors">Vickers, Chad; Hales, Paul; Kaushik, Virendar; Dick, Larry; Gavin, James; Tang, Jin; Godbout, Kevin; Parsons, Thomas; Baronas, Elizabeth; Hsieh, Frank; Acton, Susan; Patane, Michael; Nichols, Andrew; Tummino, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">14838-14843</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a zinc metalloprotease whose closest homolog is angiotensin I-converting enzyme.  To begin to elucidate the physiol. role of ACE2, ACE2 was purified, and its catalytic activity was characterized.  ACE2 proteolytic activity has a pH optimum of 6.5 and is enhanced by monovalent anions, which is consistent with the activity of ACE.  ACE2 activity is increased ∼10-fold by Cl- and F- but is unaffected by Br-.  ACE2 was screened for hydrolytic activity against a panel of 126 biol. peptides, using liq. chromatog. mass spectrometry detection.  Eleven of the peptides were hydrolyzed by ACE2, and in each case, the proteolytic activity resulted in removal of the C-terminal residue only.  ACE2 hydrolyzes three of the peptides with high catalytic efficiency: angiotensin II (1-8) (kcat/Km = 1.9×106 M-1 s-1), apelin-13 (kcat/Km = 2.1×106 M-1 s-1), and dynorphin A 1-13 (kcat/Km = 3.1×106 M-1 s-1).  The ACE2 catalytic efficiency is 400-fold higher with angiotensin II (1-8) as a substrate than with angiotensin I (1-10).  ACE2 also efficiently hydrolyzes des-Arg9-bradykinin (kcat/Km = 1.3×105 M-1 s-1), but it does not hydrolyze bradykinin.  An alignment of the ACE2 peptide substrates reveals a consensus sequence of: Pro-X(1-3 residues)-Pro-Hydrophobic, where hydrolysis occurs between proline and the hydrophobic amino acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbBD41C5xTurVg90H21EOLACvtfcHk0ljNXhAnxW-XqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjslSgsbo%253D&md5=48f777a3cc95881abc2e9e29e5e72d10</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M200581200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M200581200%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DC.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DKaushik%26aufirst%3DV.%26aulast%3DDick%26aufirst%3DL.%26aulast%3DGavin%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DGodbout%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DT.%26aulast%3DBaronas%26aufirst%3DE.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DActon%26aufirst%3DS.%26aulast%3DPatane%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DTummino%26aufirst%3DP.%26atitle%3DHydrolysis%2520of%2520biological%2520peptides%2520by%2520human%2520angiotensin-converting%2520enzyme-related%2520carboxypeptidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D14838%26epage%3D14843%26doi%3D10.1074%2Fjbc.M200581200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnie, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vederas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudit, G. Y.</span><span> </span><span class="NLM_article-title">Angiotensin converting enzyme 2 metabolizes and partially inactivates pyr-apelin-13 and apelin-17: Physiological effects in the cardiovascular system</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.115.06892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FHYPERTENSIONAHA.115.06892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=365-377&author=W.+Wangauthor=S.+M.+McKinnieauthor=M.+Farhanauthor=M.+Paulauthor=T.+McDonaldauthor=B.+McLeanauthor=C.+Llorens-Cortesauthor=S.+Hazraauthor=A.+G.+Murrayauthor=J.+C.+Vederasauthor=G.+Y.+Oudit&title=Angiotensin+converting+enzyme+2+metabolizes+and+partially+inactivates+pyr-apelin-13+and+apelin-17%3A+Physiological+effects+in+the+cardiovascular+system&doi=10.1161%2FHYPERTENSIONAHA.115.06892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.115.06892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.115.06892%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMcKinnie%26aufirst%3DS.%2BM.%26aulast%3DFarhan%26aufirst%3DM.%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DT.%26aulast%3DMcLean%26aufirst%3DB.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26aulast%3DHazra%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DA.%2BG.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26aulast%3DOudit%26aufirst%3DG.%2BY.%26atitle%3DAngiotensin%2520converting%2520enzyme%25202%2520metabolizes%2520and%2520partially%2520inactivates%2520pyr-apelin-13%2520and%2520apelin-17%253A%2520Physiological%2520effects%2520in%2520the%2520cardiovascular%2520system%26jtitle%3DHypertension%26date%3D2016%26volume%3D68%26spage%3D365%26epage%3D377%26doi%3D10.1161%2FHYPERTENSIONAHA.115.06892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">El Messari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrioz, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2004.02591.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1111%2Fj.1471-4159.2004.02591.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15341513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVGqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=1290-1301&author=S.+El+Messariauthor=X.+Iturriozauthor=C.+Fassotauthor=N.+De+Motaauthor=D.+Roeschauthor=C.+Llorens-Cortes&title=Functional+dissociation+of+apelin+receptor+signaling+and+endocytosis%3A+implications+for+the+effects+of+apelin+on+arterial+blood+pressure&doi=10.1111%2Fj.1471-4159.2004.02591.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Functional dissociation of apelin receptor signaling and endocytosis: Implications for the effects of apelin on arterial blood pressure</span></div><div class="casAuthors">El Messari, Said; Iturrioz, Xavier; Fassot, Celine; de Mota, Nadia; Roesch, Darren; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1290-1301</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Apelin is a novel neuropeptide involved in the regulation of body fluid homeostasis and cardiovascular functions.  It acts through a G protein-coupled receptor, the APJ receptor.  We studied the structure-activity relationships of apelin at the rat apelin receptor, tagged at its C-terminal end with enhanced green fluorescent protein and stably expressed in CHO cells.  We evaluated the potency of N- and C-terminal deleted fragments of K17F to bind with high affinity to the apelin receptor, and to inhibit cAMP prodn. and to induce apelin receptor internalization.  We first characterized the internalization and trafficking of the rat apelin receptor.  This receptor was internalized via a clathrin-dependent mechanism and our results suggest that receptor trafficking may follow a recycling pathway.  We then tried to identify the amino acids of K17F required for apelin activity.  The first five N-terminal and the last two C-terminal amino acids of K17F were not essential for apelin binding or the inhibition of cAMP prodn.  However, the full-length sequence of K17F was the most potent inducer of apelin receptor internalization because successive N-terminal amino-acid deletions progressively reduced internalization and the removal of a single amino acid at the C-terminus abolished this process.  Finally, the most novel observation of this work is that hypotensive actions of apelin peptides correlate best with the ability of those ligands to internalize.  Thus, apelin receptor signaling and endocytosis are functionally dissocd., possibly reflecting the existence of several conformational states of this receptor, stabilized by the binding of different apelin fragments to the apelin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOUyVAsLNAJLVg90H21EOLACvtfcHk0ljNXhAnxW-XqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVGqs7g%253D&md5=b73959e229342eb7aac10cbc8e3d07c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02591.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02591.x%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BMessari%26aufirst%3DS.%26aulast%3DIturrioz%26aufirst%3DX.%26aulast%3DFassot%26aufirst%3DC.%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DRoesch%26aufirst%3DD.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DFunctional%2520dissociation%2520of%2520apelin%2520receptor%2520signaling%2520and%2520endocytosis%253A%2520implications%2520for%2520the%2520effects%2520of%2520apelin%2520on%2520arterial%2520blood%2520pressure%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D90%26spage%3D1290%26epage%3D1301%26doi%3D10.1111%2Fj.1471-4159.2004.02591.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ceraudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galanth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpentier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banegas-Font, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonegge, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvear-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrioz, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Biased signaling favoring Gi over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">24599</span><span class="NLM_x">–</span> <span class="NLM_lpage">24610</span><span class="refDoi"> DOI: 10.1074/jbc.M113.541698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1074%2Fjbc.M113.541698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=25012663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGjt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=24599-24610&author=E.+Ceraudoauthor=C.+Galanthauthor=E.+Carpentierauthor=I.+Banegas-Fontauthor=A.+M.+Schoneggeauthor=R.+Alvear-Perezauthor=X.+Iturriozauthor=M.+Bouvierauthor=C.+Llorens-Cortes&title=Biased+signaling+favoring+Gi+over+%CE%B2-arrestin+promoted+by+an+apelin+fragment+lacking+the+C-terminal+phenylalanine&doi=10.1074%2Fjbc.M113.541698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Signaling Favoring Gi over β-Arrestin Promoted by an Apelin Fragment Lacking the C-terminal Phenylalanine</span></div><div class="casAuthors">Ceraudo, Emilie; Galanth, Cecile; Carpentier, Eric; Banegas-Font, Inmaculada; Schonegge, Anne-Marie; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Bouvier, Michel; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">24599-24610</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Apelin plays a prominent role in body fluid and cardiovascular homeostasis.  The authors previously showed that the C-terminal Phe of apelin 17 (K17F) is crucial for triggering apelin receptor internalization and decreasing blood pressure (BP) but is not required for apelin binding or Gi protein coupling.  Based on these findings, the authors hypothesized that the important role of the C-terminal Phe in BP decrease may be as a Gi-independent but β-arrestin-dependent signaling pathway that could involve MAPKs.  For this purpose, the authors have used apelin fragments K17F and K16P (K17F with the C-terminal Phe deleted), which exhibit opposite profiles on apelin receptor internalization and BP.  Using BRET-based biosensors, the authors showed that, whereas K17F activates Gi and promotes β-arrestin recruitment to the receptor, K16P had a much reduced ability to promote β-arrestin recruitment while maintaining its Gi activating property, revealing the biased agonist character of K16P.  The authors further show that both β-arrestin recruitment and apelin receptor internalization contribute to the K17F-stimulated ERK1/2 activity, whereas the K16P-promoted ERK1/2 activity is entirely Gi-dependent.  In addn. to providing new insights on the structural basis underlying the functional selectivity of apelin peptides, the authors' study indicates that the β-arrestin-dependent ERK1/2 activation and not the Gi-dependent signaling may participate in K17F-induced BP decrease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA2B14K-_mtLVg90H21EOLACvtfcHk0liFP4AVKOTi9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGjt7nJ&md5=3d412882bcb7944183ce2f5961ab58fd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.541698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.541698%26sid%3Dliteratum%253Aachs%26aulast%3DCeraudo%26aufirst%3DE.%26aulast%3DGalanth%26aufirst%3DC.%26aulast%3DCarpentier%26aufirst%3DE.%26aulast%3DBanegas-Font%26aufirst%3DI.%26aulast%3DSchonegge%26aufirst%3DA.%2BM.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DIturrioz%26aufirst%3DX.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DBiased%2520signaling%2520favoring%2520Gi%2520over%2520%25CE%25B2-arrestin%2520promoted%2520by%2520an%2520apelin%2520fragment%2520lacking%2520the%2520C-terminal%2520phenylalanine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D24599%26epage%3D24610%26doi%3D10.1074%2Fjbc.M113.541698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Murza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besserer-Offroy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadereye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarret, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsault, E.</span><span> </span><span class="NLM_article-title">Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stability</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1002/cmdc.201100492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fcmdc.201100492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=22170700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=318-325&author=A.+Murzaauthor=A.+Parentauthor=E.+Besserer-Offroyauthor=H.+Tremblayauthor=F.+Karadereyeauthor=N.+Beaudetauthor=R.+Leducauthor=P.+Sarretauthor=E.+Marsault&title=Elucidation+of+the+structure-activity+relationships+of+apelin%3A+influence+of+unnatural+amino+acids+on+binding%2C+signaling%2C+and+plasma+stability&doi=10.1002%2Fcmdc.201100492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of the Structure-Activity Relationships of Apelin: Influence of Unnatural Amino Acids on Binding, Signaling, and Plasma Stability</span></div><div class="casAuthors">Murza, Alexandre; Parent, Alexandre; Besserer-Offroy, Elie; Tremblay, Hugo; Karadereye, Felix; Beaudet, Nicolas; Leduc, Richard; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-325</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of the APJ receptor, a member of the G-protein-coupled receptor family.  The apelin-APJ complex has been detected in many tissues and is emerging as a promising target for several pathophysiol. conditions.  There is currently little information on the structure-activity relationship (SAR) of the apelin hormone.  In an effort to better delineate SAR, we synthesized analogs of apelin-13 modified at selected positions with unnatural amino acids, with a particular emphasis on the C-terminal portion.  Analogs were then tested in binding and functional assays by evaluating Gi/o-mediated decreases in cAMP levels and by assessing β-arrestin2 recruitment to the APJ receptor.  The plasma stability of new compds. was also assessed.  Several analogs were found to possess increased binding and higher stability than the parent peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb17rjHTl2IrVg90H21EOLACvtfcHk0liFP4AVKOTi9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgur%252FL&md5=01202090f34b4a1933a0a3045cdf5763</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100492%26sid%3Dliteratum%253Aachs%26aulast%3DMurza%26aufirst%3DA.%26aulast%3DParent%26aufirst%3DA.%26aulast%3DBesserer-Offroy%26aufirst%3DE.%26aulast%3DTremblay%26aufirst%3DH.%26aulast%3DKaradereye%26aufirst%3DF.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3DE.%26atitle%3DElucidation%2520of%2520the%2520structure-activity%2520relationships%2520of%2520apelin%253A%2520influence%2520of%2520unnatural%2520amino%2520acids%2520on%2520binding%252C%2520signaling%252C%2520and%2520plasma%2520stability%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D318%26epage%3D325%26doi%3D10.1002%2Fcmdc.201100492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhungana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S. P.</span><span> </span><span class="NLM_article-title">Identifying structural determinants of potency for analogs of apelin-13: integration of C-terminal truncation with structure-activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2992</span><span class="NLM_x">–</span> <span class="NLM_lpage">2997</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.bmc.2014.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=24755525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2992-2997&author=Y.+Zhangauthor=R.+Maitraauthor=D.+L.+Harrisauthor=S.+Dhunganaauthor=R.+Snyderauthor=S.+P.+Runyon&title=Identifying+structural+determinants+of+potency+for+analogs+of+apelin-13%3A+integration+of+C-terminal+truncation+with+structure-activity&doi=10.1016%2Fj.bmc.2014.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure-activity</span></div><div class="casAuthors">Zhang, Yanyan; Maitra, Rangan; Harris, Danni L.; Dhungana, Suraj; Snyder, Rodney; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2992-2997</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apelin peptides function as endogenous ligands of the APJ receptor and have been implicated in a no. of important biol. processes.  While several apelinergic peptides have been reported, apelin-13 (Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe) remains the most commonly studied and reported ligand of APJ.  This study examines the effect of C-terminal peptide truncations and comprehensive structure-activity relationship (SAR) for a series of analogs based on apelin-13 to develop more potent and stable analogs.  C-terminal truncation studies identified apelin-13 (N-acetyl 2-11) amide as a potent agonist (EC50 = 4.4 nM).  Comprehensive SAR studies also detd. that Arg 2, Leu 5, Lys 8, Met 11, were key positions for detg. agonist potency, whereas the hydrophobic vol. of Lys-8 was a specific determinate of activity.  Plasma stability studies on the truncated 10-mer peptide (EC50 = 33 nM) indicated the primary sites of cleavage occurred between Nle 3 and Leu 4 and also between Ala 5 and Ala-6.  These new ligands represent the shortest known apelin peptides with good functional potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvVQ3Bxd0D_bVg90H21EOLACvtfcHk0liFP4AVKOTi9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCmurg%253D&md5=6f04420714d191792dd27d43796d886d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DD.%2BL.%26aulast%3DDhungana%26aufirst%3DS.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DIdentifying%2520structural%2520determinants%2520of%2520potency%2520for%2520analogs%2520of%2520apelin-13%253A%2520integration%2520of%2520C-terminal%2520truncation%2520with%2520structure-activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2992%26epage%3D2997%26doi%3D10.1016%2Fj.bmc.2014.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Murza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belleville, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longpre, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarret, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsault, E.</span><span> </span><span class="NLM_article-title">Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1002/bip.22498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fbip.22498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=24728860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFajtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2014&pages=297-303&author=A.+Murzaauthor=K.+Bellevilleauthor=J.+M.+Longpreauthor=P.+Sarretauthor=E.+Marsault&title=Stability+and+degradation+patterns+of+chemically+modified+analogs+of+apelin-13+in+plasma+and+cerebrospinal+fluid&doi=10.1002%2Fbip.22498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid</span></div><div class="casAuthors">Murza, Alexandre; Belleville, Karine; Longpre, Jean-Michel; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-303</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of APJ, which belongs to the superfamily of G protein-coupled receptors.  In recent years, the apelin/APJ system has been detected in many tissues and emerges as a promising target for the treatment of various pathophysiol. conditions.  Pyr1-apelin-13 is the major isoform of apelin in human plasma; however its stability and proteolytic degrdn. pattern remain poorly understood.  The aim of the present study was first to identify the cleavage sites of Pyr1-apelin-13 in mouse, rat and human plasma and rat cerebrospinal fluid, then to det. its stability to proteolytic degrdn. following i.v. administration in rats.  Secondly, key residues were substituted by natural and unnatural amino acids in order to examine the impact on in vitro stability and degrdn. pattern.  The kinetics of degrdn. revealed that the Leu5-Ser6 peptide bond of Pyr1-apelin-13 is the first cleavage obsd. in plasma, independently of the species.  Replacement of Phe13 by unnatural amino acids showed a 10-fold increase in plasma stability although the hydrolysis of Pro12-Phe13 bond, previously described as a site of cleavage by ACE-2, was not obsd.  In vivo, this Pro12-Phe13 bond was cleaved yet appears as a minor product compared to hydrolysis of the Pro10-Met11 bond.  This study pinpoints the most crit. amino acids targeted by proteases and will be instrumental for the design of Pyr1-apelin-13 analogs possessing increased stability.  © 2014 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 102: 297-303, 2014.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEbpU8iN3a-bVg90H21EOLACvtfcHk0ljav2evCnzfag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFajtLc%253D&md5=cf77c3c930a4dc5dcbe6ffb9778b54bf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fbip.22498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.22498%26sid%3Dliteratum%253Aachs%26aulast%3DMurza%26aufirst%3DA.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DLongpre%26aufirst%3DJ.%2BM.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3DE.%26atitle%3DStability%2520and%2520degradation%2520patterns%2520of%2520chemically%2520modified%2520analogs%2520of%2520apelin-13%2520in%2520plasma%2520and%2520cerebrospinal%2520fluid%26jtitle%3DBiopolymers%26date%3D2014%26volume%3D102%26spage%3D297%26epage%3D303%26doi%3D10.1002%2Fbip.22498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">McKinnie, S. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosquera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudit, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vederas, J. C.</span><span> </span><span class="NLM_article-title">The metalloprotease neprilysin degrades and inactivates apelin peptides</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span><span class="refDoi"> DOI: 10.1002/cbic.201600244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fcbic.201600244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=27377680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSitbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1495-1498&author=S.+M.+K.+McKinnieauthor=C.+Fischerauthor=K.+M.+H.+Tranauthor=W.+Wangauthor=F.+Mosqueraauthor=G.+Y.+Ouditauthor=J.+C.+Vederas&title=The+metalloprotease+neprilysin+degrades+and+inactivates+apelin+peptides&doi=10.1002%2Fcbic.201600244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Metalloprotease Neprilysin Degrades and Inactivates Apelin Peptides</span></div><div class="casAuthors">McKinnie, Shaun M. K.; Fischer, Conrad; Tran, Kelvin M. H.; Wang, Wang; Mosquera, Fabricio; Oudit, Gavin Y.; Vederas, John C.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1495-1498</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The apelinergic system is a mammalian peptide hormone network with key physiol. roles.  Apelin isoforms and analogs are believed to be promising therapeutics for cardiovascular disease.  Despite extensive studies on apelin-13 degrdn. patterns, only one protease, angiotensin-converting enzyme 2 (ACE2), had been implicated in its physiol. regulation.  Through use of a peptide-based fluorescent probe, we identified the metalloprotease neprilysin (NEP, a target for Entresto used in treatment of heart failure) as an enzyme that cleaves apelin isoforms.  In vitro NEP proteolysis generated fragments that lacked the ability to bind to the apelin receptor, thereby making NEP the first protease to fully inactivate apelin.  The involvement of NEP in the apelinergic system contributes to the understanding of its role in cardiovascular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7gZ2z2xeP-bVg90H21EOLACvtfcHk0ljav2evCnzfag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSitbjE&md5=bbcbfe56ccc7b6012c8a5912b7de7bc3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600244%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinnie%26aufirst%3DS.%2BM.%2BK.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DK.%2BM.%2BH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMosquera%26aufirst%3DF.%26aulast%3DOudit%26aufirst%3DG.%2BY.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520metalloprotease%2520neprilysin%2520degrades%2520and%2520inactivates%2520apelin%2520peptides%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26spage%3D1495%26epage%3D1498%26doi%3D10.1002%2Fcbic.201600244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Gafford, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skidgel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdös, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersh, L. B.</span><span> </span><span class="NLM_article-title">Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3265</span><span class="NLM_x">–</span> <span class="NLM_lpage">3271</span><span class="refDoi"> DOI: 10.1021/bi00282a035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00282a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1983&pages=3265-3271&author=J.+T.+Gaffordauthor=R.+A.+Skidgelauthor=E.+G.+Erd%C3%B6sauthor=L.+B.+Hersh&title=Human+kidney+%22enkephalinase%22%2C+a+neutral+metalloendopeptidase+that+cleaves+active+peptides&doi=10.1021%2Fbi00282a035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi00282a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00282a035%26sid%3Dliteratum%253Aachs%26aulast%3DGafford%26aufirst%3DJ.%2BT.%26aulast%3DSkidgel%26aufirst%3DR.%2BA.%26aulast%3DErd%25C3%25B6s%26aufirst%3DE.%2BG.%26aulast%3DHersh%26aufirst%3DL.%2BB.%26atitle%3DHuman%2520kidney%2520%2522enkephalinase%2522%252C%2520a%2520neutral%2520metalloendopeptidase%2520that%2520cleaves%2520active%2520peptides%26jtitle%3DBiochemistry%26date%3D1983%26volume%3D22%26spage%3D3265%26epage%3D3271%26doi%3D10.1021%2Fbi00282a035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rice, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, N. M.</span><span> </span><span class="NLM_article-title">Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1042/BJ20040634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1042%2FBJ20040634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15283675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslOqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2004&pages=45-51&author=G.+I.+Riceauthor=D.+A.+Thomasauthor=P.+J.+Grantauthor=A.+J.+Turnerauthor=N.+M.+Hooper&title=Evaluation+of+angiotensin-converting+enzyme+%28ACE%29%2C+its+homologue+ACE2+and+neprilysin+in+angiotensin+peptide+metabolism&doi=10.1042%2FBJ20040634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism</span></div><div class="casAuthors">Rice, Gillian I.; Thomas, Daniel A.; Grant, Peter J.; Turner, Anthony J.; Hooper, Nigel M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In the RAS (renin-angiotensin system), Ang I (angiotensin I) is cleaved by ACE (angiotensin-converting enzyme) to form Ang II (angiotensin II), which has effects on blood pressure, fluid and electrolyte homeostasis.  We have examd. the kinetics of angiotensin peptide cleavage by full-length human ACE, the sep. N- and C-domains of ACE, the homolog of ACE, ACE2, and NEP (neprilysin).  The activity of the enzyme prepns. was detd. by active-site titrns. using competitive tight-binding inhibitors and fluorogenic substrates.  Ang I was effectively cleaved by NEP to Ang (1-7) (kcat/Km of 6.2×105 M-1·s-1), but was a poor substrate for ACE2 (kcat/Km of 3.3×104 M-1·s-1).  Ang (1-9) was a better substrate for NEP than ACE (kcat/Km of 3.7×105 M-1·s-1 compared with kcat/Km of 6.8×104 M-1·s-1).  Ang II was cleaved efficiently by ACE2 to Ang (1-7) (kcat/Km of 2.2×106 M-1·s-1) and was cleaved by NEP (kcat/Km of 2.2×105 M-1·s-1) to several degrdn. products.  In contrast with a previous report, Ang (1-7), like Ang I and Ang (1-9), was cleaved with a similar efficiency by both the N- and C-domains of ACE (kcat/Km of 3.6×105 M-1·s-1 compared with kcat/Km of 3.3×105 M-1·s-1).  The two active sites of ACE exhibited neg. co-operativity when either Ang I or Ang (1-7) was the substrate.  In addn., a range of ACE inhibitors failed to inhibit ACE2.  These kinetic data highlight that the flux of peptides through the RAS is complex, with the levels of ACE, ACE2 and NEP dictating whether vasoconstriction or vasodilation will predominate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-F-14Hfcq7Vg90H21EOLACvtfcHk0ljav2evCnzfag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslOqs7s%253D&md5=a17a1c5031b55362e691c7f31272eea6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1042%2FBJ20040634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040634%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DG.%2BI.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DGrant%26aufirst%3DP.%2BJ.%26aulast%3DTurner%26aufirst%3DA.%2BJ.%26aulast%3DHooper%26aufirst%3DN.%2BM.%26atitle%3DEvaluation%2520of%2520angiotensin-converting%2520enzyme%2520%2528ACE%2529%252C%2520its%2520homologue%2520ACE2%2520and%2520neprilysin%2520in%2520angiotensin%2520peptide%2520metabolism%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D383%26spage%3D45%26epage%3D51%26doi%3D10.1042%2FBJ20040634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, Y.</span><span> </span><span class="NLM_article-title">Comparison of the hydrolysis of the three types of natriuretic peptides by human kidney neutral endopeptidase 24.11</span> <span class="citation_source-journal">Biochem. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1006/bmme.1997.2584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1006%2Fbmme.1997.2584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=9232196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADyaK2sXksFGisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=47-51&author=Y.+Watanabeauthor=K.+Nakajimaauthor=Y.+Shimamoriauthor=Y.+Fujimoto&title=Comparison+of+the+hydrolysis+of+the+three+types+of+natriuretic+peptides+by+human+kidney+neutral+endopeptidase+24.11&doi=10.1006%2Fbmme.1997.2584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the hydrolysis of the three types of natriuretic peptides by human kidney neutral endopeptidase 24.11</span></div><div class="casAuthors">Watanabe, Yasuhiro; Nakajima, Kenjiro; Shimamori, Yoshimitsu; Fujimoto, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Molecular Medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-51</span>CODEN:
                <span class="NLM_cas:coden">BMMEF4</span>;
        ISSN:<span class="NLM_cas:issn">1077-3150</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The degrdn. of 3 human natriuretic peptides by human kidney neutral endopeptidase 24.11 has been investigated.  The studies revealed that hANP-28 and hCNP-22 are the preferred substrates, whereas hBNP-32 is not.  The enzyme has been known to inactivate hANP-28 from cleavage at the Cys-Phe bond at the beginning of its ring structure.  Anal. of the cleavage sites of each peptide indicated that the initial cleavage site of hCNP-22 is analogous to that of hANP-28.  The Cys-Phe bond of hBNP-32 was insensitive to this enzymic cleavage.  We speculate that the stability of hBNP-32 may result from the insusceptibility of its Cys-Phe bond at the beginning of the ring structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3eC2dwPjInbVg90H21EOLACvtfcHk0ljih63rVqLJFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFGisLc%253D&md5=693a285f2686032adeb4565878a52c16</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1006%2Fbmme.1997.2584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbmme.1997.2584%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DShimamori%26aufirst%3DY.%26aulast%3DFujimoto%26aufirst%3DY.%26atitle%3DComparison%2520of%2520the%2520hydrolysis%2520of%2520the%2520three%2520types%2520of%2520natriuretic%2520peptides%2520by%2520human%2520kidney%2520neutral%2520endopeptidase%252024.11%26jtitle%3DBiochem.%2520Mol.%2520Med.%26date%3D1997%26volume%3D61%26spage%3D47%26epage%3D51%26doi%3D10.1006%2Fbmme.1997.2584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Vijayaraghavan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carretero, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersh, L. B.</span><span> </span><span class="NLM_article-title">Hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">14150</span><span class="NLM_x">–</span> <span class="NLM_lpage">14155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=14150-14155&author=J.+Vijayaraghavanauthor=A.+G.+Scicliauthor=O.+A.+Carreteroauthor=C.+Slaughterauthor=C.+Moomawauthor=L.+B.+Hersh&title=Hydrolysis+of+endothelins+by+neutral+endopeptidase+24.11+%28enkephalinase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVijayaraghavan%26aufirst%3DJ.%26aulast%3DScicli%26aufirst%3DA.%2BG.%26aulast%3DCarretero%26aufirst%3DO.%2BA.%26aulast%3DSlaughter%26aufirst%3DC.%26aulast%3DMoomaw%26aufirst%3DC.%26aulast%3DHersh%26aufirst%3DL.%2BB.%26atitle%3DHydrolysis%2520of%2520endothelins%2520by%2520neutral%2520endopeptidase%252024.11%2520%2528enkephalinase%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D14150%26epage%3D14155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Nalivaeva, N. N.; Turner, A. J.</span>, <span> </span><span class="NLM_article-title">Neprilysin</span>. In  <span class="citation_source-book">Handbook of Proteolytic Enzymes</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group">Rawlings, N. D.; Salvesen, G. S.</span>, Eds.; <span class="NLM_publisher-name">Academic Press,</span>: <span class="NLM_publisher-loc">London, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">1</span>, pp  <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2FB978-0-12-382219-2.00127-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=612-619&author=N.+N.+Nalivaeva&author=A.+J.+Turnerauthor=N.+D.+Rawlings&author=G.+S.+Salvesen&title=Handbook+of+Proteolytic+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-382219-2.00127-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-382219-2.00127-7%26sid%3Dliteratum%253Aachs%26aulast%3DNalivaeva%26aufirst%3DN.%2BN.%26atitle%3DNeprilysin%26btitle%3DHandbook%2520of%2520Proteolytic%2520Enzymes%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26pub%3DAcademic%2520Press%26date%3D2013%26volume%3D1%26spage%3D612%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Langelaan, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebbington, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainey, J. K.</span><span> </span><span class="NLM_article-title">Structural insight into G-protein coupled receptor binding by apelin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1021/bi801864b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi801864b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=537-548&author=D.+N.+Langelaanauthor=E.+M.+Bebbingtonauthor=T.+Reddyauthor=J.+K.+Rainey&title=Structural+insight+into+G-protein+coupled+receptor+binding+by+apelin&doi=10.1021%2Fbi801864b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insight into G-Protein Coupled Receptor Binding by Apelin</span></div><div class="casAuthors">Langelaan, David N.; Bebbington, E. Meghan; Reddy, Tyler; Rainey, Jan K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-548</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apelin peptides are the cognate ligands for the G-protein coupled receptor APJ, with functions in the cardiovascular and central nervous systems, in glucose metab. and as a human immunodeficiency virus (HIV-1) coreceptor.  Apelin is found in 13-36 residue forms in vivo.  The structures of five isoforms of apelin at physiol. vs. low (5-6°) temp. are compared here using CD and NMR spectroscopy, demonstrating increased structure at low temp.  Far-UV CD spectra are predominantly random coil for apelin isoforms, but are convoluted by unusual bands from the C-terminal phenylalanine side chain.  These bands, assigned using F13A-apelin-13, are accentuated at 5° and imply conformational restriction.  At 35°, the R6-L9 region of apelin-17 is well structured, consistent with previous mutagenesis results showing necessity of this segment for apelin-APJ binding and activation.  At 5°, R6-L9 retains its structuring while the functionally crit. C-terminal G13-F17 region also becomes highly structured.  Type IV β-turns and some polyproline-II structure alongside F17 side chain motional redn. correlate well with CD spectral properties.  Cis-trans peptide bond isomerization at P14 and P16 produces two sequentially assignable conformers (both trans:both cis ∼4:1) alongside less populated conformers.  Chem. shift assignment of apelin-12, -13 and pyroglutamate-apelin-13 implies highly similar structuring and the same isomerization at the C-terminus.  Based on the apelin-17 structure, a two-step binding and activation mechanism is hypothesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbPwNz_BRlEbVg90H21EOLACvtfcHk0ljih63rVqLJFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlaltw%253D%253D&md5=21a18651653a9c28fcdb3a3101908228</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi801864b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801864b%26sid%3Dliteratum%253Aachs%26aulast%3DLangelaan%26aufirst%3DD.%2BN.%26aulast%3DBebbington%26aufirst%3DE.%2BM.%26aulast%3DReddy%26aufirst%3DT.%26aulast%3DRainey%26aufirst%3DJ.%2BK.%26atitle%3DStructural%2520insight%2520into%2520G-protein%2520coupled%2520receptor%2520binding%2520by%2520apelin%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D537%26epage%3D548%26doi%3D10.1021%2Fbi801864b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Gerbier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvineau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvear-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrioz, X.</span><span> </span><span class="NLM_article-title">New structural insights into the apelin receptor: identification of key residues for apelin binding</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1096/fj.14-256339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1096%2Ffj.14-256339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=25359495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=314-322&author=R.+Gerbierauthor=V.+Lerouxauthor=P.+Couvineauauthor=R.+Alvear-Perezauthor=B.+Maigretauthor=C.+Llorens-Cortesauthor=X.+Iturrioz&title=New+structural+insights+into+the+apelin+receptor%3A+identification+of+key+residues+for+apelin+binding&doi=10.1096%2Ffj.14-256339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">New structural insights into the apelin receptor: identification of key residues for apelin binding</span></div><div class="casAuthors">Gerbier, Romain; Leroux, Vincent; Couvineau, Pierre; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">314-322, 10.1096/fj.14-256339</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of the orphan 7-transmembrane domain GPCRAPJ, now named the apelin receptor (ApelinR).  Apelin plays a prominent role in body fluid and cardiovascular homeostasis.  To better understand the structural organization of the ApelinR, we built 3 homol. 3-dimensional (3D) models of the human ApelinR using the validated cholecystokinin receptor-1 3D model or the X-ray structures of the β2-adrenergic and CXCR4 receptors as templates.  Docking of the pyroglutamyl form of apelin 13 (pE13F) into these models revealed the conservation at the bottom of the binding site of a hydrophobic cavity in which the C-terminal Phe of pE13F was embedded.  In contrast, at the top of the binding site, depending on the model, different interactions were visualized between acidic residues of the ApelinR and the basic residues of pE13F.  Using site-directed mutagenesis, we showed that Asp 92, Glu 172, and Asp 282 of rat ApelinR are key residues in apelin binding by interacting with Lys 8, Arg 2, and Arg 4 of pE13F, resp.  These residues are only seen in the CXCR4-based ApelinR 3D model, further validating this model.  These findings bring new insights into the structural organization of the ApelinR and the mode of apelin binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1rQ4zJn5Ge7Vg90H21EOLACvtfcHk0ljih63rVqLJFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGjsg%253D%253D&md5=4ec7d8ebd009a0461d1179c400f95262</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-256339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-256339%26sid%3Dliteratum%253Aachs%26aulast%3DGerbier%26aufirst%3DR.%26aulast%3DLeroux%26aufirst%3DV.%26aulast%3DCouvineau%26aufirst%3DP.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26aulast%3DIturrioz%26aufirst%3DX.%26atitle%3DNew%2520structural%2520insights%2520into%2520the%2520apelin%2520receptor%253A%2520identification%2520of%2520key%2520residues%2520for%2520apelin%2520binding%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D314%26epage%3D322%26doi%3D10.1096%2Ffj.14-256339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Langelaan, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellaire, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupre, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainey, J. K.</span><span> </span><span class="NLM_article-title">Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1828</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1483</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.bbamem.2013.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=23438363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltFCrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1828&publication_year=2013&pages=1471-1483&author=D.+N.+Langelaanauthor=T.+Reddyauthor=A.+W.+Banksauthor=G.+Dellaireauthor=D.+J.+Dupreauthor=J.+K.+Rainey&title=Structural+features+of+the+apelin+receptor+N-terminal+tail+and+first+transmembrane+segment+implicated+in+ligand+binding+and+receptor+trafficking&doi=10.1016%2Fj.bbamem.2013.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking</span></div><div class="casAuthors">Langelaan, David N.; Reddy, Tyler; Banks, Aaron W.; Dellaire, Graham; Dupre, Denis J.; Rainey, Jan K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1828</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1471-1483</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G-protein coupled receptors (GPCRs) comprise a large family of membrane proteins with rich functional diversity.  Signaling through the apelin receptor (AR or APJ) influences the cardiovascular system, central nervous system and glucose regulation.  Pathophysiol. involvement of apelin has been shown in atherosclerosis, cancer, human immunodeficiency virus-1 (HIV-1) infection and obesity.  Here, we present the high-resoln. NMR spectroscopy-based structure of the N-terminus and first transmembrane (TM) segment of AR (residues 1-55, AR55) in dodecylphosphocholine micelles.  AR55 consists of two disrupted helixes, spanning residues D14-K25 and A29-R551.59.  Mol. dynamics (MD) simulations of AR built from a hybrid of exptl. NMR and homol. model-based restraints allowed validation of the AR55 structure in the context of the full-length receptor in a hydrated bilayer.  AR55 structural features were functionally probed using mutagenesis in full-length AR through monitoring of apelin-induced extracellular signal-regulated kinase (ERK) phosphorylation in transiently transfected human embryonic kidney (HEK) 293A cells.  Residues E20 and D23 form an extracellular anionic face and interact with lipid headgroups during MD simulations in the absence of ligand, producing an ideal binding site for a cationic apelin ligand proximal to the membrane-water interface, lending credence to membrane-catalyzed apelin-AR binding.  In the TM region of AR55, N461.50 is central to a disruption in helical character.  G421.46, G451.49 and N461.50, which are all involved in the TM helical disruption, are essential for proper trafficking of AR.  In summary, we introduce a new correlative NMR spectroscopy and computational biochem. methodol. and demonstrate its utility in providing some of the first high-resoln. structural information for a peptide-activated GPCR TM domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3gBuQKnKesbVg90H21EOLACvtfcHk0liz17Irohh7Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltFCrtbs%253D&md5=dd5b01534576db5ecfd903ad8a6d7b26</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLangelaan%26aufirst%3DD.%2BN.%26aulast%3DReddy%26aufirst%3DT.%26aulast%3DBanks%26aufirst%3DA.%2BW.%26aulast%3DDellaire%26aufirst%3DG.%26aulast%3DDupre%26aufirst%3DD.%2BJ.%26aulast%3DRainey%26aufirst%3DJ.%2BK.%26atitle%3DStructural%2520features%2520of%2520the%2520apelin%2520receptor%2520N-terminal%2520tail%2520and%2520first%2520transmembrane%2520segment%2520implicated%2520in%2520ligand%2520binding%2520and%2520receptor%2520trafficking%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2013%26volume%3D1828%26spage%3D1471%26epage%3D1483%26doi%3D10.1016%2Fj.bbamem.2013.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Belokon’, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tararov, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maleev, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savel’eva, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryzhov, M. G.</span><span> </span><span class="NLM_article-title">Improved procedures for the synthesis of (<i>S</i>)-2-[<i>N</i>-(<i>N</i>′-benzyl-prolyl)amino]benzophenone (BPB) and Ni(II) complexes of Schiff’s bases derived from BPB and amino acids</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4249</span><span class="NLM_x">–</span> <span class="NLM_lpage">4252</span><span class="refDoi"> DOI: 10.1016/S0957-4166(98)00449-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2FS0957-4166%2898%2900449-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=4249-4252&author=Y.+N.+Belokon%E2%80%99author=V.+I.+Tararovauthor=V.+I.+Maleevauthor=T.+F.+Savel%E2%80%99evaauthor=M.+G.+Ryzhov&title=Improved+procedures+for+the+synthesis+of+%28S%29-2-%5BN-%28N%E2%80%B2-benzyl-prolyl%29amino%5Dbenzophenone+%28BPB%29+and+Ni%28II%29+complexes+of+Schiff%E2%80%99s+bases+derived+from+BPB+and+amino+acids&doi=10.1016%2FS0957-4166%2898%2900449-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2898%2900449-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252898%252900449-2%26sid%3Dliteratum%253Aachs%26aulast%3DBelokon%25E2%2580%2599%26aufirst%3DY.%2BN.%26aulast%3DTararov%26aufirst%3DV.%2BI.%26aulast%3DMaleev%26aufirst%3DV.%2BI.%26aulast%3DSavel%25E2%2580%2599eva%26aufirst%3DT.%2BF.%26aulast%3DRyzhov%26aufirst%3DM.%2BG.%26atitle%3DImproved%2520procedures%2520for%2520the%2520synthesis%2520of%2520%2528S%2529-2-%255BN-%2528N%25E2%2580%25B2-benzyl-prolyl%2529amino%255Dbenzophenone%2520%2528BPB%2529%2520and%2520Ni%2528II%2529%2520complexes%2520of%2520Schiff%25E2%2580%2599s%2520bases%2520derived%2520from%2520BPB%2520and%2520amino%2520acids%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1998%26volume%3D9%26spage%3D4249%26epage%3D4252%26doi%3D10.1016%2FS0957-4166%2898%2900449-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ndungu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carducci, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Large scale enantiomeric synthesis, purification, and characterization of ω-unsaturated amino acids via a Gly-Ni(II)-BPB-complex</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">8233</span><span class="NLM_x">–</span> <span class="NLM_lpage">8243</span><span class="refDoi"> DOI: 10.1016/j.tet.2004.06.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.tet.2004.06.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=8233-8243&author=X.+Guauthor=J.+M.+Ndunguauthor=W.+Qiuauthor=J.+Yingauthor=M.+D.+Carducciauthor=H.+Woodenauthor=V.+J.+Hruby&title=Large+scale+enantiomeric+synthesis%2C+purification%2C+and+characterization+of+%CF%89-unsaturated+amino+acids+via+a+Gly-Ni%28II%29-BPB-complex&doi=10.1016%2Fj.tet.2004.06.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2004.06.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2004.06.087%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DX.%26aulast%3DNdungu%26aufirst%3DJ.%2BM.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DYing%26aufirst%3DJ.%26aulast%3DCarducci%26aufirst%3DM.%2BD.%26aulast%3DWooden%26aufirst%3DH.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DLarge%2520scale%2520enantiomeric%2520synthesis%252C%2520purification%252C%2520and%2520characterization%2520of%2520%25CF%2589-unsaturated%2520amino%2520acids%2520via%2520a%2520Gly-Ni%2528II%2529-BPB-complex%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26spage%3D8233%26epage%3D8243%26doi%3D10.1016%2Fj.tet.2004.06.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Nash, H. M.; Annis, D. A.; Guerlavais, V.; Licklider, L.</span><span> </span><span class="NLM_article-title">Improved Peptidomimetic Macrocycles</span>. WO 2011047215, April 21,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=H.+M.+Nash&author=D.+A.+Annis&author=V.+Guerlavais&author=L.+Licklider&title=Improved+Peptidomimetic+Macrocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNash%26aufirst%3DH.%2BM.%26atitle%3DImproved%2520Peptidomimetic%2520Macrocycles%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Pascal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, R.</span><span> </span><span class="NLM_article-title">Preservation of the Fmoc protective group under alkaline conditions by using CaCl2. Applications in peptide synthesis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5031</span><span class="NLM_x">–</span> <span class="NLM_lpage">5034</span><span class="refDoi"> DOI: 10.1016/S0040-4039(98)00994-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2FS0040-4039%2898%2900994-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=5031-5034&author=R.+Pascalauthor=R.+Sola&title=Preservation+of+the+Fmoc+protective+group+under+alkaline+conditions+by+using+CaCl2.+Applications+in+peptide+synthesis&doi=10.1016%2FS0040-4039%2898%2900994-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900994-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900994-0%26sid%3Dliteratum%253Aachs%26aulast%3DPascal%26aufirst%3DR.%26aulast%3DSola%26aufirst%3DR.%26atitle%3DPreservation%2520of%2520the%2520Fmoc%2520protective%2520group%2520under%2520alkaline%2520conditions%2520by%2520using%2520CaCl2.%2520Applications%2520in%2520peptide%2520synthesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D5031%26epage%3D5034%26doi%3D10.1016%2FS0040-4039%2898%2900994-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Traore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubell, W. D.</span><span> </span><span class="NLM_article-title">Diversity-oriented synthesis of azapeptides with basic amino acid residues: aza-lysine, aza-ornithine, and aza-arginine</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3588</span><span class="NLM_x">–</span> <span class="NLM_lpage">3591</span><span class="refDoi"> DOI: 10.1021/ol501586y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol501586y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3588-3591&author=M.+Traoreauthor=N.+D.+Doanauthor=W.+D.+Lubell&title=Diversity-oriented+synthesis+of+azapeptides+with+basic+amino+acid+residues%3A+aza-lysine%2C+aza-ornithine%2C+and+aza-arginine&doi=10.1021%2Fol501586y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fol501586y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol501586y%26sid%3Dliteratum%253Aachs%26aulast%3DTraore%26aufirst%3DM.%26aulast%3DDoan%26aufirst%3DN.%2BD.%26aulast%3DLubell%26aufirst%3DW.%2BD.%26atitle%3DDiversity-oriented%2520synthesis%2520of%2520azapeptides%2520with%2520basic%2520amino%2520acid%2520residues%253A%2520aza-lysine%252C%2520aza-ornithine%252C%2520and%2520aza-arginine%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D3588%26epage%3D3591%26doi%3D10.1021%2Fol501586y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Garcia-Ramos, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubell, W. D.</span><span> </span><span class="NLM_article-title">Synthesis and alkylation of aza-glycinyl dipeptide building blocks</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span><span class="refDoi"> DOI: 10.1002/psc.2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fpsc.2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=24203503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslartLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=725-729&author=Y.+Garcia-Ramosauthor=W.+D.+Lubell&title=Synthesis+and+alkylation+of+aza-glycinyl+dipeptide+building+blocks&doi=10.1002%2Fpsc.2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and alkylation of aza-glycinyl dipeptide building blocks</span></div><div class="casAuthors">Garcia-Ramos, Yesica; Lubell, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">725-729</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Aza-glycinyl dipeptides are useful building blocks for the synthesis of a diverse array of azapeptides.  The construction of the aza-glycine residue is however challenging, because of the potential for side reactions, such as those leading to formation of oxadiazalone, hydantoin and sym. urea byproducts.  Employing N,N'-disuccinimidyl carbonate to activate benzophenone hydrazone, we have developed a more efficient approach for the synthesis of aza-glycinyl dipeptides.  Alkylation of the semicarbazone of the resulting protected aza-glycinyl dipeptides using tetraethylammonium hydroxide and propargyl bromide provided an efficient entry into the aza-propargylglycinyl peptide building blocks, which have served previously in various reactions including Sonogashira cross-couplings, dipolar cycloaddns. and intramol. exo-dig cycloaddns. to furnish a variety of azapeptide building blocks.  Copyright pr 2013 European Peptide Society and John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo0v3joi2aFLVg90H21EOLACvtfcHk0lieetZtsBXgPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslartLvP&md5=21698054e79619e7f8a58acd6451e188</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fpsc.2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.2572%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Ramos%26aufirst%3DY.%26aulast%3DLubell%26aufirst%3DW.%2BD.%26atitle%3DSynthesis%2520and%2520alkylation%2520of%2520aza-glycinyl%2520dipeptide%2520building%2520blocks%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2013%26volume%3D19%26spage%3D725%26epage%3D729%26doi%3D10.1002%2Fpsc.2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Betts, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leissring, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolios, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. M.</span><span> </span><span class="NLM_article-title">Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1016/j.nbd.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.nbd.2008.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=18602473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSis7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=442-450&author=V.+Bettsauthor=M.+A.+Leissringauthor=G.+Doliosauthor=R.+Wangauthor=D.+J.+Selkoeauthor=D.+M.+Walsh&title=Aggregation+and+catabolism+of+disease-associated+intra-A%CE%B2+mutations%3A+reduced+proteolysis+of+A%CE%B2A21G+by+neprilysin&doi=10.1016%2Fj.nbd.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin</span></div><div class="casAuthors">Betts, Vicki; Leissring, Malcolm A.; Dolios, Georgia; Wang, Rong; Selkoe, Dennis J.; Walsh, Dominic M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Five point mutations within the amyloid β-protein (Aβ) sequence of the APP gene are assocd. with hereditary diseases which are similar or identical to Alzheimer's disease and encode: the A21G (Flemish), E22G (Arctic), E22K (Italian), E22Q (Dutch) and the D23N (Iowa) amino acid substitutions.  Although a substantial body of data exists on the effects of these mutations on Aβ prodn., whether or not intra-Aβ mutations alter degrdn. and how this relates to their aggregation state remain unclear.  Here we report that the E22G, E22Q and the D23N substitutions significantly increase fibril nucleation and extension, whereas the E22K substitution exhibits only an increased rate of extension and the A21G substitution actually causes a decrease in the extension rate.  These substantial differences in aggregation together with our observation that aggregated wild type Aβ(1-40) was much less well degraded than monomeric wild type Aβ(1-40), prompted us to assess whether or not disease-assocd. intra-Aβ mutations alter proteolysis independent of their effects on aggregation.  Neprilysin (NEP), insulin degrading enzyme (IDE) and plasmin play a major role in Aβ catabolism, therefore we compared the ability of these enzymes to degrade wild type and mutant monomeric Aβ peptides.  Expts. investigating proteolysis revealed that all monomeric peptides are degraded similarly by IDE and plasmin, but that the Flemish peptide was degraded significantly more slowly by NEP than wild type Aβ or any of the other mutant peptides.  This finding suggests that resistance to NEP-mediated proteolysis may underlie the pathogenicity assocd. with the A21G mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIuMAcFIAve7Vg90H21EOLACvtfcHk0lieetZtsBXgPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSis7%252FK&md5=03807ec73cdb586a1edd70b4aa2eaf2c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBetts%26aufirst%3DV.%26aulast%3DLeissring%26aufirst%3DM.%2BA.%26aulast%3DDolios%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26atitle%3DAggregation%2520and%2520catabolism%2520of%2520disease-associated%2520intra-A%25CE%25B2%2520mutations%253A%2520reduced%2520proteolysis%2520of%2520A%25CE%25B2A21G%2520by%2520neprilysin%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2008%26volume%3D31%26spage%3D442%26epage%3D450%26doi%3D10.1016%2Fj.nbd.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Almenoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, M.</span><span> </span><span class="NLM_article-title">Membrane-bound kidney neutral metalloendopeptidase: Interaction with synthetic substrates, natural peptides, and inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1021/bi00272a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00272a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1983&pages=590-599&author=J.+Almenoffauthor=M.+Orlowski&title=Membrane-bound+kidney+neutral+metalloendopeptidase%3A+Interaction+with+synthetic+substrates%2C+natural+peptides%2C+and+inhibitors&doi=10.1021%2Fbi00272a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbi00272a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00272a011%26sid%3Dliteratum%253Aachs%26aulast%3DAlmenoff%26aufirst%3DJ.%26aulast%3DOrlowski%26aufirst%3DM.%26atitle%3DMembrane-bound%2520kidney%2520neutral%2520metalloendopeptidase%253A%2520Interaction%2520with%2520synthetic%2520substrates%252C%2520natural%2520peptides%252C%2520and%2520inhibitors%26jtitle%3DBiochemistry%26date%3D1983%26volume%3D22%26spage%3D590%26epage%3D599%26doi%3D10.1021%2Fbi00272a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Dion, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Moual, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournie-Zaluski, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roques, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, G.</span><span> </span><span class="NLM_article-title">Evidence that Asn542 of neprilysin (EC 3.4.24.11) is involved in binding of the P2′ residue of substrates and inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span><span class="refDoi"> DOI: 10.1042/bj3110623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1042%2Fbj3110623" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=1995&pages=623-627&author=N.+Dionauthor=H.+Le+Moualauthor=M.+C.+Fournie-Zaluskiauthor=B.+P.+Roquesauthor=P.+Crineauthor=G.+Boileau&title=Evidence+that+Asn542+of+neprilysin+%28EC+3.4.24.11%29+is+involved+in+binding+of+the+P2%E2%80%B2+residue+of+substrates+and+inhibitors&doi=10.1042%2Fbj3110623"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1042%2Fbj3110623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3110623%26sid%3Dliteratum%253Aachs%26aulast%3DDion%26aufirst%3DN.%26aulast%3DLe%2BMoual%26aufirst%3DH.%26aulast%3DFournie-Zaluski%26aufirst%3DM.%2BC.%26aulast%3DRoques%26aufirst%3DB.%2BP.%26aulast%3DCrine%26aufirst%3DP.%26aulast%3DBoileau%26aufirst%3DG.%26atitle%3DEvidence%2520that%2520Asn542%2520of%2520neprilysin%2520%2528EC%25203.4.24.11%2529%2520is%2520involved%2520in%2520binding%2520of%2520the%2520P2%25E2%2580%25B2%2520residue%2520of%2520substrates%2520and%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D1995%26volume%3D311%26spage%3D623%26epage%3D627%26doi%3D10.1042%2Fbj3110623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Bateman, R. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unnithan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersh, L. B.</span><span> </span><span class="NLM_article-title">Identification of the active-site arginine in rat neutral endopeptidase 24.11 (enkephalinase) as arginine 102 and analysis of a glutamine 102 mutant</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">6151</span><span class="NLM_x">–</span> <span class="NLM_lpage">6157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=6151-6157&author=R.+C.+Batemanauthor=D.+Jacksonauthor=C.+A.+Slaughterauthor=S.+Unnithanauthor=Y.+G.+Chaiauthor=C.+Moomawauthor=L.+B.+Hersh&title=Identification+of+the+active-site+arginine+in+rat+neutral+endopeptidase+24.11+%28enkephalinase%29+as+arginine+102+and+analysis+of+a+glutamine+102+mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BC.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3DSlaughter%26aufirst%3DC.%2BA.%26aulast%3DUnnithan%26aufirst%3DS.%26aulast%3DChai%26aufirst%3DY.%2BG.%26aulast%3DMoomaw%26aufirst%3DC.%26aulast%3DHersh%26aufirst%3DL.%2BB.%26atitle%3DIdentification%2520of%2520the%2520active-site%2520arginine%2520in%2520rat%2520neutral%2520endopeptidase%252024.11%2520%2528enkephalinase%2529%2520as%2520arginine%2520102%2520and%2520analysis%2520of%2520a%2520glutamine%2520102%2520mutant%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D6151%26epage%3D6157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">McMurray, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizkala, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swedberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zile, M. R.</span><span> </span><span class="NLM_article-title">PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1056/NEJMoa1409077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1056%2FNEJMoa1409077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=25176015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12hs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=993-1004&author=J.+J.+McMurrayauthor=M.+Packerauthor=A.+S.+Desaiauthor=J.+Gongauthor=M.+P.+Lefkowitzauthor=A.+R.+Rizkalaauthor=J.+L.+Rouleauauthor=V.+C.+Shiauthor=S.+D.+Solomonauthor=K.+Swedbergauthor=M.+R.+Zile&title=PARADIGM-HF+Investigators+and+Committees.+Angiotensin-neprilysin+inhibition+versus+enalapril+in+heart+failure&doi=10.1056%2FNEJMoa1409077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin-neprilysin inhibition versus enalapril in heart failure</span></div><div class="casAuthors">McMurray, John J. V.; Packer, Milton; Desai, Akshay S.; Gong, Jianjian; Lefkowitz, Martin P.; Rizkala, Adel R.; Rouleau, Jean L.; Shi, Victor C.; Solomon, Scott D.; Swedberg, Karl; Zile, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">993-1004, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: We compared the angiotensin receptor-neprilysin inhibitor LCZ696 with enalapril in patients who had heart failure with a reduced ejection fraction.  In previous studies, enalapril improved survival in such patients.  Methods: In this double-blind trial, we randomly assigned 8442 patients with class II, III, or IV heart failure and an ejection fraction of 40% or less to receive either LCZ696 (at a dose of 200 mg twice daily) or enalapril (at a dose of 10 mg twice daily), in addn. to recommended therapy.  The primary outcome was a composite of death from cardiovascular causes or hospitalization for heart failure, but the trial was designed to detect a difference in the rates of death from cardiovascular causes.  Results: The trial was stopped early, according to prespecified rules, after a median follow-up of 27 mo, because the boundary for an overwhelming benefit with LCZ696 had been crossed.  At the time of study closure, the primary outcome had occurred in 914 patients (21.8%) in the LCZ696 group and 1117 patients (26.5%) in the enalapril group (hazard ratio in the LCZ696 group, 0.80; 95% confidence interval [CI], 0.73 to 0.87; P < 0.001).  A total of 711 patients (17.0%) receiving LCZ696 and 835 patients (19.8%) receiving enalapril died (hazard ratio for death from any cause, 0.84; 95% CI, 0.76 to 0.93; P < 0.001); of these patients, 558 (13.3%) and 693 (16.5%), resp., died from cardiovascular causes (hazard ratio, 0.80; 95% CI, 0.71 to 0.89; P < 0.001).  As compared with enalapril, LCZ696 also reduced the risk of hospitalization for heart failure by 21% (P < 0.001) and decreased the symptoms and phys. limitations of heart failure (P = 0.001).  The LCZ696 group had higher proportions of patients with hypotension and nonserious angioedema but lower proportions with renal impairment, hyperkalemia, and cough than the enalapril group.  Conclusions: LCZ696 was superior to enalapril in reducing the risks of death and of hospitalization for heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2JML5-2xPNrVg90H21EOLACvtfcHk0lhv_z_fILMWPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12hs73N&md5=46efccc50e492a1ae5354073e0ea71e8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1409077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1409077%26sid%3Dliteratum%253Aachs%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DPacker%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DA.%2BS.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLefkowitz%26aufirst%3DM.%2BP.%26aulast%3DRizkala%26aufirst%3DA.%2BR.%26aulast%3DRouleau%26aufirst%3DJ.%2BL.%26aulast%3DShi%26aufirst%3DV.%2BC.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DSwedberg%26aufirst%3DK.%26aulast%3DZile%26aufirst%3DM.%2BR.%26atitle%3DPARADIGM-HF%2520Investigators%2520and%2520Committees.%2520Angiotensin-neprilysin%2520inhibition%2520versus%2520enalapril%2520in%2520heart%2520failure%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D993%26epage%3D1004%26doi%3D10.1056%2FNEJMoa1409077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, C. C. Y.</span><span> </span><span class="NLM_article-title">Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">470</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1016/S0014-2999(03)01821-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2FS0014-2999%2803%2901821-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=12798955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVegsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=470&publication_year=2003&pages=171-175&author=X.+Chengauthor=X.+S.+Chengauthor=C.+C.+Y.+Pang&title=Venous+dilator+effect+of+apelin%2C+an+endogenous+peptide+ligand+for+the+orphan+APJ+receptor%2C+in+conscious+rats&doi=10.1016%2FS0014-2999%2803%2901821-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats</span></div><div class="casAuthors">Cheng, Xing; Cheng, Xiao Shuo; Pang, Catherine C. Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">470</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-175</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Apelin is an endogenous depressor peptide for the G protein-coupled APJ receptor.  The authors' hypothesis is that apelin is a venodilator, and it reduces mean circulatory filling pressure (MCFP; index of venous tone).  Dose-response curves of apelin (10, 20 and 40 nmol/kg) or vehicle (0.9% NaCl) were constructed in two groups each of conscious, unrestrained rats: unblocked rats and rats pretreated with mecamylamine (Mec; ganglionic blocker) and noradrenaline (NA; to restore vascular tone).  The vehicle had no effects in the unblocked or ganglionic-blocked rats.  Apelin decreased mean arterial pressure (MAP) and increased heart rate (HR), but it did not alter mean circulatory filling pressure in the unblocked rats.  In the ganglionic-blocked rats, apelin did not alter heart rate but decreased mean arterial pressure and mean circulatory filling pressure.  These results show that apelin is an arterial and venous dilator in vivo.  The depressor effect of apelin is accompanied by tachycardia which is abolished by ganglion blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgvqaUB-MclrVg90H21EOLACvtfcHk0lhv_z_fILMWPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVegsbc%253D&md5=f24b446470d5fc32950a3f826abea8d1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901821-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901821-1%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DX.%2BS.%26aulast%3DPang%26aufirst%3DC.%2BC.%2BY.%26atitle%3DVenous%2520dilator%2520effect%2520of%2520apelin%252C%2520an%2520endogenous%2520peptide%2520ligand%2520for%2520the%2520orphan%2520APJ%2520receptor%252C%2520in%2520conscious%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D470%26spage%3D171%26epage%3D175%26doi%3D10.1016%2FS0014-2999%2803%2901821-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Gerbier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvear-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margathe, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flahault, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvineau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabire, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceraudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hus-Citharel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteoulle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisoo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdeaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrioz, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Development of original metabolically-stable apelin-17 analogs with diuretic and cardiovascular effects</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span><span class="refDoi"> DOI: 10.1096/fj.201600784R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1096%2Ffj.201600784R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=27815337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslehs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=687-700&author=R.+Gerbierauthor=R.+Alvear-Perezauthor=J.+F.+Margatheauthor=A.+Flahaultauthor=P.+Couvineauauthor=J.+Gaoauthor=N.+De+Motaauthor=H.+Dabireauthor=B.+Liauthor=E.+Ceraudoauthor=A.+Hus-Citharelauthor=L.+Esteoulleauthor=C.+Bisooauthor=M.+Hibertauthor=A.+Berdeauxauthor=X.+Iturriozauthor=D.+Bonnetauthor=C.+Llorens-Cortes&title=Development+of+original+metabolically-stable+apelin-17+analogs+with+diuretic+and+cardiovascular+effects&doi=10.1096%2Ffj.201600784R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects</span></div><div class="casAuthors">Gerbier, Romain; Alvear-Perez, Rodrigo; Margathe, Jean-Francois; Flahault, Adrien; Couvineau, Pierre; Gao, Ji; De Mota, Nadia; Dabire, Hubert; Li, Bo; Ceraudo, Emilie; Hus-Citharel, Annette; Esteoulle, Lucie; Bisoo, Cynthia; Hibert, Marcel; Berdeaux, Alain; Iturrioz, Xavier; Bonnet, Dominique; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-700</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Apelin, a (neuro)vasoactive peptide, plays a prominent role in controlling cardiovascular functions and water balance.  Because the in vivo apelin half-life is in the minute range, we aimed to identify metabolically stable apelin-17 (K17F) analogs.  We generated P92 by classic chem. substitutions and LIT01-196 by original addn. of a fluorocarbon chain to the N terminus of K17F.  Both analogs were much more stable in plasma (half-life >24 h for LIT01-196) than K17F (4.6 min).  Analogs displayed a subnanomolar affinity for the apelin receptor and behaved as full agonists with regard to cAMP prodn., ERK phosphorylation, and apelin receptor internalization.  Ex vivo, these compds. induced vasorelaxation of rat aortas and glomerular arterioles, resp., precontracted with norepinephrine and angiotensin II, and increased cardiac contractility.  In vivo, after intracerebroventricular ad- ministration in water-deprived mice, P92 and LIT01-196 were 6 and 160 times, resp., more efficient at inhibiting systemic vasopressin release than K17F.  Administered i.v. (nmol/kg range) in normotensive rats, these analogs potently increased urine output and induced a profound and sustained decrease in arterial blood pressure.  In summary, these new compds., which favor diuresis and improve cardiac contractility while reducing vascular resistances, represent promising candidates for the treatment of heart failure and water retention/ hyponatremic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUo5SAnSahoLVg90H21EOLACvtfcHk0lh6NMKtgdKL5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslehs78%253D&md5=919d64864e9c257e8b0a942f2fd904c6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1096%2Ffj.201600784R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201600784R%26sid%3Dliteratum%253Aachs%26aulast%3DGerbier%26aufirst%3DR.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DMargathe%26aufirst%3DJ.%2BF.%26aulast%3DFlahault%26aufirst%3DA.%26aulast%3DCouvineau%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DDabire%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DCeraudo%26aufirst%3DE.%26aulast%3DHus-Citharel%26aufirst%3DA.%26aulast%3DEsteoulle%26aufirst%3DL.%26aulast%3DBisoo%26aufirst%3DC.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DBerdeaux%26aufirst%3DA.%26aulast%3DIturrioz%26aufirst%3DX.%26aulast%3DBonnet%26aufirst%3DD.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520original%2520metabolically-stable%2520apelin-17%2520analogs%2520with%2520diuretic%2520and%2520cardiovascular%2520effects%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26spage%3D687%26epage%3D700%26doi%3D10.1096%2Ffj.201600784R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Iturrioz, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerbier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvear-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">32627</span><span class="NLM_x">–</span> <span class="NLM_lpage">32637</span><span class="refDoi"> DOI: 10.1074/jbc.M110.127167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1074%2Fjbc.M110.127167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=20675385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GqurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32627-32637&author=X.+Iturriozauthor=R.+Gerbierauthor=V.+Lerouxauthor=R.+Alvear-Perezauthor=B.+Maigretauthor=C.+Llorens-Cortes&title=By+interacting+with+the+C-terminal+Phe+of+apelin%2C+Phe255+and+Trp259+in+helix+VI+of+the+apelin+receptor+are+critical+for+internalization&doi=10.1074%2Fjbc.M110.127167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">By Interacting with the C-terminal Phe of Apelin, Phe255 and Trp259 in Helix VI of the Apelin Receptor Are Critical for Internalization</span></div><div class="casAuthors">Iturrioz, Xavier; Gerbier, Romain; Leroux, Vincent; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">32627-32637</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of the orphan seven-transmembrane domain (TM) G protein-coupled receptor (GPCR) APJ.  Apelin is involved in the regulation of body fluid homeostasis and cardiovascular functions.  We previously showed the importance of the C-terminal Phe of apelin 17 (K17F) in the hypotensive activity of this peptide.  Here, we show either by deleting the Phe residue (K16P) or by substituting it by an Ala (K17A), that it plays a crucial role in apelin receptor internalization but not in apelin binding or in Gαi-protein coupling.  Then we built a homol. three-dimensional model of the human apelin receptor using the cholecystokinin receptor-1 model as a template, and we subsequently docked K17F into the binding site.  We visualized a hydrophobic cavity at the bottom of the binding pocket in which the C-terminal Phe of K17F was embedded by Trp152 in TMIV and Trp259 and Phe255 in TMVI.  Using mol. modeling and site-directed mutagenesis studies, we further showed that Phe255 and Trp259 are key residues in triggering receptor internalization without playing a role in apelin binding or in Gαi-protein coupling.  These findings bring new insights into apelin receptor activation and show that Phe255 and Trp259, by interacting with the C-terminal Phe of the pyroglutamyl form of apelin 13 (pE13F) or K17F, are crucial for apelin receptor internalization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwnLuCfuGp_LVg90H21EOLACvtfcHk0lh6NMKtgdKL5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GqurzN&md5=3e3d85dc29f9ed7630d712c8ab36a9b8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.127167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.127167%26sid%3Dliteratum%253Aachs%26aulast%3DIturrioz%26aufirst%3DX.%26aulast%3DGerbier%26aufirst%3DR.%26aulast%3DLeroux%26aufirst%3DV.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DBy%2520interacting%2520with%2520the%2520C-terminal%2520Phe%2520of%2520apelin%252C%2520Phe255%2520and%2520Trp259%2520in%2520helix%2520VI%2520of%2520the%2520apelin%2520receptor%2520are%2520critical%2520for%2520internalization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32627%26epage%3D32637%26doi%3D10.1074%2Fjbc.M110.127167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Perjes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoumal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenhunen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konyi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruskoaho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szokodi, I.</span><span> </span><span class="NLM_article-title">Apelin increases cardiac contractility via protein kinase C epsilon- and extracellular signal-regulated kinase-dependent mechanisms</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e93473</span><span class="refDoi"> DOI: 10.1371/journal.pone.0093473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1371%2Fjournal.pone.0093473" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e93473&author=A.+Perjesauthor=R.+Skoumalauthor=O.+Tenhunenauthor=A.+Konyiauthor=M.+Simonauthor=I.+G.+Horvathauthor=R.+Kerkelaauthor=H.+Ruskoahoauthor=I.+Szokodi&title=Apelin+increases+cardiac+contractility+via+protein+kinase+C+epsilon-+and+extracellular+signal-regulated+kinase-dependent+mechanisms&doi=10.1371%2Fjournal.pone.0093473"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093473%26sid%3Dliteratum%253Aachs%26aulast%3DPerjes%26aufirst%3DA.%26aulast%3DSkoumal%26aufirst%3DR.%26aulast%3DTenhunen%26aufirst%3DO.%26aulast%3DKonyi%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DM.%26aulast%3DHorvath%26aufirst%3DI.%2BG.%26aulast%3DKerkela%26aufirst%3DR.%26aulast%3DRuskoaho%26aufirst%3DH.%26aulast%3DSzokodi%26aufirst%3DI.%26atitle%3DApelin%2520increases%2520cardiac%2520contractility%2520via%2520protein%2520kinase%2520C%2520epsilon-%2520and%2520extracellular%2520signal-regulated%2520kinase-dependent%2520mechanisms%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De93473%26doi%3D10.1371%2Fjournal.pone.0093473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Brame, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, A. P.</span><span> </span><span class="NLM_article-title">Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.114.05099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FHYPERTENSIONAHA.114.05099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=25712721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVGrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=834-840&author=A.+L.+Brameauthor=J.+J.+Maguireauthor=P.+Yangauthor=A.+Dysonauthor=R.+Torellaauthor=J.+Cheriyanauthor=M.+Singerauthor=R.+C.+Glenauthor=I.+B.+Wilkinsonauthor=A.+P.+Davenport&title=Design%2C+characterization%2C+and+first-in-human+study+of+the+vascular+actions+of+a+novel+biased+apelin+receptor+agonist&doi=10.1161%2FHYPERTENSIONAHA.114.05099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist</span></div><div class="casAuthors">Brame, Aimee L.; Maguire, Janet J.; Yang, Peiran; Dyson, Alex; Torella, Rubben; Cheriyan, Joseph; Singer, Mervyn; Glen, Robert C.; Wilkinson, Ian B.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">834-840</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">[Pyr]apelin-13 is an endogenous vasodilator and inotrope but is downregulated in pulmonary hypertension and heart failure, making the apelin receptor an attractive therapeutic target.  Agonists acting at the same G-protein-coupled receptor can be engineered to stabilize different conformational states and function as biased ligands, selectively stimulating either G-protein or β-arrestin pathways.  We used mol. dynamics simulations of apelin/receptor interactions to design cyclic analogs and identified MM07 as a biased agonist.  In β-arrestin and internalization assays (G-protein-independent), MM07 was 2 orders of magnitude less potent than [Pyr]apelin-13.  In a G-protein-dependent saphenous vein contraction assay, both peptides had comparable potency (pD2:[Pyr]apelin-13 9.93±0.24; MM07 9.54±0.42) and max. responses with a resulting bias for MM07 of ≈350- to 1300-fold for the G-protein pathway.  In rats, systemic infusions of MM07 (10-100 nmol) caused a dose-dependent increase in cardiac output that was significantly greater than the response to [Pyr]apelin-13.  Similarly, in human volunteers, MM07 produced a significant dose-dependent increase in forearm blood flow with a max. dilatation double that is seen with [Pyr]apelin-13.  Addnl., repeated doses of MM07 produced reproducible increases in forearm blood flow.  These responses are consistent with a more efficacious action of the biased agonist.  In human hand vein, both peptides reversed an established norepinephrine constrictor response and significantly increased venous flow.  Our results suggest that MM07 acting as a biased agonist at the apelin receptor can preferentially stimulate the G-protein pathway, which could translate to improved efficacy in the clinic by selectively stimulating vasodilatation and inotropic actions but avoiding activating detrimental β-arrestin-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVwBeW0p9RgbVg90H21EOLACvtfcHk0liFlCKnE7k0CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVGrtr0%253D&md5=908911768ffa6edcd2ef9b1e80c8826a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.114.05099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.114.05099%26sid%3Dliteratum%253Aachs%26aulast%3DBrame%26aufirst%3DA.%2BL.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DDyson%26aufirst%3DA.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DCheriyan%26aufirst%3DJ.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DWilkinson%26aufirst%3DI.%2BB.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DDesign%252C%2520characterization%252C%2520and%2520first-in-human%2520study%2520of%2520the%2520vascular%2520actions%2520of%2520a%2520novel%2520biased%2520apelin%2520receptor%2520agonist%26jtitle%3DHypertension%26date%3D2015%26volume%3D65%26spage%3D834%26epage%3D840%26doi%3D10.1161%2FHYPERTENSIONAHA.114.05099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Kehoe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Elzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkerk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1864</span><span class="NLM_x">, </span> <span class="NLM_fpage">1481</span><span class="NLM_x">–</span> <span class="NLM_lpage">1488</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2016.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.bbapap.2016.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=27449720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SgsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2016&pages=1481-1488&author=K.+Kehoeauthor=R.+Van+Elzenauthor=R.+Verkerkauthor=Y.+Simauthor=P.+Van+der+Vekenauthor=A.+M.+Lambeirauthor=I.+De+Meester&title=Prolyl+carboxypeptidase+purified+from+human+placenta%3A+its+characterization+and+identification+as+an+apelin-cleaving+enzyme&doi=10.1016%2Fj.bbapap.2016.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme</span></div><div class="casAuthors">Kehoe, Kaat; Van Elzen, Roos; Verkerk, Robert; Sim, Yani; Van der Veken, Pieter; Lambeir, Anne-Marie; De Meester, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1481-1488</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The proteolytic regulation of peptides involved in feeding behavior is poorly understood.  Prolyl carboxypeptidase (PRCP) is particularly known for its role in body wt. control by converting the anorexigenic peptide, α-MSH 1-13, into the inactive 1-12 form.  The purpose of this study was to characterize purified human PRCP, to investigate its substrate specificity and to discover novel substrates linked to obesity.  Pyroglutamated apelin-13, ghrelin, enterostatin and obestatin were investigated since these are feeding-regulating peptides with potential cleaving sites for PRCP.  PRCP was purified 575-fold from human placenta and successfully identified as human lysosomal Pro-X carboxypeptidase.  The kinetic parameters of purified and com. available PRCP for known and potential peptide substrates were detd. and compared using a RP-HPLC activity assay, isothermal titrn. calorimetry, and mass spectrometry.  Purified and recombinant PRCP had similar substrate specificities with angiotensin III as the substrate of preference.  Pyroglutamated apelin-13 was obsd. to be a novel substrate for human PRCP in vitro and PRCP-dependent cleavage was shown in a human umbilical vein endothelial cell culture expt.  Other potential substrates, e.g., obestatin, ghrelin, and enterostatin, were not hydrolyzed by PRCP.  These results showed that the placenta is a good source of human PRCP and that PRCP removes the C-terminal phenylalanine from pyroglutamated apelin-13.  Thus, for the 1st time, PRCP is identified as an apelin-cleaving enzyme.  This finding adds evidence to the hypothesis that PRCP plays a role in energy homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLgRJIzYyKJLVg90H21EOLACvtfcHk0liFlCKnE7k0CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SgsL7M&md5=0e5883ddc7f957a622564548d5b39a00</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2016.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2016.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DKehoe%26aufirst%3DK.%26aulast%3DVan%2BElzen%26aufirst%3DR.%26aulast%3DVerkerk%26aufirst%3DR.%26aulast%3DSim%26aufirst%3DY.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DProlyl%2520carboxypeptidase%2520purified%2520from%2520human%2520placenta%253A%2520its%2520characterization%2520and%2520identification%2520as%2520an%2520apelin-cleaving%2520enzyme%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2016%26volume%3D1864%26spage%3D1481%26epage%3D1488%26doi%3D10.1016%2Fj.bbapap.2016.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Baker, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, M.</span><span> </span><span class="NLM_article-title">Preparation and use of N,N′-di-Boc-N″-triflylguanidine</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="refDoi"> DOI: 10.15227/orgsyn.078.0091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.15227%2Forgsyn.078.0091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVeisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2002&pages=91&author=T.+J.+Bakerauthor=M.+Tomiokaauthor=M.+Goodman&title=Preparation+and+use+of+N%2CN%E2%80%B2-di-Boc-N%E2%80%B3-triflylguanidine&doi=10.15227%2Forgsyn.078.0091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and use of N,N'-di-Boc-N''-triflylguanidine</span></div><div class="casAuthors">Baker, Tracy J.; Tomioka, Mika; Goodman, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Organic Syntheses</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">ORSYAT</span>;
        ISSN:<span class="NLM_cas:issn">0078-6209</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The title compd. (I) was prepd. in 90% yield by reaction of N,N'-di-Boc-guanidine with triflic anhydride.  Reaction of I with benzylamine gave N''-benzyl-N,N'-di-Boc-guanidine in quant. yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoId-KoXWFk9bVg90H21EOLACvtfcHk0liFlCKnE7k0CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVeisLg%253D&md5=51c874fb5bacc271dc04cc100951e0c6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.15227%2Forgsyn.078.0091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15227%252Forgsyn.078.0091%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DT.%2BJ.%26aulast%3DTomioka%26aufirst%3DM.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DPreparation%2520and%2520use%2520of%2520N%252CN%25E2%2580%25B2-di-Boc-N%25E2%2580%25B3-triflylguanidine%26jtitle%3DOrg.%2520Synth.%26date%3D2002%26volume%3D78%26spage%3D91%26doi%3D10.15227%2Forgsyn.078.0091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Bourguet, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klocek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubell, W. D.</span><span> </span><span class="NLM_article-title">Solution-phase submonomer diversification of aza-dipeptide building blocks and their application in aza-peptide and aza-DKP synthesis</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1002/psc.1235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fpsc.1235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=20474040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVyrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=284-296&author=C.+B.+Bourguetauthor=C.+Proulxauthor=S.+Klocekauthor=D.+Sabatinoauthor=W.+D.+Lubell&title=Solution-phase+submonomer+diversification+of+aza-dipeptide+building+blocks+and+their+application+in+aza-peptide+and+aza-DKP+synthesis&doi=10.1002%2Fpsc.1235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Solution-phase submonomer diversification of aza-dipeptide building blocks and their application in aza-peptide and aza-DKP synthesis</span></div><div class="casAuthors">Bourguet, Carine B.; Proulx, Caroline; Klocek, Sophie; Sabatino, David; Lubell, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">284-296</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Aza-peptides have been used as tools for studying SARs in programs aimed at drug discovery and chem. biol.  Protected aza-dipeptides were synthesized by a soln.-phase submonomer approach featuring alkylation of N-terminal benzophenone semicarbazone aza-Gly-Xaa dipeptides using different alkyl halides in the presence of potassium tert-butoxide as base.  Benzophenone protected aza-dipeptide tert-Bu ester (I) was selectively deprotected at the C-terminal ester or N-terminal hydrazone to afford, resp., aza-dipeptide acid and amine building blocks (II) (R1 = CH2C6H5) and (III), which were introduced into longer aza-peptides.  Alternatively, removal of the benzophenone semicarbazone protection from aza-dipeptide Me esters (IV) (R1 = propargyl, allyl, benzyl) led to intramol. cyclization to produce aza-DKPs (V) (R1 = propargyl, allyl, benzyl).  In light of the importance of aza-peptides and DKPs as therapeutic agents and probes of biol. processes, this diversity-oriented soln.-phase approach may provide useful tools for studying peptide science.  Copyright © 2010 European Peptide Society and John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgPA72MWamoLVg90H21EOLACvtfcHk0liFlCKnE7k0CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVyrsLc%253D&md5=9712f2ae151cf6436a8b4821002be4f5</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fpsc.1235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.1235%26sid%3Dliteratum%253Aachs%26aulast%3DBourguet%26aufirst%3DC.%2BB.%26aulast%3DProulx%26aufirst%3DC.%26aulast%3DKlocek%26aufirst%3DS.%26aulast%3DSabatino%26aufirst%3DD.%26aulast%3DLubell%26aufirst%3DW.%2BD.%26atitle%3DSolution-phase%2520submonomer%2520diversification%2520of%2520aza-dipeptide%2520building%2520blocks%2520and%2520their%2520application%2520in%2520aza-peptide%2520and%2520aza-DKP%2520synthesis%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2010%26volume%3D16%26spage%3D284%26epage%3D296%26doi%3D10.1002%2Fpsc.1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 23 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">James A. Johnson, Soong-Hoon Kim, Ji Jiang, Monique Phillips, William A. Schumacher, Jeffrey S. Bostwick, Peter S. Gargalovic, Joelle M. Onorato, Chiuwa E. Luk, Claudia Generaux, Yan He, Xue-Qing Chen, Carrie Xu, Michael A. Galella, Tao Wang, David A. Gordon, Ruth R. Wexler, <span class="NLM_string-name hlFld-ContribAuthor">Heather J. Finlay</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3086-3099. <a href="https://doi.org/10.1021/acs.jmedchem.0c01878" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01878%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BHydroxypyridinone%252BAPJ%252BReceptor%252BAgonist%252Bas%252Ba%252BClinical%252BCandidate%26aulast%3DJohnson%26aufirst%3DJames%2BA.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29102020%26date%3D09032021%26volume%3D64%26issue%3D6%26spage%3D3086%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kien Trân, Alexandre Murza, Xavier Sainsily, Eugénie Delile, Pierre Couvineau, Jérôme Côté, David Coquerel, Maude Peloquin, Mannix Auger-Messier, Michel Bouvier, Olivier Lesur, Philippe Sarret, <span class="NLM_string-name hlFld-ContribAuthor">Éric Marsault</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 602-615. <a href="https://doi.org/10.1021/acs.jmedchem.0c01547" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01547%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252Band%252BBioactivity%252Bof%252BShort%252BAnalogues%252Bof%252BELABELA%252Bas%252BAgonists%252Bof%252Bthe%252BApelin%252BReceptor%26aulast%3DTr%25C3%25A2n%26aufirst%3DKien%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D04092020%26date%3D22122020%26volume%3D64%26issue%3D1%26spage%3D602%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chao Wang, Mingrui Xiong, Chen Yang, Dong Yang, Jiaojiao Zheng, Yu Fan, Shun Wang, Yongkang Gai, Xiaoli Lan, Hong Chen, Ling Zheng, <span class="NLM_string-name hlFld-ContribAuthor">Kun Huang</span>. </span><span class="cited-content_cbyCitation_article-title">PEGylated and Acylated Elabela Analogues Show Enhanced Receptor Binding, Prolonged Stability, and Remedy of Acute Kidney Injury. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 16028-16042. <a href="https://doi.org/10.1021/acs.jmedchem.0c01913" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01913%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPEGylated%252Band%252BAcylated%252BElabela%252BAnalogues%252BShow%252BEnhanced%252BReceptor%252BBinding%25252C%252BProlonged%252BStability%25252C%252Band%252BRemedy%252Bof%252BAcute%252BKidney%252BInjury%26aulast%3DWang%26aufirst%3DChao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04112020%26date%3D08122020%26volume%3D63%26issue%3D24%26spage%3D16028%26epage%3D16042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Conrad Fischer, Tess Lamer, Kleinberg Fernandez, Mahmoud Gheblawi, Wang Wang, Cameron Pascoe, Gareth Lambkin, Xavier Iturrioz, Catherine Llorens-Cortes, Gavin Y. Oudit, <span class="NLM_string-name hlFld-ContribAuthor">John C. Vederas</span>. </span><span class="cited-content_cbyCitation_article-title">Optimizing PEG-Extended Apelin Analogues as Cardioprotective Drug Leads: Importance of the KFRR Motif and Aromatic Head Group for Improved Physiological Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 12073-12082. <a href="https://doi.org/10.1021/acs.jmedchem.0c01395" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01395%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimizing%252BPEG-Extended%252BApelin%252BAnalogues%252Bas%252BCardioprotective%252BDrug%252BLeads%25253A%252BImportance%252Bof%252Bthe%252BKFRR%252BMotif%252Band%252BAromatic%252BHead%252BGroup%252Bfor%252BImproved%252BPhysiological%252BActivity%26aulast%3DFischer%26aufirst%3DConrad%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08082020%26date%3D01102020%26volume%3D63%26issue%3D20%26spage%3D12073%26epage%3D12082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samantha J. Bann, Ross D. Ballantine, Conor E. McCallion, Pei-Yuan Qian, Yong-Xin Li, <span class="NLM_string-name hlFld-ContribAuthor">Stephen A. Cochrane</span>. </span><span class="cited-content_cbyCitation_article-title">A Chemical-Intervention Strategy To Circumvent Peptide Hydrolysis by d-Stereoselective Peptidases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10466-10472. <a href="https://doi.org/10.1021/acs.jmedchem.9b01078" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01078%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BChemical-Intervention%252BStrategy%252BTo%252BCircumvent%252BPeptide%252BHydrolysis%252Bby%252Bd-Stereoselective%252BPeptidases%26aulast%3DBann%26aufirst%3DSamantha%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D18072019%26date%3D08112019%26date%3D28102019%26volume%3D62%26issue%3D22%26spage%3D10466%26epage%3D10472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kien Trân, Alexandre Murza, Xavier Sainsily, David Coquerel, Jérôme Côté, Karine Belleville, Lounès Haroune, Jean-Michel Longpré, Robert Dumaine, Dany Salvail, Olivier Lesur, Mannix Auger-Messier, Philippe Sarret, <span class="NLM_string-name hlFld-ContribAuthor">Éric Marsault</span>. </span><span class="cited-content_cbyCitation_article-title">A Systematic Exploration of Macrocyclization in Apelin-13: Impact on Binding, Signaling, Stability, and Cardiovascular Effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2266-2277. <a href="https://doi.org/10.1021/acs.jmedchem.7b01353" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01353%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BSystematic%252BExploration%252Bof%252BMacrocyclization%252Bin%252BApelin-13%25253A%252BImpact%252Bon%252BBinding%25252C%252BSignaling%25252C%252BStability%25252C%252Band%252BCardiovascular%252BEffects%26aulast%3DTr%25C3%25A2n%26aufirst%3DKien%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D13092017%26date%3D26022018%26date%3D20022018%26volume%3D61%26issue%3D6%26spage%3D2266%26epage%3D2277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto G. S.  Berlinck</span>, <span class="hlFld-ContribAuthor ">Darlon I.  Bernardi</span>, <span class="hlFld-ContribAuthor ">Taicia  Fill</span>, <span class="hlFld-ContribAuthor ">Alessandra A. G.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Igor D.  Jurberg</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry and biology of guanidine secondary metabolites. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2021,</strong> <em>66 </em><a href="https://doi.org/10.1039/D0NP00051E" title="DOI URL">https://doi.org/10.1039/D0NP00051E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NP00051E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NP00051E%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DThe%252Bchemistry%252Band%252Bbiology%252Bof%252Bguanidine%252Bsecondary%252Bmetabolites%26aulast%3DBerlinck%26aufirst%3DRoberto%2BG.%2BS.%26date%3D2021%26date%3D2021%26volume%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kleinberg X.  Fernandez</span>, <span class="hlFld-ContribAuthor ">Conrad  Fischer</span>, <span class="hlFld-ContribAuthor ">Jennie  Vu</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Gheblawi</span>, <span class="hlFld-ContribAuthor ">Wang  Wang</span>, <span class="hlFld-ContribAuthor ">Samantha  Gottschalk</span>, <span class="hlFld-ContribAuthor ">Xavier  Iturrioz</span>, <span class="hlFld-ContribAuthor ">Catherine  Llorens-Cortés</span>, <span class="hlFld-ContribAuthor ">Gavin Y.  Oudit</span>, <span class="hlFld-ContribAuthor ">John C.  Vederas</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>18 </em><a href="https://doi.org/10.1039/D1MD00120E" title="DOI URL">https://doi.org/10.1039/D1MD00120E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00120E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00120E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DMetabolically%252Bstable%252Bapelin-analogues%25252C%252Bincorporating%252Bcyclohexylalanine%252Band%252Bhomoarginine%25252C%252Bas%252Bpotent%252Bapelin%252Breceptor%252Bactivators%26aulast%3DFernandez%26aufirst%3DKleinberg%2BX.%26date%3D2021%26date%3D2021%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paulami  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Gheblawi</span>, <span class="hlFld-ContribAuthor ">Kaiming  Wang</span>, <span class="hlFld-ContribAuthor ">Jeannie  Vu</span>, <span class="hlFld-ContribAuthor ">Palsa  Kondaiah</span>, <span class="hlFld-ContribAuthor ">Gavin Y.  Oudit</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications. </span><span class="cited-content_cbyCitation_journal-name">Clinical Science</span><span> <strong>2020,</strong> <em>134 </em>
                                    (17)
                                     , 2319-2336. <a href="https://doi.org/10.1042/CS20200479" title="DOI URL">https://doi.org/10.1042/CS20200479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/CS20200479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FCS20200479%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Science%26atitle%3DInteraction%252Bbetween%252Bthe%252Bapelinergic%252Bsystem%252Band%252BACE2%252Bin%252Bthe%252Bcardiovascular%252Bsystem%25253A%252Btherapeutic%252Bimplications%26aulast%3DChatterjee%26aufirst%3DPaulami%26date%3D2020%26date%3D2020%26volume%3D134%26issue%3D17%26spage%3D2319%26epage%3D2336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Sidorova</span>, <span class="hlFld-ContribAuthor ">Irina  Studneva</span>, <span class="hlFld-ContribAuthor ">Valery  Bushuev</span>, <span class="hlFld-ContribAuthor ">Marina  Pal’keeva</span>, <span class="hlFld-ContribAuthor ">Alexander  Molokoedov</span>, <span class="hlFld-ContribAuthor ">Oksana  Veselova</span>, <span class="hlFld-ContribAuthor ">Michael  Ovchinnikov</span>, <span class="hlFld-ContribAuthor ">Oleg  Pisarenko</span>. </span><span class="cited-content_cbyCitation_article-title">[MeArg1, NLe10]-apelin-12: Optimization of solid-phase synthesis and evaluation of biological properties in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Peptides</span><span> <strong>2020,</strong> <em>129 </em>, 170320. <a href="https://doi.org/10.1016/j.peptides.2020.170320" title="DOI URL">https://doi.org/10.1016/j.peptides.2020.170320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.peptides.2020.170320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.peptides.2020.170320%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptides%26atitle%3D%25255BMeArg1%25252C%252BNLe10%25255D-apelin-12%25253A%252BOptimization%252Bof%252Bsolid-phase%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bbiological%252Bproperties%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DSidorova%26aufirst%3DMaria%26date%3D2020%26volume%3D129%26spage%3D170320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Conrad  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of apelin receptor (APJR) modulators (2014-2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 251-261. <a href="https://doi.org/10.1080/13543776.2020.1731473" title="DOI URL">https://doi.org/10.1080/13543776.2020.1731473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1731473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1731473%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Bapelin%252Breceptor%252B%252528APJR%252529%252Bmodulators%252B%2525282014-2019%252529%26aulast%3DFischer%26aufirst%3DConrad%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D251%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael C.  Myers</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Cullen L.  Cavallaro</span>, <span class="hlFld-ContribAuthor ">Hannguang J.  Chao</span>, <span class="hlFld-ContribAuthor ">Shun  Su</span>, <span class="hlFld-ContribAuthor ">Neil T.  Burford</span>, <span class="hlFld-ContribAuthor ">Akbar  Nayeem</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Mujing  Yan</span>, <span class="hlFld-ContribAuthor ">Robert A.  Langish</span>, <span class="hlFld-ContribAuthor ">Marta  Dabros</span>, <span class="hlFld-ContribAuthor ">Yi-Xin  Li</span>, <span class="hlFld-ContribAuthor ">Anne V.  Rose</span>, <span class="hlFld-ContribAuthor ">Kamelia  Behnia</span>, <span class="hlFld-ContribAuthor ">Joelle M.  Onorato</span>, <span class="hlFld-ContribAuthor ">Peter S.  Gargalovic</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">R. Michael  Lawrence</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (7)
                                     , 126955. <a href="https://doi.org/10.1016/j.bmcl.2020.126955" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126955%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BSAR%252Bof%252Baryl%252Bhydroxy%252Bpyrimidinones%252Bas%252Bpotent%252Bsmall%252Bmolecule%252Bagonists%252Bof%252Bthe%252BGPCR%252BAPJ%26aulast%3DMyers%26aufirst%3DMichael%2BC.%26date%3D2020%26volume%3D30%26issue%3D7%26spage%3D126955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Gheblawi</span>, <span class="hlFld-ContribAuthor ">Jiu-Chang  Zhong</span>, <span class="hlFld-ContribAuthor ">Gavin Y.  Oudit</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Epicardial Adipose Tissue in Heart Failure: From Basic to Clinical Perspectives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 173-194. <a href="https://doi.org/10.1007/978-3-030-47336-5_10" title="DOI URL">https://doi.org/10.1007/978-3-030-47336-5_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-47336-5_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-47336-5_10%26sid%3Dliteratum%253Aachs%26atitle%3DRole%252Bof%252BEpicardial%252BAdipose%252BTissue%252Bin%252BHeart%252BFailure%25253A%252BFrom%252BBasic%252Bto%252BClinical%252BPerspectives%26aulast%3DZhang%26aufirst%3DHao%26date%3D2020%26date%3D2020%26spage%3D173%26epage%3D194%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DBiochemistry%252Bof%252BCardiovascular%252BDysfunction%252Bin%252BObesity%26aulast%3DTappia%26aufirst%3DParamjit%2BS.%26date%3D2020%26volume%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew G.  Masoud</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Lin</span>, <span class="hlFld-ContribAuthor ">Abul K.  Azad</span>, <span class="hlFld-ContribAuthor ">Maikel A.  Farhan</span>, <span class="hlFld-ContribAuthor ">Conrad  Fischer</span>, <span class="hlFld-ContribAuthor ">Lin F.  Zhu</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Banu  Sis</span>, <span class="hlFld-ContribAuthor ">Zamaneh  Kassiri</span>, <span class="hlFld-ContribAuthor ">Ronald B.  Moore</span>, <span class="hlFld-ContribAuthor ">Daniel  Kim</span>, <span class="hlFld-ContribAuthor ">Colin C.  Anderson</span>, <span class="hlFld-ContribAuthor ">John C.  Vederas</span>, <span class="hlFld-ContribAuthor ">Benjamin A.  Adam</span>, <span class="hlFld-ContribAuthor ">Gavin Y.  Oudit</span>, <span class="hlFld-ContribAuthor ">Allan G.  Murray</span>. </span><span class="cited-content_cbyCitation_article-title">Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2019,</strong> <em>130 </em>
                                    (1)
                                     , 94-107. <a href="https://doi.org/10.1172/JCI128469" title="DOI URL">https://doi.org/10.1172/JCI128469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI128469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI128469%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DApelin%252Bdirects%252Bendothelial%252Bcell%252Bdifferentiation%252Band%252Bvascular%252Brepair%252Bfollowing%252Bimmune-mediated%252Binjury%26aulast%3DMasoud%26aufirst%3DAndrew%2BG.%26date%3D2019%26date%3D2019%26volume%3D130%26issue%3D1%26spage%3D94%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Marsault</span>, <span class="hlFld-ContribAuthor ">Catherine  Llorens‐Cortes</span>, <span class="hlFld-ContribAuthor ">Xavier  Iturrioz</span>, <span class="hlFld-ContribAuthor ">Hyung J.  Chun</span>, <span class="hlFld-ContribAuthor ">Olivier  Lesur</span>, <span class="hlFld-ContribAuthor ">Gavin Y.  Oudit</span>, <span class="hlFld-ContribAuthor ">Mannix  Auger‐Messier</span>. </span><span class="cited-content_cbyCitation_article-title">The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders. </span><span class="cited-content_cbyCitation_journal-name">Annals of the New York Academy of Sciences</span><span> <strong>2019,</strong> <em>1455 </em>
                                    (1)
                                     , 12-33. <a href="https://doi.org/10.1111/nyas.14123" title="DOI URL">https://doi.org/10.1111/nyas.14123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nyas.14123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnyas.14123%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520New%2520York%2520Academy%2520of%2520Sciences%26atitle%3DThe%252Bapelinergic%252Bsystem%25253A%252Ba%252Bperspective%252Bon%252Bchallenges%252Band%252Bopportunities%252Bin%252Bcardiovascular%252Band%252Bmetabolic%252Bdisorders%26aulast%3DMarsault%26aufirst%3DEric%26date%3D2019%26date%3D2019%26volume%3D1455%26issue%3D1%26spage%3D12%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wang  Wang</span>, <span class="hlFld-ContribAuthor ">Mengcheng  Shen</span>, <span class="hlFld-ContribAuthor ">Conrad  Fischer</span>, <span class="hlFld-ContribAuthor ">Ratnadeep  Basu</span>, <span class="hlFld-ContribAuthor ">Saugata  Hazra</span>, <span class="hlFld-ContribAuthor ">Pierre  Couvineau</span>, <span class="hlFld-ContribAuthor ">Manish  Paul</span>, <span class="hlFld-ContribAuthor ">Faqi  Wang</span>, <span class="hlFld-ContribAuthor ">Sandra  Toth</span>, <span class="hlFld-ContribAuthor ">Doran S.  Mix</span>, <span class="hlFld-ContribAuthor ">Marko  Poglitsch</span>, <span class="hlFld-ContribAuthor ">Norma P.  Gerard</span>, <span class="hlFld-ContribAuthor ">Michel  Bouvier</span>, <span class="hlFld-ContribAuthor ">John C.  Vederas</span>, <span class="hlFld-ContribAuthor ">Josef M.  Penninger</span>, <span class="hlFld-ContribAuthor ">Zamaneh  Kassiri</span>, <span class="hlFld-ContribAuthor ">Gavin Y.  Oudit</span>. </span><span class="cited-content_cbyCitation_article-title">Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (26)
                                     , 13006-13015. <a href="https://doi.org/10.1073/pnas.1900152116" title="DOI URL">https://doi.org/10.1073/pnas.1900152116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1900152116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1900152116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DApelin%252Bprotects%252Bagainst%252Babdominal%252Baortic%252Baneurysm%252Band%252Bthe%252Btherapeutic%252Brole%252Bof%252Bneutral%252Bendopeptidase%252Bresistant%252Bapelin%252Banalogs%26aulast%3DWang%26aufirst%3DWang%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D26%26spage%3D13006%26epage%3D13015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabelle  Castan-Laurell</span>, <span class="hlFld-ContribAuthor ">Bernard  Masri</span>, <span class="hlFld-ContribAuthor ">Philippe  Valet</span>. </span><span class="cited-content_cbyCitation_article-title">The apelin/APJ system as a therapeutic target in metabolic diseases. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2019,</strong> <em>23 </em>
                                    (3)
                                     , 215-225. <a href="https://doi.org/10.1080/14728222.2019.1561871" title="DOI URL">https://doi.org/10.1080/14728222.2019.1561871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2019.1561871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2019.1561871%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DThe%252Bapelin%25252FAPJ%252Bsystem%252Bas%252Ba%252Btherapeutic%252Btarget%252Bin%252Bmetabolic%252Bdiseases%26aulast%3DCastan-Laurell%26aufirst%3DIsabelle%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D3%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Conrad  Fischer</span>, <span class="hlFld-ContribAuthor ">Tess  Lamer</span>, <span class="hlFld-ContribAuthor ">Wang  Wang</span>, <span class="hlFld-ContribAuthor ">Shaun M.K.  McKinnie</span>, <span class="hlFld-ContribAuthor ">Xavier  Iturrioz</span>, <span class="hlFld-ContribAuthor ">Catherine  Llorens-Cortes</span>, <span class="hlFld-ContribAuthor ">Gavin Y.  Oudit</span>, <span class="hlFld-ContribAuthor ">John C.  Vederas</span>. </span><span class="cited-content_cbyCitation_article-title">Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 119-124. <a href="https://doi.org/10.1016/j.ejmech.2019.01.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPlasma%252Bkallikrein%252Bcleaves%252Band%252Binactivates%252Bapelin-17%25253A%252BPalmitoyl-%252Band%252BPEG-extended%252Bapelin-17%252Banalogs%252Bas%252Bmetabolically%252Bstable%252Bblood%252Bpressure-lowering%252Bagents%26aulast%3DFischer%26aufirst%3DConrad%26date%3D2019%26volume%3D166%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandre  Murza</span>, <span class="hlFld-ContribAuthor ">Kien  Trân</span>, <span class="hlFld-ContribAuthor ">Laurent  Bruneau-Cossette</span>, <span class="hlFld-ContribAuthor ">Olivier  Lesur</span>, <span class="hlFld-ContribAuthor ">Mannix  Auger-Messier</span>, <span class="hlFld-ContribAuthor ">Pierre  Lavigne</span>, <span class="hlFld-ContribAuthor ">Philippe  Sarret</span>, <span class="hlFld-ContribAuthor ">Éric  Marsault</span>. </span><span class="cited-content_cbyCitation_article-title">Apelins, ELABELA, and their derivatives: Peptidic regulators of the cardiovascular system and beyond. </span><span class="cited-content_cbyCitation_journal-name">Peptide Science</span><span> <strong>2019,</strong> <em>111 </em>
                                    (1)
                                     , e24064. <a href="https://doi.org/10.1002/pep2.24064" title="DOI URL">https://doi.org/10.1002/pep2.24064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pep2.24064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpep2.24064%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptide%2520Science%26atitle%3DApelins%25252C%252BELABELA%25252C%252Band%252Btheir%252Bderivatives%25253A%252BPeptidic%252Bregulators%252Bof%252Bthe%252Bcardiovascular%252Bsystem%252Band%252Bbeyond%26aulast%3DMurza%26aufirst%3DAlexandre%26date%3D2019%26date%3D2018%26volume%3D111%26issue%3D1%26spage%3De24064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amreen  Mughal</span>, <span class="hlFld-ContribAuthor ">Stephen T.  O'Rourke</span>. </span><span class="cited-content_cbyCitation_article-title">Vascular effects of apelin: Mechanisms and therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>190 </em>, 139-147. <a href="https://doi.org/10.1016/j.pharmthera.2018.05.013" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2018.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2018.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2018.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DVascular%252Beffects%252Bof%252Bapelin%25253A%252BMechanisms%252Band%252Btherapeutic%252Bpotential%26aulast%3DMughal%26aufirst%3DAmreen%26date%3D2018%26volume%3D190%26spage%3D139%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Biondi</span>, <span class="hlFld-ContribAuthor ">Cristina  Peggion</span>, <span class="hlFld-ContribAuthor ">Marta  De Zotti</span>, <span class="hlFld-ContribAuthor ">Chiara  Pignaffo</span>, <span class="hlFld-ContribAuthor ">Annalisa  Dalzini</span>, <span class="hlFld-ContribAuthor ">Marco  Bortolus</span>, <span class="hlFld-ContribAuthor ">Simona  Oancea</span>, <span class="hlFld-ContribAuthor ">Geta  Hilma</span>, <span class="hlFld-ContribAuthor ">Annalisa  Bortolotti</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Stella</span>, <span class="hlFld-ContribAuthor ">Jens Z.  Pedersen</span>, <span class="hlFld-ContribAuthor ">Victoria N.  Syryamina</span>, <span class="hlFld-ContribAuthor ">Yuri D.  Tsvetkov</span>, <span class="hlFld-ContribAuthor ">Sergei A.  Dzuba</span>, <span class="hlFld-ContribAuthor ">Claudio  Toniolo</span>, <span class="hlFld-ContribAuthor ">Fernando  Formaggio</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational properties, membrane interaction, and antibacterial activity of the peptaibiotic chalciporin A: Multitechnique spectroscopic and biophysical investigations on the natural compound and labeled analogs. </span><span class="cited-content_cbyCitation_journal-name">Peptide Science</span><span> <strong>2018,</strong> <em>110 </em>
                                    (5)
                                     , e23083. <a href="https://doi.org/10.1002/bip.23083" title="DOI URL">https://doi.org/10.1002/bip.23083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bip.23083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbip.23083%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptide%2520Science%26atitle%3DConformational%252Bproperties%25252C%252Bmembrane%252Binteraction%25252C%252Band%252Bantibacterial%252Bactivity%252Bof%252Bthe%252Bpeptaibiotic%252Bchalciporin%252BA%25253A%252BMultitechnique%252Bspectroscopic%252Band%252Bbiophysical%252Binvestigations%252Bon%252Bthe%252Bnatural%252Bcompound%252Band%252Blabeled%252Banalogs%26aulast%3DBiondi%26aufirst%3DBarbara%26date%3D2018%26date%3D2018%26volume%3D110%26issue%3D5%26spage%3De23083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Finbarr P.M.  O'Harte</span>, <span class="hlFld-ContribAuthor ">Vadivel  Parthsarathy</span>, <span class="hlFld-ContribAuthor ">Christopher  Hogg</span>, <span class="hlFld-ContribAuthor ">Peter R  Flatt</span>. </span><span class="cited-content_cbyCitation_article-title">Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2017,</strong> <em>146 </em>, 165-173. <a href="https://doi.org/10.1016/j.bcp.2017.10.002" title="DOI URL">https://doi.org/10.1016/j.bcp.2017.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2017.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DAcylated%252Bapelin-13%252Bamide%252Banalogues%252Bexhibit%252Benzyme%252Bresistance%252Band%252Bprolonged%252Binsulin%252Breleasing%25252C%252Bglucose%252Blowering%252Band%252Banorexic%252Bproperties%26aulast%3DO%2527Harte%26aufirst%3DFinbarr%2BP.M.%26date%3D2017%26volume%3D146%26spage%3D165%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-Zhou  Zhang</span>, <span class="hlFld-ContribAuthor ">Wang  Wang</span>, <span class="hlFld-ContribAuthor ">Hai-Yan  Jin</span>, <span class="hlFld-ContribAuthor ">Xueyi  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-Wen  Cheng</span>, <span class="hlFld-ContribAuthor ">Ying-Le  Xu</span>, <span class="hlFld-ContribAuthor ">Bei  Song</span>, <span class="hlFld-ContribAuthor ">Josef M.  Penninger</span>, <span class="hlFld-ContribAuthor ">Gavin Y.  Oudit</span>, <span class="hlFld-ContribAuthor ">Jiu-Chang  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Apelin Is a Negative Regulator of Angiotensin II–Mediated Adverse Myocardial Remodeling and Dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Hypertension</span><span> <strong>2017,</strong> <em>70 </em>
                                    (6)
                                     , 1165-1175. <a href="https://doi.org/10.1161/HYPERTENSIONAHA.117.10156" title="DOI URL">https://doi.org/10.1161/HYPERTENSIONAHA.117.10156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/HYPERTENSIONAHA.117.10156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FHYPERTENSIONAHA.117.10156%26sid%3Dliteratum%253Aachs%26jtitle%3DHypertension%26atitle%3DApelin%252BIs%252Ba%252BNegative%252BRegulator%252Bof%252BAngiotensin%252BII%2525E2%252580%252593Mediated%252BAdverse%252BMyocardial%252BRemodeling%252Band%252BDysfunction%26aulast%3DZhang%26aufirst%3DZhen-Zhou%26date%3D2017%26volume%3D70%26issue%3D6%26spage%3D1165%26epage%3D1175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Bioactive apelin isoforms <b>1</b>–<b>3</b>, with identified sites of NEP and ACE2 proteolytic degradation highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General SPPS Approach for the Divergent Syntheses of Arg/Leu Modified Apelin A2 Analogues, with Areas of Synthetic Modification Shown in Red</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Targeted synthetic modifications to improve apelin proteolytic stability against NEP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Dipeptide <b>22</b> for the Preparation of <i>N</i>-Methylleucine Apelin A2 Analogues <b>10</b> and <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Dipeptide <b>29</b> for the Preparation of α-Methylarginine Apelin A2 Analogues <b>12</b> and <b>13</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Dipeptide <b>33</b> for the Preparation of α-Methylleucine Apelin A2 Analogues <b>14</b> and <b>15</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Azatripeptide <b>39</b> for the Preparation of Aza-arginine Apelin A2 Analogues <b>16</b> and <b>17</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Azatripeptide <b>45</b> for the Preparation of Aza-leucine Apelin A2 Analogues <b>18</b> and <b>19</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro NEP degradation trends for (a) pyr-1-apelin-13 analogues and (b) apelin-17 analogues, comparing native apelin isoforms (<b>1</b>, <b>2</b>), ACE2-resistant analogues (<b>4</b>, <b>5</b>), and novel Arg/Leu substituted analogues <b>8</b>–<b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo systolic (SBP, A/E), diastolic (DBP, B/F), mean arterial blood pressure (MABP, C/G), and heart rate analyses (HR, D/H) following injection of pyr-1-apelin-13 A2 (left) and apelin-17 A2 (right) analogues in anesthetized mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/medium/jm-2017-00723f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Langendorff experiments following reperfusion of saline (negative control, sham), native <b>2</b> (positive control) and analogues <b>11</b>, <b>17</b>–<b>19</b> after a 30 min period of ischemia, assessing heart rate (HR, A), maximum derivative of change in systolic pressure over time (max d<i>P</i>/d<i>t</i>, B), left ventricle developed pressure (LVDP, C), minimum derivative of change in diastolic pressure over time (min d<i>P</i>/d<i>t</i>, D), and rate–pressure product (RPP, E).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00723/20170721/images/large/jm-2017-00723f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00723&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Tatemoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukusumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, M.</span><span> </span><span class="NLM_article-title">Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span><span class="refDoi"> DOI: 10.1006/bbrc.1998.9489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1006%2Fbbrc.1998.9489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=9792798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADyaK1cXmvF2msbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1998&pages=471-476&author=K.+Tatemotoauthor=M.+Hosoyaauthor=Y.+Habataauthor=R.+Fujiiauthor=T.+Kakegawaauthor=M.-X.+Zouauthor=Y.+Kawamataauthor=S.+Fukusumiauthor=S.+Hinumaauthor=C.+Kitadaauthor=T.+Kurokawaauthor=H.+Ondaauthor=M.+Fujino&title=Isolation+and+characterization+of+a+novel+endogenous+peptide+ligand+for+the+human+APJ+receptor&doi=10.1006%2Fbbrc.1998.9489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor</span></div><div class="casAuthors">Tatemoto, Kazuhiko; Hosoya, Masaki; Habata, Yugo; Fujii, Ryo; Kakegawa, Tadao; Zou, Min-Xu; Kawamata, Yuji; Fukusumi, Shoji; Hinuma, Shuji; Kitada, Chieko; Kurokawa, Tsutomu; Onda, Haruo; Fujino, Masahiko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">In the search for an endogenous ligand of the orphan G protein-coupled receptor APJ, the presence of the ligand in various tissue exts. was examd. by measuring the increase in extracellular acidification rate of the cells expressing the APJ receptor as a specific signal induced by the interaction of the receptor and ligand.  By monitoring this activity, the authors isolated an APJ receptor ligand, designated apelin, from bovine stomach exts.  The structures of bovine and human apelin preproproteins were deduced from the sequences of the corresponding cDNAs.  The preproproteins consisted of 77 amino acid residues, and the apelin sequence was encoded in the C-terminal regions.  Synthetic peptides derived from the C-terminal amino acid sequence of bovine preproapelin were capable of specifically promoting the acidification rate in the cells expressing the APJ receptor in a range from 10-7 to 10-10 M, indicating that apelin is an endogenous ligand for the APJ receptor.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfZFYcVKcQs7Vg90H21EOLACvtfcHk0ljnDAmXpPU-DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvF2msbY%253D&md5=54a069e5884731979abfdc1738ba6d44</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.9489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.9489%26sid%3Dliteratum%253Aachs%26aulast%3DTatemoto%26aufirst%3DK.%26aulast%3DHosoya%26aufirst%3DM.%26aulast%3DHabata%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DR.%26aulast%3DKakegawa%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DM.-X.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DFukusumi%26aufirst%3DS.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DKitada%26aufirst%3DC.%26aulast%3DKurokawa%26aufirst%3DT.%26aulast%3DOnda%26aufirst%3DH.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520a%2520novel%2520endogenous%2520peptide%2520ligand%2520for%2520the%2520human%2520APJ%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1998%26volume%3D251%26spage%3D471%26epage%3D476%26doi%3D10.1006%2Fbbrc.1998.9489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Maguire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitkin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, A. P.</span><span> </span><span class="NLM_article-title">[Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span><span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.109.134619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FHYPERTENSIONAHA.109.134619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=19597036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsleksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=598-604&author=J.+J.+Maguireauthor=M.+J.+Kleinzauthor=S.+L.+Pitkinauthor=A.+P.+Davenport&title=%5BPyr1%5Dapelin-13+identified+as+the+predominant+apelin+isoform+in+the+human+heart%3A+vasoactive+mechanisms+and+inotropic+action+in+disease&doi=10.1161%2FHYPERTENSIONAHA.109.134619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">[Pyr1]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart</span></div><div class="casAuthors">Maguire, Janet J.; Kleinz, Matthias J.; Pitkin, Sarah L.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">598-604</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Apelin receptors, present on vascular smooth muscle cells, endothelium, and cardiomyocytes, are activated by the family of apelin peptides to elicit cardiovascular effects in exptl. animals, but functional activity in humans has not been studied in detail.  The authors detected low levels of apelin immunoreactivity in plasma of volunteers consistent with an autocrine/paracrine action and detected apelin immunoreactivity in the supernatant from human cultured endothelial cells.  The authors found that [Pyr1]apelin-13 was the predominant isoform in cardiac tissue from patients with coronary artery disease.  The authors tested the hypothesis that apelins have vascular and cardiac actions in human tissues in vitro and compared responses to [Pyr1]apelin-13, apelin-13, and apelin-36.  In endothelium-intact mammary artery, all 3 of the apelins induced concn.-dependent vasodilatation with comparable potency (EC50: 0.6 to 1.6 nM; max. response: 40% to 50%).  Vasodilatation was abolished after endothelial removal or preincubation with indomethacin but was unaffected by preincubation with NG-nitro-l-arginine Me ester, indicating involvement of prostanoids but not NO in dilatation by apelins in this patient group.  Apelins were potent constrictors of endothelium-denuded saphenous vein (EC50: 0.6 to 1.6 nM; max. response: 17% to 26%) and mammary artery ([Pyr1]apelin-13; EC50: 0.2 nM; max. response: 29%).  In paced atrial strips, all 3 of the peptides increased the force of contraction with subnanomolar potencies (EC50: 40 to 125 pM).  For the first time, the authors demonstrate that the 3 principal forms of apelin have comparable potency and efficacy in human cardiovascular tissues.  Apelins are potent endothelium-dependent vasodilators acting via a prostanoid-dependent mechanism; however, removal of the endothelium revealed direct vasoconstrictor actions in both the artery and vein.  Furthermore, in human cardiac tissue, the apelin peptides are among the most potent endogenous pos. inotropic agents yet reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0rlY7c6SsibVg90H21EOLACvtfcHk0ljnDAmXpPU-DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsleksL4%253D&md5=bf568a68931b0815502522cc785df8ca</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.109.134619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.109.134619%26sid%3Dliteratum%253Aachs%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DKleinz%26aufirst%3DM.%2BJ.%26aulast%3DPitkin%26aufirst%3DS.%2BL.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3D%255BPyr1%255Dapelin-13%2520identified%2520as%2520the%2520predominant%2520apelin%2520isoform%2520in%2520the%2520human%2520heart%253A%2520vasoactive%2520mechanisms%2520and%2520inotropic%2520action%2520in%2520disease%26jtitle%3DHypertension%26date%3D2009%26volume%3D54%26spage%3D598%26epage%3D604%26doi%3D10.1161%2FHYPERTENSIONAHA.109.134619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Pitkin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, A. P.</span><span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span><span class="refDoi"> DOI: 10.1124/pr.110.002949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1124%2Fpr.110.002949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=20605969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=331-342&author=S.+L.+Pitkinauthor=J.+J.+Maguireauthor=T.+I.+Bonnerauthor=A.+P.+Davenport&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXIV.+Apelin+receptor+nomenclature%2C+distribution%2C+pharmacology%2C+and+function&doi=10.1124%2Fpr.110.002949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function</span></div><div class="casAuthors">Pitkin, Sarah L.; Maguire, Janet J.; Bonner, Tom I.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-342</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  A gene encoding a novel class a G-protein-coupled receptor was discovered in 1993 by homol. cloning and was called APJ.  It was designated an "orphan" receptor until 1998, when its endogenous ligand was identified and named apelin (for APJ endogenous ligand).  Since this pairing, both apelin and its receptor have been found to have a widespread distribution in both the central nervous system and the periphery.  A no. of physiol. and pathophysiol. roles for the receptor have emerged, including regulation of cardiovascular function, fluid homeostasis, and the adipoinsular axis.  This review outlines the official International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification nomenclature, designating the receptor protein as the apelin receptor, together with current knowledge of its pharmacol., distribution, and functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFGewTc6bK7Vg90H21EOLACvtfcHk0li6he9AYN1ROw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbO&md5=d2a5fb55e8436a098491c1eb002fd971</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002949%26sid%3Dliteratum%253Aachs%26aulast%3DPitkin%26aufirst%3DS.%2BL.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXIV.%2520Apelin%2520receptor%2520nomenclature%252C%2520distribution%252C%2520pharmacology%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D331%26epage%3D342%26doi%3D10.1124%2Fpr.110.002949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S. P.</span><span> </span><span class="NLM_article-title">Regulation of the apelinergic system and its potential in cardiovascular disease: Peptides and small molecules as tools for discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7913</span><span class="NLM_x">–</span> <span class="NLM_lpage">7927</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00527</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00527" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7913-7927&author=S.+Narayananauthor=D.+L.+Harrisauthor=R.+Maitraauthor=S.+P.+Runyon&title=Regulation+of+the+apelinergic+system+and+its+potential+in+cardiovascular+disease%3A+Peptides+and+small+molecules+as+tools+for+discovery&doi=10.1021%2Facs.jmedchem.5b00527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery</span></div><div class="casAuthors">Narayanan, Sanju; Harris, Danni L.; Maitra, Rangan; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7913-7927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apelin peptides and the apelin receptor represent a relatively new therapeutic axis for the potential treatment of cardiovascular disease.  Several reports suggest apelin receptor activation with apelin peptides results in cardioprotection as noted through pos. ionotropy, angiogenesis, redn. of mean arterial blood pressure, and apoptosis.  Considering the potential therapeutic benefit attainable through modulation of the apelinergic system, research is expanding to develop novel therapies that limit the inherent rapid degrdn. of endogenous apelin peptides and produce metabolically stable small mol. agonists and antagonists to more rigorously interrogate the apelin receptor system.  This review details the structure-activity relationships for chem. modified apelin peptides and recent disclosures of small mol. agonists and antagonists and summarizes the peer reviewed and patented literature.  Development of metabolically stable ligands of apelin receptor and their effects in various models over the coming years will hopefully lead to establishment of this receptor as a validated target for cardiovascular indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTIngNdWxX87Vg90H21EOLACvtfcHk0li6he9AYN1ROw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7rN&md5=6c116a42d7b523905e811c33c46e256f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00527%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DD.%2BL.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DRegulation%2520of%2520the%2520apelinergic%2520system%2520and%2520its%2520potential%2520in%2520cardiovascular%2520disease%253A%2520Peptides%2520and%2520small%2520molecules%2520as%2520tools%2520for%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7913%26epage%3D7927%26doi%3D10.1021%2Facs.jmedchem.5b00527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Zhong, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnie, S. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vederas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudit, G. Y.</span><span> </span><span class="NLM_article-title">Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">1863</span><span class="NLM_x">, </span> <span class="NLM_fpage">1942</span><span class="NLM_x">–</span> <span class="NLM_lpage">1950</span><span class="refDoi"> DOI: 10.1016/j.bbadis.2016.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.bbadis.2016.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=27825851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVahtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2017&pages=1942-1950&author=J.-C.+Zhongauthor=Z.-Z.+Zhangauthor=W.+Wangauthor=S.+M.+K.+McKinnieauthor=J.+C.+Vederasauthor=G.+Y.+Oudit&title=Targeting+the+apelin+pathway+as+a+novel+therapeutic+approach+for+cardiovascular+diseases&doi=10.1016%2Fj.bbadis.2016.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases</span></div><div class="casAuthors">Zhong, Jiu-Chang; Zhang, Zhen-Zhou; Wang, Wang; McKinnie, Shaun M. K.; Vederas, John C.; Oudit, Gavin Y.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1942-1950</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The apelin/apelin receptor system is widely distributed and has a dominant role in cardiovascular homeostasis and disease.  The apelin gene is X-linked and is synthesized as a 77 amino acid pre-pro-peptide that is subsequently cleaved to generate a family of apelin peptides that possess similar functions but display different tissue distribution, potency and receptor binding affinity.  Loss-of-function expts. using the apelin and the apelin receptor knockout mice and gain-of-function expts. using apelin peptides have delineated a well-defined role of the apelin axis in cardiovascular physiol. and diseases.  Activation of the apelin receptor by its cognate peptide ligand, apelin, induces a wide range of physiol. effects, including vasodilation, increased myocardial contractility, angiogenesis, and balanced energy metab. and fluid homeostasis.  The apelin/apelin receptor pathway is also implicated in atherosclerosis, hypertension, coronary artery disease, heart failure, diabetes and obesity, making it a promising therapeutic target.  Hence, research is expanding to develop novel therapies that inhibit degrdn. of endogenous apelin peptides or their analogs.  Chem. synthesis of stable apelin receptor agonists aims to more efficiently enhance the activation of the apelin system.  Targeting the apelin/apelin receptor axis has emerged as a novel therapeutic approach against cardiovascular diseases and an increased understanding of cardiovascular actions of the apelin system will help to develop effective interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqosnvaOVUBwrVg90H21EOLACvtfcHk0ljHR26JFZmpFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVahtLvK&md5=915d2b52697db35097bc1794506ff779</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2016.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2016.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DJ.-C.%26aulast%3DZhang%26aufirst%3DZ.-Z.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMcKinnie%26aufirst%3DS.%2BM.%2BK.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26aulast%3DOudit%26aufirst%3DG.%2BY.%26atitle%3DTargeting%2520the%2520apelin%2520pathway%2520as%2520a%2520novel%2520therapeutic%2520approach%2520for%2520cardiovascular%2520diseases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2017%26volume%3D1863%26spage%3D1942%26epage%3D1950%26doi%3D10.1016%2Fj.bbadis.2016.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, A. P.</span><span> </span><span class="NLM_article-title">Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1016/j.tips.2015.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.tips.2015.06.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=560-567&author=P.+Yangauthor=J.+J.+Maguireauthor=A.+P.+Davenport&title=Apelin%2C+Elabela%2FToddler%2C+and+biased+agonists+as+novel+therapeutic+agents+in+the+cardiovascular+system&doi=10.1016%2Fj.tips.2015.06.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DApelin%252C%2520Elabela%252FToddler%252C%2520and%2520biased%2520agonists%2520as%2520novel%2520therapeutic%2520agents%2520in%2520the%2520cardiovascular%2520system%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D560%26epage%3D567%26doi%3D10.1016%2Fj.tips.2015.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">O’Dowd, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, H. H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petronis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span> </span><span class="NLM_article-title">A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/0378-1119(93)90495-O</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2F0378-1119%2893%2990495-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=8294032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFGnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1993&pages=355-360&author=B.+F.+O%E2%80%99Dowdauthor=M.+Heiberauthor=A.+Chanauthor=H.+H.+Q.+Hengauthor=L.-C.+Tsuiauthor=J.+L.+Kennedyauthor=X.+Shiauthor=A.+Petronisauthor=S.+R.+Georgeauthor=T.+Nguyen&title=A+human+gene+that+shows+identity+with+the+gene+encoding+the+angiotensin+receptor+is+located+on+chromosome+11&doi=10.1016%2F0378-1119%2893%2990495-O"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11</span></div><div class="casAuthors">O'Dowd, Brian F.; Heiber, Michael; Chan, Audrey; Heng, Henry H. Q.; Tsui, Lap Chee; Kennedy, James L.; Shi, Xiaomei; Petronis, Arturas; George, Susan R.; Nguyen Tuan</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">355-60</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    </div><div class="casAbstract">The authors report the cloning of a gene, intron-less in its coding region, which the authors have named APJ.  This gene was cloned using the polymerase chain reaction (PCR), with a set of primers designed on the basis of the conservation that members of G protein-coupled receptors (GPCR) have in their transmembrane (TM) regions.  The putative receptor protein, APJ, shares closest identity to the angiotensin receptor (AT1) ranging from 40 to 50% in the hydrophobic TM regions of these receptors.  The transcripts for this gene were detected in many regions of the brain.  PCR anal. of somatic cell lines found APJ-related sequences to be only present on chromosome 11, and high-resoln. mapping by fluorescence in situ hybridization (FISH) sub-localized APJ on band q12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqp2kdIKETdbVg90H21EOLACvtfcHk0ljHR26JFZmpFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFGnsL0%253D&md5=4beb37696cbf0f919df6c1d22088e719</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2F0378-1119%2893%2990495-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-1119%252893%252990495-O%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DB.%2BF.%26aulast%3DHeiber%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DHeng%26aufirst%3DH.%2BH.%2BQ.%26aulast%3DTsui%26aufirst%3DL.-C.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DPetronis%26aufirst%3DA.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DNguyen%26aufirst%3DT.%26atitle%3DA%2520human%2520gene%2520that%2520shows%2520identity%2520with%2520the%2520gene%2520encoding%2520the%2520angiotensin%2520receptor%2520is%2520located%2520on%2520chromosome%252011%26jtitle%3DGene%26date%3D1993%26volume%3D136%26spage%3D355%26epage%3D360%26doi%3D10.1016%2F0378-1119%2893%2990495-O" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Reaux-Le Goazigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skultetyova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenkei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Messari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallatz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvol, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkovits, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2001.00320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1046%2Fj.1471-4159.2001.00320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=11359874" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2001&pages=1085-1096&author=A.+Reaux-Le+Goazigoauthor=N.+De+Motaauthor=I.+Skultetyovaauthor=Z.+Lenkeiauthor=S.+El+Messariauthor=K.+Gallatzauthor=P.+Corvolauthor=M.+Palkovitsauthor=C.+Llorens-Cortes&title=Physiological+role+of+a+novel+neuropeptide%2C+apelin%2C+and+its+receptor+in+the+rat+brain&doi=10.1046%2Fj.1471-4159.2001.00320.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00320.x%26sid%3Dliteratum%253Aachs%26aulast%3DReaux-Le%2BGoazigo%26aufirst%3DA.%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DSkultetyova%26aufirst%3DI.%26aulast%3DLenkei%26aufirst%3DZ.%26aulast%3DEl%2BMessari%26aufirst%3DS.%26aulast%3DGallatz%26aufirst%3DK.%26aulast%3DCorvol%26aufirst%3DP.%26aulast%3DPalkovits%26aufirst%3DM.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DPhysiological%2520role%2520of%2520a%2520novel%2520neuropeptide%252C%2520apelin%252C%2520and%2520its%2520receptor%2520in%2520the%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D77%26spage%3D1085%26epage%3D1096%26doi%3D10.1046%2Fj.1471-4159.2001.00320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">De Mota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaux-Le Goazigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Messari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chartrel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dujardin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaudry, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">10464</span><span class="NLM_x">–</span> <span class="NLM_lpage">10469</span><span class="refDoi"> DOI: 10.1073/pnas.0403518101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1073%2Fpnas.0403518101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15231996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVyrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=10464-10469&author=N.+De+Motaauthor=A.+Reaux-Le+Goazigoauthor=S.+El+Messariauthor=N.+Chartrelauthor=D.+Roeschauthor=C.+Dujardinauthor=C.+Kordonauthor=H.+Vaudryauthor=F.+Moosauthor=C.+Llorens-Cortes&title=Apelin%2C+a+potent+diuretic+neuropeptide+counteracting+vasopressin+actions+through+inhibition+of+vasopressin+neuron+activity+and+vasopressin+release&doi=10.1073%2Fpnas.0403518101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release</span></div><div class="casAuthors">De Mota, Nadia; Reaux-Le Goazigo, Annabelle; El Messari, Said; Chartrel, Nicolas; Roesch, Darren; Dujardin, Cynthia; Kordon, Claude; Vaudry, Hubert; Moos, Francoise; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10464-10469</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apelin, a recently isolated neuropeptide that is expressed in the supraoptic and the paraventricular nuclei, acts on specific receptors located on vasopressinergic neurons.  The increased phasic pattern of these neurons facilitates sustained antidiuresis during dehydration or lactation.  Here, we investigated whether apelin interacts with arginine vasopressin (AVP) to maintain body fluid homeostasis.  We first characterized the predominant mol. forms of endogenous hypothalamic and plasma apelin as corresponding to apelin 13 and, to a lesser extent, to apelin 17.  We then demonstrated that, in lactating rats, apelin was colocalized with AVP in supraoptic nucleus magnocellular neurons and given intracerebroventricularly inhibited the phasic elec. activity of AVP neurons.  In lactating mice, intracerebroventricular administration of apelin 17 reduced plasma AVP levels and increased diuresis.  Moreover, water deprivation, which increases systemic AVP release and causes depletion of hypothalamic AVP stores, decreased plasma apelin concns. and induced hypothalamic accumulation of the peptide, indicating that AVP and apelin are conversely regulated to facilitate systemic AVP release and suppress diuresis.  Opposite effects of AVP and apelin are likely to occur at the hypothalamic level through autocrine modulation of the phasic elec. activity of AVP neurons.  Altogether, these data demonstrate that apelin acts as a potent diuretic neuropeptide counteracting AVP actions through inhibition of AVP neuron activity and AVP release.  The coexistence of apelin and AVP in magnocellular neurons, their opposite biol. effects, and regulation are likely to play a key role for maintaining body fluid homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXfnm1Ia_ee7Vg90H21EOLACvtfcHk0ljRx0DT9LI-AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVyrsLg%253D&md5=3890a3d0ab4318b3e57d1c528b17599c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0403518101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0403518101%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DReaux-Le%2BGoazigo%26aufirst%3DA.%26aulast%3DEl%2BMessari%26aufirst%3DS.%26aulast%3DChartrel%26aufirst%3DN.%26aulast%3DRoesch%26aufirst%3DD.%26aulast%3DDujardin%26aufirst%3DC.%26aulast%3DKordon%26aufirst%3DC.%26aulast%3DVaudry%26aufirst%3DH.%26aulast%3DMoos%26aufirst%3DF.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DApelin%252C%2520a%2520potent%2520diuretic%2520neuropeptide%2520counteracting%2520vasopressin%2520actions%2520through%2520inhibition%2520of%2520vasopressin%2520neuron%2520activity%2520and%2520vasopressin%2520release%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D10464%26epage%3D10469%26doi%3D10.1073%2Fpnas.0403518101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Boucher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daviaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guigne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzucotelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castan-Laurell, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tack, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knibiehler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpene, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audigier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valet, P.</span><span> </span><span class="NLM_article-title">Apelin, a newly identified adipokine up-regulated by insulin and obesity</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">1764</span><span class="NLM_x">–</span> <span class="NLM_lpage">1771</span><span class="refDoi"> DOI: 10.1210/en.2004-1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1210%2Fen.2004-1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15677759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1yqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=1764-1771&author=J.+Boucherauthor=B.+Masriauthor=D.+Daviaudauthor=S.+Gestaauthor=C.+Guigneauthor=A.+Mazzucotelliauthor=I.+Castan-Laurellauthor=I.+Tackauthor=B.+Knibiehlerauthor=C.+Carpeneauthor=Y.+Audigierauthor=J.+S.+Saulnier-Blacheauthor=P.+Valet&title=Apelin%2C+a+newly+identified+adipokine+up-regulated+by+insulin+and+obesity&doi=10.1210%2Fen.2004-1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, a newly identified adipokine up-regulated by insulin and obesity</span></div><div class="casAuthors">Boucher, Jeremie; Masri, Bernard; Daviaud, Daniele; Gesta, Stephane; Guigne, Charlotte; Mazzucotelli, Anne; Castan-Laurell, Isabelle; Tack, Ivan; Knibiehler, Bernard; Carpene, Christian; Audigier, Yves; Saulnier-Blache, Jean-Sebastien; Valet, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1764-1771</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The results presented herein demonstrate that apelin is expressed and secreted by both human and mouse adipocytes.  Apelin mRNA levels in isolated adipocytes are close to other cell types present in white adipose tissue or other organs known to express apelin such as kidney, heart, and to a lesser extent brown adipose tissue.  Apelin expression is increased during adipocyte differentiation stage.  A comparison of four different models of obesity in mice showed a large increase in both apelin expression in fat cells and apelin plasma levels in all the hyperinsulinemia-assocd. obesities and clearly demonstrated that obesity or high-fat feeding are not the main determinants of the rise of apelin expression.  The lack of insulin in streptozotocin-treated mice is assocd. with a decreased expression of apelin in adipocytes.  Furthermore, apelin expression in fat cells is strongly inhibited by fasting and recovered after refeeding, in a similar way to insulin.  A direct regulation of apelin expression by insulin is obsd. in both human and mouse adipocytes and clearly assocd. with the stimulation of phosphatidylinositol 3-kinase, protein kinase C, and MAPK.  These data provide evidence that insulin exerts a direct control on apelin gene expression in adipocytes.  In obese patients, both plasma apelin and insulin levels were significantly higher, suggesting that the regulation of apelin by insulin could influence blood concns. of apelin.  The present work identifies apelin as a novel adipocyte endocrine secretion and focuses on its potential link with obesity-assocd. variations of insulin sensitivity status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJGvlrRJpOQrVg90H21EOLACvtfcHk0ljRx0DT9LI-AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1yqtLo%253D&md5=5cc5ffb5bae182603c1d567f44b287fd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1210%2Fen.2004-1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2004-1427%26sid%3Dliteratum%253Aachs%26aulast%3DBoucher%26aufirst%3DJ.%26aulast%3DMasri%26aufirst%3DB.%26aulast%3DDaviaud%26aufirst%3DD.%26aulast%3DGesta%26aufirst%3DS.%26aulast%3DGuigne%26aufirst%3DC.%26aulast%3DMazzucotelli%26aufirst%3DA.%26aulast%3DCastan-Laurell%26aufirst%3DI.%26aulast%3DTack%26aufirst%3DI.%26aulast%3DKnibiehler%26aufirst%3DB.%26aulast%3DCarpene%26aufirst%3DC.%26aulast%3DAudigier%26aufirst%3DY.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DValet%26aufirst%3DP.%26atitle%3DApelin%252C%2520a%2520newly%2520identified%2520adipokine%2520up-regulated%2520by%2520insulin%2520and%2520obesity%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26spage%3D1764%26epage%3D1771%26doi%3D10.1210%2Fen.2004-1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Heinonen, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purhonen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miettinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhava, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, K. H.</span><span> </span><span class="NLM_article-title">Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding</span> <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1016/j.regpep.2005.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.regpep.2005.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15970339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1Srs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2005&pages=7-13&author=M.+V.+Heinonenauthor=A.+K.+Purhonenauthor=P.+Miettinenauthor=M.+Paakkonenauthor=E.+Pirinenauthor=E.+Alhavaauthor=K.+Akermanauthor=K.+H.+Herzig&title=Apelin%2C+orexin-A+and+leptin+plasma+levels+in+morbid+obesity+and+effect+of+gastric+banding&doi=10.1016%2Fj.regpep.2005.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding</span></div><div class="casAuthors">Heinonen, M. V.; Purhonen, A. K.; Miettinen, P.; Paeaekkoenen, M.; Pirinen, E.; Alhava, E.; Aakerman, K.; Herzig, K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">7-13</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maintenance of human energy homeostasis is regulated by a complex network.  Peptides secreted from the gastrointestinal tract (GI) are signaling to the brain and other organs initiating or terminating food intake and energy expenditure.  In the present study we investigated basal plasma levels of apelin, orexin-A, and leptin in morbid obese patients.  In addn., we measured in a subgroup of these patients in the same individual orexin-A and leptin plasma levels one year after gastric banding surgery.  Methods: Basal plasma values were detd. in obese patients (BMI = 48±1 kg/m2 n = 32) after an overnight fast and compared to healthy, normal weighted (BMI = 22±2 kg/m2 n = 12) controls.  In addn., blood samples were collected in a subgroup of patients (BMI = 48±1 kg/m2 n = 8) the day before surgery and 1 yr after the operation.  Apelin, orexin-A, and leptin levels were analyzed using ELISAs.  Results: One year after the operation obese patients significantly lost wt. (from 48±2 kg/m2 to 39±2 kg/m2; p < 0,001).  Apelin, orexin-A and leptin levels in obese patients were significantly higher compared to control individuals (736±50 pg/mL vs. 174±14 pg/mL, p < 0.0001; 75.3±24.1 pg/mL vs. 0.8±0.4 pg/mL, p < 0.0001; 79.0±2.4 ng/mL vs. 5.8±0.8 ng/mL, p < 0.0001, resp.).  Apelin and leptin plasma concns. also correlated significantly with BMI (r = 0.769, p < 0.0001; r = 0.778; p < 0.0001, resp.), while orexin-A correlation was rather weak (r = 0.335, p < 0.03).  No difference between pre- and post-operative orexin-A levels was obsd., while leptin plasma levels significantly decreased from 45.1±5.4 ng/mL to 27.3±6.0 ng/mL (p = 0.015).  Conclusions: Apelin, orexin-A, and leptin plasma levels correlated pos. with the BMI.  One year after gastric banding with significant loss in BMI basal plasma levels of leptin decreased, while orexin-A remained unchanged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzXQz_ivPw27Vg90H21EOLACvtfcHk0likqSWQyM0tEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1Srs7k%253D&md5=666856f02b2187fc35d30cd9c13de12c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.regpep.2005.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.regpep.2005.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DHeinonen%26aufirst%3DM.%2BV.%26aulast%3DPurhonen%26aufirst%3DA.%2BK.%26aulast%3DMiettinen%26aufirst%3DP.%26aulast%3DPaakkonen%26aufirst%3DM.%26aulast%3DPirinen%26aufirst%3DE.%26aulast%3DAlhava%26aufirst%3DE.%26aulast%3DAkerman%26aufirst%3DK.%26aulast%3DHerzig%26aufirst%3DK.%2BH.%26atitle%3DApelin%252C%2520orexin-A%2520and%2520leptin%2520plasma%2520levels%2520in%2520morbid%2520obesity%2520and%2520effect%2520of%2520gastric%2520banding%26jtitle%3DRegul.%2520Pept.%26date%3D2005%26volume%3D130%26spage%3D7%26epage%3D13%26doi%3D10.1016%2Fj.regpep.2005.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aillaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaven, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quertermous, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, P. S.</span><span> </span><span class="NLM_article-title">Apelin is necessary for the maintenance of insulin sensitivity</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">E59</span><span class="NLM_x">–</span> <span class="NLM_lpage">E67</span><span class="refDoi"> DOI: 10.1152/ajpendo.00385.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1152%2Fajpendo.00385.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=19861585" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2010&pages=E59-E67&author=P.+Yueauthor=H.+Jinauthor=M.+Aillaudauthor=A.+C.+Dengauthor=J.+Azumaauthor=T.+Asagamiauthor=R.+K.+Kunduauthor=G.+M.+Reavenauthor=T.+Quertermousauthor=P.+S.+Tsao&title=Apelin+is+necessary+for+the+maintenance+of+insulin+sensitivity&doi=10.1152%2Fajpendo.00385.2009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00385.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00385.2009%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DAillaud%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DA.%2BC.%26aulast%3DAzuma%26aufirst%3DJ.%26aulast%3DAsagami%26aufirst%3DT.%26aulast%3DKundu%26aufirst%3DR.%2BK.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26aulast%3DQuertermous%26aufirst%3DT.%26aulast%3DTsao%26aufirst%3DP.%2BS.%26atitle%3DApelin%2520is%2520necessary%2520for%2520the%2520maintenance%2520of%2520insulin%2520sensitivity%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D298%26spage%3DE59%26epage%3DE67%26doi%3D10.1152%2Fajpendo.00385.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span> </span><span class="NLM_article-title">Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1634</span><span class="NLM_x">–</span> <span class="NLM_lpage">1639</span><span class="refDoi"> DOI: 10.1016/j.peptides.2011.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.peptides.2011.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1634-1639&author=H.+Chenauthor=C.+Zhengauthor=X.+Zhangauthor=J.+Liauthor=J.+Liauthor=L.+Zhengauthor=K.+Huang&title=Apelin+alleviates+diabetes-associated+endoplasmic+reticulum+stress+in+the+pancreas+of+Akita+mice&doi=10.1016%2Fj.peptides.2011.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2011.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2011.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DK.%26atitle%3DApelin%2520alleviates%2520diabetes-associated%2520endoplasmic%2520reticulum%2520stress%2520in%2520the%2520pancreas%2520of%2520Akita%2520mice%26jtitle%3DPeptides%26date%3D2011%26volume%3D32%26spage%3D1634%26epage%3D1639%26doi%3D10.1016%2Fj.peptides.2011.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Attané, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foussal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gonidec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daviaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanecq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzmán-Ruiz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezaire, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancoule, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Gayo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burcelin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pénicaud, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castan-Laurell, I.</span><span> </span><span class="NLM_article-title">Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span><span class="refDoi"> DOI: 10.2337/db11-0100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.2337%2Fdb11-0100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=310-320&author=C.+Attan%C3%A9author=C.+Foussalauthor=S.+Le+Gonidecauthor=A.+Benaniauthor=D.+Daviaudauthor=E.+Wanecqauthor=R.+Guzm%C3%A1n-Ruizauthor=C.+Drayauthor=V.+Bezaireauthor=C.+Rancouleauthor=K.+Kubaauthor=M.+Ruiz-Gayoauthor=T.+Levadeauthor=J.+M.+Penningerauthor=R.+Burcelinauthor=L.+P%C3%A9nicaudauthor=P.+Valetauthor=I.+Castan-Laurell&title=Apelin+treatment+increases+complete+fatty+acid+oxidation%2C+mitochondrial+oxidative+capacity%2C+and+biogenesis+in+muscle+of+insulin-resistant+mice&doi=10.2337%2Fdb11-0100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2337%2Fdb11-0100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb11-0100%26sid%3Dliteratum%253Aachs%26aulast%3DAttan%25C3%25A9%26aufirst%3DC.%26aulast%3DFoussal%26aufirst%3DC.%26aulast%3DLe%2BGonidec%26aufirst%3DS.%26aulast%3DBenani%26aufirst%3DA.%26aulast%3DDaviaud%26aufirst%3DD.%26aulast%3DWanecq%26aufirst%3DE.%26aulast%3DGuzm%25C3%25A1n-Ruiz%26aufirst%3DR.%26aulast%3DDray%26aufirst%3DC.%26aulast%3DBezaire%26aufirst%3DV.%26aulast%3DRancoule%26aufirst%3DC.%26aulast%3DKuba%26aufirst%3DK.%26aulast%3DRuiz-Gayo%26aufirst%3DM.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DBurcelin%26aufirst%3DR.%26aulast%3DP%25C3%25A9nicaud%26aufirst%3DL.%26aulast%3DValet%26aufirst%3DP.%26aulast%3DCastan-Laurell%26aufirst%3DI.%26atitle%3DApelin%2520treatment%2520increases%2520complete%2520fatty%2520acid%2520oxidation%252C%2520mitochondrial%2520oxidative%2520capacity%252C%2520and%2520biogenesis%2520in%2520muscle%2520of%2520insulin-resistant%2520mice%26jtitle%3DDiabetes%26date%3D2012%26volume%3D61%26spage%3D310%26epage%3D320%26doi%3D10.2337%2Fdb11-0100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Choe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cayabyab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorf, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J.</span><span> </span><span class="NLM_article-title">The orphan seven-transmembrane receptor Apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">6113</span><span class="NLM_x">–</span> <span class="NLM_lpage">6118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=9621075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFGltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1998&pages=6113-6118&author=H.+Choeauthor=M.+Farzanauthor=M.+Konkelauthor=K.+Martinauthor=Y.+Sunauthor=L.+Marconauthor=M.+Cayabyabauthor=M.+Bermanauthor=M.+E.+Dorfauthor=N.+Gerardauthor=C.+Gerardauthor=J.+Sodroski&title=The+orphan+seven-transmembrane+receptor+Apj+supports+the+entry+of+primary+T-cell-line-tropic+and+dualtropic+human+immunodeficiency+virus+type+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan seven-transmembrane receptor Apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1</span></div><div class="casAuthors">Choe, Hyeryun; Farzan, Michael; Konkel, Miriam; Martin, Kathleen; Sun, Ying; Marcon, Luisa; Cayabyab, Mark; Berman, Michael; Dorf, Martin E.; Gerard, Norma; Gerard, Craig; Sodroski, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">6113-6118</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 (HIV-1) enters target cells by sequential binding to CD4 and specific seven-transmembrane-segment (7TMS) coreceptors.  Viruses use the chemokine receptor CCR5 as a coreceptor in the early, asymptomatic stages of HIV-1 infection but can adapt to the use of other receptors such as CXCR4 and CCR3 as the infection proceeds.  Here the authors identify one such coreceptor, Apj, which supported the efficient entry of several primary T-cell-line tropic (T-tropic) and dual-tropic HIV-1 isolates and the simian immunodeficiency virus SIVmac316.  Another 7TMS protein, CCR9, supported the less efficient entry of one primary T-tropic isolate.  MRNAs for both receptors were present in phytohemagglutinin- and interleukin-2-activated peripheral blood mononuclear cells.  Apj and CCR9 share with other coreceptors for HIV-1 and SIV an N-terminal region rich in arom. and acidic residues.  These results highlight properties common to 7TMS proteins that can function as HIV-1 coreceptors, and they may contribute to an understanding of viral evolution in infected individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbgaNfbFnzebVg90H21EOLACvtfcHk0lgo0dTcz7eKwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFGltb4%253D&md5=8f1bfc80c58dfc8e5382d09aaf72e3fd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DKonkel%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMarcon%26aufirst%3DL.%26aulast%3DCayabyab%26aufirst%3DM.%26aulast%3DBerman%26aufirst%3DM.%26aulast%3DDorf%26aufirst%3DM.%2BE.%26aulast%3DGerard%26aufirst%3DN.%26aulast%3DGerard%26aufirst%3DC.%26aulast%3DSodroski%26aufirst%3DJ.%26atitle%3DThe%2520orphan%2520seven-transmembrane%2520receptor%2520Apj%2520supports%2520the%2520entry%2520of%2520primary%2520T-cell-line-tropic%2520and%2520dualtropic%2520human%2520immunodeficiency%2520virus%2520type%25201%26jtitle%3DJ.%2520Virol.%26date%3D1998%26volume%3D72%26spage%3D6113%26epage%3D6118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Fan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhtar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, R. J.</span><span> </span><span class="NLM_article-title">Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">10163</span><span class="NLM_x">–</span> <span class="NLM_lpage">10168</span><span class="refDoi"> DOI: 10.1021/bi030049s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi030049s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=10163-10168&author=X.+Fanauthor=N.+Zhouauthor=X.+Zhangauthor=M.+Mukhtarauthor=Z.+Luauthor=J.+Fangauthor=G.+C.+DuBoisauthor=R.+J.+Pomerantz&title=Structural+and+functional+study+of+the+apelin-13+peptide%2C+an+endogenous+ligand+of+the+HIV-1+coreceptor%2C+APJ&doi=10.1021%2Fbi030049s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi030049s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030049s%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMukhtar%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DDuBois%26aufirst%3DG.%2BC.%26aulast%3DPomerantz%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520and%2520functional%2520study%2520of%2520the%2520apelin-13%2520peptide%252C%2520an%2520endogenous%2520ligand%2520of%2520the%2520HIV-1%2520coreceptor%252C%2520APJ%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D10163%26epage%3D10168%26doi%3D10.1021%2Fbi030049s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lee, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariyawasam, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osmond, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dowd, B. F.</span><span> </span><span class="NLM_article-title">Characterization of apelin, the ligand for the APJ receptor</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0740034.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1046%2Fj.1471-4159.2000.0740034.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10617103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Oi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=34-41&author=D.+K.+Leeauthor=R.+Chengauthor=T.+Nguyenauthor=T.+Fanauthor=A.+P.+Kariyawasamauthor=Y.+Liuauthor=D.+H.+Osmondauthor=S.+R.+Georgeauthor=B.+F.+O%E2%80%99Dowd&title=Characterization+of+apelin%2C+the+ligand+for+the+APJ+receptor&doi=10.1046%2Fj.1471-4159.2000.0740034.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of apelin, the ligand for the APJ receptor</span></div><div class="casAuthors">Lee, Dennis K.; Cheng, Regina; Nguyen, Tuan; Fan, Theresa; Kariyawasam, Anula P.; Liu, Yang; Osmond, Daniel H.; George, Susan R.; O'Dowd, Brian F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The apelin peptide was recently discovered and demonstrated to be the endogenous ligand for the G protein-coupled receptor, APJ.  A search of the GenBank databases retrieved a rat expressed sequence tag partially encoding the preproapelin sequence.  The GenBank search also revealed a human sequence on chromosome Xq25-26.1, contg. the gene encoding preproapelin.  We have used the rat sequence to screen a rat brain cDNA library to obtain a cDNA encoding the full-length open reading frame of rat preproapelin.  This cDNA encoded a protein of 77 amino acids, sharing an identity of 82% with human preproapelin.  Northern and in situ hybridization analyses revealed both human and rat apelin and APJ to be expressed in the brain and periphery.  Both sequence and mRNA expression distribution analyses revealed similarities between apelin and angiotensin II, suggesting they that share related physiol. roles.  A synthetic apelin peptide was injected i.v. into male Wistar rats, resulting in immediate lowering of both systolic and diastolic blood pressure, which persisted for several minutes.  The i.p. apelin injections induced an increase in drinking behavior within the first 30 min after injection, with a return to baseline within 1 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpATFrP5oOMprVg90H21EOLACvtfcHk0lgo0dTcz7eKwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Oi&md5=1481d406743b55c8efb532ffb80fe782</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0740034.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0740034.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BK.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DT.%26aulast%3DKariyawasam%26aufirst%3DA.%2BP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DOsmond%26aufirst%3DD.%2BH.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DB.%2BF.%26atitle%3DCharacterization%2520of%2520apelin%252C%2520the%2520ligand%2520for%2520the%2520APJ%2520receptor%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D34%26epage%3D41%26doi%3D10.1046%2Fj.1471-4159.2000.0740034.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winborn, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrie, K. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hervieu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolaky, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrity, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdock, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darker, J. G.</span><span> </span><span class="NLM_article-title">Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.01587.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1046%2Fj.1471-4159.2003.01587.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=12603839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1ejtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=1162-1172&author=A.+D.+Medhurstauthor=C.+A.+Jenningsauthor=M.+J.+Robbinsauthor=R.+P.+Davisauthor=C.+Ellisauthor=K.+Y.+Winbornauthor=K.+W.+M.+Lawrieauthor=G.+Hervieuauthor=G.+Rileyauthor=J.+E.+Bolakyauthor=N.+C.+Herrityauthor=P.+Murdockauthor=J.+G.+Darker&title=Pharmacological+and+immunohistochemical+characterization+of+the+APJ+receptor+and+its+endogenous+ligand+apelin&doi=10.1046%2Fj.1471-4159.2003.01587.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin</span></div><div class="casAuthors">Medhurst, Andrew D.; Jennings, Carol A.; Robbins, Melanie J.; Davis, Robert P.; Ellis, Catherine; Winborn, Kim Y.; Lawrie, Kenneth W. M.; Hervieu, Guillaume; Riley, Graham; Bolaky, Jane E.; Herrity, Nicole C.; Murdock, Paul; Darker, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1162-1172</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Apelin peptides have recently been identified to be the endogenous ligands for the G protein-coupled receptor APJ.  However, little is known about the physiol. roles of this ligand-receptor pairing.  In the present study the authors investigated the pharmacol. of several apelin analogs at the human recombinant APJ receptor using radioligand binding and functional assays.  This has led to the identification of key residues in the apelin peptide required for functional potency and binding affinity through structure-activity studies.  In particular, the authors have identified that replacement of leucine in position 5, or arginine in position 2 and 4 of the C-terminal apelin peptide, apelin-13, resulted in significant changes in pharmacol.  The authors also investigated the detailed localization of pre-proapelin and APJ receptor mRNA in a wide range of human, rat and mouse tissues using quant. RT-PCR, and carried out a detailed immunohistochem. study of the distribution of the APJ receptor in rat brain and spinal cord.  Interestingly, the APJ receptor was not only co-localized in white matter with GFAP in the spinal cord, but was also clearly localized on neurons in the brain, suggesting that this receptor and its peptide may be involved in a wide range of biol. process yet to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99tyPHrKfxLVg90H21EOLACvtfcHk0lhfej9x5LaFWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1ejtb8%253D&md5=4a83eb10e5612872943c2a327659ab6d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.01587.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.01587.x%26sid%3Dliteratum%253Aachs%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DJennings%26aufirst%3DC.%2BA.%26aulast%3DRobbins%26aufirst%3DM.%2BJ.%26aulast%3DDavis%26aufirst%3DR.%2BP.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DWinborn%26aufirst%3DK.%2BY.%26aulast%3DLawrie%26aufirst%3DK.%2BW.%2BM.%26aulast%3DHervieu%26aufirst%3DG.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DBolaky%26aufirst%3DJ.%2BE.%26aulast%3DHerrity%26aufirst%3DN.%2BC.%26aulast%3DMurdock%26aufirst%3DP.%26aulast%3DDarker%26aufirst%3DJ.%2BG.%26atitle%3DPharmacological%2520and%2520immunohistochemical%2520characterization%2520of%2520the%2520APJ%2520receptor%2520and%2520its%2520endogenous%2520ligand%2520apelin%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D84%26spage%3D1162%26epage%3D1172%26doi%3D10.1046%2Fj.1471-4159.2003.01587.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Japp, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruden, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudie, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megson, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flapan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newby, D. E.</span><span> </span><span class="NLM_article-title">Vascular effects of apelin in vivo in man</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1016/j.jacc.2008.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.jacc.2008.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=18772060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyjsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=908-913&author=A.+G.+Jappauthor=N.+L.+Crudenauthor=D.+A.+Amerauthor=V.+K.+Liauthor=E.+B.+Goudieauthor=N.+R.+Johnstonauthor=S.+Sharmaauthor=I.+Neilsonauthor=D.+J.+Webbauthor=I.+L.+Megsonauthor=A.+D.+Flapanauthor=D.+E.+Newby&title=Vascular+effects+of+apelin+in+vivo+in+man&doi=10.1016%2Fj.jacc.2008.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Effects of Apelin In Vivo in Man</span></div><div class="casAuthors">Japp, Alan G.; Cruden, Nicholas L.; Amer, David A. B.; Li, Vivienne K. Y.; Goudie, Ewan B.; Johnston, Neil R.; Sharma, Sushma; Neilson, Ilene; Webb, David J.; Megson, Ian L.; Flapan, Andrew D.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">908-913</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This study was designed to establish the direct vascular effects of apelin in vivo in man.  Apelin is the endogenous ligand for the previously orphaned G-protein-coupled receptor, APJ.  This novel pathway is widely expressed in the cardiovascular system and is emerging as an important mediator of cardiovascular homeostasis.  In pre-clin. models, apelin causes venous and arterial vasodilation.  Vascular effects of apelin were assessed in 24 healthy volunteers.  Dorsal hand vein diam. was measured by the Aellig technique during local i.v. infusions (0.1 to 3 nmol/min) of apelin-36, (Pyr1)apelin-13, and sodium nitroprusside (0.6 nmol/min).  Forearm blood flow was measured by venous occlusion plethysmog. during intrabrachial infusions of apelin-36 and (Pyr1)apelin-13 (0.1 to 30 nmol/min) and subsequently in the presence or absence of a "nitric oxide clamp" (nitric oxide synthase inhibitor, L-N G-monomethylarginine [8 μmol/min], coinfused with nitric oxide donor, sodium nitroprusside [90 to 900 ng/min]), or a single oral dose of aspirin (600 mg) or matched placebo.  Although sodium nitroprusside caused venodilation (p < 0.0001), apelin-36 and (Pyr1)apelin-13 had no effect on dorsal hand vein diam. (p = 0.2).  Both apelin isoforms caused reproducible vasodilation in forearm resistance vessels (p < 0.0001).  (Pyr1)apelin-13-mediated vasodilation was attenuated by the nitric oxide clamp (p = 0.004) but unaffected by aspirin (p = 0.7).  Although having no apparent effect on venous tone, apelin causes nitric oxide-dependent arterial vasodilation in vivo in man.  The apelin-APJ system merits further clin. investigation to det. its role in cardiovascular homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFV91OuN1h07Vg90H21EOLACvtfcHk0lhfej9x5LaFWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyjsbnE&md5=77645b8ab8034837a4f6c3f02868f4ab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2008.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2008.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DAmer%26aufirst%3DD.%2BA.%26aulast%3DLi%26aufirst%3DV.%2BK.%26aulast%3DGoudie%26aufirst%3DE.%2BB.%26aulast%3DJohnston%26aufirst%3DN.%2BR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DNeilson%26aufirst%3DI.%26aulast%3DWebb%26aufirst%3DD.%2BJ.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26aulast%3DFlapan%26aufirst%3DA.%2BD.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DVascular%2520effects%2520of%2520apelin%2520in%2520vivo%2520in%2520man%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2008%26volume%3D52%26spage%3D908%26epage%3D913%26doi%3D10.1016%2Fj.jacc.2008.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Barnes, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veitch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruden, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Japp, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newby, D. E.</span><span> </span><span class="NLM_article-title">Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure</span> <span class="citation_source-journal">Circ.: Heart Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span><span class="refDoi"> DOI: 10.1161/CIRCHEARTFAILURE.111.000077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FCIRCHEARTFAILURE.111.000077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=23519586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSntbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=482-491&author=G.+D.+Barnesauthor=S.+Alamauthor=G.+Carterauthor=C.+M.+Pedersenauthor=K.+M.+Leeauthor=T.+J.+Hubbardauthor=S.+Veitchauthor=H.+Jeongauthor=A.+Whiteauthor=N.+L.+Crudenauthor=L.+Husonauthor=A.+G.+Jappauthor=D.+E.+Newby&title=Sustained+cardiovascular+actions+of+APJ+agonism+during+renin-angiotensin+system+activation+and+in+patients+with+heart+failure&doi=10.1161%2FCIRCHEARTFAILURE.111.000077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained Cardiovascular Actions of APJ Agonism During Renin-Angiotensin System Activation and in Patients With Heart Failure</span></div><div class="casAuthors">Barnes, Gareth D.; Alam, Shirjel; Carter, Gordon; Pedersen, Christian M.; Lee, Kristina M.; Hubbard, Thomas J.; Veitch, Scott; Jeong, Herim; White, Audrey; Cruden, Nicholas L.; Huson, Les; Japp, Alan G.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation: Heart Failure</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">CHFICM</span>;
        ISSN:<span class="NLM_cas:issn">1941-3289</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: To assess cardiovascular actions of APJ agonism during prolonged (Pyr)apelin-13 infusion and renin-angiotensin system activation.  METHODS AND RESULTS-: Forty-eight volunteers and 12 patients with chronic stable heart failure attended a series of randomized placebo-controlled studies.  Forearm blood flow, cardiac index, left ventricular dimensions, and mean arterial pressure were measured using bilateral venous occlusion plethysmog., bioimpedance cardiog., transthoracic echocardiog., and sphygmomanometry, resp., during brief local (0.3-3.0 nmol/min) and systemic (30-300 nmol/min) or prolonged systemic (30 nmol/min) (Pyr)apelin-13 infusions in the presence or absence of renin-angiotensin system activation with sodium depletion or angiotensin II coinfusion.  During sodium depletion and angiotensin II coinfusion, (Pyr)apelin-13-induced vasodilatation was preserved (P<0.02 for both).  Systemic i.v. (Pyr)apelin-13 infusion increased cardiac index, whereas reducing mean arterial pressure and peripheral vascular resistance index (P<0.001 for all) irresp. of sodium depletion or angiotensin II (0.5 ng/kg per min) coinfusion (P>0.05 for all).  Prolonged 6-h (Pyr)apelin-13 infusion caused a sustained increase in cardiac index with increased left ventricular ejection fraction in patients with chronic heart failure (ANOVA; P<0.001 for all).  CONCLUSIONS-: APJ agonism has sustained cardiovascular effects that are preserved in the presence of renin-angiotensin system activation or heart failure.  APJ agonism may hold major promise to complement current optimal medical therapy in patients with chronic heart failure.  Clin. TRIAL REGISTRATION-: URL: http://www.clinicaltrials.gov.  Unique identifiers: NCT00901719, NCT00901888, NCT01049646, NCT01179061.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWOAUpCsQtubVg90H21EOLACvtfcHk0lhfej9x5LaFWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSntbvM&md5=7aa0219a8f5a363c3092b1b6a0631ed2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1161%2FCIRCHEARTFAILURE.111.000077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCHEARTFAILURE.111.000077%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DG.%2BD.%26aulast%3DAlam%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DG.%26aulast%3DPedersen%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DK.%2BM.%26aulast%3DHubbard%26aufirst%3DT.%2BJ.%26aulast%3DVeitch%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DHuson%26aufirst%3DL.%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DSustained%2520cardiovascular%2520actions%2520of%2520APJ%2520agonism%2520during%2520renin-angiotensin%2520system%2520activation%2520and%2520in%2520patients%2520with%2520heart%2520failure%26jtitle%3DCirc.%253A%2520Heart%2520Failure%26date%3D2013%26volume%3D6%26spage%3D482%26epage%3D491%26doi%3D10.1161%2FCIRCHEARTFAILURE.111.000077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Japp, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruden, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gemeren, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denvir, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megson, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flapan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newby, D. E.</span><span> </span><span class="NLM_article-title">Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">1818</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.109.911339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FCIRCULATIONAHA.109.911339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=20385929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2010&pages=1818-1827&author=A.+G.+Jappauthor=N.+L.+Crudenauthor=G.+Barnesauthor=N.+van+Gemerenauthor=J.+Mathewsauthor=J.+Adamsonauthor=N.+R.+Johnstonauthor=M.+A.+Denvirauthor=I.+L.+Megsonauthor=A.+D.+Flapanauthor=D.+E.+Newby&title=Acute+cardiovascular+effects+of+apelin+in+humans%3A+potential+role+in+patients+with+chronic+heart+failure&doi=10.1161%2FCIRCULATIONAHA.109.911339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Acute Cardiovascular Effects of Apelin in Humans: Potential Role in Patients With Chronic Heart Failure</span></div><div class="casAuthors">Japp, A. G.; Cruden, N. L.; Barnes, G.; van Gemeren, N.; Mathews, J.; Adamson, J.; Johnston, N. R.; Denvir, M. A.; Megson, I. L.; Flapan, A. D.; Newby, D. E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1818-1827</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND: Apelin, the endogenous ligand for the novel G protein-coupled receptor APJ, has major cardiovascular effects in preclin. models.  The study objectives were to establish the effects of acute apelin administration on peripheral, cardiac, and systemic hemodynamic variables in healthy volunteers and patients with heart failure.  METHODS AND RESULTS: Eighteen patients with New York Heart Assocn. class II to III chronic heart failure, 6 patients undergoing diagnostic coronary angiog., and 26 healthy volunteers participated in a series of randomized, double-blind, placebo-controlled studies.  Measurements of forearm blood flow, coronary blood flow, left ventricular pressure, and cardiac output were made by venous occlusion plethysmog., Doppler flow wire and quant. coronary angiog., pressure wire, and thoracic bioimpedance, resp.  Intrabrachial infusions of (Pyr)apelin-13, acetylcholine, and sodium nitroprusside caused forearm vasodilatation in patients and control subjects (all P < 0.0001).  Vasodilatation to acetylcholine (P = 0.01) but not apelin (P = 0.3) or sodium nitroprusside (P = 0.9) was attenuated in patients with heart failure.  Intracoronary bolus of apelin-36 increased coronary blood flow and the max. rate of rise in left ventricular pressure and reduced peak and end-diastolic left ventricular pressures (all P < 0.05).  Systemic infusions of (Pyr)apelin-13 (30 to 300 nmol/min) increased cardiac index and lowered mean arterial pressure and peripheral vascular resistance in patients and healthy control subjects (all P<0.01) but increased heart rate only in control subjects (P < 0.01).  CONCLUSIONS: Acute apelin administration in humans causes peripheral and coronary vasodilatation and increases cardiac output.  APJ agonism represents a novel potential therapeutic target for patients with heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiqCbkcSGzQ7Vg90H21EOLACvtfcHk0lj6KeQ1aYqa-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVOls7k%253D&md5=35dd169c74c36b03d9c82c1215401467</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.109.911339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.109.911339%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DBarnes%26aufirst%3DG.%26aulast%3Dvan%2BGemeren%26aufirst%3DN.%26aulast%3DMathews%26aufirst%3DJ.%26aulast%3DAdamson%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DN.%2BR.%26aulast%3DDenvir%26aufirst%3DM.%2BA.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26aulast%3DFlapan%26aufirst%3DA.%2BD.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DAcute%2520cardiovascular%2520effects%2520of%2520apelin%2520in%2520humans%253A%2520potential%2520role%2520in%2520patients%2520with%2520chronic%2520heart%2520failure%26jtitle%3DCirculation%26date%3D2010%26volume%3D121%26spage%3D1818%26epage%3D1827%26doi%3D10.1161%2FCIRCULATIONAHA.109.911339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Szokodi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Földes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voutilainen-Myllylä, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilves, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokola, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikkarainen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piuhola, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rysä, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tóth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruskoaho, H.</span><span> </span><span class="NLM_article-title">Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1161/01.RES.0000033522.37861.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2F01.RES.0000033522.37861.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=12215493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2002&pages=434-440&author=I.+Szokodiauthor=P.+Taviauthor=G.+F%C3%B6ldesauthor=S.+Voutilainen-Myllyl%C3%A4author=M.+Ilvesauthor=H.+Tokolaauthor=S.+Pikkarainenauthor=J.+Piuholaauthor=H.+Rys%C3%A4author=M.+T%C3%B3thauthor=H.+Ruskoaho&title=Apelin%2C+the+novel+endogenous+ligand+of+the+orphan+receptor+APJ%2C+regulates+cardiac+contractility&doi=10.1161%2F01.RES.0000033522.37861.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility</span></div><div class="casAuthors">Szokodi, Istvan; Tavi, Pasi; Foeldes, Gabor; Voutilainen-Myllylae, Sari; Ilves, Mika; Tokola, Heikki; Pikkarainen, Sampsa; Piuhola, Jarkko; Rysae, Jaana; Toth, Miklos; Ruskoaho, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The orphan receptor APJ and its recently identified endogenous ligand, apelin, exhibit high levels of mRNA expression in the heart.  However, the functional importance of apelin in the cardiovascular system is not known.  In isolated perfused rat hearts, infusion of apelin (0.01 to 10 nmol/L) induced a dose-dependent pos. inotropic effect (EC50: 33.1±1.5 pmol/L).  Moreover, preload-induced increase in dP/dtmax was significantly augmented (P<0.05) in the presence of apelin.  Inhibition of phospholipase C (PLC) with U-73122 and suppression of protein kinase C (PKC) with staurosporine and GF-109203X markedly attenuated the apelin-induced inotropic effect (P<0.001).  In addn., zoniporide, a selective inhibitor of Na+-H+ exchange (NHE) isoform-1, and KB-R7943, a potent inhibitor of the reverse mode Na+-Ca2+ exchange (NCX), significantly suppressed the response to apelin (P<0.001).  Perforated patch-clamp recordings showed that apelin did not modulate L-type Ca2+ current or voltage-activated K+ currents in isolated adult rat ventricular myocytes.  Apelin mRNA was markedly downregulated in cultured neonatal rat ventricular myocytes subjected to mech. stretch and in vivo in two models of chronic ventricular pressure overload.  The present study provides the first evidence for the physiol. significance of apelin in the heart.  Our results show that apelin is one of the most potent endogenous pos. inotropic substances yet identified and that the inotropic response to apelin may involve activation of PLC, PKC, and sarcolemmal NHE and NCX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAJihT3bR9_bVg90H21EOLACvtfcHk0lj6KeQ1aYqa-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVKktL0%253D&md5=78b3fb521970692595debb7c819f0e3b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000033522.37861.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000033522.37861.69%26sid%3Dliteratum%253Aachs%26aulast%3DSzokodi%26aufirst%3DI.%26aulast%3DTavi%26aufirst%3DP.%26aulast%3DF%25C3%25B6ldes%26aufirst%3DG.%26aulast%3DVoutilainen-Myllyl%25C3%25A4%26aufirst%3DS.%26aulast%3DIlves%26aufirst%3DM.%26aulast%3DTokola%26aufirst%3DH.%26aulast%3DPikkarainen%26aufirst%3DS.%26aulast%3DPiuhola%26aufirst%3DJ.%26aulast%3DRys%25C3%25A4%26aufirst%3DH.%26aulast%3DT%25C3%25B3th%26aufirst%3DM.%26aulast%3DRuskoaho%26aufirst%3DH.%26atitle%3DApelin%252C%2520the%2520novel%2520endogenous%2520ligand%2520of%2520the%2520orphan%2520receptor%2520APJ%252C%2520regulates%2520cardiac%2520contractility%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D91%26spage%3D434%26epage%3D440%26doi%3D10.1161%2F01.RES.0000033522.37861.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kidoya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7601982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1038%2Fsj.emboj.7601982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=18200044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1KgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=522-534&author=H.+Kidoyaauthor=M.+Uenoauthor=Y.+Yamadaauthor=N.+Mochizukiauthor=M.+Nakataauthor=T.+Yanoauthor=R.+Fujiiauthor=N.+Takakura&title=Spatial+and+temporal+role+of+the+apelin%2FAPJ+system+in+the+caliber+size+regulation+of+blood+vessels+during+angiogenesis&doi=10.1038%2Fsj.emboj.7601982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis</span></div><div class="casAuthors">Kidoya, Hiroyasu; Ueno, Masaya; Yamada, Yoshihiro; Mochizuki, Naoki; Nakata, Mitsugu; Yano, Takashi; Fujii, Ryo; Takakura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">522-534</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Blood vessels change their caliber to adapt to the demands of tissues or organs for oxygen and nutrients.  This event is mainly organized at the capillary level and requires a size-sensing mechanism.  However, the mol. regulatory mechanism involved in caliber size modification in blood vessels is not clear.  Here we show that apelin, a protein secreted from endothelial cells under the activation of Tie2 receptor tyrosine kinase on endothelial cells, plays a role in the regulation of caliber size of blood vessel through its cognate receptor APJ, which is expressed on endothelial cells.  During early embryogenesis, APJ is expressed on endothelial cells of the new blood vessels sprouted from the dorsal aorta, but not on pre-existing endothelial cells of the dorsal aorta.  Apelin-deficient mice showed narrow blood vessels in intersomitic vessels during embryogenesis.  Apelin enhanced endothelial cell proliferation in the presence of vascular endothelial growth factor and promoted cell-to-cell aggregation.  These results indicated that the apelin/APJ system is involved in the regulation of blood vessel diam. during angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhOQ-cRW5awbVg90H21EOLACvtfcHk0lj6KeQ1aYqa-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1KgtL0%253D&md5=ecd5cf685abcf0ed85c225c29fc815ad</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601982%26sid%3Dliteratum%253Aachs%26aulast%3DKidoya%26aufirst%3DH.%26aulast%3DUeno%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DNakata%26aufirst%3DM.%26aulast%3DYano%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DR.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSpatial%2520and%2520temporal%2520role%2520of%2520the%2520apelin%252FAPJ%2520system%2520in%2520the%2520caliber%2520size%2520regulation%2520of%2520blood%2520vessels%2520during%2520angiogenesis%26jtitle%3DEMBO%2520J.%26date%3D2008%26volume%3D27%26spage%3D522%26epage%3D534%26doi%3D10.1038%2Fsj.emboj.7601982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnie, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddad, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhabyeyev, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandalam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiri, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vederas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudit, G. Y.</span><span> </span><span class="NLM_article-title">Loss of apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic apelin analogues</span> <span class="citation_source-journal">J. Am. Heart Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e000249</span><span class="refDoi"> DOI: 10.1161/JAHA.113.000249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FJAHA.113.000249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=23817469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yrs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e000249&author=W.+Wangauthor=S.+M.+McKinnieauthor=V.+B.+Patelauthor=G.+Haddadauthor=Z.+Wangauthor=P.+Zhabyeyevauthor=S.+K.+Dasauthor=R.+Basuauthor=B.+McLeanauthor=V.+Kandalamauthor=J.+M.+Penningerauthor=Z.+Kassiriauthor=J.+C.+Vederasauthor=A.+G.+Murrayauthor=G.+Y.+Oudit&title=Loss+of+apelin+exacerbates+myocardial+infarction+adverse+remodeling+and+ischemia-reperfusion+injury%3A+therapeutic+potential+of+synthetic+apelin+analogues&doi=10.1161%2FJAHA.113.000249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic apelin analogues</span></div><div class="casAuthors">Wang, Wang; McKinnie, Shaun M. K.; Patel, Vaibhav B.; Haddad, George; Wang, Zuocheng; Zhabyeyev, Pavel; Das, Subhash K.; Basu, Ratnadeep; McLean, Brent; Kandalam, Vijay; Penninger, Josef M.; Kassiri, Zamaneh; Vederas, John C.; Murray, Allan G.; Oudit, Gavin Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Heart Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">E000249/1-E000249/17, SE000249/1-SE000249/16</span>CODEN:
                <span class="NLM_cas:coden">JAHABZ</span>;
        ISSN:<span class="NLM_cas:issn">2047-9980</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background-Coronary artery disease leading to myocardial ischemia is the most common cause of heart failure.  Apelin (APLN), the endogenous peptide ligand of the APJ receptor, has emerged as a novel regulator of the cardiovascular system.  Methods and Results-Here we show a crit. role of APLN in myocardial infarction (MI) and ischemia-reperfusion (IR) injury in patients and animal models.  Myocardial APLN levels were reduced in patients with ischemic heart failure.  Loss of APLN increased MI-related mortality, infarct size, and inflammation with drastic redns. in prosurvival pathways resulting in greater systolic dysfunction and heart failure.  APLN deficiency decreased vascular sprouting, impaired sprouting of human endothelial progenitor cells, and compromised in vivo myocardial angiogenesis.  Lack of APLN enhanced susceptibility to ischemic injury and compromised functional recovery following ex vivo and in vivo IR injury.  We designed and synthesized two novel APLN analogs resistant to angiotensin converting enzyme 2 cleavage and identified one analog, which mimicked the function of APLN, to be markedly protective against ex vivo and in vivo myocardial IR injury linked to greater activation of survival pathways and promotion of angiogenesis.  Conclusions-APLN is a crit. regulator of the myocardial response to infarction and ischemia and pharmacol. targeting this pathway is feasible and represents a new class of potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxx4Vdp5pa0rVg90H21EOLACvtfcHk0lhyeyTYcf5Rgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yrs7jN&md5=9d8c022491281ef1688196cb1886e6cb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1161%2FJAHA.113.000249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FJAHA.113.000249%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMcKinnie%26aufirst%3DS.%2BM.%26aulast%3DPatel%26aufirst%3DV.%2BB.%26aulast%3DHaddad%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhabyeyev%26aufirst%3DP.%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DBasu%26aufirst%3DR.%26aulast%3DMcLean%26aufirst%3DB.%26aulast%3DKandalam%26aufirst%3DV.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DKassiri%26aufirst%3DZ.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26aulast%3DMurray%26aufirst%3DA.%2BG.%26aulast%3DOudit%26aufirst%3DG.%2BY.%26atitle%3DLoss%2520of%2520apelin%2520exacerbates%2520myocardial%2520infarction%2520adverse%2520remodeling%2520and%2520ischemia-reperfusion%2520injury%253A%2520therapeutic%2520potential%2520of%2520synthetic%2520apelin%2520analogues%26jtitle%3DJ.%2520Am.%2520Heart%2520Assoc.%26date%3D2013%26volume%3D2%26spage%3De000249%26doi%3D10.1161%2FJAHA.113.000249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Vickers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaushik, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baronas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P.</span><span> </span><span class="NLM_article-title">Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">14838</span><span class="NLM_x">–</span> <span class="NLM_lpage">14843</span><span class="refDoi"> DOI: 10.1074/jbc.M200581200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1074%2Fjbc.M200581200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=11815627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD38XjslSgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=14838-14843&author=C.+Vickersauthor=P.+Halesauthor=V.+Kaushikauthor=L.+Dickauthor=J.+Gavinauthor=J.+Tangauthor=K.+Godboutauthor=T.+Parsonsauthor=E.+Baronasauthor=F.+Hsiehauthor=S.+Actonauthor=M.+Pataneauthor=A.+Nicholsauthor=P.+Tummino&title=Hydrolysis+of+biological+peptides+by+human+angiotensin-converting+enzyme-related+carboxypeptidase&doi=10.1074%2Fjbc.M200581200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase</span></div><div class="casAuthors">Vickers, Chad; Hales, Paul; Kaushik, Virendar; Dick, Larry; Gavin, James; Tang, Jin; Godbout, Kevin; Parsons, Thomas; Baronas, Elizabeth; Hsieh, Frank; Acton, Susan; Patane, Michael; Nichols, Andrew; Tummino, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">14838-14843</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a zinc metalloprotease whose closest homolog is angiotensin I-converting enzyme.  To begin to elucidate the physiol. role of ACE2, ACE2 was purified, and its catalytic activity was characterized.  ACE2 proteolytic activity has a pH optimum of 6.5 and is enhanced by monovalent anions, which is consistent with the activity of ACE.  ACE2 activity is increased ∼10-fold by Cl- and F- but is unaffected by Br-.  ACE2 was screened for hydrolytic activity against a panel of 126 biol. peptides, using liq. chromatog. mass spectrometry detection.  Eleven of the peptides were hydrolyzed by ACE2, and in each case, the proteolytic activity resulted in removal of the C-terminal residue only.  ACE2 hydrolyzes three of the peptides with high catalytic efficiency: angiotensin II (1-8) (kcat/Km = 1.9×106 M-1 s-1), apelin-13 (kcat/Km = 2.1×106 M-1 s-1), and dynorphin A 1-13 (kcat/Km = 3.1×106 M-1 s-1).  The ACE2 catalytic efficiency is 400-fold higher with angiotensin II (1-8) as a substrate than with angiotensin I (1-10).  ACE2 also efficiently hydrolyzes des-Arg9-bradykinin (kcat/Km = 1.3×105 M-1 s-1), but it does not hydrolyze bradykinin.  An alignment of the ACE2 peptide substrates reveals a consensus sequence of: Pro-X(1-3 residues)-Pro-Hydrophobic, where hydrolysis occurs between proline and the hydrophobic amino acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbBD41C5xTurVg90H21EOLACvtfcHk0lhyeyTYcf5Rgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjslSgsbo%253D&md5=48f777a3cc95881abc2e9e29e5e72d10</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M200581200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M200581200%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DC.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DKaushik%26aufirst%3DV.%26aulast%3DDick%26aufirst%3DL.%26aulast%3DGavin%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DGodbout%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DT.%26aulast%3DBaronas%26aufirst%3DE.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DActon%26aufirst%3DS.%26aulast%3DPatane%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DTummino%26aufirst%3DP.%26atitle%3DHydrolysis%2520of%2520biological%2520peptides%2520by%2520human%2520angiotensin-converting%2520enzyme-related%2520carboxypeptidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D14838%26epage%3D14843%26doi%3D10.1074%2Fjbc.M200581200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnie, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vederas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudit, G. Y.</span><span> </span><span class="NLM_article-title">Angiotensin converting enzyme 2 metabolizes and partially inactivates pyr-apelin-13 and apelin-17: Physiological effects in the cardiovascular system</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.115.06892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FHYPERTENSIONAHA.115.06892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=365-377&author=W.+Wangauthor=S.+M.+McKinnieauthor=M.+Farhanauthor=M.+Paulauthor=T.+McDonaldauthor=B.+McLeanauthor=C.+Llorens-Cortesauthor=S.+Hazraauthor=A.+G.+Murrayauthor=J.+C.+Vederasauthor=G.+Y.+Oudit&title=Angiotensin+converting+enzyme+2+metabolizes+and+partially+inactivates+pyr-apelin-13+and+apelin-17%3A+Physiological+effects+in+the+cardiovascular+system&doi=10.1161%2FHYPERTENSIONAHA.115.06892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.115.06892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.115.06892%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMcKinnie%26aufirst%3DS.%2BM.%26aulast%3DFarhan%26aufirst%3DM.%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DT.%26aulast%3DMcLean%26aufirst%3DB.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26aulast%3DHazra%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DA.%2BG.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26aulast%3DOudit%26aufirst%3DG.%2BY.%26atitle%3DAngiotensin%2520converting%2520enzyme%25202%2520metabolizes%2520and%2520partially%2520inactivates%2520pyr-apelin-13%2520and%2520apelin-17%253A%2520Physiological%2520effects%2520in%2520the%2520cardiovascular%2520system%26jtitle%3DHypertension%26date%3D2016%26volume%3D68%26spage%3D365%26epage%3D377%26doi%3D10.1161%2FHYPERTENSIONAHA.115.06892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">El Messari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrioz, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2004.02591.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1111%2Fj.1471-4159.2004.02591.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15341513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVGqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=1290-1301&author=S.+El+Messariauthor=X.+Iturriozauthor=C.+Fassotauthor=N.+De+Motaauthor=D.+Roeschauthor=C.+Llorens-Cortes&title=Functional+dissociation+of+apelin+receptor+signaling+and+endocytosis%3A+implications+for+the+effects+of+apelin+on+arterial+blood+pressure&doi=10.1111%2Fj.1471-4159.2004.02591.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Functional dissociation of apelin receptor signaling and endocytosis: Implications for the effects of apelin on arterial blood pressure</span></div><div class="casAuthors">El Messari, Said; Iturrioz, Xavier; Fassot, Celine; de Mota, Nadia; Roesch, Darren; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1290-1301</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Apelin is a novel neuropeptide involved in the regulation of body fluid homeostasis and cardiovascular functions.  It acts through a G protein-coupled receptor, the APJ receptor.  We studied the structure-activity relationships of apelin at the rat apelin receptor, tagged at its C-terminal end with enhanced green fluorescent protein and stably expressed in CHO cells.  We evaluated the potency of N- and C-terminal deleted fragments of K17F to bind with high affinity to the apelin receptor, and to inhibit cAMP prodn. and to induce apelin receptor internalization.  We first characterized the internalization and trafficking of the rat apelin receptor.  This receptor was internalized via a clathrin-dependent mechanism and our results suggest that receptor trafficking may follow a recycling pathway.  We then tried to identify the amino acids of K17F required for apelin activity.  The first five N-terminal and the last two C-terminal amino acids of K17F were not essential for apelin binding or the inhibition of cAMP prodn.  However, the full-length sequence of K17F was the most potent inducer of apelin receptor internalization because successive N-terminal amino-acid deletions progressively reduced internalization and the removal of a single amino acid at the C-terminus abolished this process.  Finally, the most novel observation of this work is that hypotensive actions of apelin peptides correlate best with the ability of those ligands to internalize.  Thus, apelin receptor signaling and endocytosis are functionally dissocd., possibly reflecting the existence of several conformational states of this receptor, stabilized by the binding of different apelin fragments to the apelin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOUyVAsLNAJLVg90H21EOLACvtfcHk0lgryoCCG5q-8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVGqs7g%253D&md5=b73959e229342eb7aac10cbc8e3d07c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02591.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02591.x%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BMessari%26aufirst%3DS.%26aulast%3DIturrioz%26aufirst%3DX.%26aulast%3DFassot%26aufirst%3DC.%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DRoesch%26aufirst%3DD.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DFunctional%2520dissociation%2520of%2520apelin%2520receptor%2520signaling%2520and%2520endocytosis%253A%2520implications%2520for%2520the%2520effects%2520of%2520apelin%2520on%2520arterial%2520blood%2520pressure%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D90%26spage%3D1290%26epage%3D1301%26doi%3D10.1111%2Fj.1471-4159.2004.02591.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ceraudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galanth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpentier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banegas-Font, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonegge, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvear-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrioz, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Biased signaling favoring Gi over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">24599</span><span class="NLM_x">–</span> <span class="NLM_lpage">24610</span><span class="refDoi"> DOI: 10.1074/jbc.M113.541698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1074%2Fjbc.M113.541698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=25012663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGjt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=24599-24610&author=E.+Ceraudoauthor=C.+Galanthauthor=E.+Carpentierauthor=I.+Banegas-Fontauthor=A.+M.+Schoneggeauthor=R.+Alvear-Perezauthor=X.+Iturriozauthor=M.+Bouvierauthor=C.+Llorens-Cortes&title=Biased+signaling+favoring+Gi+over+%CE%B2-arrestin+promoted+by+an+apelin+fragment+lacking+the+C-terminal+phenylalanine&doi=10.1074%2Fjbc.M113.541698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Signaling Favoring Gi over β-Arrestin Promoted by an Apelin Fragment Lacking the C-terminal Phenylalanine</span></div><div class="casAuthors">Ceraudo, Emilie; Galanth, Cecile; Carpentier, Eric; Banegas-Font, Inmaculada; Schonegge, Anne-Marie; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Bouvier, Michel; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">24599-24610</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Apelin plays a prominent role in body fluid and cardiovascular homeostasis.  The authors previously showed that the C-terminal Phe of apelin 17 (K17F) is crucial for triggering apelin receptor internalization and decreasing blood pressure (BP) but is not required for apelin binding or Gi protein coupling.  Based on these findings, the authors hypothesized that the important role of the C-terminal Phe in BP decrease may be as a Gi-independent but β-arrestin-dependent signaling pathway that could involve MAPKs.  For this purpose, the authors have used apelin fragments K17F and K16P (K17F with the C-terminal Phe deleted), which exhibit opposite profiles on apelin receptor internalization and BP.  Using BRET-based biosensors, the authors showed that, whereas K17F activates Gi and promotes β-arrestin recruitment to the receptor, K16P had a much reduced ability to promote β-arrestin recruitment while maintaining its Gi activating property, revealing the biased agonist character of K16P.  The authors further show that both β-arrestin recruitment and apelin receptor internalization contribute to the K17F-stimulated ERK1/2 activity, whereas the K16P-promoted ERK1/2 activity is entirely Gi-dependent.  In addn. to providing new insights on the structural basis underlying the functional selectivity of apelin peptides, the authors' study indicates that the β-arrestin-dependent ERK1/2 activation and not the Gi-dependent signaling may participate in K17F-induced BP decrease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA2B14K-_mtLVg90H21EOLACvtfcHk0lgryoCCG5q-8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGjt7nJ&md5=3d412882bcb7944183ce2f5961ab58fd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.541698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.541698%26sid%3Dliteratum%253Aachs%26aulast%3DCeraudo%26aufirst%3DE.%26aulast%3DGalanth%26aufirst%3DC.%26aulast%3DCarpentier%26aufirst%3DE.%26aulast%3DBanegas-Font%26aufirst%3DI.%26aulast%3DSchonegge%26aufirst%3DA.%2BM.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DIturrioz%26aufirst%3DX.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DBiased%2520signaling%2520favoring%2520Gi%2520over%2520%25CE%25B2-arrestin%2520promoted%2520by%2520an%2520apelin%2520fragment%2520lacking%2520the%2520C-terminal%2520phenylalanine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D24599%26epage%3D24610%26doi%3D10.1074%2Fjbc.M113.541698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Murza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besserer-Offroy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadereye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarret, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsault, E.</span><span> </span><span class="NLM_article-title">Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stability</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1002/cmdc.201100492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fcmdc.201100492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=22170700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=318-325&author=A.+Murzaauthor=A.+Parentauthor=E.+Besserer-Offroyauthor=H.+Tremblayauthor=F.+Karadereyeauthor=N.+Beaudetauthor=R.+Leducauthor=P.+Sarretauthor=E.+Marsault&title=Elucidation+of+the+structure-activity+relationships+of+apelin%3A+influence+of+unnatural+amino+acids+on+binding%2C+signaling%2C+and+plasma+stability&doi=10.1002%2Fcmdc.201100492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of the Structure-Activity Relationships of Apelin: Influence of Unnatural Amino Acids on Binding, Signaling, and Plasma Stability</span></div><div class="casAuthors">Murza, Alexandre; Parent, Alexandre; Besserer-Offroy, Elie; Tremblay, Hugo; Karadereye, Felix; Beaudet, Nicolas; Leduc, Richard; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-325</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of the APJ receptor, a member of the G-protein-coupled receptor family.  The apelin-APJ complex has been detected in many tissues and is emerging as a promising target for several pathophysiol. conditions.  There is currently little information on the structure-activity relationship (SAR) of the apelin hormone.  In an effort to better delineate SAR, we synthesized analogs of apelin-13 modified at selected positions with unnatural amino acids, with a particular emphasis on the C-terminal portion.  Analogs were then tested in binding and functional assays by evaluating Gi/o-mediated decreases in cAMP levels and by assessing β-arrestin2 recruitment to the APJ receptor.  The plasma stability of new compds. was also assessed.  Several analogs were found to possess increased binding and higher stability than the parent peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb17rjHTl2IrVg90H21EOLACvtfcHk0lgryoCCG5q-8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgur%252FL&md5=01202090f34b4a1933a0a3045cdf5763</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100492%26sid%3Dliteratum%253Aachs%26aulast%3DMurza%26aufirst%3DA.%26aulast%3DParent%26aufirst%3DA.%26aulast%3DBesserer-Offroy%26aufirst%3DE.%26aulast%3DTremblay%26aufirst%3DH.%26aulast%3DKaradereye%26aufirst%3DF.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3DE.%26atitle%3DElucidation%2520of%2520the%2520structure-activity%2520relationships%2520of%2520apelin%253A%2520influence%2520of%2520unnatural%2520amino%2520acids%2520on%2520binding%252C%2520signaling%252C%2520and%2520plasma%2520stability%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D318%26epage%3D325%26doi%3D10.1002%2Fcmdc.201100492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhungana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S. P.</span><span> </span><span class="NLM_article-title">Identifying structural determinants of potency for analogs of apelin-13: integration of C-terminal truncation with structure-activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2992</span><span class="NLM_x">–</span> <span class="NLM_lpage">2997</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.bmc.2014.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=24755525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2992-2997&author=Y.+Zhangauthor=R.+Maitraauthor=D.+L.+Harrisauthor=S.+Dhunganaauthor=R.+Snyderauthor=S.+P.+Runyon&title=Identifying+structural+determinants+of+potency+for+analogs+of+apelin-13%3A+integration+of+C-terminal+truncation+with+structure-activity&doi=10.1016%2Fj.bmc.2014.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure-activity</span></div><div class="casAuthors">Zhang, Yanyan; Maitra, Rangan; Harris, Danni L.; Dhungana, Suraj; Snyder, Rodney; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2992-2997</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apelin peptides function as endogenous ligands of the APJ receptor and have been implicated in a no. of important biol. processes.  While several apelinergic peptides have been reported, apelin-13 (Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe) remains the most commonly studied and reported ligand of APJ.  This study examines the effect of C-terminal peptide truncations and comprehensive structure-activity relationship (SAR) for a series of analogs based on apelin-13 to develop more potent and stable analogs.  C-terminal truncation studies identified apelin-13 (N-acetyl 2-11) amide as a potent agonist (EC50 = 4.4 nM).  Comprehensive SAR studies also detd. that Arg 2, Leu 5, Lys 8, Met 11, were key positions for detg. agonist potency, whereas the hydrophobic vol. of Lys-8 was a specific determinate of activity.  Plasma stability studies on the truncated 10-mer peptide (EC50 = 33 nM) indicated the primary sites of cleavage occurred between Nle 3 and Leu 4 and also between Ala 5 and Ala-6.  These new ligands represent the shortest known apelin peptides with good functional potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvVQ3Bxd0D_bVg90H21EOLACvtfcHk0lgGkEUtPyt_Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCmurg%253D&md5=6f04420714d191792dd27d43796d886d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DD.%2BL.%26aulast%3DDhungana%26aufirst%3DS.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DIdentifying%2520structural%2520determinants%2520of%2520potency%2520for%2520analogs%2520of%2520apelin-13%253A%2520integration%2520of%2520C-terminal%2520truncation%2520with%2520structure-activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2992%26epage%3D2997%26doi%3D10.1016%2Fj.bmc.2014.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Murza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belleville, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longpre, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarret, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsault, E.</span><span> </span><span class="NLM_article-title">Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1002/bip.22498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fbip.22498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=24728860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFajtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2014&pages=297-303&author=A.+Murzaauthor=K.+Bellevilleauthor=J.+M.+Longpreauthor=P.+Sarretauthor=E.+Marsault&title=Stability+and+degradation+patterns+of+chemically+modified+analogs+of+apelin-13+in+plasma+and+cerebrospinal+fluid&doi=10.1002%2Fbip.22498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid</span></div><div class="casAuthors">Murza, Alexandre; Belleville, Karine; Longpre, Jean-Michel; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-303</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of APJ, which belongs to the superfamily of G protein-coupled receptors.  In recent years, the apelin/APJ system has been detected in many tissues and emerges as a promising target for the treatment of various pathophysiol. conditions.  Pyr1-apelin-13 is the major isoform of apelin in human plasma; however its stability and proteolytic degrdn. pattern remain poorly understood.  The aim of the present study was first to identify the cleavage sites of Pyr1-apelin-13 in mouse, rat and human plasma and rat cerebrospinal fluid, then to det. its stability to proteolytic degrdn. following i.v. administration in rats.  Secondly, key residues were substituted by natural and unnatural amino acids in order to examine the impact on in vitro stability and degrdn. pattern.  The kinetics of degrdn. revealed that the Leu5-Ser6 peptide bond of Pyr1-apelin-13 is the first cleavage obsd. in plasma, independently of the species.  Replacement of Phe13 by unnatural amino acids showed a 10-fold increase in plasma stability although the hydrolysis of Pro12-Phe13 bond, previously described as a site of cleavage by ACE-2, was not obsd.  In vivo, this Pro12-Phe13 bond was cleaved yet appears as a minor product compared to hydrolysis of the Pro10-Met11 bond.  This study pinpoints the most crit. amino acids targeted by proteases and will be instrumental for the design of Pyr1-apelin-13 analogs possessing increased stability.  © 2014 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 102: 297-303, 2014.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEbpU8iN3a-bVg90H21EOLACvtfcHk0lgGkEUtPyt_Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFajtLc%253D&md5=cf77c3c930a4dc5dcbe6ffb9778b54bf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fbip.22498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.22498%26sid%3Dliteratum%253Aachs%26aulast%3DMurza%26aufirst%3DA.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DLongpre%26aufirst%3DJ.%2BM.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3DE.%26atitle%3DStability%2520and%2520degradation%2520patterns%2520of%2520chemically%2520modified%2520analogs%2520of%2520apelin-13%2520in%2520plasma%2520and%2520cerebrospinal%2520fluid%26jtitle%3DBiopolymers%26date%3D2014%26volume%3D102%26spage%3D297%26epage%3D303%26doi%3D10.1002%2Fbip.22498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">McKinnie, S. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosquera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudit, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vederas, J. C.</span><span> </span><span class="NLM_article-title">The metalloprotease neprilysin degrades and inactivates apelin peptides</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span><span class="refDoi"> DOI: 10.1002/cbic.201600244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fcbic.201600244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=27377680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSitbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1495-1498&author=S.+M.+K.+McKinnieauthor=C.+Fischerauthor=K.+M.+H.+Tranauthor=W.+Wangauthor=F.+Mosqueraauthor=G.+Y.+Ouditauthor=J.+C.+Vederas&title=The+metalloprotease+neprilysin+degrades+and+inactivates+apelin+peptides&doi=10.1002%2Fcbic.201600244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Metalloprotease Neprilysin Degrades and Inactivates Apelin Peptides</span></div><div class="casAuthors">McKinnie, Shaun M. K.; Fischer, Conrad; Tran, Kelvin M. H.; Wang, Wang; Mosquera, Fabricio; Oudit, Gavin Y.; Vederas, John C.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1495-1498</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The apelinergic system is a mammalian peptide hormone network with key physiol. roles.  Apelin isoforms and analogs are believed to be promising therapeutics for cardiovascular disease.  Despite extensive studies on apelin-13 degrdn. patterns, only one protease, angiotensin-converting enzyme 2 (ACE2), had been implicated in its physiol. regulation.  Through use of a peptide-based fluorescent probe, we identified the metalloprotease neprilysin (NEP, a target for Entresto used in treatment of heart failure) as an enzyme that cleaves apelin isoforms.  In vitro NEP proteolysis generated fragments that lacked the ability to bind to the apelin receptor, thereby making NEP the first protease to fully inactivate apelin.  The involvement of NEP in the apelinergic system contributes to the understanding of its role in cardiovascular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7gZ2z2xeP-bVg90H21EOLACvtfcHk0lgGkEUtPyt_Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSitbjE&md5=bbcbfe56ccc7b6012c8a5912b7de7bc3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600244%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinnie%26aufirst%3DS.%2BM.%2BK.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DK.%2BM.%2BH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMosquera%26aufirst%3DF.%26aulast%3DOudit%26aufirst%3DG.%2BY.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520metalloprotease%2520neprilysin%2520degrades%2520and%2520inactivates%2520apelin%2520peptides%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26spage%3D1495%26epage%3D1498%26doi%3D10.1002%2Fcbic.201600244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Gafford, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skidgel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdös, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersh, L. B.</span><span> </span><span class="NLM_article-title">Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3265</span><span class="NLM_x">–</span> <span class="NLM_lpage">3271</span><span class="refDoi"> DOI: 10.1021/bi00282a035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00282a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1983&pages=3265-3271&author=J.+T.+Gaffordauthor=R.+A.+Skidgelauthor=E.+G.+Erd%C3%B6sauthor=L.+B.+Hersh&title=Human+kidney+%22enkephalinase%22%2C+a+neutral+metalloendopeptidase+that+cleaves+active+peptides&doi=10.1021%2Fbi00282a035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi00282a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00282a035%26sid%3Dliteratum%253Aachs%26aulast%3DGafford%26aufirst%3DJ.%2BT.%26aulast%3DSkidgel%26aufirst%3DR.%2BA.%26aulast%3DErd%25C3%25B6s%26aufirst%3DE.%2BG.%26aulast%3DHersh%26aufirst%3DL.%2BB.%26atitle%3DHuman%2520kidney%2520%2522enkephalinase%2522%252C%2520a%2520neutral%2520metalloendopeptidase%2520that%2520cleaves%2520active%2520peptides%26jtitle%3DBiochemistry%26date%3D1983%26volume%3D22%26spage%3D3265%26epage%3D3271%26doi%3D10.1021%2Fbi00282a035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rice, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, N. M.</span><span> </span><span class="NLM_article-title">Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1042/BJ20040634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1042%2FBJ20040634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=15283675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslOqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2004&pages=45-51&author=G.+I.+Riceauthor=D.+A.+Thomasauthor=P.+J.+Grantauthor=A.+J.+Turnerauthor=N.+M.+Hooper&title=Evaluation+of+angiotensin-converting+enzyme+%28ACE%29%2C+its+homologue+ACE2+and+neprilysin+in+angiotensin+peptide+metabolism&doi=10.1042%2FBJ20040634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism</span></div><div class="casAuthors">Rice, Gillian I.; Thomas, Daniel A.; Grant, Peter J.; Turner, Anthony J.; Hooper, Nigel M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In the RAS (renin-angiotensin system), Ang I (angiotensin I) is cleaved by ACE (angiotensin-converting enzyme) to form Ang II (angiotensin II), which has effects on blood pressure, fluid and electrolyte homeostasis.  We have examd. the kinetics of angiotensin peptide cleavage by full-length human ACE, the sep. N- and C-domains of ACE, the homolog of ACE, ACE2, and NEP (neprilysin).  The activity of the enzyme prepns. was detd. by active-site titrns. using competitive tight-binding inhibitors and fluorogenic substrates.  Ang I was effectively cleaved by NEP to Ang (1-7) (kcat/Km of 6.2×105 M-1·s-1), but was a poor substrate for ACE2 (kcat/Km of 3.3×104 M-1·s-1).  Ang (1-9) was a better substrate for NEP than ACE (kcat/Km of 3.7×105 M-1·s-1 compared with kcat/Km of 6.8×104 M-1·s-1).  Ang II was cleaved efficiently by ACE2 to Ang (1-7) (kcat/Km of 2.2×106 M-1·s-1) and was cleaved by NEP (kcat/Km of 2.2×105 M-1·s-1) to several degrdn. products.  In contrast with a previous report, Ang (1-7), like Ang I and Ang (1-9), was cleaved with a similar efficiency by both the N- and C-domains of ACE (kcat/Km of 3.6×105 M-1·s-1 compared with kcat/Km of 3.3×105 M-1·s-1).  The two active sites of ACE exhibited neg. co-operativity when either Ang I or Ang (1-7) was the substrate.  In addn., a range of ACE inhibitors failed to inhibit ACE2.  These kinetic data highlight that the flux of peptides through the RAS is complex, with the levels of ACE, ACE2 and NEP dictating whether vasoconstriction or vasodilation will predominate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-F-14Hfcq7Vg90H21EOLACvtfcHk0lhR25rKiVeP2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslOqs7s%253D&md5=a17a1c5031b55362e691c7f31272eea6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1042%2FBJ20040634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040634%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DG.%2BI.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DGrant%26aufirst%3DP.%2BJ.%26aulast%3DTurner%26aufirst%3DA.%2BJ.%26aulast%3DHooper%26aufirst%3DN.%2BM.%26atitle%3DEvaluation%2520of%2520angiotensin-converting%2520enzyme%2520%2528ACE%2529%252C%2520its%2520homologue%2520ACE2%2520and%2520neprilysin%2520in%2520angiotensin%2520peptide%2520metabolism%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D383%26spage%3D45%26epage%3D51%26doi%3D10.1042%2FBJ20040634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, Y.</span><span> </span><span class="NLM_article-title">Comparison of the hydrolysis of the three types of natriuretic peptides by human kidney neutral endopeptidase 24.11</span> <span class="citation_source-journal">Biochem. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1006/bmme.1997.2584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1006%2Fbmme.1997.2584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=9232196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADyaK2sXksFGisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=47-51&author=Y.+Watanabeauthor=K.+Nakajimaauthor=Y.+Shimamoriauthor=Y.+Fujimoto&title=Comparison+of+the+hydrolysis+of+the+three+types+of+natriuretic+peptides+by+human+kidney+neutral+endopeptidase+24.11&doi=10.1006%2Fbmme.1997.2584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the hydrolysis of the three types of natriuretic peptides by human kidney neutral endopeptidase 24.11</span></div><div class="casAuthors">Watanabe, Yasuhiro; Nakajima, Kenjiro; Shimamori, Yoshimitsu; Fujimoto, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Molecular Medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-51</span>CODEN:
                <span class="NLM_cas:coden">BMMEF4</span>;
        ISSN:<span class="NLM_cas:issn">1077-3150</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The degrdn. of 3 human natriuretic peptides by human kidney neutral endopeptidase 24.11 has been investigated.  The studies revealed that hANP-28 and hCNP-22 are the preferred substrates, whereas hBNP-32 is not.  The enzyme has been known to inactivate hANP-28 from cleavage at the Cys-Phe bond at the beginning of its ring structure.  Anal. of the cleavage sites of each peptide indicated that the initial cleavage site of hCNP-22 is analogous to that of hANP-28.  The Cys-Phe bond of hBNP-32 was insensitive to this enzymic cleavage.  We speculate that the stability of hBNP-32 may result from the insusceptibility of its Cys-Phe bond at the beginning of the ring structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3eC2dwPjInbVg90H21EOLACvtfcHk0lhR25rKiVeP2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFGisLc%253D&md5=693a285f2686032adeb4565878a52c16</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1006%2Fbmme.1997.2584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbmme.1997.2584%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DShimamori%26aufirst%3DY.%26aulast%3DFujimoto%26aufirst%3DY.%26atitle%3DComparison%2520of%2520the%2520hydrolysis%2520of%2520the%2520three%2520types%2520of%2520natriuretic%2520peptides%2520by%2520human%2520kidney%2520neutral%2520endopeptidase%252024.11%26jtitle%3DBiochem.%2520Mol.%2520Med.%26date%3D1997%26volume%3D61%26spage%3D47%26epage%3D51%26doi%3D10.1006%2Fbmme.1997.2584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Vijayaraghavan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carretero, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersh, L. B.</span><span> </span><span class="NLM_article-title">Hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">14150</span><span class="NLM_x">–</span> <span class="NLM_lpage">14155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=14150-14155&author=J.+Vijayaraghavanauthor=A.+G.+Scicliauthor=O.+A.+Carreteroauthor=C.+Slaughterauthor=C.+Moomawauthor=L.+B.+Hersh&title=Hydrolysis+of+endothelins+by+neutral+endopeptidase+24.11+%28enkephalinase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVijayaraghavan%26aufirst%3DJ.%26aulast%3DScicli%26aufirst%3DA.%2BG.%26aulast%3DCarretero%26aufirst%3DO.%2BA.%26aulast%3DSlaughter%26aufirst%3DC.%26aulast%3DMoomaw%26aufirst%3DC.%26aulast%3DHersh%26aufirst%3DL.%2BB.%26atitle%3DHydrolysis%2520of%2520endothelins%2520by%2520neutral%2520endopeptidase%252024.11%2520%2528enkephalinase%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D14150%26epage%3D14155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Nalivaeva, N. N.; Turner, A. J.</span>, <span> </span><span class="NLM_article-title">Neprilysin</span>. In  <span class="citation_source-book">Handbook of Proteolytic Enzymes</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group">Rawlings, N. D.; Salvesen, G. S.</span>, Eds.; <span class="NLM_publisher-name">Academic Press,</span>: <span class="NLM_publisher-loc">London, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">1</span>, pp  <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2FB978-0-12-382219-2.00127-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=612-619&author=N.+N.+Nalivaeva&author=A.+J.+Turnerauthor=N.+D.+Rawlings&author=G.+S.+Salvesen&title=Handbook+of+Proteolytic+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-382219-2.00127-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-382219-2.00127-7%26sid%3Dliteratum%253Aachs%26aulast%3DNalivaeva%26aufirst%3DN.%2BN.%26atitle%3DNeprilysin%26btitle%3DHandbook%2520of%2520Proteolytic%2520Enzymes%26aulast%3DRawlings%26aufirst%3DN.%2BD.%26pub%3DAcademic%2520Press%26date%3D2013%26volume%3D1%26spage%3D612%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Langelaan, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebbington, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainey, J. K.</span><span> </span><span class="NLM_article-title">Structural insight into G-protein coupled receptor binding by apelin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1021/bi801864b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi801864b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=537-548&author=D.+N.+Langelaanauthor=E.+M.+Bebbingtonauthor=T.+Reddyauthor=J.+K.+Rainey&title=Structural+insight+into+G-protein+coupled+receptor+binding+by+apelin&doi=10.1021%2Fbi801864b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insight into G-Protein Coupled Receptor Binding by Apelin</span></div><div class="casAuthors">Langelaan, David N.; Bebbington, E. Meghan; Reddy, Tyler; Rainey, Jan K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-548</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apelin peptides are the cognate ligands for the G-protein coupled receptor APJ, with functions in the cardiovascular and central nervous systems, in glucose metab. and as a human immunodeficiency virus (HIV-1) coreceptor.  Apelin is found in 13-36 residue forms in vivo.  The structures of five isoforms of apelin at physiol. vs. low (5-6°) temp. are compared here using CD and NMR spectroscopy, demonstrating increased structure at low temp.  Far-UV CD spectra are predominantly random coil for apelin isoforms, but are convoluted by unusual bands from the C-terminal phenylalanine side chain.  These bands, assigned using F13A-apelin-13, are accentuated at 5° and imply conformational restriction.  At 35°, the R6-L9 region of apelin-17 is well structured, consistent with previous mutagenesis results showing necessity of this segment for apelin-APJ binding and activation.  At 5°, R6-L9 retains its structuring while the functionally crit. C-terminal G13-F17 region also becomes highly structured.  Type IV β-turns and some polyproline-II structure alongside F17 side chain motional redn. correlate well with CD spectral properties.  Cis-trans peptide bond isomerization at P14 and P16 produces two sequentially assignable conformers (both trans:both cis ∼4:1) alongside less populated conformers.  Chem. shift assignment of apelin-12, -13 and pyroglutamate-apelin-13 implies highly similar structuring and the same isomerization at the C-terminus.  Based on the apelin-17 structure, a two-step binding and activation mechanism is hypothesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbPwNz_BRlEbVg90H21EOLACvtfcHk0lg_maIhHVM8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlaltw%253D%253D&md5=21a18651653a9c28fcdb3a3101908228</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi801864b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801864b%26sid%3Dliteratum%253Aachs%26aulast%3DLangelaan%26aufirst%3DD.%2BN.%26aulast%3DBebbington%26aufirst%3DE.%2BM.%26aulast%3DReddy%26aufirst%3DT.%26aulast%3DRainey%26aufirst%3DJ.%2BK.%26atitle%3DStructural%2520insight%2520into%2520G-protein%2520coupled%2520receptor%2520binding%2520by%2520apelin%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D537%26epage%3D548%26doi%3D10.1021%2Fbi801864b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Gerbier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvineau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvear-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrioz, X.</span><span> </span><span class="NLM_article-title">New structural insights into the apelin receptor: identification of key residues for apelin binding</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1096/fj.14-256339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1096%2Ffj.14-256339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=25359495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=314-322&author=R.+Gerbierauthor=V.+Lerouxauthor=P.+Couvineauauthor=R.+Alvear-Perezauthor=B.+Maigretauthor=C.+Llorens-Cortesauthor=X.+Iturrioz&title=New+structural+insights+into+the+apelin+receptor%3A+identification+of+key+residues+for+apelin+binding&doi=10.1096%2Ffj.14-256339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">New structural insights into the apelin receptor: identification of key residues for apelin binding</span></div><div class="casAuthors">Gerbier, Romain; Leroux, Vincent; Couvineau, Pierre; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">314-322, 10.1096/fj.14-256339</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of the orphan 7-transmembrane domain GPCRAPJ, now named the apelin receptor (ApelinR).  Apelin plays a prominent role in body fluid and cardiovascular homeostasis.  To better understand the structural organization of the ApelinR, we built 3 homol. 3-dimensional (3D) models of the human ApelinR using the validated cholecystokinin receptor-1 3D model or the X-ray structures of the β2-adrenergic and CXCR4 receptors as templates.  Docking of the pyroglutamyl form of apelin 13 (pE13F) into these models revealed the conservation at the bottom of the binding site of a hydrophobic cavity in which the C-terminal Phe of pE13F was embedded.  In contrast, at the top of the binding site, depending on the model, different interactions were visualized between acidic residues of the ApelinR and the basic residues of pE13F.  Using site-directed mutagenesis, we showed that Asp 92, Glu 172, and Asp 282 of rat ApelinR are key residues in apelin binding by interacting with Lys 8, Arg 2, and Arg 4 of pE13F, resp.  These residues are only seen in the CXCR4-based ApelinR 3D model, further validating this model.  These findings bring new insights into the structural organization of the ApelinR and the mode of apelin binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1rQ4zJn5Ge7Vg90H21EOLACvtfcHk0lg_maIhHVM8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGjsg%253D%253D&md5=4ec7d8ebd009a0461d1179c400f95262</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-256339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-256339%26sid%3Dliteratum%253Aachs%26aulast%3DGerbier%26aufirst%3DR.%26aulast%3DLeroux%26aufirst%3DV.%26aulast%3DCouvineau%26aufirst%3DP.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26aulast%3DIturrioz%26aufirst%3DX.%26atitle%3DNew%2520structural%2520insights%2520into%2520the%2520apelin%2520receptor%253A%2520identification%2520of%2520key%2520residues%2520for%2520apelin%2520binding%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D314%26epage%3D322%26doi%3D10.1096%2Ffj.14-256339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Langelaan, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellaire, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupre, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainey, J. K.</span><span> </span><span class="NLM_article-title">Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1828</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1483</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.bbamem.2013.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=23438363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltFCrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1828&publication_year=2013&pages=1471-1483&author=D.+N.+Langelaanauthor=T.+Reddyauthor=A.+W.+Banksauthor=G.+Dellaireauthor=D.+J.+Dupreauthor=J.+K.+Rainey&title=Structural+features+of+the+apelin+receptor+N-terminal+tail+and+first+transmembrane+segment+implicated+in+ligand+binding+and+receptor+trafficking&doi=10.1016%2Fj.bbamem.2013.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking</span></div><div class="casAuthors">Langelaan, David N.; Reddy, Tyler; Banks, Aaron W.; Dellaire, Graham; Dupre, Denis J.; Rainey, Jan K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1828</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1471-1483</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G-protein coupled receptors (GPCRs) comprise a large family of membrane proteins with rich functional diversity.  Signaling through the apelin receptor (AR or APJ) influences the cardiovascular system, central nervous system and glucose regulation.  Pathophysiol. involvement of apelin has been shown in atherosclerosis, cancer, human immunodeficiency virus-1 (HIV-1) infection and obesity.  Here, we present the high-resoln. NMR spectroscopy-based structure of the N-terminus and first transmembrane (TM) segment of AR (residues 1-55, AR55) in dodecylphosphocholine micelles.  AR55 consists of two disrupted helixes, spanning residues D14-K25 and A29-R551.59.  Mol. dynamics (MD) simulations of AR built from a hybrid of exptl. NMR and homol. model-based restraints allowed validation of the AR55 structure in the context of the full-length receptor in a hydrated bilayer.  AR55 structural features were functionally probed using mutagenesis in full-length AR through monitoring of apelin-induced extracellular signal-regulated kinase (ERK) phosphorylation in transiently transfected human embryonic kidney (HEK) 293A cells.  Residues E20 and D23 form an extracellular anionic face and interact with lipid headgroups during MD simulations in the absence of ligand, producing an ideal binding site for a cationic apelin ligand proximal to the membrane-water interface, lending credence to membrane-catalyzed apelin-AR binding.  In the TM region of AR55, N461.50 is central to a disruption in helical character.  G421.46, G451.49 and N461.50, which are all involved in the TM helical disruption, are essential for proper trafficking of AR.  In summary, we introduce a new correlative NMR spectroscopy and computational biochem. methodol. and demonstrate its utility in providing some of the first high-resoln. structural information for a peptide-activated GPCR TM domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3gBuQKnKesbVg90H21EOLACvtfcHk0lg_maIhHVM8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltFCrtbs%253D&md5=dd5b01534576db5ecfd903ad8a6d7b26</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLangelaan%26aufirst%3DD.%2BN.%26aulast%3DReddy%26aufirst%3DT.%26aulast%3DBanks%26aufirst%3DA.%2BW.%26aulast%3DDellaire%26aufirst%3DG.%26aulast%3DDupre%26aufirst%3DD.%2BJ.%26aulast%3DRainey%26aufirst%3DJ.%2BK.%26atitle%3DStructural%2520features%2520of%2520the%2520apelin%2520receptor%2520N-terminal%2520tail%2520and%2520first%2520transmembrane%2520segment%2520implicated%2520in%2520ligand%2520binding%2520and%2520receptor%2520trafficking%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2013%26volume%3D1828%26spage%3D1471%26epage%3D1483%26doi%3D10.1016%2Fj.bbamem.2013.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Belokon’, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tararov, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maleev, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savel’eva, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryzhov, M. G.</span><span> </span><span class="NLM_article-title">Improved procedures for the synthesis of (<i>S</i>)-2-[<i>N</i>-(<i>N</i>′-benzyl-prolyl)amino]benzophenone (BPB) and Ni(II) complexes of Schiff’s bases derived from BPB and amino acids</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4249</span><span class="NLM_x">–</span> <span class="NLM_lpage">4252</span><span class="refDoi"> DOI: 10.1016/S0957-4166(98)00449-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2FS0957-4166%2898%2900449-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=4249-4252&author=Y.+N.+Belokon%E2%80%99author=V.+I.+Tararovauthor=V.+I.+Maleevauthor=T.+F.+Savel%E2%80%99evaauthor=M.+G.+Ryzhov&title=Improved+procedures+for+the+synthesis+of+%28S%29-2-%5BN-%28N%E2%80%B2-benzyl-prolyl%29amino%5Dbenzophenone+%28BPB%29+and+Ni%28II%29+complexes+of+Schiff%E2%80%99s+bases+derived+from+BPB+and+amino+acids&doi=10.1016%2FS0957-4166%2898%2900449-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2898%2900449-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252898%252900449-2%26sid%3Dliteratum%253Aachs%26aulast%3DBelokon%25E2%2580%2599%26aufirst%3DY.%2BN.%26aulast%3DTararov%26aufirst%3DV.%2BI.%26aulast%3DMaleev%26aufirst%3DV.%2BI.%26aulast%3DSavel%25E2%2580%2599eva%26aufirst%3DT.%2BF.%26aulast%3DRyzhov%26aufirst%3DM.%2BG.%26atitle%3DImproved%2520procedures%2520for%2520the%2520synthesis%2520of%2520%2528S%2529-2-%255BN-%2528N%25E2%2580%25B2-benzyl-prolyl%2529amino%255Dbenzophenone%2520%2528BPB%2529%2520and%2520Ni%2528II%2529%2520complexes%2520of%2520Schiff%25E2%2580%2599s%2520bases%2520derived%2520from%2520BPB%2520and%2520amino%2520acids%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1998%26volume%3D9%26spage%3D4249%26epage%3D4252%26doi%3D10.1016%2FS0957-4166%2898%2900449-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ndungu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carducci, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Large scale enantiomeric synthesis, purification, and characterization of ω-unsaturated amino acids via a Gly-Ni(II)-BPB-complex</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">8233</span><span class="NLM_x">–</span> <span class="NLM_lpage">8243</span><span class="refDoi"> DOI: 10.1016/j.tet.2004.06.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.tet.2004.06.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=8233-8243&author=X.+Guauthor=J.+M.+Ndunguauthor=W.+Qiuauthor=J.+Yingauthor=M.+D.+Carducciauthor=H.+Woodenauthor=V.+J.+Hruby&title=Large+scale+enantiomeric+synthesis%2C+purification%2C+and+characterization+of+%CF%89-unsaturated+amino+acids+via+a+Gly-Ni%28II%29-BPB-complex&doi=10.1016%2Fj.tet.2004.06.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2004.06.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2004.06.087%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DX.%26aulast%3DNdungu%26aufirst%3DJ.%2BM.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DYing%26aufirst%3DJ.%26aulast%3DCarducci%26aufirst%3DM.%2BD.%26aulast%3DWooden%26aufirst%3DH.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DLarge%2520scale%2520enantiomeric%2520synthesis%252C%2520purification%252C%2520and%2520characterization%2520of%2520%25CF%2589-unsaturated%2520amino%2520acids%2520via%2520a%2520Gly-Ni%2528II%2529-BPB-complex%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26spage%3D8233%26epage%3D8243%26doi%3D10.1016%2Fj.tet.2004.06.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Nash, H. M.; Annis, D. A.; Guerlavais, V.; Licklider, L.</span><span> </span><span class="NLM_article-title">Improved Peptidomimetic Macrocycles</span>. WO 2011047215, April 21,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=H.+M.+Nash&author=D.+A.+Annis&author=V.+Guerlavais&author=L.+Licklider&title=Improved+Peptidomimetic+Macrocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNash%26aufirst%3DH.%2BM.%26atitle%3DImproved%2520Peptidomimetic%2520Macrocycles%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Pascal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, R.</span><span> </span><span class="NLM_article-title">Preservation of the Fmoc protective group under alkaline conditions by using CaCl2. Applications in peptide synthesis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5031</span><span class="NLM_x">–</span> <span class="NLM_lpage">5034</span><span class="refDoi"> DOI: 10.1016/S0040-4039(98)00994-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2FS0040-4039%2898%2900994-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=5031-5034&author=R.+Pascalauthor=R.+Sola&title=Preservation+of+the+Fmoc+protective+group+under+alkaline+conditions+by+using+CaCl2.+Applications+in+peptide+synthesis&doi=10.1016%2FS0040-4039%2898%2900994-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900994-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900994-0%26sid%3Dliteratum%253Aachs%26aulast%3DPascal%26aufirst%3DR.%26aulast%3DSola%26aufirst%3DR.%26atitle%3DPreservation%2520of%2520the%2520Fmoc%2520protective%2520group%2520under%2520alkaline%2520conditions%2520by%2520using%2520CaCl2.%2520Applications%2520in%2520peptide%2520synthesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D5031%26epage%3D5034%26doi%3D10.1016%2FS0040-4039%2898%2900994-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Traore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubell, W. D.</span><span> </span><span class="NLM_article-title">Diversity-oriented synthesis of azapeptides with basic amino acid residues: aza-lysine, aza-ornithine, and aza-arginine</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3588</span><span class="NLM_x">–</span> <span class="NLM_lpage">3591</span><span class="refDoi"> DOI: 10.1021/ol501586y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol501586y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3588-3591&author=M.+Traoreauthor=N.+D.+Doanauthor=W.+D.+Lubell&title=Diversity-oriented+synthesis+of+azapeptides+with+basic+amino+acid+residues%3A+aza-lysine%2C+aza-ornithine%2C+and+aza-arginine&doi=10.1021%2Fol501586y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fol501586y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol501586y%26sid%3Dliteratum%253Aachs%26aulast%3DTraore%26aufirst%3DM.%26aulast%3DDoan%26aufirst%3DN.%2BD.%26aulast%3DLubell%26aufirst%3DW.%2BD.%26atitle%3DDiversity-oriented%2520synthesis%2520of%2520azapeptides%2520with%2520basic%2520amino%2520acid%2520residues%253A%2520aza-lysine%252C%2520aza-ornithine%252C%2520and%2520aza-arginine%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D3588%26epage%3D3591%26doi%3D10.1021%2Fol501586y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Garcia-Ramos, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubell, W. D.</span><span> </span><span class="NLM_article-title">Synthesis and alkylation of aza-glycinyl dipeptide building blocks</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span><span class="refDoi"> DOI: 10.1002/psc.2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fpsc.2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=24203503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslartLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=725-729&author=Y.+Garcia-Ramosauthor=W.+D.+Lubell&title=Synthesis+and+alkylation+of+aza-glycinyl+dipeptide+building+blocks&doi=10.1002%2Fpsc.2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and alkylation of aza-glycinyl dipeptide building blocks</span></div><div class="casAuthors">Garcia-Ramos, Yesica; Lubell, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">725-729</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Aza-glycinyl dipeptides are useful building blocks for the synthesis of a diverse array of azapeptides.  The construction of the aza-glycine residue is however challenging, because of the potential for side reactions, such as those leading to formation of oxadiazalone, hydantoin and sym. urea byproducts.  Employing N,N'-disuccinimidyl carbonate to activate benzophenone hydrazone, we have developed a more efficient approach for the synthesis of aza-glycinyl dipeptides.  Alkylation of the semicarbazone of the resulting protected aza-glycinyl dipeptides using tetraethylammonium hydroxide and propargyl bromide provided an efficient entry into the aza-propargylglycinyl peptide building blocks, which have served previously in various reactions including Sonogashira cross-couplings, dipolar cycloaddns. and intramol. exo-dig cycloaddns. to furnish a variety of azapeptide building blocks.  Copyright pr 2013 European Peptide Society and John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo0v3joi2aFLVg90H21EOLACvtfcHk0ljx_fhCUDXyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslartLvP&md5=21698054e79619e7f8a58acd6451e188</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fpsc.2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.2572%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Ramos%26aufirst%3DY.%26aulast%3DLubell%26aufirst%3DW.%2BD.%26atitle%3DSynthesis%2520and%2520alkylation%2520of%2520aza-glycinyl%2520dipeptide%2520building%2520blocks%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2013%26volume%3D19%26spage%3D725%26epage%3D729%26doi%3D10.1002%2Fpsc.2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Betts, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leissring, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolios, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. M.</span><span> </span><span class="NLM_article-title">Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1016/j.nbd.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.nbd.2008.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=18602473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSis7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=442-450&author=V.+Bettsauthor=M.+A.+Leissringauthor=G.+Doliosauthor=R.+Wangauthor=D.+J.+Selkoeauthor=D.+M.+Walsh&title=Aggregation+and+catabolism+of+disease-associated+intra-A%CE%B2+mutations%3A+reduced+proteolysis+of+A%CE%B2A21G+by+neprilysin&doi=10.1016%2Fj.nbd.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin</span></div><div class="casAuthors">Betts, Vicki; Leissring, Malcolm A.; Dolios, Georgia; Wang, Rong; Selkoe, Dennis J.; Walsh, Dominic M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Five point mutations within the amyloid β-protein (Aβ) sequence of the APP gene are assocd. with hereditary diseases which are similar or identical to Alzheimer's disease and encode: the A21G (Flemish), E22G (Arctic), E22K (Italian), E22Q (Dutch) and the D23N (Iowa) amino acid substitutions.  Although a substantial body of data exists on the effects of these mutations on Aβ prodn., whether or not intra-Aβ mutations alter degrdn. and how this relates to their aggregation state remain unclear.  Here we report that the E22G, E22Q and the D23N substitutions significantly increase fibril nucleation and extension, whereas the E22K substitution exhibits only an increased rate of extension and the A21G substitution actually causes a decrease in the extension rate.  These substantial differences in aggregation together with our observation that aggregated wild type Aβ(1-40) was much less well degraded than monomeric wild type Aβ(1-40), prompted us to assess whether or not disease-assocd. intra-Aβ mutations alter proteolysis independent of their effects on aggregation.  Neprilysin (NEP), insulin degrading enzyme (IDE) and plasmin play a major role in Aβ catabolism, therefore we compared the ability of these enzymes to degrade wild type and mutant monomeric Aβ peptides.  Expts. investigating proteolysis revealed that all monomeric peptides are degraded similarly by IDE and plasmin, but that the Flemish peptide was degraded significantly more slowly by NEP than wild type Aβ or any of the other mutant peptides.  This finding suggests that resistance to NEP-mediated proteolysis may underlie the pathogenicity assocd. with the A21G mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIuMAcFIAve7Vg90H21EOLACvtfcHk0ljx_fhCUDXyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSis7%252FK&md5=03807ec73cdb586a1edd70b4aa2eaf2c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBetts%26aufirst%3DV.%26aulast%3DLeissring%26aufirst%3DM.%2BA.%26aulast%3DDolios%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26atitle%3DAggregation%2520and%2520catabolism%2520of%2520disease-associated%2520intra-A%25CE%25B2%2520mutations%253A%2520reduced%2520proteolysis%2520of%2520A%25CE%25B2A21G%2520by%2520neprilysin%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2008%26volume%3D31%26spage%3D442%26epage%3D450%26doi%3D10.1016%2Fj.nbd.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Almenoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, M.</span><span> </span><span class="NLM_article-title">Membrane-bound kidney neutral metalloendopeptidase: Interaction with synthetic substrates, natural peptides, and inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.1021/bi00272a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00272a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1983&pages=590-599&author=J.+Almenoffauthor=M.+Orlowski&title=Membrane-bound+kidney+neutral+metalloendopeptidase%3A+Interaction+with+synthetic+substrates%2C+natural+peptides%2C+and+inhibitors&doi=10.1021%2Fbi00272a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbi00272a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00272a011%26sid%3Dliteratum%253Aachs%26aulast%3DAlmenoff%26aufirst%3DJ.%26aulast%3DOrlowski%26aufirst%3DM.%26atitle%3DMembrane-bound%2520kidney%2520neutral%2520metalloendopeptidase%253A%2520Interaction%2520with%2520synthetic%2520substrates%252C%2520natural%2520peptides%252C%2520and%2520inhibitors%26jtitle%3DBiochemistry%26date%3D1983%26volume%3D22%26spage%3D590%26epage%3D599%26doi%3D10.1021%2Fbi00272a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Dion, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Moual, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournie-Zaluski, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roques, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, G.</span><span> </span><span class="NLM_article-title">Evidence that Asn542 of neprilysin (EC 3.4.24.11) is involved in binding of the P2′ residue of substrates and inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span><span class="refDoi"> DOI: 10.1042/bj3110623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1042%2Fbj3110623" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=1995&pages=623-627&author=N.+Dionauthor=H.+Le+Moualauthor=M.+C.+Fournie-Zaluskiauthor=B.+P.+Roquesauthor=P.+Crineauthor=G.+Boileau&title=Evidence+that+Asn542+of+neprilysin+%28EC+3.4.24.11%29+is+involved+in+binding+of+the+P2%E2%80%B2+residue+of+substrates+and+inhibitors&doi=10.1042%2Fbj3110623"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1042%2Fbj3110623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3110623%26sid%3Dliteratum%253Aachs%26aulast%3DDion%26aufirst%3DN.%26aulast%3DLe%2BMoual%26aufirst%3DH.%26aulast%3DFournie-Zaluski%26aufirst%3DM.%2BC.%26aulast%3DRoques%26aufirst%3DB.%2BP.%26aulast%3DCrine%26aufirst%3DP.%26aulast%3DBoileau%26aufirst%3DG.%26atitle%3DEvidence%2520that%2520Asn542%2520of%2520neprilysin%2520%2528EC%25203.4.24.11%2529%2520is%2520involved%2520in%2520binding%2520of%2520the%2520P2%25E2%2580%25B2%2520residue%2520of%2520substrates%2520and%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D1995%26volume%3D311%26spage%3D623%26epage%3D627%26doi%3D10.1042%2Fbj3110623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Bateman, R. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unnithan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersh, L. B.</span><span> </span><span class="NLM_article-title">Identification of the active-site arginine in rat neutral endopeptidase 24.11 (enkephalinase) as arginine 102 and analysis of a glutamine 102 mutant</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">6151</span><span class="NLM_x">–</span> <span class="NLM_lpage">6157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=6151-6157&author=R.+C.+Batemanauthor=D.+Jacksonauthor=C.+A.+Slaughterauthor=S.+Unnithanauthor=Y.+G.+Chaiauthor=C.+Moomawauthor=L.+B.+Hersh&title=Identification+of+the+active-site+arginine+in+rat+neutral+endopeptidase+24.11+%28enkephalinase%29+as+arginine+102+and+analysis+of+a+glutamine+102+mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BC.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3DSlaughter%26aufirst%3DC.%2BA.%26aulast%3DUnnithan%26aufirst%3DS.%26aulast%3DChai%26aufirst%3DY.%2BG.%26aulast%3DMoomaw%26aufirst%3DC.%26aulast%3DHersh%26aufirst%3DL.%2BB.%26atitle%3DIdentification%2520of%2520the%2520active-site%2520arginine%2520in%2520rat%2520neutral%2520endopeptidase%252024.11%2520%2528enkephalinase%2529%2520as%2520arginine%2520102%2520and%2520analysis%2520of%2520a%2520glutamine%2520102%2520mutant%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D6151%26epage%3D6157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">McMurray, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizkala, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swedberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zile, M. R.</span><span> </span><span class="NLM_article-title">PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1056/NEJMoa1409077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1056%2FNEJMoa1409077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=25176015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12hs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=993-1004&author=J.+J.+McMurrayauthor=M.+Packerauthor=A.+S.+Desaiauthor=J.+Gongauthor=M.+P.+Lefkowitzauthor=A.+R.+Rizkalaauthor=J.+L.+Rouleauauthor=V.+C.+Shiauthor=S.+D.+Solomonauthor=K.+Swedbergauthor=M.+R.+Zile&title=PARADIGM-HF+Investigators+and+Committees.+Angiotensin-neprilysin+inhibition+versus+enalapril+in+heart+failure&doi=10.1056%2FNEJMoa1409077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin-neprilysin inhibition versus enalapril in heart failure</span></div><div class="casAuthors">McMurray, John J. V.; Packer, Milton; Desai, Akshay S.; Gong, Jianjian; Lefkowitz, Martin P.; Rizkala, Adel R.; Rouleau, Jean L.; Shi, Victor C.; Solomon, Scott D.; Swedberg, Karl; Zile, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">993-1004, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: We compared the angiotensin receptor-neprilysin inhibitor LCZ696 with enalapril in patients who had heart failure with a reduced ejection fraction.  In previous studies, enalapril improved survival in such patients.  Methods: In this double-blind trial, we randomly assigned 8442 patients with class II, III, or IV heart failure and an ejection fraction of 40% or less to receive either LCZ696 (at a dose of 200 mg twice daily) or enalapril (at a dose of 10 mg twice daily), in addn. to recommended therapy.  The primary outcome was a composite of death from cardiovascular causes or hospitalization for heart failure, but the trial was designed to detect a difference in the rates of death from cardiovascular causes.  Results: The trial was stopped early, according to prespecified rules, after a median follow-up of 27 mo, because the boundary for an overwhelming benefit with LCZ696 had been crossed.  At the time of study closure, the primary outcome had occurred in 914 patients (21.8%) in the LCZ696 group and 1117 patients (26.5%) in the enalapril group (hazard ratio in the LCZ696 group, 0.80; 95% confidence interval [CI], 0.73 to 0.87; P < 0.001).  A total of 711 patients (17.0%) receiving LCZ696 and 835 patients (19.8%) receiving enalapril died (hazard ratio for death from any cause, 0.84; 95% CI, 0.76 to 0.93; P < 0.001); of these patients, 558 (13.3%) and 693 (16.5%), resp., died from cardiovascular causes (hazard ratio, 0.80; 95% CI, 0.71 to 0.89; P < 0.001).  As compared with enalapril, LCZ696 also reduced the risk of hospitalization for heart failure by 21% (P < 0.001) and decreased the symptoms and phys. limitations of heart failure (P = 0.001).  The LCZ696 group had higher proportions of patients with hypotension and nonserious angioedema but lower proportions with renal impairment, hyperkalemia, and cough than the enalapril group.  Conclusions: LCZ696 was superior to enalapril in reducing the risks of death and of hospitalization for heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2JML5-2xPNrVg90H21EOLACvtfcHk0ljOs5tBjXjsQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12hs73N&md5=46efccc50e492a1ae5354073e0ea71e8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1409077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1409077%26sid%3Dliteratum%253Aachs%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DPacker%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DA.%2BS.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLefkowitz%26aufirst%3DM.%2BP.%26aulast%3DRizkala%26aufirst%3DA.%2BR.%26aulast%3DRouleau%26aufirst%3DJ.%2BL.%26aulast%3DShi%26aufirst%3DV.%2BC.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DSwedberg%26aufirst%3DK.%26aulast%3DZile%26aufirst%3DM.%2BR.%26atitle%3DPARADIGM-HF%2520Investigators%2520and%2520Committees.%2520Angiotensin-neprilysin%2520inhibition%2520versus%2520enalapril%2520in%2520heart%2520failure%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D993%26epage%3D1004%26doi%3D10.1056%2FNEJMoa1409077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, C. C. Y.</span><span> </span><span class="NLM_article-title">Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">470</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1016/S0014-2999(03)01821-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2FS0014-2999%2803%2901821-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=12798955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVegsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=470&publication_year=2003&pages=171-175&author=X.+Chengauthor=X.+S.+Chengauthor=C.+C.+Y.+Pang&title=Venous+dilator+effect+of+apelin%2C+an+endogenous+peptide+ligand+for+the+orphan+APJ+receptor%2C+in+conscious+rats&doi=10.1016%2FS0014-2999%2803%2901821-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats</span></div><div class="casAuthors">Cheng, Xing; Cheng, Xiao Shuo; Pang, Catherine C. Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">470</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-175</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Apelin is an endogenous depressor peptide for the G protein-coupled APJ receptor.  The authors' hypothesis is that apelin is a venodilator, and it reduces mean circulatory filling pressure (MCFP; index of venous tone).  Dose-response curves of apelin (10, 20 and 40 nmol/kg) or vehicle (0.9% NaCl) were constructed in two groups each of conscious, unrestrained rats: unblocked rats and rats pretreated with mecamylamine (Mec; ganglionic blocker) and noradrenaline (NA; to restore vascular tone).  The vehicle had no effects in the unblocked or ganglionic-blocked rats.  Apelin decreased mean arterial pressure (MAP) and increased heart rate (HR), but it did not alter mean circulatory filling pressure in the unblocked rats.  In the ganglionic-blocked rats, apelin did not alter heart rate but decreased mean arterial pressure and mean circulatory filling pressure.  These results show that apelin is an arterial and venous dilator in vivo.  The depressor effect of apelin is accompanied by tachycardia which is abolished by ganglion blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgvqaUB-MclrVg90H21EOLACvtfcHk0lhYp1zvajdhPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVegsbc%253D&md5=f24b446470d5fc32950a3f826abea8d1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901821-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901821-1%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DX.%2BS.%26aulast%3DPang%26aufirst%3DC.%2BC.%2BY.%26atitle%3DVenous%2520dilator%2520effect%2520of%2520apelin%252C%2520an%2520endogenous%2520peptide%2520ligand%2520for%2520the%2520orphan%2520APJ%2520receptor%252C%2520in%2520conscious%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D470%26spage%3D171%26epage%3D175%26doi%3D10.1016%2FS0014-2999%2803%2901821-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Gerbier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvear-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margathe, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flahault, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvineau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabire, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceraudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hus-Citharel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteoulle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisoo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdeaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrioz, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">Development of original metabolically-stable apelin-17 analogs with diuretic and cardiovascular effects</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span><span class="refDoi"> DOI: 10.1096/fj.201600784R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1096%2Ffj.201600784R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=27815337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslehs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=687-700&author=R.+Gerbierauthor=R.+Alvear-Perezauthor=J.+F.+Margatheauthor=A.+Flahaultauthor=P.+Couvineauauthor=J.+Gaoauthor=N.+De+Motaauthor=H.+Dabireauthor=B.+Liauthor=E.+Ceraudoauthor=A.+Hus-Citharelauthor=L.+Esteoulleauthor=C.+Bisooauthor=M.+Hibertauthor=A.+Berdeauxauthor=X.+Iturriozauthor=D.+Bonnetauthor=C.+Llorens-Cortes&title=Development+of+original+metabolically-stable+apelin-17+analogs+with+diuretic+and+cardiovascular+effects&doi=10.1096%2Ffj.201600784R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects</span></div><div class="casAuthors">Gerbier, Romain; Alvear-Perez, Rodrigo; Margathe, Jean-Francois; Flahault, Adrien; Couvineau, Pierre; Gao, Ji; De Mota, Nadia; Dabire, Hubert; Li, Bo; Ceraudo, Emilie; Hus-Citharel, Annette; Esteoulle, Lucie; Bisoo, Cynthia; Hibert, Marcel; Berdeaux, Alain; Iturrioz, Xavier; Bonnet, Dominique; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-700</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Apelin, a (neuro)vasoactive peptide, plays a prominent role in controlling cardiovascular functions and water balance.  Because the in vivo apelin half-life is in the minute range, we aimed to identify metabolically stable apelin-17 (K17F) analogs.  We generated P92 by classic chem. substitutions and LIT01-196 by original addn. of a fluorocarbon chain to the N terminus of K17F.  Both analogs were much more stable in plasma (half-life >24 h for LIT01-196) than K17F (4.6 min).  Analogs displayed a subnanomolar affinity for the apelin receptor and behaved as full agonists with regard to cAMP prodn., ERK phosphorylation, and apelin receptor internalization.  Ex vivo, these compds. induced vasorelaxation of rat aortas and glomerular arterioles, resp., precontracted with norepinephrine and angiotensin II, and increased cardiac contractility.  In vivo, after intracerebroventricular ad- ministration in water-deprived mice, P92 and LIT01-196 were 6 and 160 times, resp., more efficient at inhibiting systemic vasopressin release than K17F.  Administered i.v. (nmol/kg range) in normotensive rats, these analogs potently increased urine output and induced a profound and sustained decrease in arterial blood pressure.  In summary, these new compds., which favor diuresis and improve cardiac contractility while reducing vascular resistances, represent promising candidates for the treatment of heart failure and water retention/ hyponatremic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUo5SAnSahoLVg90H21EOLACvtfcHk0lhYp1zvajdhPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslehs78%253D&md5=919d64864e9c257e8b0a942f2fd904c6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1096%2Ffj.201600784R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201600784R%26sid%3Dliteratum%253Aachs%26aulast%3DGerbier%26aufirst%3DR.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DMargathe%26aufirst%3DJ.%2BF.%26aulast%3DFlahault%26aufirst%3DA.%26aulast%3DCouvineau%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DDabire%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DCeraudo%26aufirst%3DE.%26aulast%3DHus-Citharel%26aufirst%3DA.%26aulast%3DEsteoulle%26aufirst%3DL.%26aulast%3DBisoo%26aufirst%3DC.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DBerdeaux%26aufirst%3DA.%26aulast%3DIturrioz%26aufirst%3DX.%26aulast%3DBonnet%26aufirst%3DD.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520original%2520metabolically-stable%2520apelin-17%2520analogs%2520with%2520diuretic%2520and%2520cardiovascular%2520effects%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26spage%3D687%26epage%3D700%26doi%3D10.1096%2Ffj.201600784R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Iturrioz, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerbier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvear-Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorens-Cortes, C.</span><span> </span><span class="NLM_article-title">By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">32627</span><span class="NLM_x">–</span> <span class="NLM_lpage">32637</span><span class="refDoi"> DOI: 10.1074/jbc.M110.127167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1074%2Fjbc.M110.127167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=20675385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GqurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32627-32637&author=X.+Iturriozauthor=R.+Gerbierauthor=V.+Lerouxauthor=R.+Alvear-Perezauthor=B.+Maigretauthor=C.+Llorens-Cortes&title=By+interacting+with+the+C-terminal+Phe+of+apelin%2C+Phe255+and+Trp259+in+helix+VI+of+the+apelin+receptor+are+critical+for+internalization&doi=10.1074%2Fjbc.M110.127167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">By Interacting with the C-terminal Phe of Apelin, Phe255 and Trp259 in Helix VI of the Apelin Receptor Are Critical for Internalization</span></div><div class="casAuthors">Iturrioz, Xavier; Gerbier, Romain; Leroux, Vincent; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">32627-32637</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of the orphan seven-transmembrane domain (TM) G protein-coupled receptor (GPCR) APJ.  Apelin is involved in the regulation of body fluid homeostasis and cardiovascular functions.  We previously showed the importance of the C-terminal Phe of apelin 17 (K17F) in the hypotensive activity of this peptide.  Here, we show either by deleting the Phe residue (K16P) or by substituting it by an Ala (K17A), that it plays a crucial role in apelin receptor internalization but not in apelin binding or in Gαi-protein coupling.  Then we built a homol. three-dimensional model of the human apelin receptor using the cholecystokinin receptor-1 model as a template, and we subsequently docked K17F into the binding site.  We visualized a hydrophobic cavity at the bottom of the binding pocket in which the C-terminal Phe of K17F was embedded by Trp152 in TMIV and Trp259 and Phe255 in TMVI.  Using mol. modeling and site-directed mutagenesis studies, we further showed that Phe255 and Trp259 are key residues in triggering receptor internalization without playing a role in apelin binding or in Gαi-protein coupling.  These findings bring new insights into apelin receptor activation and show that Phe255 and Trp259, by interacting with the C-terminal Phe of the pyroglutamyl form of apelin 13 (pE13F) or K17F, are crucial for apelin receptor internalization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwnLuCfuGp_LVg90H21EOLACvtfcHk0lhYp1zvajdhPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GqurzN&md5=3e3d85dc29f9ed7630d712c8ab36a9b8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.127167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.127167%26sid%3Dliteratum%253Aachs%26aulast%3DIturrioz%26aufirst%3DX.%26aulast%3DGerbier%26aufirst%3DR.%26aulast%3DLeroux%26aufirst%3DV.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DBy%2520interacting%2520with%2520the%2520C-terminal%2520Phe%2520of%2520apelin%252C%2520Phe255%2520and%2520Trp259%2520in%2520helix%2520VI%2520of%2520the%2520apelin%2520receptor%2520are%2520critical%2520for%2520internalization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32627%26epage%3D32637%26doi%3D10.1074%2Fjbc.M110.127167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Perjes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoumal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenhunen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konyi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruskoaho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szokodi, I.</span><span> </span><span class="NLM_article-title">Apelin increases cardiac contractility via protein kinase C epsilon- and extracellular signal-regulated kinase-dependent mechanisms</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e93473</span><span class="refDoi"> DOI: 10.1371/journal.pone.0093473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1371%2Fjournal.pone.0093473" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e93473&author=A.+Perjesauthor=R.+Skoumalauthor=O.+Tenhunenauthor=A.+Konyiauthor=M.+Simonauthor=I.+G.+Horvathauthor=R.+Kerkelaauthor=H.+Ruskoahoauthor=I.+Szokodi&title=Apelin+increases+cardiac+contractility+via+protein+kinase+C+epsilon-+and+extracellular+signal-regulated+kinase-dependent+mechanisms&doi=10.1371%2Fjournal.pone.0093473"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093473%26sid%3Dliteratum%253Aachs%26aulast%3DPerjes%26aufirst%3DA.%26aulast%3DSkoumal%26aufirst%3DR.%26aulast%3DTenhunen%26aufirst%3DO.%26aulast%3DKonyi%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DM.%26aulast%3DHorvath%26aufirst%3DI.%2BG.%26aulast%3DKerkela%26aufirst%3DR.%26aulast%3DRuskoaho%26aufirst%3DH.%26aulast%3DSzokodi%26aufirst%3DI.%26atitle%3DApelin%2520increases%2520cardiac%2520contractility%2520via%2520protein%2520kinase%2520C%2520epsilon-%2520and%2520extracellular%2520signal-regulated%2520kinase-dependent%2520mechanisms%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De93473%26doi%3D10.1371%2Fjournal.pone.0093473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Brame, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, A. P.</span><span> </span><span class="NLM_article-title">Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.114.05099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1161%2FHYPERTENSIONAHA.114.05099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=25712721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVGrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=834-840&author=A.+L.+Brameauthor=J.+J.+Maguireauthor=P.+Yangauthor=A.+Dysonauthor=R.+Torellaauthor=J.+Cheriyanauthor=M.+Singerauthor=R.+C.+Glenauthor=I.+B.+Wilkinsonauthor=A.+P.+Davenport&title=Design%2C+characterization%2C+and+first-in-human+study+of+the+vascular+actions+of+a+novel+biased+apelin+receptor+agonist&doi=10.1161%2FHYPERTENSIONAHA.114.05099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist</span></div><div class="casAuthors">Brame, Aimee L.; Maguire, Janet J.; Yang, Peiran; Dyson, Alex; Torella, Rubben; Cheriyan, Joseph; Singer, Mervyn; Glen, Robert C.; Wilkinson, Ian B.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">834-840</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">[Pyr]apelin-13 is an endogenous vasodilator and inotrope but is downregulated in pulmonary hypertension and heart failure, making the apelin receptor an attractive therapeutic target.  Agonists acting at the same G-protein-coupled receptor can be engineered to stabilize different conformational states and function as biased ligands, selectively stimulating either G-protein or β-arrestin pathways.  We used mol. dynamics simulations of apelin/receptor interactions to design cyclic analogs and identified MM07 as a biased agonist.  In β-arrestin and internalization assays (G-protein-independent), MM07 was 2 orders of magnitude less potent than [Pyr]apelin-13.  In a G-protein-dependent saphenous vein contraction assay, both peptides had comparable potency (pD2:[Pyr]apelin-13 9.93±0.24; MM07 9.54±0.42) and max. responses with a resulting bias for MM07 of ≈350- to 1300-fold for the G-protein pathway.  In rats, systemic infusions of MM07 (10-100 nmol) caused a dose-dependent increase in cardiac output that was significantly greater than the response to [Pyr]apelin-13.  Similarly, in human volunteers, MM07 produced a significant dose-dependent increase in forearm blood flow with a max. dilatation double that is seen with [Pyr]apelin-13.  Addnl., repeated doses of MM07 produced reproducible increases in forearm blood flow.  These responses are consistent with a more efficacious action of the biased agonist.  In human hand vein, both peptides reversed an established norepinephrine constrictor response and significantly increased venous flow.  Our results suggest that MM07 acting as a biased agonist at the apelin receptor can preferentially stimulate the G-protein pathway, which could translate to improved efficacy in the clinic by selectively stimulating vasodilatation and inotropic actions but avoiding activating detrimental β-arrestin-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVwBeW0p9RgbVg90H21EOLACvtfcHk0liSm0OBeYSerA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVGrtr0%253D&md5=908911768ffa6edcd2ef9b1e80c8826a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.114.05099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.114.05099%26sid%3Dliteratum%253Aachs%26aulast%3DBrame%26aufirst%3DA.%2BL.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DDyson%26aufirst%3DA.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DCheriyan%26aufirst%3DJ.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DWilkinson%26aufirst%3DI.%2BB.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DDesign%252C%2520characterization%252C%2520and%2520first-in-human%2520study%2520of%2520the%2520vascular%2520actions%2520of%2520a%2520novel%2520biased%2520apelin%2520receptor%2520agonist%26jtitle%3DHypertension%26date%3D2015%26volume%3D65%26spage%3D834%26epage%3D840%26doi%3D10.1161%2FHYPERTENSIONAHA.114.05099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Kehoe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Elzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkerk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1864</span><span class="NLM_x">, </span> <span class="NLM_fpage">1481</span><span class="NLM_x">–</span> <span class="NLM_lpage">1488</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2016.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1016%2Fj.bbapap.2016.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=27449720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SgsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2016&pages=1481-1488&author=K.+Kehoeauthor=R.+Van+Elzenauthor=R.+Verkerkauthor=Y.+Simauthor=P.+Van+der+Vekenauthor=A.+M.+Lambeirauthor=I.+De+Meester&title=Prolyl+carboxypeptidase+purified+from+human+placenta%3A+its+characterization+and+identification+as+an+apelin-cleaving+enzyme&doi=10.1016%2Fj.bbapap.2016.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme</span></div><div class="casAuthors">Kehoe, Kaat; Van Elzen, Roos; Verkerk, Robert; Sim, Yani; Van der Veken, Pieter; Lambeir, Anne-Marie; De Meester, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1481-1488</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The proteolytic regulation of peptides involved in feeding behavior is poorly understood.  Prolyl carboxypeptidase (PRCP) is particularly known for its role in body wt. control by converting the anorexigenic peptide, α-MSH 1-13, into the inactive 1-12 form.  The purpose of this study was to characterize purified human PRCP, to investigate its substrate specificity and to discover novel substrates linked to obesity.  Pyroglutamated apelin-13, ghrelin, enterostatin and obestatin were investigated since these are feeding-regulating peptides with potential cleaving sites for PRCP.  PRCP was purified 575-fold from human placenta and successfully identified as human lysosomal Pro-X carboxypeptidase.  The kinetic parameters of purified and com. available PRCP for known and potential peptide substrates were detd. and compared using a RP-HPLC activity assay, isothermal titrn. calorimetry, and mass spectrometry.  Purified and recombinant PRCP had similar substrate specificities with angiotensin III as the substrate of preference.  Pyroglutamated apelin-13 was obsd. to be a novel substrate for human PRCP in vitro and PRCP-dependent cleavage was shown in a human umbilical vein endothelial cell culture expt.  Other potential substrates, e.g., obestatin, ghrelin, and enterostatin, were not hydrolyzed by PRCP.  These results showed that the placenta is a good source of human PRCP and that PRCP removes the C-terminal phenylalanine from pyroglutamated apelin-13.  Thus, for the 1st time, PRCP is identified as an apelin-cleaving enzyme.  This finding adds evidence to the hypothesis that PRCP plays a role in energy homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLgRJIzYyKJLVg90H21EOLACvtfcHk0liSm0OBeYSerA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SgsL7M&md5=0e5883ddc7f957a622564548d5b39a00</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2016.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2016.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DKehoe%26aufirst%3DK.%26aulast%3DVan%2BElzen%26aufirst%3DR.%26aulast%3DVerkerk%26aufirst%3DR.%26aulast%3DSim%26aufirst%3DY.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DProlyl%2520carboxypeptidase%2520purified%2520from%2520human%2520placenta%253A%2520its%2520characterization%2520and%2520identification%2520as%2520an%2520apelin-cleaving%2520enzyme%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2016%26volume%3D1864%26spage%3D1481%26epage%3D1488%26doi%3D10.1016%2Fj.bbapap.2016.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Baker, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, M.</span><span> </span><span class="NLM_article-title">Preparation and use of N,N′-di-Boc-N″-triflylguanidine</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="refDoi"> DOI: 10.15227/orgsyn.078.0091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.15227%2Forgsyn.078.0091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVeisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2002&pages=91&author=T.+J.+Bakerauthor=M.+Tomiokaauthor=M.+Goodman&title=Preparation+and+use+of+N%2CN%E2%80%B2-di-Boc-N%E2%80%B3-triflylguanidine&doi=10.15227%2Forgsyn.078.0091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and use of N,N'-di-Boc-N''-triflylguanidine</span></div><div class="casAuthors">Baker, Tracy J.; Tomioka, Mika; Goodman, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Organic Syntheses</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">ORSYAT</span>;
        ISSN:<span class="NLM_cas:issn">0078-6209</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The title compd. (I) was prepd. in 90% yield by reaction of N,N'-di-Boc-guanidine with triflic anhydride.  Reaction of I with benzylamine gave N''-benzyl-N,N'-di-Boc-guanidine in quant. yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoId-KoXWFk9bVg90H21EOLACvtfcHk0ljl3ZicqM3-ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVeisLg%253D&md5=51c874fb5bacc271dc04cc100951e0c6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.15227%2Forgsyn.078.0091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15227%252Forgsyn.078.0091%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DT.%2BJ.%26aulast%3DTomioka%26aufirst%3DM.%26aulast%3DGoodman%26aufirst%3DM.%26atitle%3DPreparation%2520and%2520use%2520of%2520N%252CN%25E2%2580%25B2-di-Boc-N%25E2%2580%25B3-triflylguanidine%26jtitle%3DOrg.%2520Synth.%26date%3D2002%26volume%3D78%26spage%3D91%26doi%3D10.15227%2Forgsyn.078.0091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Bourguet, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klocek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubell, W. D.</span><span> </span><span class="NLM_article-title">Solution-phase submonomer diversification of aza-dipeptide building blocks and their application in aza-peptide and aza-DKP synthesis</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1002/psc.1235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=10.1002%2Fpsc.1235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=20474040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVyrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=284-296&author=C.+B.+Bourguetauthor=C.+Proulxauthor=S.+Klocekauthor=D.+Sabatinoauthor=W.+D.+Lubell&title=Solution-phase+submonomer+diversification+of+aza-dipeptide+building+blocks+and+their+application+in+aza-peptide+and+aza-DKP+synthesis&doi=10.1002%2Fpsc.1235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Solution-phase submonomer diversification of aza-dipeptide building blocks and their application in aza-peptide and aza-DKP synthesis</span></div><div class="casAuthors">Bourguet, Carine B.; Proulx, Caroline; Klocek, Sophie; Sabatino, David; Lubell, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">284-296</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Aza-peptides have been used as tools for studying SARs in programs aimed at drug discovery and chem. biol.  Protected aza-dipeptides were synthesized by a soln.-phase submonomer approach featuring alkylation of N-terminal benzophenone semicarbazone aza-Gly-Xaa dipeptides using different alkyl halides in the presence of potassium tert-butoxide as base.  Benzophenone protected aza-dipeptide tert-Bu ester (I) was selectively deprotected at the C-terminal ester or N-terminal hydrazone to afford, resp., aza-dipeptide acid and amine building blocks (II) (R1 = CH2C6H5) and (III), which were introduced into longer aza-peptides.  Alternatively, removal of the benzophenone semicarbazone protection from aza-dipeptide Me esters (IV) (R1 = propargyl, allyl, benzyl) led to intramol. cyclization to produce aza-DKPs (V) (R1 = propargyl, allyl, benzyl).  In light of the importance of aza-peptides and DKPs as therapeutic agents and probes of biol. processes, this diversity-oriented soln.-phase approach may provide useful tools for studying peptide science.  Copyright © 2010 European Peptide Society and John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgPA72MWamoLVg90H21EOLACvtfcHk0ljl3ZicqM3-ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVyrsLc%253D&md5=9712f2ae151cf6436a8b4821002be4f5</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fpsc.1235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.1235%26sid%3Dliteratum%253Aachs%26aulast%3DBourguet%26aufirst%3DC.%2BB.%26aulast%3DProulx%26aufirst%3DC.%26aulast%3DKlocek%26aufirst%3DS.%26aulast%3DSabatino%26aufirst%3DD.%26aulast%3DLubell%26aufirst%3DW.%2BD.%26atitle%3DSolution-phase%2520submonomer%2520diversification%2520of%2520aza-dipeptide%2520building%2520blocks%2520and%2520their%2520application%2520in%2520aza-peptide%2520and%2520aza-DKP%2520synthesis%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2010%26volume%3D16%26spage%3D284%26epage%3D296%26doi%3D10.1002%2Fpsc.1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00723">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_71806"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00723">10.1021/acs.jmedchem.7b00723</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Crystal structures of <b>25</b> and <b>30</b>, LCMS chromatograms, MS profiles, and results of degradation studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Crystallographic information for C<sub>31</sub>H<sub>32</sub>N<sub>6</sub>NiO<sub>3</sub> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_002.cif">CIF</a>)</p></li><li><p class="inline">Crystallographic information for C<sub>32</sub>H<sub>35</sub>N<sub>3</sub>NiO<sub>3</sub> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_003.cif">CIF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_004.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_001.pdf">jm7b00723_si_001.pdf (2.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_002.cif">jm7b00723_si_002.cif (871.45 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_003.cif">jm7b00723_si_003.cif (665.45 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00723/suppl_file/jm7b00723_si_004.csv">jm7b00723_si_004.csv (8.07 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00723&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00723" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00723" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679972ac9cd82428","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
